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Abstract  
This work describes the application of a variety of Lewis bases, encompassing predominantly 
N-heterocyclic carbenes (NHCs), but also the use of imidazoles, aminopyridines, amidines and 
isothioureas, as effective catalysts in the dearomatisation of heterocyclic carbonates, 
predominantly the rearrangement of oxazolyl carbonates to their C-carboxyazlactone isomers by 
means of the Steglich rearrangement. This rearrangement reaction has been investigated 
extensively, with the development of simplified reaction procedures and the invention of domino 
cascade protocols incorporating this transformation. In an attempt to understand the mechanism 
of this O- to C-carboxylation process, a number of interesting observations have been made. 
Firstly, the class of NHC has an important factor in promoting the rearrangement, with 
triazolinylidenes being the most effective. Secondly, an interesting chemoselectivity has been 
delineated using triazolium-derived NHCs, prepared using weak bases (typically Et3N) or strong 
metallated bases; both alkyl and aryl oxazolyl carbonates undergo smooth rearrangement with 
triazolinylidenes derived from strong metallated bases such as KHMDS, while only aryl 
oxazolyl carbonates undergo rearrangement using Et3N. Extensive effort has focused towards the 
development of asymmetric variants of these protocols, primarily towards the design, synthesis 
and evaluation of chiral NHC precatalysts. To this end, a number of chiral azolium salts have 
been prepared, encompassing a number of different NHC classes, including C1- and 
C2-imidazolinium salts, C2-imidazolium salts and a range of triazolium salts. Efforts towards the 
asymmetric catalysis of the Steglich rearrangement of oxazolyl carbonate substrates have given 
an optimal 66% ee. Similar rearrangements have been demonstrated with the related furanyl 
heterocyclic substrate class, producing a mixture of α- and γ-carboxybutenolides. In contrast to 
the analogous oxazolyl carbonates, the regioselectivity of this rearrangement is dependent upon 
the nature of the Lewis base employed. Amidines and aminopyridines give a mixture of the α- 
and γ- regioisomers with generally the α-regioisomer being preferred, while a triazolium-derived 
NHC gives rise to predominantly the thermodynamically more stable γ-carboxybutenolide. 
Using amidines or aminopyridines, this rearrangement has been shown to proceed via an 
irreversible C-C bond-forming process, but in contrast, the rearrangement using the NHC 
proceeds via an equilibrium process with an optimised regioselectivity of >98:2 for the 
γ-carboxybutenolide regioisomer over the α-regioisomer. Whilst the asymmetric variant using 
chiral NHCs has proven unfruitful, rearrangements using a chiral isothiourea have given high 
levels of regioselectivity towards the α- regioisomer and with excellent levels of 
enantiodiscrimination (77–95% ee). 
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Section 1.1: Organocatalysis 
In an effort to maximise the efficiency of organic reactions, specifically, in order to limit the 
quantities of reagents, reaction time and the purification of the product, catalysis has proven to 
be an important solution. While traditional catalysis is most commonly effected by acid, base or 
metals (and metal complexes), biochemical investigations have illuminated numerous biological 
catalysts which are organic in nature. Enzymes provide a large number of such catalysts, but 
vitamins have also been discovered to play an integral part in affecting many biochemical 
transformations and are often referred to as co-catalysts. In the past ten years, with increasing 
understanding into the modes of action of these biological catalysts, organic chemists have 
exploited these important motifs in order to develop and utilise simplified “organocatalysts”. The 
term “organocatalysis” describes the promotion or acceleration of a chemical reaction through 
the addition of a substoichiometric quantity of a metal-free organic compound.1 The appeal of 
this type of catalysis, in comparison with metal-catalysed processes, is that it precludes the use 
of heavy metals, many of which are highly toxic and cumulative poisons. Many metal-catalysed 
processes also require the use of sensitive ligands (such as phosphines) and/or catalysts. 
Organocatalysts generally do not suffer such difficulties in either their preparation or their 
application, and thus, provide a convenient alternative to such strategies. Furthermore, the use of 
generally mild reaction conditions allows for greater functional group tolerance in such 
transformations. As such, this field of research has seen a revitalisation of interest with a 
multitude of reaction types being developed.2 In broad terms, the field of organocatalysis can be 
grouped into four main classes, based upon the mode of action of the catalyst: Brønsted acid, 
Brønsted base, Lewis acid and Lewis base. Representative examples from each of these classes 
follow. 
Section 1.1.1: Brønsted acid catalysis 
A Brønsted acid is defined as a substance that can donate a proton to an acceptor, itself termed a 
Brønsted base. In this area, key hydrogen bond interactions give rise to accelerated reaction 
rates, whilst also allowing for the development of asymmetric variants. As an illustration, Gong 
and co-workers have elegantly demonstrated chiral BINOL-derived phosphoric acid 4 as a 
Brønsted acid catalyst to promote asymmetric Mannich reactions, providing β-aminoketone 
products 5 with excellent diastereo- and enantioselectivity, via proposed transition state 6 
(Figure 1).3 
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Figure 1: Asymmetric phosphoric acid catalysis  
Section 1.1.2: Brønsted base catalysis 
An approach to the asymmetric Strecker reaction has been developed by Corey and co-workers 
using a C2-symmetric Brønsted base catalyst 9. It is proposed that the guanidine 9, pKaH ~13–
14,4 initially increases the nucleophilicity of hydrogen cyanide by aiding in deprotonation to 
generate the cyanide anion (pKaH 12.95), remaining as a complex with the guanidinium cation. 
This in turn also activates the imine reagent (acting as a Brønsted acid), delivering the cyanide 
selectively to the Si-face of the imine 7, giving rise to the aminonitrile product 10 in excellent ee 
(Figure 2).6  
 
 
Figure 2: Asymmetric Strecker reaction 
Section 1.1.3: Lewis acid catalysis 
Lewis acids are defined as substances that can accept a lone pair of electrons from another 
species, defined as a Lewis base. Phase transfer reagents are an example of Lewis acid 
organocatalysts, which associate with substrate as ion pairs. Most often these are ammonium or 
phosphonium7 species, and a number of such chiral species have been utilised in asymmetric 
transformations catalytically. A recent example by Maruoka and co-workers employed axially 
chiral phosphonium salt 14 in asymmetric Mannich reactions of β-ketoesters 12 with 
azodicarboxylates 13. The reaction is general and delivers the product in very good to 
excellent ee (Figure 3).8  
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Figure 3: Asymmetric amination 
Section 1.1.4: Lewis base catalysis 
The most widely applied mode of organocatalysis may be classified as Lewis base catalysis, 
promoted by a species bearing a lone pair of electrons. The reaction scope is ever expanding and 
still remains a field of extensive research. Within this area, a range of reactions have been 
developed, most notably in the fields of aldol reactions, Michael-type additions, esterification, 
Mannich reactions, Diels-Alder reactions and transfer hydrogenation. The utility of hydrogen 
bonding to effect asymmetric organocatalysis has been exploited successfully by a number of 
groups,9 whilst arguably the most developed area of asymmetric organocatalysis has been 
demonstrated by MacMillan and co-workers with the use of chiral imidazolidinones as Lewis 
base organocatalysts. As an illustration, these secondary amine based catalysts react with 
aldehydes to form reactive electrophilic iminium species. In a given reaction, a stereodirecting 
unit blocks one face of the iminium intermediate, affording highly enantiomerically enriched 
products. As an illustration, MacMillan and co-workers have used this methodology to perform 
domino Friedel-Crafts alkylation–chlorination reactions using secondary amine 19 in 
conjunction with activated arenes 18 and electrophilic chlorine source 17 (Figure 4). In addition, 
these chiral imidazolidinones have also been applied in cycloaddition reactions, including 
Diels-Alder reactions10 and nitrone [3+2] cycloadditions,11 and in conjunction with CAN, in 
SOMO catalysis.12 
 
 
Figure 4: Lewis base promoted domino cascade 
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Many organocatalysed processes, although highly selective, typically require high catalyst 
loading (up to 20 mol%), long reaction times (>24 h) and the use of highly polar aprotic solvents 
such as DMSO or DMF. These problems illustrate some of the challenges of organocatalysis, 
namely, that there is still considerable scope for optimisation, such as through design of catalysts 
with greater reactivity. 
Section 1.2: Carbenes 
Carbenes are neutral, divalent, reactive species bearing a carbon atom with two non-bonding 
electrons in their valence shell. Most carbenes have a ‘bent’ structure (bond angles in the range 
of 100–150º) which imposes sp2-type hybridisation at the carbon centre. Two possible electronic 
configurations of a carbene are permitted, the electron-paired singlet state carbene (2Σms + 1 = 
1), or the unpaired triplet state (2Σms + 1 = 3) (Figure 5).13 
 
 
Figure 5: Singlet and triplet carbenes 
The difference in spin multiplicity between these two states gives rise to a difference in 
reactivity: singlet carbenes show ambiphilic activity due to the filled σ-type (or n) orbital and 
unfilled pz-orbital but, in contrast, the unpaired electrons of triplet carbenes give rise to diradical 
reactivity. 
Given the unusually electron-deficient nature of carbenes, these species are highly reactive and 
typically exhibit only transient lifetimes, though the stability of these species can be increased by 
both electronic (inductive and mesomeric) and steric effects. Inductively, σ-electron 
withdrawing groups lead to an increase in s character of the non-bonding σ-orbital, resulting in 
an increased difference between the σ and pz orbital energies, thus favouring the spin-paired (i.e. 
singlet) state. Mesomerically electron donating groups lead to a greater occupation of the pz 
orbital, destabilising the triplet state carbene, whilst also stabilising the singlet state. Sterically 
bulky groups flanking the carbene centre are able to stabilise the carbene, possibly through 
hyperconjugation or simply by protection from the surrounding environment, due to the large 
van der Waals radii of the substituents. 
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Section 1.3: Nature’s carbene source: thiamine diphosphate 
Thiamine, also known as vitamin B1, is an important dietary requirement for the conversion of 
carbohydrates and lipids into energy, and for the maintenance of the digestive system, heart 
function and nervous system. Thiamine is the precursor to the active coenzyme thiamine 
diphosphate, ThDP, 22, which is involved in the action of a number of enzymes, including 
pyruvate dehydrogenase and decarboxylase, α-ketoglutarate dehydrogenase, branched-chain 
α-keto acid dehydrogenase and transketolase.14 The ability of ThDP 22 to facilitate these 
reactions is due to the properties and reactivity of the thiazolium ring system. The C(2) proton, 
flanked by the heteroatoms of the ring, is relatively acidic (pKa ~17),15 and is readily 
deprotonated under physiological conditions to generate the conjugate base 25, a 
thiazolinylidene carbene (Figure 6). The rate of exchange of this proton in water is rapid, as 
demonstrated with deuterium labelling studies, with t1/2 ~20 min.16 The active catalyst then 
facilitates decarboxylation of the requisite substrate in order to generate the well-established 
“Breslow intermediate”, a formal acyl anion equivalent (Figure 6). In conjunction with ThDP 22, 
decarboxylase enzymes can perform the (asymmetric) synthesis of a variety of chiral 
α-hydroxyketones by trapping of the Breslow intermediate with an aldehyde (Figure 6).17 
 
 
Figure 6: Action of thiamine diphosphate 22 
Section 1.4: N-Heterocyclic carbenes (NHCs) 
Similar in nature to the thiazolinylidene carbene 25, N-heterocyclic carbenes (NHCs) are a 
specific class of carbene bearing two nitrogen atoms flanking the formally electron deficient 
carbene centre. Arduengo and co-workers isolated the first stable crystalline NHC 27 by 
deprotonation of imidazolium salt 26 with NaH and catalytic DMSO (Figure 7).18 
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Figure 7: Preparation of stable crystalline carbene 27 
A combination of steric and electronic effects contribute to the stability of carbene 27, via a 
“push-pull” mechanism: mesomeric electron donation from the lone pairs of the nitrogen atoms 
into the empty pz orbital of the carbon atom stabilises the carbene, whilst electron density is 
withdrawn inductively through the σ-system by the electronegative nitrogen atoms (Figure 8). 
Furthermore, the introduction of sterically bulky N-adamantyl substituents also protects the 
electron-deficient centre from subsequent reactions such as reprotonation and dimerisation, thus 
accounting for the enhanced kinetic stability of the NHC. 
 
Figure 8: Electronic stabilisation of NHCs 
These stabilisation factors have been exploited in the synthesis and application of a wide range 
of NHCs. By virtue of the singlet (i.e. Lewis basic) nature of NHCs, in addition to the ability to 
design and vary the N-substituents, these molecules have proven good candidates as ligands for 
metal-based catalysts and also as Lewis base organocatalysts. 
Section 1.5: NHCs as ligands in catalysis 
NHCs have played an important part in the development of organometallic chemistry, with 
considerable focus upon their inclusion as ligands in transition metal-based catalysts. Some of 
the most well known demonstrations are the ruthenium complexes developed by Grubbs and 
co-workers19,20 and then Hoveyda and co-workers21,22 for the catalysis of olefin metathesis 
reactions,23 while Nolan and co-workers have demonstrated a range of noteworthy applications 
of NHCs as palladium ligands in the catalysis of Buchwald-Hartwig amination and 
Suzuki-Miyaura cross-coupling.24 This thesis focuses upon applications of NHCs as 
organocatalysts, and the remainder of this introduction will exemplify their use as such Lewis 
basic catalysts. 
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Section 1.6: N-Heterocyclic carbenes in organocatalysis 
Section 1.6.1: Introduction 
The ability of N-heterocyclic carbenes (NHCs) to promote a remarkably diverse series of 
organocatalytic transformations has been identified in recent years, with a series of excellent 
reviews documenting progress in this area.25 The aim of this section is two-fold; firstly, to 
describe the ability of NHCs to generate synthetically useful intermediates and illustrate their 
reactivity, and secondly, to review the use of NHCs in stereoselective reaction processes. In 
order to categorise the recent advances in reactivity involving NHC mediated transformations, 
this chapter will classify reaction processes by the type of intermediate through which C-C, C-H 
or C-heteroatom bond-forming processes proceed. Within this framework, four main synthetic 
intermediates are accessed: three nucleophilic species 28–30, formally resulting in the formation 
of d1, d2 and d3 synthons26 (acyl anion, azolium enol or enolate, and azolium homoenolate 
intermediates, respectively) and an electrophilic a1 synthon (acylazolium species 31) (Figure 9).  
 
Figure 9: Synthetic intermediates generated with NHCs 
In each case, an illustration of an asymmetric variant will be given in order to highlight the 
significance of the application of chiral NHCs in these transformations. In the event that a 
reaction proceeds through a number of these intermediates, the reaction will be categorised 
according to the first asymmetric step in the transformation, with a miscellaneous section 
covering other reaction types. Of particular note to this thesis is the application of NHCs as 
acylazolium species, for which a fuller discussion will be described.  
Section 1.6.2: Reactivity of NHC derived synthons 
Section 1.6.2.1: Generation of acyl anion equivalents (d1 synthons) from aldehydes 
Practically, the simplest and most direct manner to generate acyl anion equivalents is through 
reaction of an NHC 33 with an aldehyde 32, generating an enamine species 35, commonly 
referred to as a “Breslow intermediate”. Subsequent reaction with an electrophile, classically 
using aldehydes or enones, generates the benzoin27 and Stetter products 37 and 38 respectively 
(Figure 10). 
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Figure 10: Generation of acyl anion equivalents with NHCs 
The same “Breslow intermediate” has been employed from acyl silanes28 or α-ketoacids,29 
although these processes have yet to be utilised in asymmetric transformations. 
A wide range of chiral thiazolium salt precatalysts have been studied in order to perform the 
benzoin reaction asymmetrically, however, the enantioselectivities obtained for the condensation 
of benzaldehyde using thiazolium precatalysts are generally poor, with 41 proving optimal on 
balance of both yield and enantioselectivity.30 Following studies of triazolium-based NHC 
catalysts,31 Enders and co-workers studied chiral triazolium salt precatalysts for the asymmetric 
benzoin reaction. The NHC derived from 42 provided acyloin products 40 in moderate to good 
yields and up to 84% ee, although the asymmetric benzoin reaction of electron-deficient 
aldehydes remained a challenge.32 In 1997, Knight and Leeper developed the bicyclic triazolium 
salt 43, derived from L-phenylalanine. Good enantioselectivities (up to 83% ee) were obtained 
for a range of aromatic aldehydes, although the isolated yields were modest, even with high 
catalyst loadings (30 mol%).33 In 2002, Enders and co-workers reported triazolium salt 44, 
derived from L-tert-leucine, as an effective catalyst for the asymmetric benzoin reaction. 
Excellent enantioselectivities (up to 99% ee) were observed for a range of aromatic aldehydes, 
with electron-rich aldehydes generally giving higher enantioselectivities (but lower yields) than 
electron-deficient aldehydes (Figure 11).34,35  
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Figure 11: Chiral azolium precatalysts for the asymmetric benzoin reaction 
Suzuki and co-workers recently applied the asymmetric intramolecular benzoin reaction to the 
synthesis of the homoisoflavonoid (+)-sappanone B 48.36 The authors found that triazolium salt 
precatalyst 46 gave the best results for the cyclisation of ketoaldehyde 45, with 
electron-withdrawing N-aryl substituents on the NHC important in order to suppress competing 
aldol pathways. The synthesis of (+)-sappanone B 48 from benzoin product 47 was achieved in 
two steps by sequential deprotection of the aryl methyl ethers (Figure 12). 
 
 
Figure 12: Synthesis of sappanone B using NHC-mediated catalysis 
The first asymmetric intramolecular Stetter reactions were reported by Enders and co-workers 
utilising triazolium salt precatalyst 51. Treatment of substrates 49 generated 1,4-dicarbonyl 
compounds 50 in good yield and enantioselectivity.37 These salicylaldehyde-derived substrates 
49 have since become the standard test substrates for the development of new catalysts for the 
asymmetric intramolecular Stetter reaction. Bach and co-workers have achieved moderate 
enantioselectivities using axially-chiral thiazolium precatalyst 52,30f whilst Miller and 
co-workers have developed peptidic thiazolium precatalyst 53.38 In 2005, Rovis and co-workers 
showed that the NHCs derived from triazolium salts 54–56 were excellent catalysts for the 
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asymmetric intramolecular Stetter reaction of a wide range of substrates, giving typically 
excellent yields and enantioselectivities.39 The N-pentafluorophenyl substituted catalyst 55 
currently represents the state of the art in asymmetric Stetter reactions (Figure 13).40 
 
 
Figure 13: Asymmetric intramolecular Stetter reactions 
Rovis and co-workers have also shown that precatalyst 55 is competent with a wide range of 
Michael acceptors including enals, amides, nitriles, esters, thioesters, vinylphosphonates and 
vinylphosphine oxides (Figure 14).39b,41 Further developments have allowed Stetter reactions to 
be extended to the use of aliphatic aldehydes,42 the formation of quaternary stereocentres43 and 
to intermolecular reactions.44 
 
 
Figure 14: Scope of the asymmetric intramolecular Stetter reaction 
Section 1.6.2.2: Generation of homoenolates, enolates and acylazoliums from enals  
Treatment of enals with NHCs allows the generation of nucleophilic (homoenolate and enolate) 
and electrophilic (acylazolium) species. Initial addition of an NHC to an enal 59 generates 
hydroxyazolium 60, that can either be oxidised in situ to generate α,β-unsaturated acylazolium 
66, or, after proton transfer, generates Breslow-type intermediate 61 which acts as a homoenolate 
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equivalent 62. Azolium enol or enolate species can also be accessed through variation of the 
reaction conditions and electrophilic partner in these reactions; selective β-protonation or 
tautomerisation of the homoenolate 62 can generate an intermediate 63 with enolate reactivity. 
Enolate 63 can undergo either protonation or further reaction with an electrophile to generate an 
acylazolium 64, with nucleophilic attack giving the desired product 65 and regenerating the 
NHC (Figure 15).  
 
 
Figure 15: Modes of reactivity of enals with NHCs 
Representative examples of the synthetic utility of these reaction processes, all of which have 
been utilised in asymmetric transformations, are covered below. 
Section 1.6.2.2a: Oxidation processes 
Scheidt and co-workers have employed cascade oxidation pathways from allylic or propargylic 
alcohols 68 to afford unsaturated ester products 72. In situ oxidation of an unsaturated alcohol 68 
to an enal 69 using MnO2, followed by NHC addition, affords hydroxyazolium 70 that is 
oxidised to acylazolium 71 and trapped with an alcohol. The oxidation of the hydroxyazolium 
intermediate is assumed to occur considerably faster than deprotonation to afford the 
Breslow-type intermediate 73 in this process, as no homoenolate-derived products are observed 
under these conditions (Figure 16).45  
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Figure 16: Cascade oxidation pathway by hydroxyazolium trapping 
Related oxidation processes have been reported that allow the generation of esters directly from 
aryl aldehydes46 and the hydroacylation of α-ketoesters with aldehydes.47 Scheidt and 
co-workers have used their in situ hydroxyazolium oxidation strategy to allow the 
desymmetrisation of diol 74 using chiral triazolium salt 76, giving mono-ester 77 in 80% ee 
(Figure 17).48 
 
 
Figure 17: Desymmetrisation via oxidation pathway 
Section 1.6.2.2b: Homoenolate reactivity 
The ability to generate homoenolates from enals was reported independently by Glorius and 
Burstein,49 and Bode and co-workers50 in the preparation of γ-butyrolactones 80 (Figure 18). A 
sterically demanding NHC catalyst is required to promote reactivity at the d3 terminus and to 
prevent competitive benzoin dimerisation. The asymmetric variant has been investigated by 
Glorius and Burstein, though ees of up to only 25% were obtained.49 You and co-workers have 
demonstrated enantioselective γ-lactone formations using glyoxalate 82, achieving up to 78% ee 
with the NHC derived from chiral triazolium salt 83, although with low levels of 
diastereoselectivity (Figure 19).51 
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Figure 18: γ-Butyrolactone formation with homoenolates 
 
Ph
O
Ph CO2Et
O
O
O
Ph
CO2EtPh
O
O
CO2Et
PhPh
N N
N
O
Mes
Ph
Ph
BF4
DBU
THF, rt
74%
84, cis
40%
55% ee
85, trans
60%
78% ee
75 82
83 (20 mol%)
 
Figure 19: Asymmetric γ-butyrolactone synthesis with glyoxalates 
Nair and co-workers have reported a related spiro-γ-lactone formation reaction using cyclic 
1,2-diones, including cyclohexane-1,2-dione and substituted isatin derivatives,52 and have also 
extended the utility of homoenolates to allow ring annulation with enones.53 Cyclopentene 
formation is achieved via homoenolate attack upon the enone 86, generating β-lactone 87 after 
cyclisation, which undergoes spontaneous decarboxylation to afford the trans-substituted 
cyclopentene products 88 in good to excellent yield (Figure 20). 
 
 
Figure 20: Scope of cyclopentene formation 
Bode and co-workers have used NHCs to form cis−γ-butyrolactams (such as 96) from a range of 
β-alkyl and β-aryl substituted enals and saccharin-derived cyclic sulfonylimines (e.g. 95),54 with 
a single example of an asymmetric variant giving good levels of both diastereo- and 
enantioselectivity. Scheidt and Chan have shown enals and azomethine imines 91 can generate 
pyridazinones 92 with high diastereoselectivity,55 and Scheidt and co-workers have shown that 
nitrones 93 give rise to enantiomerically enriched γ-amino esters 94 following methanolysis of 
the oxazinone intermediate (Figure 21).56  
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Figure 21: Asymmetric γ-lactamisation and preparation of amino esters 
Nair and co-workers have demonstrated NHC-catalysed formation of spirocyclic diketones 99 
from enals 97 and substituted dibenzylidene-cyclopentanones 98. Where chalcones and 
dibenzylidene cyclohexanones give only cyclopentene products (as a result of β-lactone 
formation then decarboxylation), cyclopentanones 98 give only the spirocyclic diketone products 
99.57 Of particular note are the formation of an all-carbon quaternary centre and the excellent 
level of diastereoselectivity observed in the reaction. An asymmetric variant of this reaction has 
been demonstrated by Bode and co-workers using chiral imidazolium salt 100, obtaining the 
desymmetrised product with good diastereo- and enantioselectivity, though in modest yield 
(Figure 22).58 
 
 
Figure 22: Spirocyclopentanone formation 
A formal [3+2] cycloaddition reaction with homoenolates has also been realised with 
nitrogen-based electrophiles. Scheidt and Chan have shown that pyrazolidinones 104 can be 
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prepared from enals 27 and acyldiazenes 102.59 An example of the asymmetric variant 
demonstrates excellent levels of enantioselectivity in this reaction (90% ee) (Figure 23). 
 
 
Figure 23: Pyrazolidinone formation 
Section 1.6.2.2c: Homoenolate protonation 
The β-protonation of homoenolates has been observed by Scheidt and co-workers, resulting in a 
redox transformation of enals 106 to afford saturated esters 109. This process is catalysed by the 
NHC derived from imidazolium salt 107 and utilises phenol as a proton source.60 A range of 
primary and secondary alcohols, and phenol itself, are competent nucleophiles with which to trap 
the acylazolium intermediate 108 generated upon protonation (Figure 24). 
 
 
Figure 24: Redox reaction of enals to saturated esters 
In addition to the use of homoenolates to access C-C or C-heteroatom bond formation, Scheidt 
and co-workers have investigated enantioselective homoenolate protonation using chiral 
triazolium salt 111 as the NHC precatalyst. Moderate but similar levels of enantioselectivity are 
observed in both polar and non-polar solvents, though a competing in situ oxidation process is 
more pronounced in THF than in toluene (Figure 25).61 
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Figure 25: Enantioselective homoenolate protonation vs oxidation 
NHC-Catalysed homoenolate generation has been applied by Bode and Struble in the formal 
synthesis of the natural product salinosporamide A.62 The key step in the synthesis is a late-stage 
NHC-catalysed intramolecular lactonisation. With an achiral triazolium-derived NHC, a 4:1 
diastereomeric ratio of products was obtained in preference for the undesired product 116. To 
suppress this, chiral triazolium salt ent-76 was employed, giving an approximately 1:1 mixture 
of desired:undesired diastereomers (Figure 26). 
 
 
Figure 26: Homoenolate methodology in natural product synthesis 
Section 1.6.2.2d: α-Hydroxyenones as homoenolate surrogates 
Whilst enals can be used as homoenolate equivalents, these substrates have significant synthetic 
drawbacks: they suffer from aerobic instability, generally require multi-step synthesis, and 
competitive benzoin dimerisation is often an issue. Bode and co-workers have addressed these 
issues by employing air-stable, crystalline α-hydroxyenones 117 as homoenolate surrogates, 
which can be prepared readily from commercially available 3-hydroxy-3-methylbutanone and 
the requisite aldehyde in one step.63 Significantly, these species are unable to participate in 
benzoin dimerisation. Upon treatment of the α-hydroxyenone 117 with an NHC, the intermediate 
hydroxyazolium 119 undergoes a retro-benzoin reaction, liberating acetone and the homoenolate 
equivalent 61 (Figure 27). Interestingly, whilst practical to prepare and handle, the relative 
reactivity of these α-hydroxyenones is significantly reduced in comparison with their enal 
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counterparts. Competition experiments show that hydroxyenones are ~5–6 times less reactive 
than the corresponding enals in cyclopentene formation. 
 
 
Figure 27: Generation of homoenolate equivalent from α-hydroxyenones 
Bode and co-workers have demonstrated the application of such substrates in a number of 
reactions, including cyclopentene ring formation, amidation and γ-lactamisation.64 For example, 
cyclopentene 126 is obtained using enone 125 with good levels of both diastereoselectivity and 
enantioselectivity but in only moderate yield,63 and γ-lactamisation with saccharin-derived 
sulfonylimines 122 has been achieved with moderate to excellent stereocontrol (Figure 28).  
 
 
Figure 28: Applications α-hydroxyenones 
Section 1.6.2.3: Azolium enolates from ketene activation 
Azolium enolates such as 63 can be generated directly through addition of NHCs to symmetrical 
or unsymmetrical ketenes. For example, we have shown that NHC promoted β-lactam formation 
from isobutylphenylketene 127 and N-tosyl imines 129 proceeds with good yields and moderate 
levels of diastereoselectivity via enolate 131 (Figure 30).65 
 
Figure 29: β-Lactam formation promoted by NHCs 
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Applications of this methodology using chiral NHCs were independently investigated by the Ye 
and Smith groups for the asymmetric synthesis of β-lactams. Ye and co-workers showed that the 
pyroglutamic acid derived NHC precatalyst 134 gave good diastereocontrol (up to 99:1 dr) and 
excellent levels of enantiocontrol (up to 99% ee) for the preparation of β-lactams 135 using a 
range of unsymmetrical alkylarylketenes 132 and N-Boc imines 133.66 We showed that good 
catalytic activity and good levels of enantioselectivity (up to 74% ee) could be observed in the 
reaction of diphenylketene 136 with N-tosyl imines 129 employing the NHCs from either 
triazolium or imidazolidinium precatalysts 137 or 138, with crystallisation generating products 
139 with excellent ee (up to >99% ee, Figure 30).65  
 
 
Figure 30: Asymmetric β-lactam synthesis using chiral NHCs 
Ye and co-workers have extended this methodology to a range of enantioselective formal [2+2] 
and [4+2] cycloaddition processes involving unsymmetrical ketenes and a range of electrophiles. 
All of these processes utilise structurally related NHCs derived from pyroglutamic acid. For 
example, the formal asymmetric [2+2] reaction of alkylarylketenes 132 with 2-oxoaldehydes 148 
generates the corresponding β-lactones 149 with good levels of diastereo- and enantiocontrol;67 
it is notable that a preference for the anti-diastereomer is noted in this reaction, in contrast to the 
syn-stereoisomeric preference in the β-lactam series. This chemistry has been extended to 
encompass trifluoromethylketones 14668 and diazenes 142 and 144 as the electrophile; with 
diazenes, however, both formal [2+2] and [4+2] cycloaddition processes are possible by 
changing the nature of the N-substituent of the diazene (Figure 31).69  
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Figure 31: Applications of ketenes in [2+2] and [4+2] cycloadditions 
A change in enantioselectivity is observed with variation of the N-substituent of the NHC used 
to catalyse the [4+2] addition of ketenes and N-aryl-N-benzoyldiazenes. For example, N-phenyl 
substituted NHC 150 (Ar = Ph) gave (R)-154 in 40% yield and 86% ee in the reaction with 
ethylphenylketene 152 and N-phenyl-N-benzoyldiazene 153, whereas N-mesityl substituted 
NHC 151 (Ar = Mes) gave (S)-154 in 76% yield and 96% ee (Figure 32). 
 
 
Figure 32: Effect of NHC N-aryl substituent on enantioselectivity 
Further work by the Ye group has shown that NHCs derived from precatalyst 156 can also 
promote the asymmetric dimerisation of alkylarylketenes 155 to generate alkylidene β-lactones 
157 in good diastereo- and enantioselectivity.70 The asymmetric [4+2] addition of enones and 
alkylarylketenes to generate δ-lactones 160 in excellent ee has also been accomplished,71 as has 
the asymmetric esterification of alkylarylketenes to give esters 162 using benzhydrol 161, which 
is assumed to proceed via a Lewis-base mediated mechanism (Figure 33).72 
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Figure 33: Further applications of ketenes as enolate equivalents 
Within the latter area, we have also shown that asymmetric NHC promoted esterifications of 
alkylarylketenes 158 can also be achieved with 2-phenylphenol 163, using the oxazolidinone 
derived triazolium precatalyst 164 (up to 84% ee) (Figure 34).73 
 
 
Figure 34: Asymmetric esterification of ketenes with 2-phenylphenol 
Section 1.6.2.4: Azolium enolates from α-functionalised aldehydes 
Whilst the addition of a NHC to a ketene generates an azolium enolate directly, a number of 
strategies have been developed that allow asymmetric reactions to proceed via an enol or enolate 
intermediate starting from α-functionalised aldehydes. For example, Rovis and co-workers have 
shown that chiral azolium enolate species can be generated from α,α-dihaloaldehydes 166, with 
enantioselective protonation and subsequent esterification generating α-chloroesters 168 in 
excellent ee (84–93% ee). Notably, in this process a bulky acidic phenol 167 is used as a buffer 
alongside an excess of an alternative phenolic component to minimise product epimerisation. 
This transformation is thought to proceed via an azolium enolate 169 and subsequent 
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protonation/phenoxide trapping (Figure 35). An extension of this approach allows the synthesis 
of enantiomerically enriched α-chloroamides (80% ee).74 
 
 
Figure 35: Asymmetric protodehalogenation 
Bode and co-workers have used the NHC derived from precatalyst 171 to generate an enolate 
172 from a range of enals 69, with subsequent hetero-Diels-Alder type reaction with an 
α,β-unsaturated imine 173 generating dihydropyridinones 174 in excellent diastereo- and 
enantioselectivities (Figure 36).75 This methodology has recently been applied to the synthesis of 
3,4-dihydropyranones in high ee, with a stepwise, rather than a concerted, process thought to be 
operating.76 
 
 
Figure 36: Asymmetric dihydropyridone formation 
Further studies by Bode and co-workers have shown that enolate formation from 
α-chloroaldehydes 175 and subsequent reaction with 4-oxo-enoates or unsaturated α-ketoesters 
176 generates dihydropyranones 177 in excellent diastereo- and enantioselectivities, and with 
impressively low catalyst loadings.77 This work has been extended to the generation of enolate 
equivalents from bisulfite adducts of α-haloaldehydes 178 under aqueous conditions 
(Figure 37).78  
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Figure 37: Asymmetric dihydropyranone formation 
Formation of the enolate equivalent from enals with the NHC derived from 171, followed by an 
intramolecular Michael reaction and O-acylation, gives the lactone products 180. These products 
are readily opened by either alcohols or amines to generate functionalised cyclopentane 
derivatives 181 in excellent ee. This reaction is equally amenable to enals with both aliphatic and 
aromatic β-substituents, although the formation of substituted cyclohexanes (from analogous 
enals) proceeds with reduced enantioselectivity (Figure 38).79 The same reaction is also 
promoted by camphor-derived triazolium salts in high ee.80 
 
 
Figure 38: Intramolecular Michael reactions 
Scheidt and co-workers have generated functionalised cyclopentenes 184 in high ee by 
desymmetrisation of substrates such as 182 (Figure 39).81 NHC-Promoted enolate formation 
from an enal, followed by a desymmetrising aldol event, generates β-lactones 183, and 
subsequent loss of CO2 affords the cyclopentene product 184; with acyclic diketones, the 
β-lactones are formed with the R1 group anti- to the tertiary alkoxide, while with cyclic 
diketones, the β-lactone products have the R1 group with a syn-stereochemical relationship to the 
alkoxide.82  
 
 
Figure 39: Desymmetrisation of 1,3-diketones 
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Section 1.6.2.5: Generation of acylazoliums (a1 synthons) 
Section 1.6.2.5a: Transesterification 
Acylazolium species can be prepared through a number of discrete reaction pathways. The first 
catalytic reactions that proceed through such an intermediate were the transesterification 
processes published independently by the Nolan83 and Hedrick groups (Figure 40).84,85 This 
work has been extended to transesterification with secondary alcohols,86 and of phosphonate 
esters.87 Movassaghi and co-workers have demonstrated that NHCs effectively catalyse the 
amidation of esters with amino alcohols. An alternative mechanism involving the NHC acting as 
a Brønsted base has been proposed, resulting in nucleophilic activation of the alcohol for an 
initial transesterification event, followed by rapid O- to N-acyl transfer.88,89 
 
 
Figure 40: Acyl transfer using NHCs 
This concept has been extended to the use of enantiomerically pure NHCs to facilitate 
asymmetric O-acylations. For example, Marouka and co-workers have employed chiral 
C2-symmetric imidazolium salt 191 and a hindered enol ester to achieve excellent levels of 
enantioselectivity (s values up to 80) in the kinetic resolutions of alkyl-aryl carbinols 190 
(Figure 41).90 Related work by Suzuki and co-workers has shown that good selectivity (s values 
up to 37) in the kinetic resolution of 2-naphthylethanol can be achieved using a related 
imidazolium salt as a precatalyst and vinyl acetate as the acyl donor.91 
 
 
Figure 41: Kinetic resolution of alkyl-aryl alcohols 
Section 1.6.2.5b: Enol to acylazolium tautomerisation - Redox transformations  
A range of α-functionalised aldehydes generate acylazoliums via the corresponding enol 
intermediate. Presumably, addition of an NHC to an α-haloaldehyde 193 generates the Breslow 
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species 195, with elimination of HX affording the enol 196. Subsequent in situ tautomerisation 
generates the acylazolium species 197 that can be trapped by a nucleophile to afford the product 
198 that has formally undergone a redox reaction (Figure 42). 
 
Figure 42: Redox reactions with α-haloaldehydes 
This approach has been applied by Rovis and co-workers to the formation of saturated esters 
from α-haloaldehydes and alcohols. A range of alcohols is tolerated, including isopropanol, 
cyclohexanol and phenol, and aniline proved a competent nucleophile to prepare anilides 
(Figure 43).92  
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Figure 43: Acyl transfer using α-haloaldehydes 
A conceptually similar protocol was reported simultaneously by Bode and co-workers, 
employing α,β-epoxyaldehydes 202 as acylazolium precursors (Figure 44). With these 
substrates, good levels of diastereoselectivity for the β-hydroxyester products 204 are obtained 
resulting from stereoselective protonation of the enol intermediate.93 A related ring opening 
reaction catalysed by NHCs was subsequently reported, using chiral formylketocyclopropanes.94  
 
 
Figure 44: Other representative redox transformation 
Related redox transformations allow the conversion of ynals to α,β-unsaturated esters,95 as well 
as the ring expansion of formyl β-lactams,96 oxacycloalkane-2-carboxaldehydes,97 and 
2-acyl-1-formylcyclopropanes.98 Further developments allow the synthesis of amides from enals, 
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α-chloro or α,α-dichloroaldehydes, α,β-epoxy or aziridinoaldehydes and formyl-cyclopropanes, 
but require an additive, such as imidazole, HOAt or HOBt to allow efficient amidation.99 
As an extension of their redox transformations, Rovis and co-workers have used α-haloaldehyde 
205 to generate a chiral acylazolium species with the NHC derived from precatalyst 207, 
allowing desymmetrisation of meso-diol 206 in good yield and enantioselectivity (Figure 45).92 
 
 
Figure 45: Desymmetrisation using α-haloaldehydes 
Section 1.6.2.6: Miscellaneous asymmetric reactions 
Bode and He have shown that chalcone-derived (acyclic) α,β-unsaturated sulfonylketimines 209 
can act as competent electrophiles with enals 16, giving highly enantioenriched β-lactam 
products 210.100 The scope and generality of the reaction has been widely examined and a range 
of enals 16 and sulfonylketimines 209 are tolerated. Notably, alkyl-substituted enals, acrolein 
and 3,3-dimethylacrolein are all suitable substrates, all giving excellent levels of enantio- and 
diastereoselectivity, although the acroleins give only moderate yields (45–50%) (Figure 46). 
Notably, this reaction follows a different pathway to the related work by the same authors using 
sulfonylaldimines 172, which give rise to dihydropyridone products 173.  
 
 
Figure 46: Enantioselective γ-lactamisation 
Related work by Nair and co-workers (using enones in place of α,β-unsaturated sulfonylimines 
(see page 14), generates β-lactones with trans-ring substituents, while the β-lactam products 210 
possess a cis-stereochemical relationship. A mechanistic rationale for the observed cis-selectivity 
has been proposed based on preorganisation of the Breslow-type intermediate and imine through 
hydrogen bonding 211, with an aza-benzoin oxy-Cope process proposed. Reaction via a boat 
transition state delivers the observed cis-stereochemistry of the product (Figure 47). 
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Figure 47: Rationale for enantio- and diastereoselective β-lactam formation 
Bode and Kaeobamrung have demonstrated an analogous reaction using α-hydroxyenone 217 as 
the electrophile.101 Interestingly, triazolium-derived NHCs give β-lactones 219 and 
imidazolium-derived NHCs give γ-lactones 218, both with excellent levels of enantioselectivity. 
The authors postulate a similar benzoin oxy-Cope mechanism to account for the high level of 
stereoselectivity in the process. This divergence in behaviour has been attributed to the leaving 
group ability of the NHC: the triazolinylidene has a significantly lower pKa than the respective 
imidazolinylidene, so in the case of the triazolium catalyst, the NHC is a sufficiently good 
leaving group to afford β-lactones as the major product. In contrast, the intermediate derived 
from the imidazolium catalyst undergoes preferential alkoxide elimination to afford an 
acylimidazolium intermediate, which undergoes a retro-aldol–aldol sequence (Figure 48). 
 
 
Figure 48: Divergence between triazolium- and imidazolium-derived NHCs in lactone formation with 
hydroxyenones 
Recent developments by Lupton and co-workers have shown alternative uses for NHCs in 
organocatalysis through trapping of α,β-unsaturated azolium intermediates.102 Treatment of enol 
esters 220 with an imidazolium-derived NHC gives pyranones 221 in good yield. 
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Mechanistically, it is proposed that nucleophilic addition of the NHC to the enol ester generates 
an α,β-unsaturated azolium intermediate and enolate, which recombine in a conjugate manner to 
afford pyranones 221. An enantioselective variant of this reaction has been demonstrated using 
chiral triazolium salt 55 as the NHC precatalyst, obtaining the product in good yield and 50% ee 
(Figure 49). The intermolecular version of this reaction has also been achieved with TMS enol 
ethers and α,β-unsaturated acyl fluorides, but not yet in an enantioselective fashion. 
 
 
Figure 49: Pyranone formation 
Section 1.7: Steglich rearrangement 
While many developments have been made in NHC-mediated organocatalysis, their ability to 
mimic classical Lewis bases, such as the aminopyridine DMAP (4-dimethylaminopyridine), have 
been relatively less investigated. This thesis sets out to exploit this reactivity, with the goal of 
extending the substrate scope due to their increased reactivity in comparison with the traditional 
aminopyridines.   
This thesis focuses on the transformation first described by Steglich and Höfle, the 
rearrangement of oxazolyl esters and carbonates 223 to their C-acylazlactone isomers 226 and 
227. This reaction, known as the Steglich rearrangement, was shown to be catalysed by the 
aminopyridines DMAP 224 and PPY (4-pyrrolidinopyridine) 225.103 Variation of the steric and 
electronic properties of the substrates was investigated, whereby generally the 
α-carboxyazlactone product 227 is obtained in preference over the γ-carboxyazlactone product 
226. Regioselectivity in this process can be altered by choice of the R1 and R2 substituents: if R1 
is highly electron-withdrawing (i.e. CF3 or 4-O2NC6H4), this overrides the general preference 
for α-carboxylation, thereby giving the γ-carboxyazlactone 226; furthermore, attempts to 
perform the rearrangement of the highly sterically encumbered substrate 223 with R2 = t-Bu give 
rise to the γ-carboxyazlactone 226, possibly due to the reduced steric interactions in this product 
in comparison to the α-carboxyazlactone, which would bear vicinal quaternary stereocentres. 
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Figure 50: Dearomatisation of oxazolyl esters/carbonates – the Steglich rearrangement 
This transformation allows for the catalytic formation of a new quaternary centre, a particular 
challenge in organic synthesis.104 The products of the reaction, in particular the 
C-carboxyazlactones, are masked forms of quaternary amino acids, biologically important 
products.105 Quaternary amino acids are generally unnatural amino acids, playing a key role in 
higher order protein structure by giving unique folding to polypeptide structures (such as the 
Aib-Pro β-turn), and the amino acids have increased chemical and metabolic stability compared 
to natural amino acids. The azlactone products can be treated with a range of 
nucleophiles106,107,108 to give access to highly functionalised products (Figure 51) which can be 
further elaborated as required. 
 
 
Figure 51: Illustration of product derivatisation 
Whilst this transformation has proven highly valuable, there are several drawbacks to the 
reaction. Reaction times often extend from several hours to days, and the regioselectivity of the 
reaction is dependent upon both the steric and electronic properties of the 2- and 4- substituents 
of the oxazolyl framework 223.  
Mechanistically, it has been proposed that both DMAP 224 and PPY 225 act as nucleophilic 
(Lewis basic) catalysts by attack at the carbonyl of 223, generating an acyl transfer agent 233 
and an aromatic dienolate anion 232 (Figure 52). This dienolate 232 can undergo addition to the 
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acyl transfer reagent 233 to yield the rearranged isomer 227 (or 226) with regeneration of the 
DMAP catalyst 224.  
 
 
Figure 52: Catalytic cycle of the Steglich rearrangement 
As this rearrangement gives rise to the formation of a new stereocentre, there has been 
significant interest in effecting this transformation asymmetrically, with several publications 
detailing such efforts.109 Fu and co-workers published the first enantioselective Steglich 
rearrangement using a planar-chiral catalyst PPY* 235, a ferrocene-fused PPY analogue 
(Figure 53).106 This catalyst promoted the enantioselective rearrangement of a number of 
oxazolyl carbonates 234 at low catalyst loadings (typically >2 mol%), but the reaction requires 
the use of a polar solvent (tert-amyl alcohol) and a relatively long reaction time of >6 h. The 
synthesis of the catalyst 235 also requires numerous steps, including a late-stage resolution to 
facilitate its preparation in enantiomerically pure form. Importantly, α-branched substitution at 
C(4) is also not tolerated. 
 
 
Figure 53: Enantioselective Steglich rearrangement using PPY* (Fu) 
Subsequently, Vedejs and co-workers have introduced two new chiral Lewis basic catalysts to 
perform the Steglich rearrangement enantioselectively. The first is a related aminopyridine 
TADMAP 238, based upon the structural core of DMAP but with a proximal stereocentre.107 The 
catalytic activity and level of asymmetric induction of 238 is comparable to that published by Fu 
and co-workers for similar rearrangements (Figure 54). These studies extended the range of 
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successful rearrangement substrates described by Fu and co-workers, although reaction times 
remain long, a polar solvent is still required, and α-branched alkyl carbonates are not tolerated. 
 
 
Figure 54: Enantioselective Steglich rearrangement using aminopyridine TADMAP (Vedejs) 
The second was the chiral phosphine-based catalyst 240. Similarly to the results of Fu, the 
phosphine promoted rearrangement of C(4)-alkyl substituted oxazolyl carbonate substrates 234 
in good yield and up to excellent levels of asymmetry, but again, α-branched substituents are not 
tolerated.  
 
 
Figure 55: Chiral phosphine-promoted asymmetric Steglich rearrangement 
A recent publication by Richards and co-workers utilised chiral relay technology to induce 
enantioselectivity (Figure 56), with low catalyst loadings of cobaltocene 242 and the use of the 
non-polar solvent toluene.108  Extensive reaction times were still necessary and cryogenic 
incubation at -20 ºC was required to induce higher enantioselectivity, at the expense of decreased 
product conversion. 
 
 
* Determined by methanolysis of the product and analysis by chiral HPLC. Assumed retention of configuration.  
Figure 56: Chiral relay effect to effect enantioselective Steglich rearrangement (Richards)   
Section 1.8: Previous work in the Smith group 
Preliminary work within the Smith group has utilised achiral NHCs as efficient catalysts to effect 
the Steglich rearrangement of oxazolyl carbonates.110 Initial investigation of model substrate 224 
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using the NHCs derived from imidazolium salts 79 and 245 showed limited success at effecting 
the Steglich rearrangement (Figure 57). A vast improvement in the protocol was made by using 
triazolium salt precatalyst 128 and KHMDS as the base to generate the active NHC; using Et3N 
as the base, no product conversion was observed. 
 
 
Figure 57: Initial previous studies of the Steglich rearrangement using NHCs 
The generality of this rearrangement protocol was demonstrated by variation of the carbonate 
functionality with a number of unbranched oxazolyl carbonate substrates, giving the products in 
generally very good isolated yield (Figure 58). 
 
 
 
 
Figure 58: Demonstration of the effectiveness of the NHC in catalysis of the Steglich rearrangement 
Mechanistically, a similar catalytic cycle to that for DMAP 224 is proposed, supported by 
studies using crossover experiments. These studies have also shown that the C-C bond formation 
is irreversible with the rearrangement of oxazolyl carbonates, but full determination of the 
catalytic cycle was still required. 
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Section 1.9: Aims and objectives 
This work set out to further investigate the use of NHCs as Lewis basic catalysts and efficient 
carboxyl transfer reagents to effect the Steglich rearrangement.  
The first aim of the research was to probe the reactivity of both catalyst and substrate in order to 
afford an extension to the substrate scope of the rearrangement, with the potential to promote the 
rearrangement of α-branched substrates. Further to this, a fuller investigation of the mechanism 
of the rearrangement was sought. 
With an understanding of the rearrangement, the enantioselective variant of the Steglich 
rearrangement was to be investigated, through the design, synthesis and investigation of chiral 
NHCs, whilst also exploring the potential of the development of new Lewis bases capable of 
promoting these reactions.  
 
 
The final aim of this research was to extend the synthetic utility of the Lewis base-promoted 
rearrangement to other heterocyclic carbonate frameworks.  
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Section 2.1: Preparation of model oxazolyl carbonate substrates 
To further extend the scope of the Steglich rearrangement and to gain a greater understanding of 
the reactivity of the substrates and catalysts, a wide range of oxazolyl carbonate substrates were 
prepared. The principal substrates chosen for investigation were derivatives of phenylalanine, 
with differing electronic and steric characteristics, with particular focus on the effect of changing 
the electronic properties of the carbonate function.110 The p-anisyl aromatic C(2)-substituent was 
chosen as this was shown to provide highly regioselective α-carboxylation, good levels of 
stability to the final C-carboxyazlactone products, and was also shown to provide the greatest 
levels of enantioselectivity in the asymmetric rearrangement protocols adopted by Vedejs and 
Fu. The key intermediate azlactone 254, the precursor to the carbonate substrates, was ultimately 
derived from DL-phenylalanine 250 via a facile four step procedure in excellent yield 
(Scheme 1).106 To investigate the differing effects of the carbonate function, a range of 
carbonates 255–259 was prepared with the respective chloroformate and Et3N in reproducibly 
good to excellent yield. Under the reaction conditions, exclusive O-carboxylation was observed, 
with no direct C-carboxylation detected spectroscopically. 
 
 
Scheme 1: Conversion of DL-phenylalanine to oxazolyl carbonates 
Section 2.2: Synthesis of azolium salt precatalysts 
To reaffirm the suitability of NHCs to promote the Steglich rearrangement, triazolium salt 128 
was prepared according to literature precedent,110 via a three step protocol from lactam 260 
(Scheme 2). This standard protocol, originally described by Rovis and co-workers, began from a 
key amide substrate: γ-butyrolactam 260 was treated with Meerwein’s salt to obtain the 
methylamidate salt 261 and then treated directly with the requisite arylhydrazine, in this case 
Chapter 2: Scope and limitations of the Steglich rearrangement 
 
36 
phenylhydrazine, to afford the hydrazone hydrotetrafluoroborate salt 262. Final cyclisation with 
triethyl orthoformate in methanol at reflux afforded the desired triazolium salt 128 in excellent 
yield over the three steps.  
 
 
Scheme 2: Synthesis of the triazolium salt precatalyst 
To determine if other NHCs could promote the rearrangement, a selection of azolium salts from 
a range of precatalyst classes, namely, thiazolium, imidazolium and imidazolinium salts, were 
prepared and investigated. A simple thiazolium salt 203 was prepared from the commercially 
available 4,5-dimethylthiazole 263 and benzyl chloride in good yield (Figure 59). 
 
 
 
Figure 59: Synthesis of related thiazolium salt 203 
The imidazolium and imidazolinium salts IMes HCl 79 and SIMes HCl 245 are commercially 
available, but to determine the effect that the counterion of the azolium salt has upon the Steglich 
rearrangement, the related imidazolium tetrafluoroborate 265 (IMes HBF4) was prepared. This 
was prepared from mesitidine 264, glyoxal, paraformaldehyde and aqueous tetrafluoroboric acid 
in a one-pot procedure (Figure 60).  
 
  
Figure 60: Preparation of IMes HBF4 
Section 2.3: Examination of NHC catalyst classes 
With the required substrates and catalysts in hand, a full investigation of the rearrangement 
protocol was undertaken, with the aim to better understand the behaviours of the catalysts and 
substrates. It was envisaged that the results of the study would prove useful in identifying the 
requirements for successful rearrangement, and thus give an insight into understanding the 
reaction. 
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Phenylalanine-derived phenyl carbonate 256 was chosen as the model substrate and was 
investigated, using KHMDS as the base, in order to determine a reactivity profile (Figure 61, 
Table 1). The triazolium-derived NHC 247 successfully promoted complete rearrangement of the 
phenylalanine-derived phenyl carbonate 256 to its C-carboxyazlactone product 266. Thiazolium 
salts 203 and the commercially available 267 were ineffective at promoting rearrangement, but 
that imidazolium salts 79 and 245 were more effective. It appeared that the nature of the 
counterion may also play a role, with IMes HBF4 265 giving significantly less product 
conversion than with the related chloride salt 79. Although these imidazolium-derived NHCs 
promoted the rearrangement, the reaction mixture was generally contaminated with several 
side-products, of which the decarboxylated product, azlactone 254, was identified. These results 
are in contrast with those described in the original publication (see Figure 57, page 32), in which 
only the triazolium-derived NHC 247 proved effective in promoting full rearrangement of the 
alanine-derived methyl carbonate 244. Imidazolium-derived NHCs promoted only high levels of 
rearrangement of the (phenylalanine-derived) phenyl carbonate 256. 
 
 
Figure 61: Rearrangement screen with the different azolium salt classes 
Precatalyst Conversion (%) a 
Isolated 
 yield (%) b 
128 >98 80 
203 11 - 
267 <5 - 
79 >90 68 
265 ~40 - 
245 >90 - 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
b
 Isolated yield of homogeneous product following chromatographic purification 
Table 1: Evaluation of NHC catalyst classes 
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In order to investigate if this difference was due to the nature of the carbonate, the related 
phenylalanine-derived methyl carbonate 255 was evaluated using a range of azolium-derived 
NHCs (Figure 62, Table 2). Consistent with the results obtained in the original publication and 
those with the phenyl carbonate, the triazolium-derived NHC 247 proved highly effective in 
promoting rearrangement of the methyl carbonate 255. The imidazolium and imidazolinium salts 
79 and 245 also proved much less effective, with only IMes promoting appreciable 
rearrangement. Intuitively, this striking difference in chemoselectivity between the phenyl and 
methyl carbonates could be attributed primarily to the difference in electrophilicity of the 
carbonyls, as the phenyl carbonate would be expected to be more electrophilic than the methyl 
carbonate. The reactivity difference between different carbonates will be addressed in 
subsequent discussions throughout the thesis. 
 
 
Figure 62: Screening of the methyl carbonate 255 
Precatalyst 
(mol%) 
KHMDS  
(mol%) Time (min) 
Conversion 
(%) a 
128 (10) 9 90 >98 (76) b 
128 (5) 4.5 90 >98 
128 (1) 0.9 90 >98 
128 (1) 0.9 5 >98 
79 (10) 9 90 ~75 (68) b 
245 (10) 9 90 <5 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
b
 Isolated yield of homogeneous product following chromatographic purification 
Table 2: Screening of methyl carbonate 255 with NHCs 
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Section 2.4: Optimisation of the NHC-promoted Steglich rearrangement 
protocol 
Section 2.4.1: Investigation of catalyst loading and N-aryl substituent 
Returning to the model oxazolyl phenyl carbonate 256, a range of N-aryl substituted triazolium 
saltsi was screened in order to ascertain the electronic effect of variation of the N-aryl 
substituent,ii whilst also investigating reducing the catalyst loading and reaction time (Figure 63, 
Table 3). All triazolium salts gave successful rearrangement to C-carboxyazlactone 266 at low 
catalyst loadings (all <10 mol%, though generally effective at <1 mol%), and with complete 
conversion achieved smoothly in <90 min, irrespective of the electron-donating or withdrawing 
properties of the different aryl substituent. 
 
 
 
Figure 63: Rearrangement screen with triazolium salts 
Precatalyst 
(mol%) 
KHMDS 
(mol%) Time (min) 
Conversion 
(%) a 
128 (10) 9 
9 
90 >98 (80) b 
128 (10) 5 >98 (75) b 
128 (5) 4.5 5 >98 
128 (1) 0.9 5 >98 (79) b 
268 (10) 9 90 >98 
268 (1) 0.9 5 >98 
269 (10) 9 90 >98 
270 (10) 
270 (10) 
9 90 
5 
>98 
>98 9 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
b Isolated yield of homogeneous product following chromatographic purification 
Table 3: Strong base screen with triazolium salts according to standard protocol with KHMDS in THF 
                                                 
i
 Triazolium salts 268, 269 and 270 were prepared by other members of the Smith group. 
ii
 Several authors have reported that the nature of the N-aryl substituent is important in providing the desired 
reactivity; in many cases, N-mesityl substituted triazolium salts provide the desired reactivity whereas the N-phenyl 
substituent provides poor reactivity or leads to by-products. 
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The related methyl carbonate 255 was examined using several different triazolium salts in order 
to determine if the nature of the N-substituent was important (Figure 64, Table 4). Triazolium 
salt 268 also proved highly effective, but changing the N-aryl substituent to an electron-deficient 
pentafluorophenyl moiety (triazolium salt 270) proved detrimental to the efficacy of the catalyst, 
only promoting ~65% conversion to C-carboxyazlactone 249.  
 
 
Figure 64: Rearrangement screen with triazolium salts 
Precatalyst 
(mol%) 
KHMDS 
(mol%) Time (min) 
Conversion 
(%) a 
128 (10) 9 90 >98 (76) b 
128 (1) 0.9 5 >98 
268 (10) 9 90 >98 
268 (1) 0.9 90 >98 
270 (10) 9 90 ~65 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
b
 Isolated yield of homogeneous product following chromatographic purification 
Table 4: Comparison of methyl carbonate with different triazolium-derived NHCs 
Section 2.4.2: Investigation of NHC concentration 
Using the effective triazolium salt 128 as the NHC precursor, an investigation of the NHC 
concentration was undertaken, in order to assess fully a suitable concentration range with which 
to perform the rearrangement. Choosing phenylalanine-derived phenyl carbonate 256 as the 
model substrate, a wide range of concentrations for the reaction was evaluated, following the 
standard rearrangement protocol developed within the Smith group. Using a precatalyst loading 
of 10 mol% of triazolium salt 128, and assuming complete deprotonation using KHMDS, a range 
of NHC catalyst concentrations from 40 mM to 0.5 mM was examined over the timeframe of 1 h 
(Figure 65, a Determined by 1H NMR spectroscopic analysis of the crude reaction product 
Table 5). The rearrangement of 256 to 266 was shown to be effective at catalyst concentrations 
greater than 1 mM, but a considerable drop in activity was noted at the lower concentration of 
0.5 mM. Therefore, all subsequent operations were performed at an NHC concentration of 
between 2 and 40 mM. 
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Figure 65: Concentration study for the Steglich rearrangement 
Maximum catalyst 
 conc. (mM) 
Conversion  
(%) a 
40 >98 
25 >98 
5 >98 
1 >98 
0.5 15 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
Table 5: Effects of concentration of catalyst on reactivity 
Section 2.4.3: Investigation of solvents and alternative strong bases 
A range of solvents and strong bases (LiHMDS, n-BuLi and NaH) was next evaluated at a range 
of catalyst loadings, and the reaction progression monitored. Highlighted results of this screen 
are detailed (Figure 66, Table 6). The rearrangement of the model substrate 256 is highly 
efficient using a range of strong bases, allowing full rearrangement to occur rapidly (<5 min), 
even with very low catalyst loadings (<0.5 mol%). A control reaction in dichloromethane 
confirmed that the active catalytic species was indeed the triazolinylidene 247 and not any 
potential chlorocarbene generated from deprotonation of the bulk solvent. 
 
Figure 66: Further screening with a range of solvents and bases 
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Precatalyst 
(mol%) Base (mol%) Solvent 
Time 
(min) 
Conversion 
(%) a 
128 (0.5) KHMDS (0.4) THF <5 >98 
128 (1) LiHMDS (0.9) THF 5 >98 
128 (10) n-BuLi (0.9) THF 5 >98 
128 (1) NaH (9) THF 5 >98 
128 (10) KHMDS (9) toluene 60 92 
128 (10) KHMDS (9) CH2Cl2 60 >98 
no precatalyst KHMDS (9) CH2Cl2 60 0 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
Table 6: Results of rearrangement screen with a range of solvents and bases 
Section 2.4.4: Scope and limitations 
Having developed successful protocols with which to perform the rearrangement, the scope and 
limitations of the protocol were investigated using the set of phenylalanine-derived carbonates 
255–259. Employing typically 1 mol% triazolium salt and KHMDS as the base, all such 
substrates underwent rapid, complete rearrangement to the desired C-carboxyazlactones in 
reproducibly high isolated yield (75–84%) (Figure 67). 
 
Figure 67: Rearrangement of phenylalanine-derived carbonates 
To illustrate the scope and limitations of this NHC-catalysed process, a wide range of oxazolyl 
carbonate substrates 237 was prepared by variation of the C(4)-substituent. These carbonates 
were prepared via a similar synthetic procedure to that illustrated from phenylalanine, using a 
number of other commercially available amino acids 274 (Scheme 3). Of particular interest were 
the derivatives of the more sterically challenging branched amino acids leucine, valine, 
phenylglycine and tert-leucine, known to prove less amenable to rearrangement protocols 
employing DMAP 224, the related aminopyridines and chiral phosphine 240.  
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Scheme 3: Preparation of a range of other amino acid-derived substrates 
Attempts to prepare O-protected serine derivatives were unsuccessful due to elimination 
side-reactions, but phenolic relative 285 was obtained from tyrosine 279 whereby the phenol was 
O-protected (Scheme 4). O-Benzylation was achieved by alkylation of the amide intermediate 
282 with benzyl bromide in DMF, then converted to the desired phenyl carbonate 285 as 
described above, in good yield over each step.  
 
Scheme 4: Preparation of the tyrosine-derived substrate 
In collaboration with a colleague,i all such C(4)-substituted substrates were evaluated in the 
rearrangement (Figure 68, Table 7). Gratifyingly, all such substrates 237 underwent similarly 
efficient rearrangement to the C-carboxyazlactone, again with typically low catalyst loadings and 
reaction times (<10 mol%, <1 h). Of particular note is that the sterically challenging branched 
carbonate substrates 237 (R1 = i-Pr, i-Bu, t-Bu and Ph) undergo facile rearrangement using 
                                                 
i
 Collaboration with Jennifer Thomson. 
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triazolium salt 128 but, in contrast to the findings using aminopyridines, only the 
α-carboxyazlactone product 239 is obtained. These branched substrates, in particular the 
α-branched valine and tert-leucine derived carbonates, have been found to be generally 
unamenable to rearrangement with other catalysts, and thus the use of triazolium-derived NHCs 
has provided a significant extension to the reaction scope of oxazolyl carbonate substrates.  
 
 
Figure 68: Variation of C(4)-substituent 
R1 R2 Precatalyst (mol%) 
Conversion 
(%) 
Isolated yield 
(%) 
Me Me 1 >98 84 
Me Ph 1 >98 82 
Me 1-naphthyl 1 >98 80 
Me CMe2CCl3 1.5 >98 72 
Et Ph 1 >98 75 
i-Pr Ph 1.5 >98 79 
n-Bu Ph 1 >98 74 
i-Bu Ph 1 >98 80 
i-Bu CMe2CCl3 1 >98 78 
t-Bu Ph 5 >98 73 
Ph Ph 1.5 >98 81 
4-BnOC6H4CH2 Ph 1 >98 80 
MeSCH2CH2 Ph 1 >98 82 
Table 7: Results of C(4)-variation 
Section 2.5: Development of a one-pot protocol 
In the rearrangement reaction manifolds, the generation of the NHC is generally achieved by in 
situ deprotonation of the azolium salt with KHMDS over a period of 30 min in order to ensure 
complete deprotonation. In an effort to further simplify the reaction protocol, generation of the 
active NHC in the presence of the carbonate substrate was investigated. Cognisant of the recent 
publication by Wilhelm and co-workers employing KHMDS as a Lewis base catalyst,111 control 
reactions showed that KHMDS alone gave little conversion to any products, highlighting the 
necessity for the NHC as the catalyst. Having established the requirement of the NHC derived 
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from triazolium salt 128 to effect the catalysis, azolium salt and carbonate were stirred together 
in a suitable solvent then followed by addition of base (Figure 69, Table 8). Pleasingly, 
triazolium salts 128, 268 and 270 all gave clean conversion to the desired C-carboxyazlactone 
product 266, but imidazolium salts 79 and 245 were also highly effective. Thiazolium salts 203 
and 267, however, were less successful at promoting the rearrangement. These observations 
further supported the earlier findings, in which the nature of the NHC had a significant bearing 
on the successful promotion of the rearrangement.  
 
 
Figure 69: One-pot protocol with phenyl carbonate 256 
Precatalyst 
(mol%) 
KHMDS 
(mol%) Time (min) 
Conversion 
(%) a 
no precatalyst 9 60 <5 
128 (10) 9 60 >98 (80) b 
128 (10) 9 5 >98 (80) b 
128 (1) 0.9 5 >98 
268 (1) 0.9 5 >98 
270 (1) 0.9 5 >98 
79 (9) 9 60 >95 
245 (9) 9 60 >95 
203 (9) 9 60 ~30 
267 (9) 9 60 72 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
b
 Isolation of homogenous purified product by chromatography 
Table 8: Results of one-pot protocol 
To ensure that this one-pot protocol could be applied more generally to other substrates, the 
same protocol was employed for the rearrangement of other carbonates 237 (Figure 70, Table 9). 
This alternative procedure proved general, with quantitative conversion achieved at low NHC 
catalyst loading in <5 min and with consistently very good isolated yield of the 
C-carboxyazlactone products 239. 
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Figure 70: Scope of one-pot protocol  
R1 R2 Precatalyst (mol%) 
Isolated yield 
(%) 
Me Me 1 72 
Me Ph 1 82 
Me 1-naphthyl 1 80 
Me CMe2CCl3 1.5 80 
Et Ph 1 78 
i-Pr Ph 1.5 80 
n-Bu Ph 1 78 
i-Bu Ph 1.5 81 
i-Bu CMe2CCl3 1 78 
t-Bu Ph 10 70 
Ph Ph 1.5 81 
PhCH2 Me 1 82 
PhCH2 Ph 0.5 84 
PhCH2 Bn 1.5 83 
PhCH2 1-naphthyl 1 80 
4-BnOC6H4CH2 Ph 1 80 
MeSCH2CH2 Ph 1 83 
Table 9: Highlighted results of one-pot protocol 
As purification of the rearrangement products had previously required chromatographic 
separation, alternative means to purify the C-carboxyazlactone products were investigated. It 
was envisaged that, with quantitative conversion, the only ‘impurities’ in the mixture were the 
presence of ionic species (such as KBF4 and the azolium salt), the protonated base and 
potentially the free NHC. To isolate the (organic) product from the impurities, it was proposed 
that acidic aqueous workup would result in reprotonation of the NHC, to allow the removal of 
these species by extraction into the aqueous phase. Treatment of the product mixture showed that 
the product was stable to 1 M HCl(aq) and the residual impurities were indeed removed to the 
aqueous phase, giving the ‘washed’ product in comparable isolated yield (82%) to that obtained 
from chromatographic purification (80%). 
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Figure 71: One-pot protocol with purification by workup 
Section 2.6: Summary 
These investigations demonstrate a range of effective protocols to promote rapid Steglich 
rearrangement of oxazolyl carbonates to their C-carboxyazlactone isomers using low catalyst 
loadings of NHCs. Furthermore, the triazolium-derived NHC 247 has allowed extension to the 
substrate scope of the rearrangement, promoting exclusively α-carboxylation with the sterically 
challenging phenylglycine, valine and tert-leucine-derived branched substrates.  
Means to simplify the reaction protocol have been investigated, with one-pot reaction procedures 
and aqueous extraction techniques being employed. These procedures were found to be a highly 
satisfactory manner with which to perform the reaction, simplifying the reaction procedure and 
minimising the reaction time. 
Investigations have illuminated chemoselectivity between NHC classes in the rearrangement 
protocols: in conjunction with KHMDS as the base, triazolium salts have proven the most 
effective at promoting rearrangement, with both imidazolium and thiazolium salts being less 
effective. The electronic nature of the carbonate functionality appears also to have an effect on 
chemoselectivity, as the generally less effective imidazolium and thiazolium-derived NHCs 
appear to be more effective catalysts with phenyl carbonate 256 than with methyl carbonates 244 
and 255. Furthermore, the triazolium N-aryl substituent also appears to play a role in the 
chemoselectivity of the rearrangement, with phenyl and p-anisyl substituted triazolium salts 
performing the rearrangement of both phenyl and methyl carbonate 256 and 255, but the related 
pentafluorophenyl substituted triazolium salt is less effective with methyl carbonate 255. These 
observations will be reinvestigated in further chapters. 
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Section 3.1: Rearrangement protocol with weak organic bases 
Whilst the aforementioned results illustrate the effectiveness of triazolium-derived NHCs as 
catalysts to promote the Steglich rearrangement, the results had illuminated a number of 
interesting chemoselectivities. Firstly, a difference in reactivity between different azolium-based 
NHCs was observed. Secondly, a difference in reactivity of different carbonate substrates (based 
on the same core architecture) was observed. Cognisant of the results in the initial publication 
which showed that weak bases Et3N and DBU (in conjunction with the optimal triazolium salt 
128) were ineffective in promoting rearrangement of methyl carbonate 244,110 the same 
experiments were investigated using the phenylalanine-derived phenyl carbonate 256. 
Section 3.1.1: Investigations with different azolium salts 
With such a distinction in both catalyst and substrate reactivity between the phenyl and methyl 
carbonates, the possibility that relatively weak bases could be used in order to generate the active 
NHC, and thus effect the Steglich rearrangement, was re-examined. A wide range of both 
organic and inorganic weak bases was screened with model oxazolyl phenyl carbonate 256, of 
which highlighted results are detailed (Figure 72, Table 10 and Table 11). Using Et3N as the base 
(Table 10), a marked difference in reactivity was observed, both in comparison with the results 
in the initial publication and between the NHC classes. Amongst the triazolium salts, the 
N-phenyl and N-p-anisyl substituted triazolium salts 128 and 268 again proved most effective, 
promoting quantitative conversion to the desired C-carboxyazlactone 266 in 2 h; the 
N-pentafluorophenyl substituted triazolium salt 270 also promoted quantitative conversion, but 
requiring a longer reaction time (4 h) to reach completion. These reaction times were 
considerably longer when compared with the use of KHMDS as the base, whereby the reaction 
times are generally <5 min. This disparity in reaction rate is likely to be due to difference in pKa 
of the two bases. In order to try to explain the difference in reactivity, the pKa of the triazolium 
salt was determined. In collaboration with O’Donoghue and Lindsay at the University of 
Durham, the pKa of triazolium salt 128 has been determined as 17.7 ± 0.5 (in H2O).112 By 
comparison of this value with that for Et3N (pKaH 10.9), the active quantity of NHC generated in 
situ is approximately six orders of magnitude lower than for reactions with strong metallated 
bases.i By increasing the stoichiometry of Et3N to 100 mol%, quantitative conversion to the 
rearrangement product was achieved with reaction times of <5 min. Addition of 1 equiv of 
Et3N·HCl was shown to significantly impede the reaction, further supporting this hypothesis.  
 
                                                 
i
 Assuming full kinetic deprotonation is observed. 
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Figure 72: Investigations using Et3N 
Precatalyst 
(mol%) Base (mol%) Solvent Time 
Conversion 
(%) a 
128 (1) Et3N (0.9) THF >24 h <10 
128 (10) Et3N (9) +  
Et3N·HCl (1 equiv) 
THF 
2 h 
3 h 
75 
>98 
128 (10) Et3N (9) THF 2 h >98 
128 (10) Et3N (100) THF <5 min >98 
128 (10) Et3N (9) CH2Cl2 2 h ~75 
268 (10) Et3N (9) THF 2 h >98 
270 (10) Et3N (9) THF 4 h >98 
79 (10) Et3N (9) THF >24 h <10 
245 (10) Et3N (9) THF >24 h <5 
265 (10) Et3N (9) THF >24 h <5 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
Table 10: Results of Et3N-promoted rearrangement with azolium salts 
A range of alternative weak Brønsted bases was examined (Figure 73, Table 11), and there 
appears to be a subtle interplay between the nature of the base and its ability, in conjunction with 
the NHC precatalyst, to perform the rearrangement: where Et3N and proton sponge are suitable 
bases, the use of DABCO, N-methylmorpholine and 2,6-lutidine did not afford any 
rearrangement product; in addition, inorganic carbonates K2CO3 and Cs2CO3 could also be used 
to generate the active catalyst in order to promote the rearrangement. 
 
 
Figure 73: Screen of a range of weak bases 
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Base (mol%) Conversion (%) 
DBU (9) >90 
DBN (9) >95 
K2CO3 (9) >95 
Cs2CO3 (9) >95 
proton sponge (9) >95 
DABCO (9) <5 
N-methylmorpholine (9) <5 
2,6-lutidine (9) <5 
Table 11: Results of rearrangement with a range of weak bases 
Section 3.1.2: Background reactions with amidines and development of new Lewis bases 
Whilst the use of the organic bases DBU and DBN allowed successful Steglich rearrangement of 
the phenyl carbonate 256, amidines such as DBU have been used as Lewis bases to facilitate a 
number of organic transformations. In particular, such amidines have seen application in 
eliminations,113 in esterifications,114 condensations115 and the formation of trichlorocarbinols.116 
An early example of Lewis basic reactivity was shown in the silylation of a range of alcohols 
(Figure 74). Activation of the silylation species is generally achieved using imidazole, however 
Kim and Chang have shown that DBU can also be highly effective.117  
 
 
Figure 74: DBU-Catalysed alcohol silylations 
A range of other amidine-catalysed reactions are known to allow access to carbon-heteroatom 
bond formation, such as esterifications with dimethyl carbonate,118 Baylis-Hillman reactions119 
and cyanoacylation of ketones with acyl cyanides.120 In the latter case, the reaction is proposed 
to be promoted via formation of an acylamidinium cyanide intermediate 294, an acyl transfer 
species. The liberated cyanide allows for formation of the cyanohydrin anion intermediate which 
is trapped by the acyl transfer species to afford the O-acylated cyanohydrin product 297 with 
regeneration of the amidine catalyst (Figure 75). 
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Figure 75: DBU-Catalysed cyanoacylation of ketones with acyl cyanides 
Notably, Birman and co-workers have introduced a new class of amidine catalysts for 
enantioselective acyl transfer based on the 2,3-dihydroimidazo-[1,2-a]pyridine (DHIP) 
framework. These chiral catalysts have proven effective at inducing high levels of 
enantioselectivity in a number of acyl transfer reactions, notably in kinetic resolution and 
desymmetrisation of secondary alcohols.121 In the kinetic resolution of secondary benzylic and 
allylic alcohols, chiral catalysts 299 (CF3-PIP) and 300 (Cl-PIQ) were optimal, both giving good 
selectivity levels in each case (Figure 76).122  
 
 
 
 
Figure 76: DHIP-Catalysed kinetic resolution of secondary alcohols 
In addition to catalysts based on the DHIP architecture, Birman and co-workers have also shown 
that the commercially available anthelmintic (S)-tetramisole and its benzannulated derivative 303 
are also highly effective enantioselective acyl transfer catalysts, such as in the kinetic resolution 
of 1-phenylpropanol 302 (Figure 77).123 
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Figure 77: Isothiourea-catalysed kinetic resolution of 1-phenylpropanol 
In order to ascertain if such tertiary amines and amidines were indeed able to promote the 
Steglich rearrangement, background reactions were examined, using the bicyclic amidines DBU 
292 and DBN 306, and the simple tertiary amine base Et3N as catalysts in the absence of azolium 
salts (Figure 78, Table 12). The results of this study showed that Et3N alone was ineffective as a 
Lewis base in promoting the rearrangement, but the amidines exhibited a marked difference in 
reactivity. Both amidines gave rise to a mixture of products arising from interaction with the 
carbonate substrate. A distinct difference in behaviour between the 6:7-fused bicyclic amidine 
DBU 292 and its 6:5-fused relative DBN 306 was also observed, with successful rearrangement 
obtained with DBN but not with amidine DBU. In both cases, however, the carbonate substrate 
was fully consumed, with the remainder of the material identified as the azlactone 254 and 
diphenyl carbonate 305. 
 
 
Figure 78: Control experiments with amidine bases and Et3N 
Base  
(mol%) Solvent Time (h) 
Conversion 
to 266 (%) 
Conversion 
to 254 (%) 
DBU 291 (9) THF 4 <5 30 
DBN 306 (9) THF 1 80 20 
DBN 306 (9) CH2Cl2 1 90 10 
Et3N (9) THF 4 0 0 
Table 12: Results of control experiments with the weak organic bases 
These results indicate that both amidines are exhibiting Lewis basic behaviour, and presumably 
act in a similar fashion to that of DMAP, through initial addition to the carbonate carbonyl. One 
means of rationalising the observation of the azlactone and diphenyl carbonate can be made via 
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crossover between two different carboxyamidinium salts 308 and 309, generated from collapse 
of the tetrahedral intermediate 307 by two possible pathways (Figure 79). Though this 
disproportionation reaction accounts for the production of azlactone 254 and diphenyl carbonate 
305, dioxazolyl carbonate 310 would also be expected, but this species has never been detected. 
Attempts to prepare and isolate this substrate have also failed, suggesting that this product may 
be unstable and thus cannot be observed in the reaction manifold. 
 
 
Figure 79: Possible alternative fragmentation pathways leading to disproportionation 
Despite this mechanistic ambiguity, further work has being carried out in the Smith group, with 
the development of a related isothiourea 311 as a Lewis base catalyst which is highly effective in 
promoting the carboxyl rearrangement.124 In addition, further work has probed the asymmetric 
variant of the rearrangement, leading to the development of chiral isothiourea 312 which 
promotes excellent levels of asymmetry in the rearrangement (up to 94% ee at -50 ºC).125 
 
 
Figure 80: Demonstration of isothiourea-catalysed carboxyl Steglich rearrangements 
DFT-Calculations to a high level of theory (B3LYP/6-31G(d,p)) have been performed in order to 
explain the origin of enantioselectivity in the process. The lowest energy conformation of the 
presumed carboxyl transfer species, referred to as the N-carboxy species, was revealed to 
orientate the stereodirecting Ph group pseudoaxially, in order to minimise 1,2-strain in this 
intermediate. The preferred rotameric form of the carboxyl group was found to lie co-planar with 
the isothiourea motif, and with the C=O “syn” to the C=N of the isothiourea moiety. Having 
controlled the carboxyl transfer geometry, computational analysis of the possible transition states 
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showed that one possible combination of the dienolate and N-carboxy components was 
significantly lower in energy than the others (by >3.5 kcal mol-1), in agreement with the 
stereochemical outcome observed experimentally.125 
 
Ball and stick representation of the lowest energy transition 
state (B3LYP/6-31G(d,p)) accessed by a simplified  
N-carboxy intermediate and oxazolyl dienolate for the above-
illustrated C-carboxylation. Dashed lines indicate C-H···O 
interactions and the solid black line indicates the C-C bond 
forming. Carbon atoms are light grey, nitrogen and oxygen 
atoms are dark grey, and hydrogen atoms are white.i 
Figure 81: DFT Calculations on a simpler related model system, to explain the origin of enantioselectivity with the 
chiral isothiourea 
Whilst these investigations were underway, the asymmetric acyl Steglich rearrangement using 
tetramisole 314 or benzotetramisole 303 as a catalyst was reported by Gröger and Dietz.126,127 
Whilst successful, this reaction is slow and requires a high catalyst loading (up to 32 mol%), 
only proceeding to ~80% after two days (Figure 82). Related acyl Steglich rearrangements, 
however, have proven unsuccessful in our hands.ii 
  
Figure 82: Asymmetric isothiourea-catalysed acyl Steglich rearrangement 
Section 3.1.3: Investigation of phenylalanine-derived oxazolyl carbonates 
Having observed that Et3N can be used as a base to promote the rearrangement of carbonate 256, 
the generality of the process was investigated with a range of different phenylalanine-derived 
carbonates (Figure 83, Table 13). With Et3N as the base, a striking chemoselectivity was 
observed between different carbonates. Only aryl (phenyl and 1-naphthyl) carbonates underwent 
the desired rearrangement process, occurring rapidly (<5 min), but all alkyl carbonate substrates 
                                                 
i
 Reproduced with permission, from Angew. Chem., Int. Ed. 2009, 48, 8914–8918. 
ii
 Investigated by Jennifer Thomson and Caroline Joannesse. 
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failed to provide any of the rearrangement product, even with higher catalyst loadings (20 mol%) 
and after extended reaction times. In contrast, as described previously, all phenylalanine-derived 
carbonates 255–259 underwent complete rearrangement within 5 min with KHMDS as the base. 
 
 
Figure 83: Comparison of rearrangement with KHMDS and Et3N 
R Base Time Conversion (%) 
Me KHMDS 5 min >98 
Me Et3N 16 h <5 
Ph KHMDS 5 min >98 
Ph Et3N 5 min >98 
Bn KHMDS 5 min >98 
Bn Et3N 16 h <5 
CMe2CCl3 KHMDS 5 min >98 
CMe2CCl3 Et3N 16 h <5 
1-naphthyl
 
KHMDS 5 min >98 
1-naphthyl Et3N 5 h >98 
Table 13: Comparison of aryl and alkyl carbonates using KHMDS and Et3N 
Having delineated that only aryl carbonates undergo the rearrangement process using Et3N as the 
base, a range of C(4)-substituted oxazolyl carbonates was examined in the reaction manifold 
(Figure 84, Table 14). The reaction process proved quite general, with a variety of 
C(4)-substituted carbonates 316 undergoing successful rearrangement and good isolated yield, 
including the phenylglycine derivative (R = Ph). Only the α-branched valine derived substrate 
316 (R = i-Pr) proved unsuccessful.  
 
 
Figure 84: Scope and limitations of the use of Et3N as the base 
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R Ar Conversion (%) 
Isolated yield 
(%) 
Me Ph >98 81 
Me 1-naphthyl >98 77 
n-Bu Ph >98 81 
i-Bu Ph >95 78 
Ph Ph >98 72 
PhCH2 Ph >98 82 
PhCH2 1-naphthyl >95 80 
CH2CH2SMe Ph >90 - 
4-PhOC(O)O- 
C6H4CH2 
Ph >95 77 
i-Pr Ph <15 - 
Table 14: Scope and limitations of the use of Et3N as the base  
Section 3.2: Development of domino cascade protocols 
The development of cascade reaction processes that permit the efficient introduction of 
molecular complexity from simple starting materials in a single reaction sequence is highly 
desirable. A number of such so-called ‘domino’ cascade transformations have been used in 
synthesis, with several reviews dedicated to this topic.128  
Section 3.2.1: From azlactones 
Having demonstrated the effectiveness of Et3N as a base to promote the rearrangement of aryl 
oxazolyl carbonates, investigation of the incorporation of this transformation into a multi-step 
transformation was carried out. The conversion of azlactone 254 to carbonate 256 can be 
facilitated using Et3N as the base, thus, it was proposed that these two steps could be combined 
into a cascade procedure, obtaining ester 266 directly from the azlactone 254, in the presence of 
triazolium salt 128 (Figure 85). The initial findings of this investigation were encouraging: upon 
treatment of the azlactone 254 with 1 equiv of phenyl chloroformate and 1.2 equiv of Et3N, 70% 
conversion of azlactone starting material to the C-carboxyazlactone 266 was observed, with the 
remainder of the mixture present as the azlactone 254 and the carbamate 318. 
 
 
Figure 85: Two-step cascade procedure 
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The identity of carbamate 318 was confirmed unambiguously by chemical synthesis, through 
treatment of phenyl chloroformate with solely Et3N (Figure 86), thus indicating that carbamate 
formation is a competing pathway to the desired cascade reaction.  
 
 
Figure 86: Competing reaction pathway leading to carbamate adduct 318 
Upon closer inspection of the standard formation of the phenyl carbonate substrate 256 from 
azlactone 254, formation of the carbamate product 318 is also observed, but is removed upon 
purification by means of recrystallisation or chromatography. Upon inspection of the literature, it 
was found that phenyl chloroformate (and a range of other chloroformates) is known to promote 
dealkylation of tertiary amines,129 so an alternative base was sought which would not be prone to 
such reactions. A range of hindered bases, such as Hünig’s base, 2,6-lutidine, DABCO and 
1,2,2,6,6-pentamethylpiperidine was investigated in the cascade reaction. Unfortunately, neither 
2,6-lutidine, DABCO nor 1,2,2,6,6-pentamethylpiperidine were successful in affording the 
desired C-carboxyazlactone product 266. Hünig’s base proved moderately competent in the 
cascade reaction, but this trialkylamine also led to formation of a similar carbamate product 319 
as a result of highly selective dealkylation from the quaternary ammonium intermediate 320 
(Figure 87). 
 
 
Figure 87: Carbamate adduct obtained with Hünig’s base 
In light of these results, optimisation of the reaction conditions with Et3N was investigated. It 
was found that upon scale-up and by treatment of the azlactone 254 first with 1.3 equiv of phenyl 
chloroformate and then 1.5 equiv of Et3N, quantitative conversion to the desired product 266 was 
achieved and formation of the by-product 317 was minimised. Isolation of the 
C-carboxyazlactone 266 was achieved in better yield to those reactions carried out using either 
the standard protocol or the one-pot protocol, i.e. 82% via the telescoped process, compared to 
an overall 73–75% by the sequential two step process. To ensure that this process was indeed a 
cascade reaction, aliquots were taken from the reaction mixture at regular time intervals and 
analysed spectroscopically. The results indicated that the carbonate intermediate 256 was formed 
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rapidly, followed by a much slower rearrangement of the carbonate 256 to the desired 
C-carboxyazlactone 266, consistent with this being a domino cascade.  
 
 
Scheme 5: Domino cascade analysis showing initial carbonate formation 
With a successful protocol in place, the scope and limitations of the procedure were examined. 
By variation of both the aryl chloroformate and C(4)-substituted azlactone, the reaction proved 
quite general, affording the C-carboxyazlactones 317 in good isolated yield (Figure 88, Table 
13). Notably, the branched leucine-derived and phenylglycine-derived azlactones 321 (R = i-Bu 
and Ph, respectively) gave the desired products in excellent yield. This protocol is, however, 
intolerant of conversion of the α-branched valine-derived azlactone 321 (R = i-Pr), and the 
methylthio-containing substituent in the methionine-derived azlactone 321 (R = MeSCH2CH2), 
both returning predominantly the carbonate intermediate 316. Additionally, attempts to perform 
the related reactions with alkyl chloroformates gave only formation of the carbonate intermediate 
237. These results support our earlier findings, where the alkyl oxazolyl carbonates 237 
underwent no further reaction to the desired C-carboxyazlactones when the triazolinylidene was 
generated from Et3N. 
 
R
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Figure 88: Scope of the domino cascade from azlactones 
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R Ar Conversion (%) 
Isolated 
yield (%) 
Me Ph >95 81 
i-Bu Ph >95 85 
Ph Ph >95 75 
PhCH2 Ph >95 82 
PhCH2 1-naphthyl >95 85 
4-BnOC6H4CH2 Ph >95 85 
i-Pr Ph ~15 a - 
MeSCH2CH2 Ph ~10 a - 
a
 Remainder present as carbonate intermediate 316 
Table 15: Scope of the domino cascade from azlactones 
Section 3.2.2: From N-acyl amino acids 
With a successful two-step procedure developed, the next extension to the domino cascade was 
incorporation of the preparation of the azlactone intermediate. We took inspiration from the 
Dakin West reaction, a known transformation of an amino acid 274 into an amido ketone 325.130 
This occurs via N-acylation followed by O-activation to a mixed anhydride, followed by 
intramolecular cyclisation to an azlactone 323 (Figure 89). 
 
 
Figure 89: Highlighted mechanism of the Dakin-West reaction 
Section 3.2.2.1: Activation/cyclisation using DCC 
Fu and co-workers had shown that such azlactone cyclisations could be performed using the 
carbodiimide DCC, so the possibility of exploiting this transformation, in combination with our 
developed two-step cascade protocol, was explored. Using N-p-anisoyl-DL-phenylalanine 253 as 
a model substrate, attempts were made to induce cyclisation to the azlactone 254 and to promote 
carbonate formation and rearrangement (Figure 90). The result of this investigation was highly 
encouraging: upon treatment of N-p-anisoyl-DL-phenylalanine 253 with DCC, the desired 
cyclised azlactone product 254 was obtained within 1 h. To remove the dicyclohexylurea 
by-product from the activation/cyclisation, the mixture was filtered. Filtration of the mixture 
directly into a mixture of Et3N and triazolium salt in THF, followed by final addition of phenyl 
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chloroformate, gave the desired C-carboxyazlactone 266 in ~90% conversion (up to 10% 
remaining as the carbonate intermediate 256), from which 71% was isolated by chromatography. 
 
 
Figure 90: Multi-step domino cascade using DCC activation/cyclisation 
With a working protocol in hand, the scope and generality of this procedure was next 
investigated (Figure 91, Table 16). By varying both the N-p-anisoyl amino acid 326 and the aryl 
chloroformate, the protocol proved amenable to afford the C-carboxyazlactones 317, provided 
that the C(4)-substituent was not α-branched or contained the methylthio functionality. With 
N-p-anisoyl-DL-valine (R = i-Pr) and methionine (R = MeSCH2CH2), only the carbonate 
intermediate 316 was obtained, with no detected rearrangement product. With 
N-p-anisoyl-DL-phenylglycine (R = Ph), however, a complex mixture of products was obtained, 
from which the desired rearrangement product could not be isolated. Upon examination of the 
DCC cyclisation of N-p-anisoyl-DL-phenylglycine in isolation, a mixture of products was 
obtained, and carrying this mixture through the multi-step procedure proved detrimental. This 
general procedure, however, allowed rapid access to the desired C-carboxyazlactone products 
317 in very good isolated yield. 
 
 
Figure 91: Domino cascade protocol using N-acyl amino acids and DCC 
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R Ar Isolated yield (%) 
Me Ph 69 
n-Bu Ph 73 
i-Bu Ph 85 
PhCH2 Ph 71 
PhCH2 1-naphthyl 80 
4-BnOC6H4CH2 Ph 84 
i-Pr Ph - a 
MeSCH2CH2 Ph - a 
Ph Ph - b 
a
 Only carbonate intermediate 316 obtained 
b
 Complex mixture obtained 
Table 16: Domino cascade protocol using N-acyl amino acids and DCC 
Section 3.2.2.2: Activation/cyclisation using aryl chloroformates 
Whilst satisfactory, this reaction protocol required two separate manipulations, so we next 
sought to explore a single reaction vessel domino cascade. As such, the use of chloroformates 
with Et3N as both the activating agent131 and the azlactone carboxylation agent, was 
investigated. Firstly, the formation of the carbonate substrate directly from N-acyl amino acids 
was explored. Again using N-p-anisoyl-DL-phenylglycine as the model substrate, a selection of 
chloroformates (methyl, benzyl and phenyl) was investigated (Figure 92). Only phenyl 
chloroformate proved competent in promoting cyclisation to the azlactone intermediate 254. 
Neither benzyl nor methyl chloroformate afforded cyclisation to the azlactone intermediate, 
giving only the mixed anhydride intermediate 327, presumably due to the leaving group capacity 
of aryloxide vs alkoxide. 
Upon addition of an excess of phenyl chloroformate and Et3N, the azlactone 254 underwent 
further carboxylation, but, unlike in the Dakin-West reaction, only O-carboxylation (to the 
carbonate 256) was obtained, nearly instantaneously. It was noted that 2 equivalents of 
chloroformate were insufficient to provide consistently quantitative conversion to the carbonate 
substrate, but increasing to 3 equivalents gave smooth quantitative conversion to the desired 
carbonate, with the formation of diphenyl carbonate 305 as a by-product. This can be explained 
as cyclisation to the azlactone liberates phenoxide, which is then consumed stoichiometrically by 
an equivalent of phenyl chloroformate.  
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Figure 92: Activation/cyclisation using chloroformates 
With a means to preparing carbonates in a single manipulation, the possibility of extending the 
reaction cascade to incorporate an O- to C-carboxyl transfer step using a suitable Lewis base was 
investigated. The Lewis bases DMAP, isothiourea 311 and triazolium salt 128 were examined as 
suitable candidates with which to attempt the domino cascade (Figure 93). Isothiourea 311 was 
surprisingly unable to provide the desired C-carboxyazlactone 266, but pleasingly, DMAP and 
triazolium salt 128 gave good levels of conversion (>85%) the desired C-carboxyazlactone 266 
with catalytic levels of Lewis base. The O- to C-carboxyl transfer step proved relatively slow in 
comparison with the formation of the oxazolyl carbonate intermediate, as the reaction may be 
retarded by the presence of the Et3N·HCl by-product. 
 
 
Figure 93: Multi-step domino cascade using phenyl chloroformate 
With a successful protocol in place, the scope and limitations of this process were investigated 
(Figure 94). The procedure was found to be amenable to a range of primary alkyl substituted 
N-acyl amino acids and with either phenyl or 1-naphthyl chloroformate, affording the desired 
C-carboxyazlactone products 317 in typically 5–60 min and good isolated yield (70–84%). 
Derivatives of the branched amino acids leucine, valine and phenylglycine were all less 
competent with this procedure, giving rise to <60% conversion to the desired 
C-carboxyazlactone. The methionine derivative also proved incompatible, affording only the 
carbonate intermediate 316. 
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Figure 94: Multi-step single manipulation cascade from N-acyl amino acids 
R Ar Isolated yield (%) 
Me Ph 78 
Me 1-naphthyl 70 
n-Bu Ph 78 
PhCH2 Ph 71 
PhCH2 1-naphthyl 70 
4-BnOC6H4CH2 Ph 84 
i-Pr Ph - a 
i-Bu Ph - b 
MeSCH2CH2 Ph - a 
Ph Ph - b 
a
 Only carbonate intermediate 316 present 
b
 Complex mixture obtained 
Table 17: Domino cascade protocol using aryl chloroformates 
Furthermore, the unprotected N-acyl tyrosine derivative 328 (obtained by hydrolysis of ester 
281), was competent in the reaction manifold (Figure 95). By increasing the stoichiometry of 
aryl chloroformate, the protected C-carboxyazlactones 329 and 330 were obtained in very good 
isolated yield.  
 
 
Figure 95: Multi-step domino cascade using the unprotected N-acyl tyrosine 
From this result, a further chemoselectivity was observed in the reaction, namely, that the NHC 
only promoted rearrangement of the oxazolyl carbonate and not of the phenolic carbonate. 
Endeavours to investigate possible Fries rearrangement of diphenyl carbonate 305 however, 
showed that no such rearrangement reaction was possible using the triazolium-derived NHC. 
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Section 3.3: Conclusions 
The scope and limitations of the use of strong metallated base with various NHC classes 
illuminated some interesting differences in reactivity. This was further explored using weak 
bases to generate the active NHC, and this protocol was found to be highly chemoselective: only 
aryl oxazolyl carbonates underwent the desired C-carboxylation, where alkyl carbonates 
appeared inert. 
This, however, proved to be useful, as it allowed the Steglich rearrangement transformation to be 
incorporated into domino cascade protocols. Azlactones can be transformed to their 
C-carboxyazlactone products in one step, or the azlactone precursor, the N-acyl amino acid, can 
be activated and cyclised to its azlactone, and taken through one of two avenues. 
These multi-step protocols represent a synthetic advantage over the more traditional methods of 
preparation as they give rapid access to the desired product, using low catalyst loadings and 
minimal volume of solvent. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4: Mechanistic investigations 
Chapter 4: Mechanistic investigations 
 
67 
Section 4.1: Mechanistic investigations 
Throughout the investigations into the NHC-catalysed Steglich rearrangement process, a number 
of interesting selectivities have been discovered. Firstly, triazolium salts appear to be the best 
precatalyst candidates for the reaction when a strong metallated base (such as KHMDS) is used. 
Secondly, there is a striking difference in the reactivity of triazolium-derived NHCs generated 
using weak bases, promoting the Steglich rearrangements only with aryl oxazolyl carbonates and 
no rearrangement with alkyl oxazolyl carbonates. With such differences in reactivity, we 
questioned if these processes all proceeded via a similar mechanism, and probed this through 
crossover experiments. 
With a mechanism for the NHC-catalysed Steglich reaction proposed similar to that previously 
established using DMAP, namely through generation of a carboxyazolium species, attempts to 
isolate and characterise this proposed intermediate were made. Unfortunately, deprotonation of 
the triazolium salt 128 with KHMDS and treatment with phenyl chloroformate gave a mixture of 
products, from which the proposed carboxyazolium species could never be isolated nor 
identified in solution. Furthermore, identification of the proposed reaction intermediates in situ, 
in particular the hypothesised carboxyl transfer species, proved somewhat difficult to perform 
spectroscopically, even with low catalyst loadings, high dilution and cooling of the reaction. 
Section 4.1.1: Crossover experiments using KHMDS as the base 
Whilst not being able to identify or isolate the intermediate carboxyl transfer species directly, the 
behaviour of the presumed carboxyl transfer species was probed by examination of the product 
distributions arising from crossover experiments between different substrates. Based upon our 
proposed catalytic cycle (Figure 96), the triazolinylidene catalyst 247 first attacks the 
electrophilic carbonate carbonyl to form the tetrahedral intermediate 332. This intermediate then 
collapses to afford the carboxyl transfer species 333 and azlactone dienolate 232 as an ion pair, 
which then recombine to deliver the desired rearranged product 334, again, presumably via a 
tetrahedral intermediate.  
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Figure 96: Proposed catalytic cycle 
Section 4.1.1.1: Using optimal triazolium-derived NHC  
The most effective NHC catalyst in the Steglich rearrangement is that derived from triazolium 
salt 128 with KHMDS as the base, a combination that promotes rearrangement of all oxazolyl 
substrates irrespective of carbonate substituents. This set of conditions was used as a reference 
point for all of the subsequent investigations, with the hope that comparisons would help to 
explain the chemoselectivities with the less successful protocols. As such, phenylalanine-derived 
phenyl carbonate 256 and alanine-derived methyl carbonate 244 were chosen as suitable 
candidates for the initial crossover reactions, as all potential crossover products had previously 
been prepared, isolated and characterised and, importantly, could be identified spectroscopically.i 
Under the optimised reaction conditions, treatment of a 50:50 mixture of carbonates 256 and 244 
gave a near statistical mixture of all four potential rearrangement products (22:28:27:23 ratio of 
248:246:266:249) (Figure 97) upon 1H NMR spectroscopic analysis of the crude reaction 
product. The observation of crossover products indicates that there is at least one intermolecular 
step in the reaction manifold, and that any such ion pair intermediates may be held together 
relatively weakly in solution, allowing appreciable crossover. Within the group, other studies 
have shown that resubjecting mixtures of the isolated rearrangement products 246 and 266 to the 
reaction conditions, only 246 and 266 are returned, with no crossover to the recombination 
products 248 or 249. This indicates that the C-C bond-forming step in this process is irreversible. 
                                                 
i
 All further crossover experiments were also chosen as each individual possible recombination product had also 
been isolated and fully characterised. 
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Figure 97: Crossover using optimal triazolinylidene catalyst 
At this point, the only indication of the mechanism is that an intermolecular step is involved in 
the mechanism. Cognisant of the relatively reactive nature of phenyl carbonate 256, a related 
crossover experiment with two less reactive carbonate substrates was investigated, to enable 
identification of any potential intermediates in the reaction prior to the reaction reaching 
completion. By investigating two alkyl carbonates, trichlorodimethylethyl carbonate 258 and 
methyl carbonate 244, under the same reaction conditions, similarly consistent crossover was 
observed to those with the phenyl and methyl carbonates discussed above. In order to allow 
identification of any potential intermediates, the rate of rearrangement was impeded by 
employing low catalyst loading (1 mol%) and at high dilution (~2 mM for the active NHC 247) 
(Figure 98). In this case, a mixture of the four possible carbonates was obtained after only 5 min 
(6–7% of both crossover carbonates); after 30 min a mixture of all four carbonates (~80% of the 
total mixture) and all four rearrangement products (~20% of the total mixture), in approximately 
equal proportions was obtained. This near statistical mixture of the carbonates indicates that an 
initial O-transcarboxylation process is occurring, presumably through recombination of the 
postulated carboxyl transfer agent and dienolate on oxygen, and that this is a relatively fast and 
reversible process, with a subsequent slower C-carboxylation step. Though an 
O-transcarboxylation step is occurring, the nature of the final transformation (from the dienolate 
232 and carboxyazolium intermediate 333) to the C-carboxyazlactone product 334 cannot be 
investigated, as the crossover step has already occurred in the manifold (Figure 104). 
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Figure 98: Impeded crossover reaction 
Section 4.1.1.2: Using imidazolium-derived NHCs 
In light of the observation that thiazolium and imidazolium-derived NHCs were considerably 
less effective in promoting the Steglich rearrangement (Chapter 2), similar crossover 
experiments with imidazolium salts IMes HCl and SIMes HCl were investigated, to ascertain 
why these NHCs were ineffective (Figure 99). Very different results were obtained with the 
imidazolium-derived NHCs: complete crossover to a statistical mixture of all four carbonate 
substrates (as can be suggested with the triazolinylidene from an O-transcarboxylation process), 
but no rearrangement, was observed, even after an extended reaction time. This indicates that the 
NHCs are indeed highly Lewis basic in character, but that the nature of the carboxyl transfer 
species between the different catalyst classes has a dominant effect upon the viability of the 
C-carboxylation event, giving rise to this chemoselectivity. Whilst similar mechanisms could be 
invoked to explain the reactions, Zipse and co-workers have shown that Brønsted basicity (i.e. 
pKa) does not correlate directly to Lewis basicity in a related Lewis base-promoted reaction, the 
Baylis-Hillman reaction. The authors note that methyl cation affinity, rather than proton affinity, 
can be used to better correlate catalyst reactivity.132 To date, no such methyl cation affinity data 
for NHCs have been determined, but the nature of the carboxyl transfer species between these 
different classes could be sufficiently different as to observe this difference in behaviour. 
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Figure 99: Imidazolinylidene crossover reaction, giving only O-transcarboxylation 
Section 4.1.2: Crossover experiments using Et3N as the base 
Cognisant of the results obtained in crossover studies using strong metallated bases KHMDS, 
related experiments employing Et3N were investigated. In order to propose explanations for the 
observed chemoselectivity with Et3N, comparative crossover reactions were first carried out 
using an imidazolium and triazolium salt, using Et3N as the base. Having shown that aryl 
carbonates are amenable to rearrangement with Et3N as the base, a crossover reaction between a 
reactive phenyl carbonate 256 and an apparently unreactive methyl carbonate 244 was 
investigated (Figure 100). In this case, triazolium salt 128 and Et3N gave exclusively the 
rearrangement product 266 and returned carbonate 244, consistent with the chemoselectivity 
observed in the previous reactions. No O-transcarboxylation processes were observed.  
 
  
Figure 100: Chemoselectivity in crossover with Et3N 
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Having observed exclusive reactivity with only the phenyl carbonate substrate, a crossover 
reaction between two aryl carbonates was investigated (Figure 101). Treatment of a 50:50 
mixture of phenyl carbonate 256 and 1-naphthyl carbonate 338 gave, under the standard 
conditions, a near statistical mixture of the four possible rearrangement products 
266:339:272:248 (23:22:27:26 ratio). Upon adjustment of the reaction conditions in order to 
impede the reaction rate,i a mixture of all eight possible products was observed, again consistent 
with a reversible O-carboxylation process followed by a presumably slower C-carboxylation 
event. 
 
 
Figure 101: Crossover with two aryl carbonates using Et3N 
Finally, two unreactive alkyl carbonate substrates, trichlorodimethylethyl carbonate 258 and 
methyl carbonate 244, were investigated in crossover reactions. Both imidazolium and 
triazolium salt were evaluated as NHC precatalysts, in order to ascrtain if there were any 
differences in their behaviour (Figure 102). Using stoichiometric Et3N as the base, neither SIMes 
HCl nor triazolium salt 128 promoted any carboxyl transfer processes, returning exclusively the 
starting carbonates even after extended reaction times (up to 16 h). For the imidazolinium salt, 
the considerably larger difference in pKa/pKaH between the imidazolinium salt and Et3N could 
account for the poor reactivity, as a considerably lower concentration of active NHC would be 
generated than in the corresponding reaction using KHMDS (where O-transcarboxylation was 
                                                 
i
 A low catalyst loading of 1 mol%, 0.9 mol% Et3N and at a maximum theoretical NHC 247 concentration of ~2 mM 
was used. 
Chapter 4: Mechanistic investigations 
 
73 
observed). With the triazolium salt, however, this further confirms that there is a marked 
chemoselectivity difference between NHCs generated with different bases. 
 
 
Figure 102: Crossover of alkyl carbonates with NHCs generated using Et3N 
In order to underpin the nature of the final C-carboxylation step using Et3N as the base, a 50:50 
mixture of phenylalanine-derived phenyl ester 266 and alanine-derived 1-naphthyl carbonate 
substrate 338 was subjected to the reaction conditions (Figure 103). From this crossover 
reaction, unsurprisingly, only the two rearrangement products 266 and 339 were returned, 
indicating that the final C-C bond-forming step in the reaction is irreversible, consistent with the 
findings using KHMDS. 
 
 
Figure 103: Irreversible C-C bond formation from crossover reaction 
Section 4.1.3: Exploration of the chemoselectivity 
Taken together, these crossover experiments further support the findings that triazolinylidene 
NHCs generated from both KHMDS and Et3N proceed through a similar mechanistic pathway, 
via an initial O-transcarboxylation event followed by a slower C-carboxylation process in which 
the C-C bond formation is irreversible (Figure 104). 
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Figure 104: Completed catalytic cycle for triazolinylidene-promoted Steglich rearrangement 
This mechanistic proposal does not, however, account for the difference in chemoselectivity in 
the process using Et3N as the base. The results of these crossover studies allow a number of 
potential explanations for the chemoselectivity to be proposed. Firstly, the nature of the NHC 
generated with a metallated base and with Et3N could be significantly different, as to alter the 
Lewis basicity of the NHC species due to the presence (or absence) of a related counterion. In 
reactions using KHMDS to generate the NHC, the by-product KBF4 is produced, whereas when 
using Et3N as the base, the counterion is the Et3NH+ cation. The interplay between the NHC and 
the counterion (the ammonium or K+ cation) could play a role in the chemoselectivity of the 
rearrangement process, or simply, that the cation could play a role in activation of the substrate.
 
Having shown that doping of Et3N·HCl to a reaction impeded the carboxyl transfer process (see 
Table 10, page 50), the related effect with KBF4 was examined (Figure 105). Doping of 1 equiv 
of KBF4 to the reaction mixture containing phenyl carbonate 256 resulted in a significant rate 
enhancement, giving >95% conversion to the C-carboxyazlactone 266 after 60 min, as opposed 
to requiring 120 min. However, the related experiment using methyl carbonate 255 gave no 
rearrangement product, consistent with the chemoselectivity of this process not being affected by 
the presence of KBF4.  
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Figure 105: Effect of addition of KBF4 
In order to examine if the presence of KBF4 affected the O-transcarboxylation process, a related 
crossover experiment of phenyl carbonate 256 and methyl carbonate 244 was carried out in the 
presence of 1 equiv KBF4 (Figure 106). This crossover experiment also returned the same 
product distribution to that in the absence of KBF4, promoting the rearrangement of exclusively 
the phenyl carbonate. Thus, the K+ cation could be acting as a cooperative Lewis acid catalyst in 
the reaction manifold, enhancing the electrophilicity of the carbonate carbonyl, but not affecting 
the chemoselectivity of the process. 
 
  
Figure 106: Chemoselectivity in crossover with Et3N 
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In order to better understand the differences in reactivity, delineation of the exact nature of the 
generated NHC was attempted. As Alder and co-workers have shown that imidazolium-derived 
NHCs form complexes with alkali metal cations,133 a related complexation event may also be 
present in the generation of the NHC 247 using KHMDS. Alder had shown that the presence of 
such “free” or complexed NHCs can be detected spectroscopically, so related experiments were 
performed with the triazolium salt 128. To allow rapid analysis of the substrate by 13C NMR 
spectroscopy, the 13C-labelled triazolium salt 3-13C-128 was prepared from lactam 260 and 
>99% isotopically enriched triethyl orthoformate (Scheme 6), with complete 13C incorporation at 
C(3) of the triazolium salt 128.i  
 
Scheme 6: Preparation of the isotopically enriched triazolium salt 3-13C-128 
There have been only very limited investigations into the nature of such “free” triazolinylidenes, 
though Enders and co-workers have isolated NHC 341 by pyrolysis of methanol adduct 340, 
which has a characteristic free carbene chemical shift of δC ~215 ppm.134  
 
Figure 107: Preparation of the free triazolinylidene 341 
Upon inspection of a mixture of triazolium salt 3-13C-128 in THF which had been treated with 
KOt-Bu and catalytic NaH, an apparent single product, δC ~227 ppm, was obtained. Upon 
treatment of the same triazolium salt 3-13C-128 with 1 equiv of KHMDS, however, a number of 
13C-labelled species were identified, all with chemical shifts in the expected range for free NHCs 
and NHC complexes (δC >200 ppm). In this reaction manifold, solid precipitate was deposited 
over time, suggesting that the species in solution were only sparingly soluble, and thus the 
analysis was a reflection of only the species present in solution. Nonetheless, this observation 
tentatively suggests that KHMDS promotes the formation of both complexed and free NHC in 
solution.  
                                                 
i
 Incorporation determined spectroscopically by 1H and 13C NMR techniques. 
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In order to ascertain the nature of the NHC derived using Et3N, similar experiments were 
performed, but no detectable traces of any NHC species were observed. This could be due to the 
difference in pKa of the two species, so neat Et3N was employed as the solvent, but only the 
isotopically enriched triazolium salt 128 was identified in solution. 
Though attempts to rationalise the chemoselectivity by these means have proven inconclusive, a 
number of other postulated processes could account for the difference in chemoselectivity. 
If the difference in electrophilicity of the aryl and alkyl carbonate substrates was responsible for 
the chemoselectivity, the active species would still be generated in all cases, even if only in small 
quantities. As no crossover is observed after even extended reaction times, this proposal can be 
excluded. An alternative explanation is that the nature of the ion pair in the different reactions is 
important. The metallated dienolate may be responsible for the enhanced reactivity in reactions 
using KHMDS, whereas with Et3N, the conjugate acid cation may H-bond to the dienolate, thus 
changing its chemical behaviour. In order to investgate if the generated by-products have a 
bearing on the chemoselectivity, in collaboration with Prof. S. Nolan at the University of St 
Andrews, means to generate the free NHC 247 (in the absence of such by-products) is being 
investigated, with subsequent evaluation of this NHC in this rearrangement process. 
Section 4.2: Summary 
A thorough investigation of the mechanism of the Steglich rearrangement has been undertaken in 
order to rationalise the behaviour of both substrate and catalyst in the reaction manifold. 
While all metallated base-derived NHCs behave as Lewis bases, the nature of the 
carboxyazolium intermediate appears important in promoting rearrangement. Carboxytriazolium 
intermediates promote rapid and reversible O-carboxylation but also promote the desired 
C-carboxylation. The related imidazolium-derived carboxyazolium intermediates, however, 
promote rapid O-carboxylation but only promote appreciable levels of C-carboxylation with aryl 
oxazolyl carbonates. 
Et3N-Derived NHCs are considerably less reactive than those obtained using strong metallated 
bases, but aryl oxazolyl carbonates are successfully rearranged using a triazolium salt and Et3N 
as the base. The chemoselectivity in the process was further confirmed through crossover 
experiments.  
A possible explanation for this chemoselectivity could be the subtle difference in the nature of 
the NHC or the carboxyazolium intermediate, as the related counterion could affect the 
properties of the species in the reaction pathway. For example, Movassaghi and co-workers have 
shown that NHCs can form complexes with protic solvents to form azolium alkoxides which are 
held together by H-bonding interactions.135 In reactions where Et3N has been used to generate 
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the active NHC, this could give rise to a similar NHC···H-NEt3+ complex, though attempts to 
identify such species have proven unfruitful. 
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Section 5.1: Synthesis of chiral azolium salt precatalysts 
Having fully evaluated the scope and limitations of the Steglich rearrangement with achiral 
NHCs, the asymmetric variant was next examined. To investigate the asymmetric Steglich 
rearrangement, a library of enantiomerically pure azolium salts as precursors to the desired chiral 
NHC catalysts was compiled. 
Section 5.1.1: Chiral imidazolium salts 
Section 5.1.1.1: C2-Symmetric imidazolium salts 
The first set of chiral NHC precatalysts chosen for preparation were the imidazolium salts, as the 
inherent C2-symmetry of the imidazolium core was appealing. Even if predicted to be less 
effective than triazolium-derived NHCs, the C2-symmetry would restrict the number of reactive 
conformations of the proposed carboxyazolium cation 342 and may prove to be good candidates 
for asymmetric induction (Figure 108).  
 
 
Figure 108: Proposed conformational restriction of the carboxyl moiety about a C2-axis 
Choosing the α-methylbenzyl stereodirecting unit, the C2-symmetric imidazolium salt 344 was 
prepared from the commercially available (S)-α-methylbenzylamine 343, paraformaldehyde, 
glyoxal and aqueous tetrafluoroboric acid as a source of the required counterion in a one-pot 
procedure (Figure 109). 
 
 
Figure 109: Preparation of imidazolium salt 344 
The related imidazolinium salt 348 was prepared in three steps from (S)-α-methylbenzylamine 
343 and glyoxal 345. Condensation gave diimine 346 in quantitative crude yield, which was 
reduced with lithium aluminium hydride to afford the diamine 347, then cyclised using triethyl 
orthoformate and ammonium tetrafluoroborate in methanol to afford the imidazolinium salt 348 
in good yield over the two steps (Scheme 7).  
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Scheme 7: Preparation of imidazolinium salt 348 
A third imidazolium-based catalyst series was synthesised based upon the Bisox ligand 353 
scaffold (Scheme 8). By formation of an imidazolium salt between the two oxazoline rings, 
tricyclic C2-symmetric imidazolium salt IBox HOTf 354 was synthesised. Edwards and 
co-workers had reported a three step protocol for conversion of (S)-valinol 350 to the desired 
Bisox ligand 353.136 Access to (S)-valinol 350 was achieved by reduction of (S)-valine 349 using 
sodium borohydride and iodine.137 Formation of diamide 351 was achieved using diethyl oxalate, 
followed by conversion of diol 351 to dichloride 352 using thionyl chloride, with final ring 
closure to the bisoxazoline 353 using sodium hydroxide. Pleasingly, this process was achieved 
smoothly in very good yield (63% over the three steps). Cyclisation to the imidazolium salt 354 
was effected according to literature precedent138 using chloromethyl pivalate and silver triflate in 
good yield. 
 
 
Scheme 8: Preparation of IBox HOTf precatalyst 354 
A fourth NHC precatalyst class was based upon the cyclohexanediamine scaffold, by conversion 
of enantiopure (R,R)-1,2-trans-diaminocyclohexane to the imidazolinium salt 359 (Scheme 9). 
This was achieved via an initial resolution of a mixture of the three possible 
1,2-diaminocyclohexane stereoisomers using L-tartaric acid, affording the (R,R)-diamine as the 
L-tartrate salt 356,139 which was then converted to its dibenzylidene dimine 357, reduced to its 
dibenzylamine 358, then cyclised with triethyl orthoformate and ammonium tetrafluoroborate 
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promoted cyclisation to the desired imidazolinium salt 138 in very good yield. The dibenzyl 
derivative was chosen as the stereodirecting cyclohexyl unit would be somewhat remote from 
the carboxyazolium moiety, and we envisaged that the conformationally flexible N-benzyl 
groups could exhibit a chiral relay effect, a transmission or amplification of chiral information 
within that substrate close to the point of the reaction through conformational 
restraints.140,141,142,143 
 
Scheme 9: Preparation of imidazolinium salt 138 
Section 5.1.1.2: C1-Symmetric imidazolium salts 
To complement the set of C2-symmetric salts, a range of bespoke chiral imidazolinium salts were 
prepared from the chiral pool of amino acids.144 As an illustration of this methodology, several 
routes were investigated as there were a number of points of diversification. The first strategy 
illustrated preparation of a ‘mixed’ N-alkyl, N′-aryl substituted imidazolinium salt 362. Initial 
Boc protection of L-valine was achieved under Schotten-Baumann type conditions in good yield, 
followed by amide coupling via the mixed anhydride and trapping with the requisite aniline, in 
this case, 2,5-dimethylaniline. Boc-protected amide 360 was fully reduced to the desired diamine 
intermediate 361 by treatment with excess LiAlH4 at reflux in THF, affording the N-aryl, 
N′-methyl diamine in excellent yield, which was pleasingly cyclised to the desired 
imidazolinium salt 362 with triethyl orthoformate and ammonium tetrafluoroborate in moderate 
yield. 
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Scheme 10: Preparation of C1-symmetric catalyst  
A particular problem found with peptide-type coupling is that of racemisation of the sensitive 
α-position. To attempt to ascertain the stereochemical integrity of the transformations in the 
synthesis, enantiomerically pure (S)-α-methylbenzylamine was employed as a diastereomeric 
marker. The synthetic route was carried out using both enantiomerically pure L-valine and 
racemic DL-valine, with only enantiomerically pure (S)-α-methylbenzylamine as the amide 
coupling partner (Figure 110). 1H NMR Spectroscopic analysis indicated a 50:50 mixture of 
diastereomers in the preparation using DL-valine, but only one diastereomer was detected in the 
amide coupling with enantiomerically pure L-valine, so stereochemical integrity was assured 
during the amide coupling step. 
 
 
Figure 110: Use of a stereochemical marker 
To ascertain if racemisation was occurring in the reduction step, both the single diastereomer and 
the mixed diastereomeric product were both subjected to LiAlH4 reduction. Surprisingly, it 
appeared that the alkylamine-derived products 363 and 364 were ill-suited to the reduction, even 
under considerably more forcing conditions with large excesses (>10 equiv) of reducing agents 
LiAlH4 or BH3·THF at reflux for 7 days. This may be attributable to the difference in 
electrophilicity between the alkylamides and arylamides, but the exact nature of these processes 
is unclear; Voight and co-workers note that such reductions of (Boc-amino) and amino amides 
are often unreliable and give low to moderate yields of secondary amines.145 This has been 
attributed to incomplete reactions, difficulty in the cleavage of the B–N bond following 
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reduction with borane, and side-reactions, particularly leading to significant amounts of cyclic 
ureas when using LiAlH4. 
It was envisaged that a library of N-alkyl, N′-aryl substituted imidazolinium salts could be 
prepared via alkylation of imidazolines (Scheme 11). The chiral imidazoline, or amidine, 367 
was prepared by deprotection of the carbamate functionality of the previously prepared amide 
360 using TFA, followed by full reduction of the amino amide 365 with LiAlH4 to afford the 
diamine 366 in excellent yield and purity. The diamine 366 was converted to the desired amidine 
367 using triethyl orthoformate and NH4BF4 as a source of acid, in very good yield. It was noted 
at this juncture that this amidine intermediate, whilst key in attempting to prepare a number of 
imidazolinium salts, could in fact act as a Lewis base catalyst in its own right. Completing the 
synthetic strategy, alkylation was attempted using benzyl bromide followed by anion exchange 
to afford the desired imidazolinium salt 368. Whilst partially successful, purification proved 
difficult due to the polar nature of the by-products, however, alkylation of the analogous 
phenylalanine-derived amidine 372 proved highly successful in obtaining the purified product 
373, as demonstrated by a colleague in the group.i 
 
 
Scheme 11: Preparation of chiral amidines and alkylation to imidazolinium salts 
                                                 
i
  Demonstrated by Eddy Kallström, MChem Masters thesis 2009, University of St Andrews. 
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With a benzyl substituted phenylalanine-derived imidazolinium salt in hand, the related 
imidazolinium salt 377 with the isopropyl stereodirecting group was prepared via acylation of 
L-valine (Scheme 12). Under Schotten-Bauman conditions, N-benzoylvaline 374 was prepared in 
good yield, which was then transformed to the diamide via the mixed anhydride and treatment 
with the relevant aniline. Reduction of the diamide 375 with LiAlH4 or BH3 (generated in situ 
from NaBH4 and I2) gave, after extended reaction times (>7 days) with a large excess of 
reducing agent, a mixture of reduction products. Nonetheless, an acceptable yield (80%) of the 
desired diamine 376 was obtained following chromatographic purification, which was 
transformed to the desired imidazolinium salt 377 under the established protocols using triethyl 
orthoformate and ammonium tetrafluoroborate in excellent yield. 
 
 
Scheme 12: Preparation of the chiral imidazolinium salt 377 
Cognisant of the reports of Voight and the difficulties experienced in our hands, an alternative 
route to preparing such substituted imidazolinium salts was sought, particularly as a dialkyl 
substituted imidazolinium salt had yet to have been prepared readily. In collaboration with a 
colleague,i a method to prepare such dialkyl-substituted imidazolinium salts was developed by 
reductive amination of phenylalanine-derived amino amide 378 using benzaldehyde and 
NaBH(OAc)3, followed by reduction of the alkylated amide 379 and final cyclisation using 
triethyl orthoformate and NH4BF4 in excellent yield (Scheme 13). 
 
 
Scheme 13: Synthesis of the dialkyl substituted imidazolinium salt 380 (prepared by Eddy Kallström)  
                                                 
i
  Prepared by Eddy Kallström using the phenylalanine-derived substrate, MChem Masters thesis 2009, University 
of St Andrews. Attempts to repeat this strategy with the analogous valine derivative proved unsuccessful. 
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Section 5.1.2: Chiral triazolium salts 
Cognisant of the improved reactivity observed in the Steglich rearrangement employing 
triazolium-derived NHCs in the racemic series, a diverse library of chiral triazolium salts were 
designed and prepared. Such triazolium salt scaffolds were generally prepared according to the 
one-pot transformation from the requisite lactam, pioneered by Leeper and co-workers33 and 
reinvestigated by Rovis and co-workers146,147 To evaluate fully the potential of chiral 
triazolium-derived NHCs in the asymmetric Steglich rearrangement, a range of potential 
scaffolds were identified (Figure 111). The closest relative to the achiral triazolium salt 
precatalyst, the most successful NHC architecture (see Chapters 2–4), was that based upon 
structure 381, derived from chiral pyrrolidones of the form 384. Maintaining a 5:5-bicyclic 
scaffold, incorporation of an oxygen atom was envisaged to perturb the electronic properties of 
the NHC ring system (i.e. scaffolds of the form 382), which could be derived from 
oxazolidinones 385. Finally, variation of the ring size was identified, with 6:5-fused ring systems 
383 chosen as the target, ultimately derived from morpholinones 386.  
 
 
Figure 111: Set of lactam, oxazolidinone and morpholinone-derived triazolium salts 
A range of such triazolium salts was prepared following procedures described in the literature or 
from common precursors in the literature, derivatives of materials from the chiral pool. Whilst 
many of these desired salts have been prepared previously in the literature, explicit preparative 
methods of both the intermediates and product triazolium salts were often not given, so our 
initial aim was to develop successful synthetic procedures in order to prepare these precatalysts. 
The first chiral triazolium salt 56, bearing the identical bicyclic architecture to the achiral 
triazolium salt 128, was prepared following literature precedent from L-phenylalanine 
(Scheme 14).147 Treatment of L-phenylalanine with Boc2O under Schotten-Bauman type 
conditions afforded the N-Boc amino acid. The crude protected amino acid was treated with 
DCC and Meldrum’s acid to afford the ketomalonate product 387, which was again carried 
through crude to the next step. Reduction with sodium borohydride gave the coupled malonate 
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derivative 388 by full reduction of the keto-functionality, in good yield after purification. 
Pyrolysis of this malonate derivative in toluene at reflux gave the desired Boc-protected lactam 
389, which was then deprotected with trifluoroacetic acid to obtain pyrrolidinone 390 in 
quantitative yield over the two steps. Following the standard protocol for transformation of 
lactams to triazolium salts, namely, through conversion to the methyl imino ether with 
trimethyloxonium tetrafluoroborate, the amino hydrazone with phenylhydrazine and cyclisation 
with triethyl orthoformate, the desired triazolium salt 56 was obtained in good yield.  
 
 
Scheme 14: Preparation of the 5:5-fused bicyclic catalyst 56 
Another triazolium salt based on this 5:5-fused scaffold was prepared starting from 
commercially available (S)-pyroglutamic acid 391 (Scheme 15). Treatment of the pyroglutamic 
acid 392 with thionyl chloride in methanol afforded the methyl pyroglutamate 392 in 
quantitative yield, which was treated with excess phenylmagnesium bromide to afford the 
tertiary alcohol 393 in good yield. Though successful, further developments in the group have 
led to the use of phenyllithium as the organometallic reagent, generated in situ from 
bromobenzene and n-BuLi, which considerably simplifies the purification step. Silyl protection 
was achieved by treatment of the alcohol 393 with excess tert-butyldimethylsilyl triflate and 
Et3N in several portions in generally good isolated yield. The lactam 394 was then transformed 
into the desired triazolium salt 134 according to the literature procedure, using the standard 
conditions via the imino ether and imino hydrazone salts. 
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Scheme 15: Synthesis of the pyroglutamic acid-derived triazolium salt 
The related oxazolidinone-derived triazolium salts were next prepared from the known 
SuperQuat auxiliaries 385, prepared from the requisite amino acids L-phenylalanine and L-valine 
(Scheme 16).148 The amino acids were first converted to their methyl ester hydrochlorides 395 
then Boc-protected in good yield. Treatment of the esters 396 with methylmagnesium bromide 
afforded the tertiary alcohols 397 in good yield, which were then cyclised to the desired 
oxazolidinones 398 with KOt-Bu in excellent yield. With the key oxazolidinones in hand, the 
standard three-step protocol afforded the desired triazolium salts 164 and 399 in good yield over 
the three steps. 
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Scheme 16: Synthesis of oxazolidinone-derived triazolium salts  
To complement the set of 5:5-fused bicyclic triazolium salts, a number of 5:6-fused bicyclic salts 
were prepared based on the morpholinone architecture. The first of such morpholinone-derived 
triazolium salts was the phenylalanine-derived salt 403 (Scheme 17). The desired 
1,2-aminoalcohol 400, the precursor to the morpholinone, was prepared by borane reduction of 
L-phenylalanine to phenylalaninol 400 using sodium borohydride and iodine. The desired 
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morpholin-3-one 402 was obtained by a two-step sequential protocol, firstly through amide 
coupling with chloroacetyl chloride, then intramolecular cyclisation with KOt-Bu in good 
isolated yield over the two steps. With the desired lactam in hand, transformation to the desired 
triazolium salt 403 was achieved using the standard conditions in moderate yield. 
 
 
Scheme 17: Preparation of the 6:5-fused bicyclic catalyst 
In order to increase the effect of the stereodirecting group, the gem-diphenyl substituted 
triazolium salt 407 was prepared (Scheme 18). It was believed that the presence of the phenyl 
groups in the constrained ring may restrict the degrees of freedom about the stereodirecting 
benzyl group, thereby enforcing orientation further towards the active site of the generated 
NHC.149 The desired substituted morpholinone intermediate 406 was again prepared from 
L-phenylalanine, with first conversion to its methyl ester hydrochloride 251. Treatment of the 
ester hydrochloride with excess phenylmagnesium bromide gave irreproducible isolated yields of 
the desired amino alcohol 404, but conversion to the phenylalanine methyl ester free base and 
treatment with phenylmagnesium bromide gave more reliable isolated yields of the desired 
product 404. Following the same two step procedure as for phenylalaninol, the desired 
morpholinone 406 was obtained in excellent yield. Final transformation to the desired triazolium 
salt 407 was achieved by the standard three-step protocol in moderate yield. 
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Scheme 18: Preparation of the more sterically constrained 6:5-fused bicyclic catalyst 
The chiral NHC precatalyst 137 developed by Rovis looked attractive to access potential 
asymmetric Steglich rearrangements, having been demonstrated to effect asymmetric Stetter 
reactions with high enantioselectivity.146 Starting from commercially available aminoindanol 
408, the conversion to morpholin-3-one derivative 409 was investigated. Surprisingly, the two 
step sequential process using either chloroacetyl chloride or bromoacetyl bromide gave a 
complex mixture of products. Variation of the conditions and with a range of potential 
dielectrophiles gave mixtures of the desired morpholinone 409 and its regioisomeric product 
410. Where the usual two-step protocol proceeds via amidation followed by alkoxide-promoted 
SN2 ring closure, inversion of the reaction sequence was optimal in promoting successful 
morpholinone formation. The initial amidation process, however, was a significant competing 
pathway. The optimal conditions were found using ethyl chloroacetate with the anion of the 
aminoindanol 408, at elevated temperature (66 ºC). This improved the ratio of 
3-morpholinone:2-morpholinone to 71:29, from which the desired morpholinone product 409 
was isolated in good yield (63%) (Scheme 19). 
 
 
Scheme 19: Selectivity issue with formation of the desired 3-morpholinone 409 
Following the standard protocol for conversion of lactam to triazolium salt, the desired 
aminoindanol-derived triazolium salt 137 was obtained in good yield over three steps 
(Scheme 20). 
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Scheme 20: Preparation of the precatalyst 137 
Finally, oxazolidinone 413 and morpholinone 414 targets were prepared from the terpene 
D-camphor 410 (Scheme 21). α-Oximation was achieved via treatment of the camphor enolate 
with i-amyl nitrite, giving as a mixture of E- and Z- diastereomeric oximes 411 in excellent 
yield. Both the oxime and ketone functionalities were reduced with LiAlH4 to afford the 
syn-1,2-aminoalcohol 412 in excellent yield and high dr (~8:1). The amino alcohol 412 was 
diversified via treatment with triphosgene to afford the oxazolidinone 413, and using 
chloroacetyl chloride followed by intramolecular cyclisation to the morpholinone analogue 414, 
both in moderate yield. 
 
Scheme 21: Preparation of the camphor-derived oxazolidinone 413 and morpholinone 414 
With the key intermediates in hand, preparation of the desired triazolium salts via the three-step 
procedure was investigated (Scheme 22). The morpholinone 414 underwent successful 
transformation to the desired triazolium salt 416 in moderate yield, however, reaction with the 
camphor-derived oxazolidinone 413 gave a complex mixture of products. 
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Scheme 22: Preparation of the camphor-derived precatalyst 416 
Section 5.2: Enantioselective Steglich rearrangements 
Section 5.2.1: Investigations with model phenyl carbonate 
To evaluate the potential of performing the Steglich rearrangement asymmetrically using chiral 
NHCs, phenylalanine-derived phenyl carbonate 256 was chosen as the model substrate. This 
carbonate had proven to be one of the most readily rearranged substrates and the product ee 
could be determined readily by chiral HPLC.i The set of standard conditions developed in the 
achiral series, namely 10 mol% of azolium precatalyst, 9 mol% KHMDS as the base and THF as 
the solvent, were used and reactions were carried out at ambient temperature.  
Section 5.2.1.1: Imidazolium-derived NHCs 
Studies using the imidazolium-derived NHC were not encouraging (Figure 112, Table 18). 
C2-Symmetric imidazolium salts 344, 348, 354 and 138 as NHC precursors gave either low 
conversion to the desired product 266 (in the case with azolium salt 354), or quantitative 
conversion but low enantioselectivities of <5% ee. Evaluation of the C1-symmetric 
imidazolinium NHC precatalysts 362, 377 and 380 also showed that these were unsuitable 
candidates, giving low conversion to the desired rearrangement product or with low levels of 
enantiomeric enrichment (<5% ee). 
 
 
 
 
 
                                                 
i
 Chiral HPLC analysis used to determine all enantioselectivities, using a CHIRALPAK AD or OD-H column. 
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Figure 112: Asymmetric Steglich rearrangement with chiral diazolium salt-derived NHCs 
Imidazolium 
salt 
Conversion 
(%) a 
ee of (R)-266 
(%) b 
344 70 <5 
348 >98 <5 
354 <5 - 
138 65 11 
362 75 <5 
377 ~20 - 
380 ~65 <5 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
b
 Small samples of purified material isolated by silica chromatography in order to determine ee by chiral HPLC. 
Table 18: Imidazolium-derived NHCs in the asymmetric Steglich rearrangement 
The apparent low reactivity of these imidazolium-derived NHCs would not be expected due to 
steric effects, as the achiral relatives IMes and SIMes both promoted high levels of conversion to 
the desired C-carboxyazlactone product 266. With many of these chiral imidazolium-derived 
NHCs bearing less sterically demanding N-substituents than those of the achiral IMes and SIMes 
NHCs, the reduced reactivity could be due to carboxyazolium and dienolate recombination to 
reform the carbonate substrate 256. This would be consistent with the observations noted using 
SIMes in crossover experiments. Similar such studies, however, have not been undertaken using 
these chiral imidazolium-derived NHCs. 
Section 5.2.1.2: Triazolium-derived NHCs 
Having determined an enhanced reactivity profile of triazolium-derived NHCs in the achiral 
series, the asymmetric Steglich rearrangement using chiral triazolium-derived NHCs was next 
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investigated, beginning with the 5:5-fused bicyclic triazolium salts 56, 134, 399 and 164 
(Figure 113, Table 19). 
 
 
 
 
Figure 113: 5:5-Fused bicyclic triazolium-derived NHCs in the asymmetric Steglich rearrangement 
Triazolium salt Solvent Conversion (R)-266:254 (%) a 
ee of (R)-266 
(%) 
56 THF ~70:30 <5 
56 toluene ~55:45 <5 
134 THF >98:<2 20 (ent) 
134 toluene 95:5 20 (ent) 
399 THF >98:<2 <5 
399 toluene >98:<2 34 
164 THF >98:<2 16 
164 toluene 88:12 31 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
Table 19: 5:5-Fused bicyclic triazolium-derived NHCs in the asymmetric Steglich rearrangement 
Using the standard conditions in THF, these triazolium-derived NHC catalysts proved effective 
in promoting efficient rearrangement, generally obtaining the desired C-carboxyazlactone 266 in 
>98% conversion within 1 h. The least effective precatalyst was the pyrrolidinone-derived 
triazolium salt 56, affording a ~70:30 mixture of desired product 266 to the decarboxylated 
product, azlactone 254.i The levels of enantioenrichment, however, were modest (≤20% ee). By 
repeating the reactions using toluene as the solvent, the competing formation of azlactone 254 
was more pronounced, though the phenylalanine-derived precatalyst 399 suffered no such loss in 
product formation. The change of solvent to toluene also generally resulted in an increase in the 
enantioselectivity of the process, with the phenylalanine-derived precatalyst 399 proving optimal 
also in terms of enantioselectivity (34% ee). 
The range of morpholinone-derived NHC-precatalystsii was evaluated under similar conditions 
(Figure 114, Table 20). Similar trends of reactivity and enantioselectivity were obtained with 
                                                 
i
 Similar proportions of diphenyl carbonate 305 are also assumed, though precise measurement was not possible 
spectroscopically. 
ii
 Triazolium salt ent-170 was kindly donated by Prof. Jeffrey Bode. 
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these morpholinone-derived triazolium salts, in comparison with 5:5-fused bicyclic triazolium 
salts. All of these triazolium-derived NHCs proved highly effective catalysts in THF, obtaining 
exclusively the desired C-carboxyazlactone product 266, though as effectively racemic products 
in all cases. By changing the solvent to toluene, competing decarboxylation was observed in 
most cases, though this was minimal (<10%). The only catalyst which gave a significant, though 
small, increase in enantioselectivity was that derived from triazolium salt 416 (<5% → 20% ee). 
 
 
  
Figure 114: Morpholinone-derived NHCs as catalysts for the asymmetric Steglich rearrangement 
Triazolium salt Solvent Conversion (R)-266:254 (%) a 
ee of (R)-266 
(%) 
137 THF >98:<2 <5 
137 toluene >98<:2 <5 
ent-170 THF >98:<2 <5 (ent) 
ent-170 toluene >95:<5 <5 (ent) 
416 THF >98:<2 <5 (ent) 
416 toluene 95:5 20 (ent) 
403 THF >98:<2 <5 
403 toluene 88:12 <5 
407 THF >98:<2 <5 
407 toluene 90:10 6 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
Table 20: 6:5-Fused bicyclic triazolium-derived NHCs in the asymmetric Steglich rearrangement 
Having obtained relatively low levels of enantioselectivity with all NHC catalysts, other 
variables were next investigated to try to improve the enantioselectivity. Since the 
aminoindanol-derived catalysts, both known to effect excellent levels of enantioselectivity in 
Stetter reactions, proved ineffective at promoting asymmetry in the rearrangement reaction under 
the conditions evaluated, these triazolium salts were chosen for initial optimisation (Figure 115, 
Table 21). Variation of the base which generated the NHC appeared to have little effect on the ee 
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of the product, returning essentially racemic products, so the catalyst loading, solvent and 
reaction temperature were varied. Under a wide variety of conditions, with only some selected as 
an illustration, the aminoindanol-derived NHCs suffered from at least one of several drawbacks: 
at temperatures of ≥0 ºC, complete rearrangement was observed within 1 h but the products were 
essentially racemic; lowering of the reaction temperature did improve the enantioselectivity, but 
this was modest (≤20% ee), and at the detriment of requiring extended reaction times (up to 
16 h) to effect complete rearrangement. Furthermore, at low temperature, significant proportions 
of the decarboxylated azlactone precursor 254 were returned (up to 20%), even with strict 
exclusion of air and moisture from the reaction manifold, presumably as a result of competing 
decarboxylation. Variation of the N-aryl moiety from phenyl to the more hindered mesityl 
substituent also appeared detrimental to the reaction in terms of both reactivity and 
enantioselectivity, however, the role of the different counterion cannot be excluded. 
 
 
Figure 115: Optimisation studies using aminoindanol-derived triazolium salts 
Precatalyst 
Precatalyst 
loading 
(mol%) 
Base (mol%) Solvent Temp (ºC) 
Conversion 
(R)-266:254 
(%) a 
ee (%) 
 
 
10 KHMDS (9) 
THF 
0 >98:<2 <5 
10 KHMDS (9) -78 to rt ~90:10 12 
5 KHMDS (4.5) -78 to rt ~90:10 12 
1 KHMDS (0.9) -78 to rt ~85:15 13 
10 n-BuLi (9) -78 to rt ~90:10 9 
10 LiHMDS (9) -78 to rt ~90:10 10 
10 Et3N (9) rt ~90:10 11 
5 KHMDS (4.5) 
toluene 
rt >98:<2 <5 
5 KHMDS (4.5) -78 to rt ~85:15 20 
50 KHMDS (45) -78 to rt ~95:5 <5 
 
 
10 KHMDS (9) THF -78 to rt ~85:15 8 (ent) 
10 Et3N (9) THF rt ~85:15 5 (ent) 
5 KHMDS (4.5) toluene -78 to rt ~80:20 11 (ent) 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
Table 21: Optimisation studies using aminoindanol-derived triazolium salts 
The reduced reactivity of the mesityl-substituted NHC (in comparison with the 
phenyl-substituted NHC) may be due to the increased steric parameter introduced, but there may 
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also be differences in electronic properties between these systems. Nolan and co-workers have 
obtained X-ray crystal structures of NHC-Pt complexes and examined the tilt angles θ between 
different N-aryl ring substituents and the central azolium core (Figure 116).150 From the X-ray 
crystallographic data, a significant tilt angle is observed the N-phenyl substituted NHC of 419, 
with an average of 50.9º observed, presumably as a balance between the steric repulsion in the 
complex and with the orbital overlap of the aromatic substituents with the central azolium core. 
In the N-mesityl substituted NHCs of complexes 417 and 418, the steric encumbrance introduced 
by the N-substituents enforces the aromatic rings significantly out of conjugation with the 
triazolium ring, to nearly an orthogonal orientation (θ  > 74º). This loss of orbital overlap could 
have a significant impact on the electronic properties of the NHC. Whilst these observations 
have been made in the solid state and with related NHCs, these data may provide an explanation 
for the significant differences in behaviour between the differentially substituted NHCs observed 
in the Steglich rearrangement and also other NHC-catalysed processes. 
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Figure 116: Tilt angles between different N-aryl substituents 
Section 5.2.2: Optimisations of the conditions 
Having identified the oxazolidinone-derived NHCs as the best candidates for the asymmetric 
Steglich rearrangement, the process was optimised using these catalysts. In collaboration with a 
colleague,i an extensive screen of solvents, concentration, base and temperature was performed, 
for which highlighted data is described below (Figure 117, Table 22). The results of the 
extensive efforts showed that toluene was the best solvent with which to promote the 
rearrangement with highest levels of enantioselectivity. Lowering the temperature to -20 or 
-30 ºC improved the enantioselectivity of the process up to 50% ee, but at the detriment of 
formation of the decarboxylated by-product 254, and thus compromising the yield of the desired 
product. Further lowering of the reaction temperature resulted in inhibition of the rearrangement 
process, with no conversion of carbonate 254 being observed. Of note is that weak bases such as 
inorganic carbonates and Et3N could be employed in order to promote the rearrangement of the 
                                                 
i
 Collaboration with Dr Carmen Concellón. 
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phenyl carbonate, consistent with the results obtained in the racemic series, but with no 
significant impact on the enantioselectivity of the process. 
 
 
Figure 117: Optimisation using oxazolidinone-derived triazolium salts 
Precatalyst Base Solvent Temp (ºC) Time (h) 
Conversion 
(R)-266:254 
(%) a 
ee (%) 
 
 
KHMDS PhCl rt 1 >98:2 13 
KHMDS Et2O rt 1 >98:2 27 
KHMDS toluene rt 1 >98:2 34 
KHMDS toluene -20 16 74:17 b 46 
KHMDS toluene -30 16 0:0 b - 
Et3N CH2Cl2 rt 4 90:10 22 
 
 
KHMDS PhCl rt 1 >98:2 8 
KHMDS toluene rt 1 88:12 31 
KHMDS toluene -30 16 63:37 50 
Cs2CO3 THF rt 1 80:20 25 
Cs2CO3 toluene rt 1 75:25 5 
NaHMDS toluene rt 1 70:30 33 
LiHMDS toluene rt 1 >98:2 39 
n-BuLi toluene rt 1 0:0 b - 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
b Remainder present as unreacted carbonate 256 
Table 22: Optimisation using oxazolidinone-derived triazolium salts 
Section 5.2.3: Scope and generality of the asymmetric Steglich rearrangement 
Using the optimised conditions, the scope and generality of the asymmetric process was 
explored. Upon reflection of all the data, the rearrangement was investigated using the three 
most effective NHC catalysts, the most reactive catalyst derived from triazolium salt 403, and 
the oxazolidinone-derived triazolium salts 399 and 164 which gave the greatest levels of 
enantioselectivity. To establish if the results obtained from the model screen were representative, 
a range of reactive aryl carbonates and other carbonates was examined. 
Using the most reactive morpholinone-derived triazolium salt 403, the reactive 
ethylglycine-derived phenyl carbonate (R1 = Et, R2 = Ph) was chosen, and to complement the 
series, two of the most challenging substrates to undergo rearrangement, a methyl carbonate 
Chapter 5: NHC-Catalysed asymmetric Steglich rearrangement 
 
99 
(R1 = Me, R2 = Me) and trichlorodimethylethyl carbonate (R1 = i-Bu, R2 = CMe2CCl3), were 
examined (Figure 118, Table 23). All substrates underwent complete consumption, returning 
>90% C-carboxyazlactone 239 in all cases (the remaining material was present as the 
decarboxylated azlactone 276 and diphenyl carbonate 305). Very good isolated yields of the 
product were obtained, but the levels of enantioenrichment were again low (up to 31% ee). 
 
 
Figure 118: Scope of the asymmetric Steglich rearrangement using the reactive triazolium salt 
R1 R2 Conversion 
ent-239:276 (%) a 
Isolated yield 
(%) ee (%) 
PhCH2 Ph 95:5 72 <5 
Et Ph ~90:10 70 <5 
Me Me >95:5 70 31% 
i-Bu CMe2CCl3 >95:5 85 5% 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
Table 23: Scope of the asymmetric Steglich rearrangement with the reactive triazolium salt 
Having observed good reactivity but only modest levels of enantioselectivity with the 
morpholinone-derived triazolium salt 403, the oxazolidinone-derived triazolium salts 399 and 
164 were more extensively investigated with a range of aryl and alkyl oxazolyl carbonates 
(Figure 119, Table 24). Consistent with our previous observations with achiral NHCs, aryl 
oxazolyl carbonates proved most amenable to rearrangement with these oxazolidinone-derived 
NHCs, giving good levels of reactivity in all cases with both oxazolidinone-derived NHCs. 
Within 1 h, all aryl carbonates underwent complete conversion to the desired aryl ester products 
239, with the exception of the phenylalanine-derived carbonates which gave a small proportion 
(up to 12%) of azlactone 276. Methyl and benzyl carbonates proved reasonably amenable to 
rearrangement with these NHCs, with the exception of the alanine derivative (R1 = R2 = Me) 
which gave low conversions to the product (<23%). The hindered alkyl carbonates 
(R2 = CMe2CCl3) gave modest conversions (40%) to the rearrangement products. There appeared 
to be no discernible trend in terms of the enantioselectivity of the process, as a wide range of 
enantioselectivities was obtained, ranging from <5–66% ee. The nature of the alkyl or aryl 
carbonate moiety appeared not to have a consistent bearing on the level of enantioselectivity 
observed: for example, the leucine-derived trichlorodimethylethyl product was obtained in 
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66% ee, the highest level for any substrate, whilst the analogous phenylalanine-derived product 
was obtained in only 8% ee.i 
 
 
Figure 119: Scope of the asymmetric Steglich rearrangement using the oxazolidinone-derived NHCs 
Precatalyst R1 R2 
Conversion 
ent-239:276  
(%) a 
ee (%) 
399
N N
N
O
Ph
BF4
Ph
 
PhCH2 Ph >98:2 34 
Me Ph >98:2 42 
Et Ph >98:2 22 
4-BnOC6H4CH2 Ph >98:2 8 
Me Me 23:0 48 
PhCH2 Me >90:0 <24 b 
PhCH2 CMe2CCl3 40:0 c 8 d 
i-Bu CMe2CCl3 40:0 c 66 
 
PhCH2 Ph 88:12 31 
PhCH2 1-naphthyl 95:5 <5 
PhCH2 Me 50:0 <37 b 
PhCH2 Bn >98:2 25 
Me Ph >98:2 19 
Me Me 0:0 - 
a
 Remainder of material present as unreacted carbonate 
b Small quantity of co-eluting impurity in HPLC trace 
c Reaction time was extended to 16 h 
d 
ee Determined by 1H NMR spectroscopic analysis following derivatisation with (S)-α-methylbenzylamine, to 
amide 553 (see Experimental section) 
Table 24: Substrate screen with oxazolidinone-derived triazolium salts 
This wide range of ee values suggests that the nature of the transition state may be complex, with 
a number of factors important in delivering high levels of enantioselectivity. Many 
NHC-catalysed processes occur via highly organised transition states (e.g. see Introduction, 
Section 1.6), but in the Steglich rearrangement, the level of enantioselectivity in the process is 
dependent on the organisation of both the carboxyazolium and the dienolate components. As 
such, it would appear that the nature of the solvent affects the level of enantioselectivity, with 
                                                 
i
 The 8% ee of the product was determined by 1H NMR spectroscopic analysis following derivatisation with 
(S)-α-methylbenzylamine, assuming no loss in stereochemical integrity in the derivatisation step. See experimental 
section for further details. 
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non-polar solvents (e.g. toluene) promoting greater levels of enantioselectivity than polar 
solvents (e.g. THF). If the proposed ionic intermediates are formed, non-polar solvents promote 
tighter binding of the ion pair and could potentially form a more organised transition state in 
order to promote higher levels of asymmetry in the process. Cognisant of the computational 
analysis performed with the related chiral isothiourea (page 55), we showed that the 
stereochemical outcome of the transformation is reliant upon a combination of factors, including 
carboxyl orientation (i.e. lying co-planar with the core heterocycle of the Lewis base), facial 
selectivity due to the stereodirecting unit and finally, docking of the dienolate. Whilst similar 
DFT calculations have yet to be investigated with our chiral carboxyazolium species, a number 
of plausible combinations of these intermediates may have relatively similar energetic profiles, 
leading to formation of a mixture of both enantiomers of the C-carboxyazlactone product. 
Section 5.2.4: Mechanistic studies 
In order to ensure that the products of the rearrangement were configurationally stable, isolated 
samples of rearrangement products 266 of 50% and 20% ee (in separate experiments) were 
retreated under the reaction conditions, using the triazolium salt 164 and 137, respectively 
(Figure 120). Reactions with both chiral NHCs returned the C-carboxyazlactone products 266 
unchanged, indicating that the rearrangement product 266 was indeed configurationally stable, 
and thus, the observed low enantioselectivities are a reflection of the enantiodiscrimination in the 
transition state and not via a racemisation process. 
 
 
Figure 120: Configurational stability of the C-carboxyazlactone products 
In order to explain the relative lack of reactivity observed with certain substrates and to probe the 
mechanism of this asymmetric transformation, crossover experiments were investigated. A 
mixture of two relatively unreactive substrates 258 and 244, a trichlorodimethylethyl and methyl 
carbonate, respectively, were treated with the NHC derived from chiral triazolium salt 399 to 
investigate the nature of the NHC in the reaction manifold (Figure 121). No C-carboxyazlactone 
products were observed in either THF or toluene, but significant (~15%) crossover to the 
carbonates 255 and 335 was observed in THF (35:35:15:15 product ratio); a small amount (~2%) 
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of crossover was observed in toluene. These results suggest that the chiral NHC is still acting as 
a Lewis base, but may be less reactive than the achiral NHC derived from 128, as crossover is 
incomplete even after 2 h (cf. complete crossover after 1 h with the achiral triazolium salt).  
 
 
Figure 121: Crossover reaction with chiral oxazolidinone-derived triazolium salt and less reactive substrates 
As a direct comparison, the chiral triazolium salt that promoted facile rearrangement of all 
substrates, morpholinone-derived triazolium salt 403, was examined with these substrates 258 
and 244 in toluene (Figure 122). In this case, full rearrangement to the C-carboxyazlactone 
products 270:246:249:336 was obtained within 1 h, with ~13–14% crossover (36:37:14:13 ratio 
of products) being observed. 
 
 
Figure 122: Crossover reaction with reactive triazolium salt and reactive substrates 
Returning to the oxazolidinone-derived triazolium salt 399, the effect of performing a similar 
crossover experiment between two more reactive (aryl) carbonate substrates was next examined 
(Figure 123). After 1 h, a mixture of the eight possible products was obtained as a ~70:30 
mixture of C-carboxyazlactone:carbonate products, with each product in an approximately 
equimolar proportion. This further supported the previous findings of the greater reactivity of 
aryl carbonates in the reaction manifold, and whilst the C-carboxylation was still incomplete, 
Chapter 5: NHC-Catalysed asymmetric Steglich rearrangement 
 
103 
complete scrambling of the substrates could be assumed, as a statistical mixture of carbonates 
was returned.  
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Figure 123: Crossover reaction with chiral oxazolidinone-derived triazolium salt with reactive substrates 
Taken together, the results of these crossover experiments help support the hypothesis that the 
asymmetric variant of the rearrangement using chiral NHCs is likely to proceed via a similar 
mechanistic pathway to that with the achiral triazolium-derived NHC, i.e. that an intermolecular 
step is present, with a presumed carboxyazolium and dienolate being formed. The findings 
suggest that this process is kinetically slower than with the achiral triazolium-derived NHC, with 
both O-transcarboxylation and C-carboxylation steps requiring considerably longer to achieve 
conversion. It also appears that the proposed ion pair intermediate is held more tightly in toluene 
than in THF, as lower levels of crossover products were identified. 
Section 5.3: Enantioselective domino cascade reactions 
Having investigated the enantioselective Steglich rearrangement with NHCs in the single-step 
protocol, the asymmetric variant of the domino cascade reactions was pursued. Our attention was 
focused on the multi-step protocol from N-acyl amino acids, as this was deemed to be of greater 
synthetic significance than the other cascade procedures (Figure 124, Table 25). A number of 
chiral azolium salts were evaluated in the domino reaction manifold and it was found that most 
reactions gave rise only to the carbonate intermediate 256. Of the azolium salts investigated, the 
C2-symmetric azolium salt 138 and bicyclic triazolium salts 56 and 403 promoted successful 
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rearrangement. Though good isolated yields were obtained, the level of asymmetric induction in 
the process was modest (up to 14% ee). 
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Figure 124: Selected asymmetric domino cascade investigations 
Azolium salt Yield (%) ee (%) 
134 - a - 
399 - a - 
138 60 10 
56 85 14 
403 70 <5 
a
 Only carbonate 256 was obtained 
Table 25: Selected results of the asymmetric domino cascade 
Section 5.4: Summary 
A wide range of chiral azolium salts has been prepared and evaluated in the asymmetric variant 
of the established Steglich rearrangement using NHCs. Azolium salts of various classes have 
been prepared, and the results of the investigations have confirmed the findings in the racemic 
series. Aryl carbonates have proven to undergo more facile rearrangement than other carbonates, 
though the nature of the carbonate moiety does not appear to have a significant bearing on the 
level of enantioselectivity in the reaction. The enantioselectivity of the process can be increased 
by the choice of a non-polar solvent, with toluene giving optimal results, though a wide range of 
enantioselectivities has been obtained, up to 66% ee with the optimal NHC catalyst 399, derived 
from SuperQuat. Crossover studies have shown that the reactions proceed via a similar process 
to those with the achiral triazolium salt 128, and for reactions carried out in toluene, the 
presumed ion pair intermediate appears to be held more tightly than in the more polar solvent 
THF. Finally, the asymmetric variant of the domino cascade protocol from N-acyl amino acids 
has been investigated briefly, affording the product in good yield but in low ee. 
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Section 6.1: Investigation of furanyl carbonate rearrangements 
Section 6.1.1: Background 
Having demonstrated the efficacy of NHCs as Lewis bases to promote O- to C-carboxyl transfer 
in the Steglich rearrangement, the furanyl carbonate substrate class was chosen as a suitable 
alternative for study. For direct comparison to the rearrangement of oxazolyl carbonates, the key 
furanyl carbonate architecture 420 would be functionalised at C(3) and C(5). It was envisaged 
that the rearrangement of such substrates may give rise to two possible regioisomeric products, 
the α-carboxybutenolide 421 arising from carboxyl migration to C(3), or the 
γ-carboxybutenolide product 422 from carboxyl migration to C(5) (Figure 125). With a range of 
Lewis bases shown to promote rearrangement of related oxazolyl carbonates, the possibility of 
regio- and enantio-selective rearrangements, dependent upon the choice of Lewis base used, was 
investigated. 
 
 
Figure 125: Furanyl carbonate template anticipated to give rise to two regioisomeric products 
The butenolide moiety is a privileged structure, present in a wide variety of biologically active 
natural products.151 Functionalisation of butenolides has been demonstrated by reaction of a 
furanyl dienolate with an appropriate electrophile. Alkylations, vinylogous Mukaiyama aldol 
condensations, vinylogous Mukaiyama-Michael reactions and vinylogous Mukaiyama-Mannich 
reactions have all been explored, generally observing high levels of selectivity for 
γ-functionalisation.152 The majority of this methodology, however, demonstrates the preparation 
of tertiary centres, though MacMillan and co-workers have illustrated an organocatalytic strategy 
for the preparation of a single example of a quaternary-functionalised butenolide in good yield 
and excellent dr and ee using chiral imidazolidinone 424 as a catalyst (Figure 126).152i 
 
 
Figure 126: Quaternary γ-functionalisation of siloxyfuran 
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Buchwald and Hyde have also shown that quaternary-functionalised butenolides 429 can be 
prepared from the parent butenolide 426 through Pd-mediated cross-coupling (Figure 127).153 
The authors propose that the formal dienolate must be generated in situ, and the choice of 
solvent in the reaction is critical, as a number of by-products are generated if t-amyl alcohol is 
not present, attributed to solvent stabilisation of the dienolate intermediate. The authors also 
show that generally poly-substituted butenolide substrates are most effective, with 
mono-substituted substrates often giving rise to complex mixtures as the dienolates are unstable 
in the reaction manifold. In all successful cases however, only γ-arylation is observed. 
 
 
Figure 127: Arylation of butenolides 
Vedejs and co-workers have investigated the enantioselective rearrangement of a series of 
5-aryl-3-methylfuranyl carbonates 430 using the chiral aminopyridine TADMAP 238 
(Figure 128).107 In these cases, whilst very high level of enantioselectivity is achieved, a mixture 
of both regioisomers is observed, with the relative proportions dependent on the choice of 
solvent, but more crucially, upon the electronic perturbations imposed upon the dienolate (Table 
26). For example, the 5-phenyl substituted furanyl carbonate underwent successful 
rearrangement to a 60:40 mixture of α-carboxybutenolide product 431 and γ-carboxybutenolide 
product 432, respectively. A number of alternative aryl substituted carbonates also underwent 
successful rearrangement, with γ-electron-donating aromatic substituents disfavouring 
γ-functionalisation, giving predominantly the α-carboxybutenolide product 431 (up to 92:8 
mixture of products). However, the mesomerically electron-withdrawing 4-cyanophenyl 
substituent favoured predominantly γ-functionalisation, giving a 20:80 mixture of 
α-carboxy:γ-carboxy products 431:432 respectively. 
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Figure 128: TADMAP-Promoted rearrangement of 5-aryl-3-methylfuranyl carbonates (Vedejs) 
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Ar Solvent Ratio of 
α:γ products eemajor (%) 
Ph CH2Cl2 60:40 91 
4-MeOC6H4 CH2Cl2 83:17 82 
4-MeOC6H4 THF 91:9 90 
4-MeOC6H4 toluene 92:8 83 
4-MeOC6H4 t-amyl alcohol 86:14 91 
4-NCC6H4 CH2Cl2 20:80 63 
4-NCC6H4 THF 20:80 74 
4-NCC6H4 toluene 20:80 83 
4-NCC6H4 t-amyl alcohol 20:80 50 
Table 26: Results of TADMAP-promoted furanyl rearrangements (Vedejs) 
Section 6.2: Investigations of a model furanyl carbonate 
Section 6.2.1: Synthesis via keto-acid 
Commercially available 2-methyl-4-oxo-4-phenylbutyric acid 433 was chosen as a suitable 
starting material and was utilised to obtain the furanyl carbonate 435, directly comparable with 
that of Vedejs (Figure 129). Treatment of keto-acid 433 with acetic acid and acetic anhydride at 
100 ºC gave a ~35:65 mixture of 3H and 5H- butenolides 434 respectively in quantitative 
conversion. Treatment of this mixture with LDA yielded the dienolate and subsequent addition 
of phenyl chloroformate gave the desired carbonate 435 in good yield, which was used to 
investigate the heterocyclic rearrangement. In an effort to develop a more facile procedure to 
prepare the desired carbonate under similar conditions as found with azlactones, the mixture of 
butenolides 434 was treated with Et3N followed by phenyl chloroformate and this also afforded 
the desired carbonate in comparable yield, though an excess of chloroformate and Et3N was 
required due to partial consumption of phenyl chloroformate and Et3N due to competing 
dealkylation (see page 58). 
 
 
Figure 129: Synthesis of model furanyl carbonate substrate 
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Section 6.2.2: Rearrangement of model furanyl carbonate 
With the model substrate 435 in hand, the regioselectivity of the rearrangement with different 
classes of Lewis base was investigated. 
Section 6.2.2.1: Using aminopyridines 
The ‘classical’ aminopyridines DMAP 224 and PPY 225 were first evaluated to allow direct 
comparison with the results of Vedejs and to examine the effectiveness of these Lewis bases 
(Figure 130, Table 27). These catalysts successfully promoted the carboxyl transfer reaction to 
afford a mixture of C-carboxybutenolide products 436 and 437 respectively, with a bias towards 
formation of the α-regioisomer: a 60:40 mixture of α:γ-regioisomeric products was obtained 
using DMAP and a 51:49 ratio using PPY. These results are consistent with the findings of 
Vedejs using the chiral aminopyridine TADMAP, which provided a similar 60:40 mixture of 
α:γ-regioisomeric products.107 PPY also provided a significant proportion of the butenolide 438 
as a result of decarboxylation; at low catalyst loading (0.5 mol%) with DMAP, a similar effect 
was noted, but without affecting the ratio of α:γ regioisomers. As noted in the rearrangement of 
oxazolyl carbonates, where decarboxylation is observed, diphenyl carbonate 305 is also returned, 
but only one butenolide, the 5H-butenolide 438, was also recovered.  
 
 
Figure 130: Aminopyridine-catalysed furanyl rearrangement 
Catalyst mol% Solvent Conversion (%) a 
Ratio of 
α:γ products b 
Decarboxylation 
(%) b 
DMAP 10 THF >98 60:40 0 
DMAP
 
10 CH2Cl2 >98 60:40 0 
DMAP 0.5 THF >98 57:43 16 
PPY 10 THF >98 51:49 23 
a Conversion determined by consumption of carbonate 435 
b
 Values determined by 1H NMR spectroscopic analysis of crude reaction product 
Table 27: Results of aminopyridine-catalysed carboxyl transfer 
Section 6.2.2.2: Using amidines 
The rearrangement of model substrate 435 was next examined using ‘amidine’ Lewis bases 
which have been shown to induce carboxyl transfer in the related Steglich rearrangement.103,124 
N-Methylimidazole, DBN and isothiourea 311 were chosen to represent the set of different 
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amidine classes and were examined in this reaction manifold (Figure 131, Table 28). Unlike the 
Steglich rearrangement of oxazolyl phenyl carbonate 256, DBN proved the least effective 
catalyst with the furanyl carbonate, returning only a small proportion (4%) of the 
γ-carboxybutenolide 437, but giving predominantly the decarboxylated product 438 and 
unreacted furanyl carbonate 435. N-Methylimidazole 439 proved more competent, giving an 
~50:50 ratio of α:γ products, though with significant amounts (27%) of the decarboxylated 
product 438. Isothiourea 311 also gave a similar mixture of the rearrangement products and 
significant amounts of decarboxylated product 438. At lower catalyst loading of the isothiourea 
(0.5 mol%), the reaction was considerably slower, but returned similar ratios of α:γ 
regioisomers. 
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Figure 131: Amidine-catalysed furanyl rearrangement 
Catalyst mol% Conversion (%) a 
Ratio of 
α:γ products b 
Decarboxylation 
(%) b 
NMI 439 10 >98 49:51 27 
DBN 306
 
10 82 0:100 78 
isothiourea 311 10 >98 58:42 38 
isothiourea 311 0.5 15 56:44 6 
a Conversion determined by consumption of carbonate 435 
b
 Values determined by 1H NMR spectroscopic analysis of crude reaction product 
Table 28: Results of amidine-catalysed carboxyl transfer 
Section 6.2.2.3: Using NHCs 
Finally, the NHC catalysed rearrangement of the model furanyl substrate was investigated 
(Figure 132, Table 29). With 10 mol% of azolium salt and 9 mol% of KHMDS as the base, the 
rearrangement was highly effective with triazolium salt NHC precatalysts. In each case, a 16:84 
ratio of α:γ regioisomers 436:437 respectively was obtained with the rearrangement occurring 
rapidly (<5 min) and with no change in product ratio after extended reaction times. With either 
triazolium salt 128 and Et3N, or imidazolium- or imidazolinium-derived NHCs generated using 
KHMDS, no reaction was observed. These results contrast those found with the majority of the 
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other Lewis bases where the rearrangement has been effective: the NHCs show a complete 
change in selectivity towards preferential formation of the γ-regioisomer, not the α-regioisomer. 
 
 
Figure 132: NHC-Catalysed furanyl rearrangement 
Precatalyst 
(mol%) 
Base 
(mol%) 
Conversion 
(%) a 
Ratio of 
α:γ products b 
Decarboxylation 
(%) b 
128 KHMDS (9) >98 16:84 0 
128 Et3N (100) <5 - - 
268
 
KHMDS (9) >98 16:84 0 
270 KHMDS (9) >98 16:84 0 
79 KHMDS (9) <5 - - 
245 KHMDS (9) <5 - - 
a Conversion determined by consumption of carbonate 435 
b
 Values determined by 1H NMR spectroscopic analysis of crude reaction product 
Table 29: Results of NHC-catalysed carboxyl transfer 
Section 6.2.2.4: Investigation of the regioselectivity: probing thermodynamic vs kinetic 
control 
To evaluate the effectiveness of NHCs in this rearrangement, a range of NHC catalyst loadings 
(0.5–25 mol%) was investigated (Figure 133, Table 30). Operating at similar concentrations to 
those for the Steglich rearrangement (i.e. ~5–20 mM concentration of 128), the reaction was 
shown to be highly efficient, giving quantitative conversion to carboxybutenolide products 
within 1 h. The ratio of regioisomeric products appeared to be dependent on the catalyst loading. 
At higher catalyst loadings from 5–25 mol% (5–20 mM concentration of 128), a consistent 16:84 
ratio of α:γ-carboxy products 436:437 was obtained. By lowering the NHC catalyst loading to 
0.9 mol% (8 mM concentration), the reaction still progressed rapidly to completion (<5 min), but 
the ratio of α:γ-carboxy products increased from 16:84 to 4:96. Further lowering of the catalyst 
loading to 0.5 mol% and sampling the reaction immediately allowed the reaction progression to 
be examined before the carbonate starting material was fully consumed. In this case, at 92% 
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consumption of carbonate 435, the reaction had proceeded to afford exclusively the γ-carboxy 
product 437. On further sampling after 5 min, quantitative conversion of carbonate 435 to 
C-carboxybutenolides 436 and 437 was obtained, giving nearly exclusively the γ-regioisomer 
(<2:98 ratio of α:γ-carboxy products). This ratio, however, decayed slightly to 6:94 after 1 h.  
 
 
Figure 133: Carboxyl rearrangement of furanyl carbonate 435 
Precatalyst 
(mol%) 
KHMDS 
(mol%) Temp (ºC) 
Conversion     
(%) a 
Ratio of 
α:γ products b 
Isolated yield 
of α:γ products 
(%) c 
25 24 rt >98 16:84 - 
10 9 rt >98 16:84 6:72 
5 4.5 rt >98 16:84 5:70 
2 1.8 rt >98 10:90 - 
1 0.9 rt >98 4:96 0:85 
1 0.9 0 >98 <4:>96 - 
0.5 0.45 rt 92 d 0:100 - 
0.5 0.45 rt >98 <2:>98 - 
a Conversion determined by consumption of carbonate 435 
b
 Values determined by 1H NMR spectroscopic analysis of crude reaction product 
c
 Isolated yield of individual regioisomers following chromatography 
d
 Sampling the reaction mixture immediately 
Table 30: Results of screening at different catalyst loadings 
Section 6.2.2.5: Exploration of the mechanism 
From the screen of Lewis bases, two effective catalysts were identified, namely DMAP and the 
NHC derived from triazolium salt 128. These two catalysts also promote complementary 
regioselective rearrangement: with DMAP, a mixture of both α:γ-carboxy products is obtained 
but with a small preferential bias towards the α-regioisomer; with the NHC, the γ-carboxy 
product predominates, with considerably higher regioselectivity. The change in ratio of products 
with both NHC catalyst loading/concentration and reaction time suggested that there may be 
some interconversion of the two regioisomeric products, potentially promoted by the NHC. To 
investigate this potential interconversion, individual regioisomers were isolated then retreated 
under the reaction conditions with the two most effective catalysts, DMAP and NHC 247, and 
also the isothiourea 311. With DMAP or isothiourea 311, both of the individual 
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C-carboxybutenolide products 436 and 437 were stable to treatment, returning only the initial 
C-carboxybutenolide even after an extended reaction time of 5 h (Figure 134). 
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Figure 134: Results of resubjection of individual regioisomers with DMAP and isothiourea 
With the NHC, however, contrasting results were obtained (Figure 135): upon treatment of the 
α-carboxy product 436 with the NHC, a mixture of carboxybutenolide products was obtained, 
with a significant regioisomeric exchange to the γ-carboxy product 437 being observed (17:83 
ratio). Treatment of the pure γ-carboxy regioisomer 437 with the NHC also delivered a mixture 
of α- and γ- regioisomeric products in a 14:86 ratio. These ratios are (with experimental error) 
the same as was observed in the original investigations with the NHC using higher catalyst 
loading.  
 
 
Figure 135: NHC-Promoted interconversion of regioisomers  
These findings suggest that the NHC has a dual role in this reaction manifold, whereas the 
aminopyridine DMAP and isothiourea 331 appear to play a part only in the initial carboxyl 
transfer reaction. The NHC appears to promote O- to C-carboxyl transfer, but, in contrast to 
observations in the Steglich rearrangement, the interconversion of the products is also promoted 
by the active NHC. It appears that, with DMAP and isothiourea 311, the product ratio obtained is 
a reflection of the kinetic products of the transfer process, in both cases with a slight preference 
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for α-carboxylation. With the NHC however, the kinetically formed product appears to be the 
γ-carboxybutenolide, as this is the initially formed product in the reaction manifold. As the NHC 
facilitates product interconversion, it appears that the γ-carboxybutenolide is also the 
thermodynamically more stable product, as this was the predominant product obtained with high 
catalyst loading and upon extended reaction times, consistently obtained in a 14:86 
regioisomeric ratio. 
Section 6.2.2.6: Preliminary computational modelling and crossover studies 
To rationalise the interesting selectivities observed between these different bases, several issues 
had to be addressed: firstly, to determine if the observed ratio of products is a reflection of their 
relative thermodynamic stabilities; secondly, to understand the divergent behaviour in the 
regioisomeric ratio obtained with the different Lewis bases. 
Section 6.2.2.6a: Product stability computational analysis 
In collaboration with Prof. Philp at the University of St Andrews, preliminary computational 
analysis was performed. Using the B3LYP/6-31G(d,p) level of theory, energy minimisation of 
α/γ-regioisomeric products was performed and the relative stabilities computed (Figure 136).i 
The results of these calculations show that the energy difference between the two regioisomeric 
products is marginal, with the  γ-regioisomeric product 436 being slightly more stable than the 
α-regioisomeric product 437 (by 0.07 kcal mol1). The results of this calculation suggest that the 
calculations performed may require further refinement in order to obtain a more accurate 
rationale in comparison to the experimental findings, where the energy difference is more 
pronounced. 
 
 
        
 
 
 
 
 α-regioisomer 436 γ-regioisomer 437 
Figure 136: DFT Calculated energy minimisation of the dearomatised products from the model furanyl carbonate 
Section 6.2.2.6b: Crossover experiments 
As a prerequisite to the computational analysis, further experimentation was required to help 
confirm that a similar mechanism to that of the Steglich rearrangement was operating in this 
                                                 
i
 To simplify the calculations, the methyl ester, not the phenyl ester, regioisomeric products were examined. 
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system. Initial studies were carried out to confirm that the reaction was not auto-catalytic with 
respect to the dienolate (generated upon addition/elimination of the Lewis base to the carbonate 
substrate). This was investigated by preparation of a catalytic quantity (10 mol%) of the 
equivalent potassium dienolate 442 (prepared via treatment of the butenolide mixture with 
KHMDS) and treatment with the furanyl carbonate substrate (Figure 137). Upon treatment of the 
carbonate substrate 435 with the potassium dienolate 442, no rearrangement was observed, 
consistent with the reaction not being autocatalytic with respect to the dienolate. 
 
Figure 137: No autocatalytic pathway with furanyl carbonates 
Having established that the Lewis base was involved in the key C-C bond-forming event(s), 
crossover experiments were performed. A 50:50 mixture of oxazolyl and furanyl carbonates was 
treated with both DMAP and NHC 247 (in separate experiments). The possible products from 
this crossover reaction were six C-carboxy products: two carboxyazlactones and four 
carboxybutenolides, four carbonate substrates and two decarboxylated products. From the 
crossover reaction with DMAP, a mixture of the six C-carboxy products was obtained with a 
small proportion (10%) of the decarboxylated butenolide product (Figure 138). The combined 
ratio of the carboxybutenolide α:γ-regioisomers reflects the approximate ratio observed with just 
the model substrate: with the model substrate 435, a ratio of 60:40 α:γ-regioisomers was 
obtained with DMAP; in the crossover reaction, the summed percentages of the α-regioisomers 
(436+443) to the summed percentage of the γ-regioisomers (437+444) gave a similar ~60:40 
ratio of products. This observed crossover helped support the hypothesis that an intermolecular 
step must also be present in the rearrangement of the furanyl carbonate substrates. 
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Figure 138: Crossover reaction using DMAP 
The same experiment was repeated using the triazolium-derived NHC (generated using 
KHMDS) (Figure 139). In this case, similar levels of crossover were observed, and of the 
possible C-carboxybutenolide products, essentially only the γ-regioisomers were obtained, again 
reflecting the kinetic formation of the γ-regioisomer over the α-regioisomer.  
 
 
Figure 139: Crossover reaction using NHC 
Whilst not definitive, these data support the proposed mechanism of the transformation 
proceeding via a carboxyl transfer intermediate with both DMAP and the NHC, but with a 
reversible final carboxylation step only with the NHC (Figure 140). 
Chapter 6: Furanyl carbonate methodology and rearrangement 
 
117 
 
O O
Me
Ph
446
+
O
Me
O
O
OPh
Ph
437
435
447
N N
N
247
N N
N
OPhO
N N
N
H
KHMDS
O
Me
O
O
PhO
Ph
445
N
N N
Ph
Ph
Ph
Ph
O OPh
Me
O
OPh
436
N N
N
247
Ph
O
Me
PhO
O
O
Ph
KBF4 + HMDS
BF4
128
 
Figure 140: Proposed catalytic cycle using model furanyl carbonate 435 
Finally, in order to ascertain if the K+ counterion generated in the reaction manifold plays a role 
in affecting the regioselectivity, the same crossover experiment with the NHC was repeated in 
the presence of a large excess of a K+ cation source. In this case, KPF6 (5 equiv) was used, but 
the same ratio of products was obtained within experimental error, therefore, the role of the K+ 
was discounted. 
Section 6.2.2.6c: Towards transition state analysis 
To rationalise the product distributions observed with the different Lewis bases, comparison of 
the relative transition state energies for the key C-C bond-forming steps were sought. In order to 
determine such transition states, DFT calculations were performed on both the carboxyl transfer 
species and the dienolate components. Firstly, the energy-minimised structures of the carboxyl 
transfer species were computed. The structures of both the carboxy-DMAP and carboxyazolium 
species were minimised, then the rotation about the carbonyl was investigated in order to 
determine the global minimum and maximum energies. For both carboxyl species, the energies 
were calculated in 9° increments. The lowest energy conformation of the carboxy-DMAP 
species was determined as 448, having the carbonyl aligned co-planar to the aminopyridine ring 
system; the global maximum energy (species 449) is obtained when the carbonyl is placed 
orthogonally to the aminopyridine ring (Figure 141). These calculations are in agreement with 
the ab initio calculations of Vedejs for the related TADMAP-derived carboxyl transfer 
species.107 
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 Global minimum 448 Global maximum 449 
 (Iterations 19 and 39, ∠C-N-C=O ≈ 0º) (Iterations 10 and 30, ∠C-N-C=O ≈ 90º) 
Figure 141: DFT Calculations of the energy profile of the carboxy-DMAP species, and selected molecular 
representations 
For the carboxyazolium species, an asymmetric energy profile is obtained, with two minima and 
two maxima (Figure 142). As was found with the carboxy-DMAP species, both minima are 
found with the carbonyl and the central azolium ring lying co-planar, with the global minimum 
453 being ~3 kJ mol-1 more stable than the local minimum 450. Interestingly, in the global 
minimum conformer 451, the N-phenyl substituent of the triazolium ring is found to exhibit a tilt  
angle θ of 60° in relation to the central triazolium ring, similar to the observations of Nolan from 
X-ray crystallographic data for a related triazolium-derived NHC-Pt complex (see page 97).150 
Consistent with the findings for the carboxy-DMAP species, the maxima are observed with the 
carbonyl approximately orthogonal to the central ring system (species 452 and 453).  
Next, the nature of the dienolate species was investigated. The dienolate structure 446 was 
minimised, which led to the anticipated planar heterocyclic species, for which the HOMO was 
determined. The results of this calculation indicated that there is indeed considerable electron 
density located at both the C(3)- and C(5)-positions, thus giving rise to a mixture of α- and 
γ-carboxybutenolide products, but the experimentally observed ratio of products cannot be 
rationalised from these data alone. 
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 Local minimum 450 (Iteration 20)   Global minimum 451 (Iteration 40) 
 (∠N-C-C=O ≈ 180º) (∠N-C-C=O ≈ 0º) 
 
               
 Local maximum 452 (Iteration 14) Global maximum 453 (Iteration 30) 
 (∠N-C-C=O ≈ 126º) (∠N-C-C=O ≈ 270º) 
Figure 142: DFT Calculations of the energy profile of the carboxyazolium species, and selected molecular 
representations 
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Figure 143: DFT-Calculated HOMO for the furanyl dienolate 446 
With these data, DFT calculations are underway through combination of the two individual 
components, to determine the relative transition state energies for the transformations with both 
DMAP and the NHC. It is hoped that the results of these pending computations will account for 
the observed differences in the kinetic product formation with the different Lewis bases.  
Section 6.3: Preparation of 3-alkyl-5-arylfuranyl carbonates 
In order to investigate the generality of this rearrangement process, a range of 
3-alkyl-5-phenylfuranyl carbonate substrates was prepared. It was envisaged that the key to the 
synthetic routes would be construction of the butenolides, the direct precursor to the furanyl 
carbonates. These butenolides could be prepared via related keto-acid intermediates, and a 
number of routes were explored. Surprisingly, many of these routes proved synthetically 
problematic, with the keto-acid intermediate not undergoing cyclisation to the desired 
butenolide. As an illustration, chalcone 454 was successfully converted to the keto-acid 
intermediate 458 by initial conjugate cyanide addition using acetone cyanohydrin 455154 
followed by a two-step hydrolysis in good overall yield (Scheme 23). Attempts to induce 
cyclisation of the keto-acid to the butenolide 459, however, were unsuccessful using a number of 
methods, including Ac2O, POCl3, PPA, DCC and a range of chloroformates.  
 
 
Scheme 23: Installation of the carboxylic acid moiety and attempted cyclisation to butenolide 458 
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To circumvent this potential cyclisation problem, the desired lactone core structure had to be 
installed at an earlier juncture in the synthesis. A number of approaches to preparation of the 
butenolides were investigated, but the most applicable route was that developed by Lee and 
co-workers155 via formation of (phenylthio)butyrolactones of the type 462. As a recent example 
of this process in the synthesis of (+)-cis-sylvaticin 466, Donohoe and co-workers156 had shown 
that such lactones could be alkylated followed by oxidation/thermolysis to afford the desired 
butenolide architecture (Scheme 24). 
 
Scheme 24: Synthetic strategy demonstrated by Donohoe 
In order to investigate the scope and generality of the furanyl carbonate rearrangement with other 
related substrates, we initially chose to maintain a C(5)-phenyl moiety and to vary the C(3)-alkyl 
substituent. Following a similar strategy to that employed by Donohoe, using (racemic) styrene 
oxide in place of propylene oxide in the initial alkylation step gave the desired 
(phenylthio)butyrolactone intermediate 468 in good yield and as a mixture of diastereomers 
(dr 1–2:1) (Scheme 25). No regioisomeric products were observed as a result of ring opening at 
the more hindered secondary centre. 
 
 
Scheme 25: Preparation of the (phenylthio)butyrolactone 
With the parent butyrolactone 468 in hand, the alkylation step was next investigated 
(Figure 144). Donohoe had used HMPA as a co-solvent in order to achieve alkylation, and other 
related work by a number of others all used a similar strategy, all using iodides as the alkylation 
partner. In order to circumvent the use of the highly toxic and carcinogenic HMPA – which had 
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to be employed at superstoichiometric quantities – several alternative strategies were 
investigated. In the absence of any Li+ complexation agent, treatment of the enolate with either 
methyl iodide or benzyl bromide did not provide any of the desired alkylated product. Addition 
of TMEDA resulted in low levels of alkylation also, but DMPU, a common non-toxic substitute 
for HMPA, proved highly successful in delivering the desired alkylated products 469 and 470 in 
good yield and with high levels of diastereoselectivity for the syn-product (>12:1 dr).  
 
Ph O
SPh
O
LDA, DMPU
THF
R Br O
SPh
OPh
R
62-80%
dr 15:1
468 R = PhCH2 469
R = 4-BrC6H4CH2 470
 
Figure 144: Investigation of the alkylation of the butyrolactone 
The assignment of the relative configuration of the major diastereomer was determined by 
NOESY experiments, and the assignment was further supported following X-ray 
crystallographic analysis of the major diastereomer of 469 (Figure 145). 
                                                                         
Figure 145: Representation of the X-ray crystal structure of the major diastereomer, and NOESY correlation 
Following alkylation, treatment of the diastereomeric mixtures 469 and 470 with mCPBA 
provided the desired sulfoxide intermediates as a mixture of diastereomers, which underwent 
thermal elimination in toluene at reflux to afford the desired butenolide products 471 and 472 as 
a mixture of regioisomers in good yield (Figure 146). The isomerisation process, not observed in 
related C(5)-alkyl substituted butenolides, may be occurring via tautomerisation to the aromatic 
hydroxyfuran heterocycle. This may be due to the enhanced acidity of the (benzylic) proton at 
C(5), resulting in the formation of an extended conjugated aromatic framework. 
With the desired butenolides in hand, conversion to the furanyl carbonates 473 and 474 was 
achieved in good yield (58–60%) using Et3N as the base (Figure 146). The use of LDA was also 
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attempted using butenolide mixture 471, though poor conversion (~5%) to the desired carbonate 
was obtained. 
 i) mCPBA
CH2Cl2
ii) toluene,
52-72%
(2 steps)
O OPh
R
Et3N, PhOC(O)Cl
MeCN or THF
58-60%
O OPh
R
OPh
O
R = PhCH2 473 60%
R = 4-BrC6H4CH2 474 58%
O
SPh
OPh
R
R = PhCH2 471
52% (~3:1)
R = 4-BrC6H4CH2 472
72% (4:1)
R = PhCH2 469
dr 15:1
R = 4-BrC6H4CH2 470
dr 15:1
 
Figure 146: Thermolysis and O-carboxylation to 3-alkyl-5-phenylfuranyl carbonates 
With a successful means of preparing such substrates, related analogues with different electronic 
properties were investigated. Cognisant of the findings of Vedejs, electronic perturbations of the 
5-aryl moiety were investigated to observe the impact on the regioselectivity of the 
rearrangement. The 4-methoxyphenyl substituted carbonate could not be readily accessed as 
4-methoxystyrene oxide is not commercially available, however, the commercially available 
4-fluorostyrene oxide was transformed successfully to the desired carbonate 479 via a similar 
synthetic route (overall 20% yield) (Figure 147). 
 
 
Figure 147: Preparation of related 4-fluorophenyl substituted furanyl carbonate 
Section 6.4: Rearrangement of 3-alkyl-5-arylfuranyl carbonates 
With a range of furanyl carbonates in hand, the rearrangement of the 3-alkyl-5-arylfuranyl 
substrates was firstly investigated, using DMAP and the NHC derived from triazolium salt 128 
as catalysts (Figure 148, Table 31). The results of these rearrangements have shown a number of 
trends. Firstly, all 3-alkyl-5-phenylfuranyl carbonate substrates 480 (Ar = Ph) undergo rapid 
rearrangement to provide a mixture of α- and γ- regioisomers, with the major regioisomer 
dependent on the choice of Lewis base. With DMAP, a mixture of both regioisomers is obtained 
with a slight preference for the α-regioisomer 481 in each case (53–64:47–36 ratio). In contrast, 
at 9 mol% NHC catalyst loading, a mixture of regioisomers is also obtained, but in which the 
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γ-regioisomer 482 predominates (10–19:90–81 ratio). Using low NHC catalyst loadings and 
short reaction times, both the methyl and benzyl substituted carbonate indicate initial 
(presumably kinetically favoured) γ-carboxylation, giving >96% regioselectivity for the 
γ-carboxybutenolide 482. Upon variation of the electronic properties of the 5-aryl substituent to 
the 4-fluorophenyl moiety, the α-carboxybutenolide product 481 is the predominant regioisomer 
with DMAP (71:29 ratio). With the NHC, however, the γ-regioisomer 482 again predominates 
(12:88 ratio).  
 
 
Figure 148: Examination of different furanyl carbonates with Lewis bases 
R Ar Catalyst (mol%) 
Ratio of 
α:γ products a 
Decarboxylation 
(%) a 
Yield of 
major  
product (%) 
Me Ph DMAP (10) 60:40 0 60 (α) 
Me Ph NHC (9) 16:84 0 72 (γ) 
Me Ph NHC (0.9) <2:98 0 85 (γ) 
PhCH2 Ph DMAP (10) 64:36 2 45 (α) 
PhCH2 Ph NHC (9) 19:81 3 67 (γ) 
PhCH2 Ph NHC (0.9) 4:96 5 67 (γ) 
4-BrC6H4CH2 Ph DMAP (10) 53:47 0 43 (α) 
4-BrC6H4CH2 Ph NHC (9) 10:90 0 80 (γ) b 
Me 4-FC6H4 DMAP (10) 71:29 6 52 (α) 
Me 4-FC6H4 NHC (9) 12:88 3 67 (γ) 
a
 Values determined by 1H NMR spectroscopic analysis of crude reaction product  
b
 Product contaminated with 5% 483 as a result of partial decomposition on silica 
Table 31: Collated results of furanyl carbonate rearrangements 
Section 6.5: Preparation and evaluation of isomeric furanyl carbonate 
To probe further the steric and electronic requirements of the furanyl rearrangement, the 
isomeric 5-methyl-3-phenylfuranyl carbonate 487 was prepared, whereby the C(3)- and 
C(5)-substituents were switched in comparison with the model substrate 435. This isomeric 
furanyl carbonate was prepared via a strategy related to that employed with (phenylthio)acetic 
acid, but instead beginning with phenylacetic acid  (Scheme 26). Following related protocols, 
multi-gram quantities of the desired butyrolactone 484 were obtained via epoxide opening, 
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followed by dehydration.i Having experienced some minor difficulties in phenylthiolation and 
the subsequent oxidation/elimination with this substrate, phenylselenation was chosen as an 
alternative.208 Upon treatment of the butyrolactone 484 with LDA and phenylselenyl chloride, 
the selenated lactone 485 was obtained and immediately treated with mCPBA to afford the 
desired butenolide 486, exclusively as the 5H-isomer, in 41% yield over the two steps. With the 
desired butenolide 486 in hand, formation of the desired isomeric carbonate 487 was 
investigated. Treatment with Et3N and phenyl chloroformate gave no conversion to the desired 
carbonate, but pleasingly, treatment with KHMDS and phenyl chloroformate afforded the 
desired isomeric carbonate 487 in good yield. The structure of the carbonate product 487 was 
confirmed by X-ray crystallographic analysis (Figure 149).  
 
 
Scheme 26: Preparation of the isomeric 5-methyl-3-phenylfuranyl carbonate 
 
Figure 149: Representation of the X-ray crystal structure of carbonate 487 
Prior to investigation of the isomeric substrate 487 in the Lewis base promoted rearrangement, 
DFT calculations were performed on the related dienolate in order to predict regioselectivity in 
the rearrangement. The results of the calculations showed that HOMO of the isomeric dienolate 
was similar to that of the model dienolate, i.e., that both C(3)- and C(5)-functionalisation would 
be anticipated (Figure 150). 
                                                 
i
 Kindly donated by Louis Morrill. 
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Figure 150: Comparison of the HOMO of the isomeric furanyl carbonates 
Whilst the electronic distributions in the HOMO of the two dienolates were similar, the 
ground-state energies of the α- and γ-carboxybutenolide regioisomers 488 and 489, respectively, 
were markedly different (Figure 151). In this case, the γ-carboxybutenolide regioisomer 489 was 
determined to be considerably more stable than the α-carboxybutenolide regioisomer 488 (by 
12.7 kcal mol-1), which according to Boltzmann distribution calculations would be expected to 
afford nearly exclusively the γ-carboxybutenolide regioisomer 489 at equilibrium. 
              
 α-regioisomer 488 γ-regioisomer 489 
Figure 151: DFT Calculated ground state energy minimisation of the dearomatised products from the isomeric 
furanyl carbonate 
Finally, the rearrangement of the isomeric carbonate 487 was investigated (Figure 152). 
Preliminary current investigations indicate that γ-carboxylation is favoured with both DMAP and 
the NHC, with the NHC promoting exclusive γ-carboxylation. These ratios have been assigned 
by spectroscopic examination of the crude reaction product,i as attempts to isolate the individual 
regioisomers by chromatography proved unsuccessful due to complete decomposition on silica. 
These tentative assignments, however, appear to confirm the predictions of the DFT studies, 
                                                 
i
 By comparison of the indicative resonances, namely, the C=CH and the CH3 in the α-carboxy regioisomer, and the 
CH3 in the γ-carboxy regioisomer. 
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namely, that both C(3) and C(5)-carboxylation are possible pathways, but the significantly 
thermodynamically favoured product is the γ-carboxy regioisomer 489. 
 
 
Figure 152: Rearrangement of isomeric furanyl carbonate 
Section 6.6: Enantioselective furanyl carbonate rearrangements 
Having evaluated the regioselective rearrangement of furanyl carbonates in the racemic series, 
the asymmetric variant was then investigated. Using model furanyl carbonate 435, a range of 
chiral NHC precatalysts was evaluated (Figure 153). Surprisingly, none of the NHCs derived 
from triazolium salts 56, 134, 399, 403, 137 or 416 promoted rearrangement to either of the 
desired C-carboxybutenolides, returning predominantly furanyl carbonate 435 in each case (and, 
in certain instances, decarboxylated butenolide 438). Whilst unexpected, the observed ‘lack’ of 
reactivity with imidazolium derived NHCs in both the furanyl and oxazolyl carbonate systems 
suggests that the C-carboxylation process may be similarly disfavoured with these chiral NHCs. 
 
 
 
 
Figure 153: Attempted enantioselective furanyl carbonate rearrangement using chiral NHCs 
Whilst these results were discouraging, the chiral isothiourea 312 was evaluated (Figure 154). 
This catalyst was chosen as it was shown to give excellent levels of both reactivity and 
enantioselectivity in the related Steglich rearrangement.125 Pleasingly, this catalyst did indeed 
promote carboxyl transfer. Only the α-carboxybutenolide rearrangement product 436 and the 
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decarboxylated product 438 were obtained as an ~80:20 mixture. Following purification, the 
enantioenriched α-carboxybutenolide product 436 was obtained in good yield and excellent ee 
(70%, 95% ee). 
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Figure 154: Enantioselective furanyl carbonate rearrangement using chiral isothiourea 312 
The absolute configuration of this product was determined by preparation of the enantioenriched 
product by the method of Vedejs,107 as no specific rotation data was given for the product in the 
literature. Using (S)-TADMAP 238,i an authentic sample of the α-carboxybutenolide (R)-436 
was obtained, allowing assignment of the (S)-configuration of the major enantiomer of our 
enantioenriched product. This was encouraging as this indicated that catalyst 312 gave the same 
sense of induction to that observed in the related Steglich rearrangement.125 The related 
substituted carbonates 480 were also examined in the reaction manifold (Figure 155, Table 32). 
Similar results were obtained, with these substrates giving rapid rearrangement to predominantly 
the α-regioisomer 481, with either the γ-regioisomer 482 or the decarboxylated product 483 as 
the only other minor product. In all cases, the α-regioisomer 481 was obtained in good isolated 
yield and with excellent levels of enantioselectivity (77–95% ee) at ambient temperature, with 
absolute configuration assigned by analogy. The ee of the minor γ-regioisomer 482 was not 
determined, as the chromatographic method required to separate the α- and γ-regioisomers 
promoted partial decomposition of the γ-regioisomeric product. 
 
 
Figure 155: Enantioselective furanyl carbonate rearrangements using chiral isothiourea 312 
 
 
 
 
                                                 
i
 Kindly donated by Prof. Edwin Vedejs. 
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R Ar Ratio of 
α:γ products b 
Decarboxylation 
(%) b 
Yield of 
α product (%) ee (%) 
Me Ph 100:0 20 70 95 
PhCH2 Ph 100:0 22 66 95 
4-BrC6H4 Ph 69:31 0 65 87 
Me 4-FC6H4 80:20 8 72 77 
a Conversion determined by consumption of carbonate 480 
b
 Values determined by 1H NMR spectroscopic analysis of crude reaction product 
Table 32: Results of asymmetric isothiourea-catalysed carboxyl transfer 
Computational analysis is currently underway to establish the origin of the asymmetry in the 
rearrangement of the furanyl carbonate substrates. Since similar DFT analysis has already been 
performed to establish the origin of asymmetry for the related Steglich rearrangement using this 
catalyst,125 giving the same sense of stereochemical induction in both cases, a similar transition 
state model could be invoked (see page 55).  
Section 6.7: Summary 
The furanyl carbonate substrate class has proven highly amenable to Lewis base-promoted 
rearrangement to the C-carboxybutenolide isomers, with the proportion of the regioisomer 
governed by several factors. Firstly, the choice of Lewis base determines the ratio of products, 
with a triazolium-derived NHC giving preferential γ-carboxylation and aminopyridines and 
isothioureas generally favouring α-carboxylation. Investigation of the mechanism of the 
transformation has illuminated a difference between the use of DMAP and the NHC: the final 
C-C bond-forming step in the reaction is irreversible with DMAP but reversible with the NHC, 
thus, the product ratio obtained with the NHC is initially a reflection of the kinetically formed 
product, but leads to the thermodynamically derived product distribution. Computational 
analysis supports the findings that the γ-carboxybutenolide products are indeed the 
thermodynamically favoured product. The asymmetric variant of the rearrangement has been 
investigated with chiral NHCs and an isothiourea. Whilst chiral NHCs have proven unsuccessful, 
chiral isothiourea 312 has proven highly competent, giving predominantly the α-regioisomeric 
carboxybutenolide product in excellent ee (77–95%). 
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Section 7.1: Conclusions 
This work demonstrates an extensive investigation of the Steglich rearrangement of oxazolyl 
carbonates to their C-carboxyazlactone isomers using NHCs as Lewis bases. These catalysts 
have permitted extension to the substrate scope for such rearrangement, allowing the 
rearrangement to challenging α-branched substrates. 
 
 
Mechanistic studies using crossover experiments have helped propose a mechanism similar to 
that identified using aminopyridines, through generation of a carboxyl transfer species, which 
has been supported by crossover studies. From this work, the NHC promotes rapid reversible 
O-carboxylation, with the rate determining step being the final C-C bond formation to give the 
carboxyazlactone products. 
A number of chemoselectivities have been identified using NHCs, whereby triazolium-derived 
NHCs perform the rearrangement most successfully. Imidazolium-derived NHCs promote rapid 
reversible O-carboxylation, but do not efficiently promote the final C-carboxylation step. The 
reactivity profiles of different substrates, dependent on the electrophilicity of the carbonate 
carbonyl, have been identified. Aryl oxazolyl carbonates have proven most amenable to 
rearrangement, where even the weak organic base Et3N can be used to generate the active 
triazolinylidene catalyst. The exact nature of the NHC in these reaction manifolds could not be 
fully delineated, but the use of Et3N as the base has allowed us to incorporate the Steglich 
rearrangement into multi-step domino cascade protocols. This has allowed rapid access to such 
C-carboxyazlactone products by significantly reducing the number of individual steps. 
 
 
Through our investigations we have discovered that amidines such as DBU and DBN interact 
with oxazolyl carbonates, with DBN promoting the Steglich rearrangement catalytically, without 
the need for azolium salts. This has led to the development of isothioureas, a new class of 
efficient Lewis base with which to promote the Steglich rearrangement. 
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A range of different classes of chiral NHC precatalysts have been successfully prepared and 
evaluated in the asymmetric variant of the Steglich rearrangement, with modest levels of 
enantioselectivity of up to 66% ee.  
 
 
An extension to the systems suitable for carboxyl rearrangement has been established. 
Methodology has been developed to prepare furanyl carbonates by a range of methods, and 
related rearrangement reactions have been performed with a variety of Lewis bases. 
Investigations with a model furanyl carbonate have shown that mixtures of regioisomers are 
obtained. The regioselectivity of the rearrangement is dependent on the nature of the Lewis base: 
NHCs promote kinetic γ-carboxylation, but isothioureas and aminopyridines give a small 
preference for formation of the α-regioisomer. In contrast with the results obtained using NHCs 
in the rearrangement of oxazolyl carbonates, the final C-C bond-forming step in the related 
furanyl carbonate rearrangement is reversible, so the ratio of products using high catalyst 
loadings and/or extended reaction times is a reflection of the relative thermodynamic stability of 
the products. Computational studies support the findings that the γ-carboxybutenolide products, 
the major regioisomer obtained with NHCs, are indeed the thermodynamically more stable 
products. 
 
 
The asymmetric variant of the rearrangement has been investigated, but chiral NHCs have 
proven incompetent in the reaction manifold. Chiral isothiourea 312 has, however, proven highly 
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effective in promoting α-regioisomer formation with excellent levels of enantioselectivity  
(77–95% ee) at ambient temperature. 
 
 
 
Section 7.2: Further work 
In order to delineate the difference in chemoselectivity of the KHMDS and Et3N-derived NHC in 
the Steglich rearrangement, further investigations are needed in order to establish the exact 
nature of the triazolium-derived NHC. 
Differences in regioselectivity in the rearrangement of furanyl carbonates have been identified 
using different Lewis bases. Therefore a range oxazolyl carbonate substrates bearing different 
steric and electronic C(2)-substituents could be investigated to see what effect this has on the 
regioselectivity of the process (Figure 156). 
 
 
Figure 156: Possible C(2)-substituted oxazolyl carbonates to investigate regioselectivity 
The use of chiral azolium salt to effect the asymmetric Steglich rearrangement have had only 
limited success. A range of NHC types could be further explored, such as the N-alkyl substituted 
derivatives such as 499 or the recently described cyclic alkylaminocarbene (CAAC) 500 
developed by Bertrand and co-workers157 which possesses stereocentres directly adjacent to the 
Lewis basic centre (Figure 157). 
 
    
 
       
Figure 157: Potential alternative chiral NHCs    
A computational analysis of the intermediates and transition state(s) along the reaction 
coordinate, with particular focus on the final C-C bond-forming step, should be undertaken in 
order to ascertain the origin of the asymmetric induction. This insight may allow targeted design 
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of NHC scaffolds, rather than screening of an entire library. This approach may allow 
identification of new NHC candidates in order to improve the enantioselectivity of the process.  
Further investigations should be explored into the extension and application of rearrangements of 
furanyl carbonates. Rearrangement of carbonate 487, or relatives of such with greater stability, 
needs to be repeated in order to confirm the findings in the initial study. Further investigations of 
the thermodynamic versus kinetic parameters of furanyl rearrangements should be undertaken 
with carbonates bearing substituents with different electronic behaviour. Examples of such are 
the mesomerically electron-withdrawing and electron-donating 4-cyano- and 4-methoxyphenyl 
containing carbonates 501 and 502, and carbonate 503 bearing an inductively withdrawing 
trifluoromethyl group. Furthermore, there is need for development of methodology to prepare the 
dialkyl- and diaryl-substituted furanyl carbonates 504 and 505 (Figure 158). 
 
 
Figure 158: Potential furanyl carbonates for investigation 
Finally, a more extensive screen of chiral isothioureas of the type 506 should be undertaken in 
order to optimise both regioselectivity and enantioselectivity in the asymmetric rearrangement 
manifolds. 
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General information 
1H NMR Spectra were recorded using a Bruker Avance 400 spectrometer and Bruker Avance 
300 spectrometer at 400 MHz and 300 MHz respectively, using residual protonated solvent as a 
reference for internal lock. The chemical shift information (δH) for each resonance signal are 
given in units of parts per million (ppm) relative to tetramethylsilane (TMS) where δH TMS = 
0.00 ppm, or to residual (protonated) solvent. The number of protons (n) for a reported resonance 
signal are indicated by nH from their integral value and their multiplicity is reported with their 
coupling constants (J) quoted in Hz. Coupling constants are determined by analysis using 
iNMR® and Topspin®. 
13C NMR Spectra were recorded using a Bruker Avance 300 and Bruker Avance 400 
spectrometer using the PENDANT sequence at 75.5 MHz and 100 MHz respectively with 
internal deuterated solvent lock. The chemical shift information (δC) for each resonance signal is 
given in units of parts per million (ppm) relative to tetramethylsilane (TMS) where δC TMS = 
0.00 ppm, or to the relevant solvent. 
19F NMR Spectra were recorded using a Bruker Avance 400 spectrometer at 282 MHz. The 
chemical shift information (δF) for each resonance signal are given in units of parts per million 
(ppm) relative to trichlorofluoromethane (CFCl3) where δF = 0.00. 
Mass spectrometric (m/z) data were acquired by electrospray ionisation (ESI), electron impact 
(EI) or chemical ionisation (CI), either at the University of St Andrews Mass Spectrometry 
facility ([A] quoted) or at the EPSRC National Mass Spectrometry Service Centre, Swansea 
([A]+ or [A]- quoted). At the University of St Andrews, low and high resolution ESI MS was 
carried out on a Micromass LCT spectrometer and low and high resolution EI and CI MS was 
carried out on a Micromass GCT spectrometer. At the EPSRC National Mass Spectrometry 
Service Centre, low resolution ESI MS was carried out on a Waters Micromass ZQ4000 
spectrometer and low resolution EI and CI MS was carried out on a Micromass Quattro II 
spectrometer. High resolution ESI and ESI MS was carried out on a Finnigan MAT 900 XLT or 
a Finnigan MAT 95 XP; a Thermofisher LTQ Orbitrap XL spectrometer was also used to obtain 
high resolution ESI MS for accurate mass determination but also provided fragmentation data for 
the characterisation of samples. Values are quoted as a ratio of mass to charge in Daltons. 
Melting points were determined using an Electrothermal 9100 melting point apparatus and are 
uncorrected. 
Optical rotations were determined using a PerkinElmer Model 341 Polarimeter, at 20.0 ºC 
using a Na/Hal lamp tuned to 589 nm. 
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Chiral HPLC was performed on either a Varian ProStar or Gilson apparatus, using a 
CHIRALPAK OD-H, AD-H or AS-H silica column, 0.46 cm φ × 25 cm, using hexane and 
isopropanol as eluents. 
Analytical thin layer chromatography (tlc) was carried out on pre-coated 0.20 mm 
Machery-Nagel Polygram SIL G/UV254 silica plates. Visualisation was carried out by absorption 
of ultraviolet light or thermal decomposition after dipping in either an ethanolic solution of 
phosphomolybdic acid or an aqueous solution of potassium permanganate/sodium hydroxide. 
Chromatography was performed using Merck Ltd. silica gel 40–63 µm, eluting with solvents 
supplied under a positive pressure of compressed air. 
Anhydrous solvents were obtained under the following conditions: 
Dry dichloromethane was distilled from calcium hydride in a recycling still; dry THF was 
distilled from sodium in a recycling still using benzophenone ketyl as an indicator; dry diethyl 
ether was distilled from sodium in a recycling still using benzophenone ketyl as an indicator. 
From January 2007, anhydrous solvents were obtained from the MBraun SPS-800 solvent 
purification system. 
Chemicals were purchased from Acros UK, Sigma-Aldrich UK, Alfa Aeasar UK, Fisher UK or 
Merck. Brine refers to a saturated aqueous solution of sodium chloride.  
Reactions involving moisture sensitive reagents were performed under an atmosphere of N2 or 
Ar using standard vacuum line techniques and with freshly distilled solvents. All glassware was 
flame-dried and allowed to cool under vacuum.  
For known compounds, where certain elements of analytical data are not described in the 
literature, these data have been reported in this thesis and are marked §. 
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General Procedures: 
When more than one procedure has been followed, an example procedure is described as an 
illustration. 
Conversion of amino acids to their azlactone: 
General procedure A (Methyl ester hydrochloride formation) 
Thionyl chloride (1.5 equiv) was carefully added dropwise to a stirred suspension of amino acid 
(1 equiv) in MeOH at 0 ºC. The reaction mixture was then allowed to warm to ambient 
temperature and stirred for 16 h, after which time the solvent was removed in vacuo. Trituration 
with Et2O may be used for further purification if necessary. 
General procedure B (Amidation)  
Et3N (2.35 equiv) was added to a stirred suspension of amino acid methyl ester hydrochloride 
(1 equiv) in CH2Cl2 at 0 ºC. A solution of p-anisoyl chloride (0.98 equiv) in CH2Cl2 was added 
dropwise to the solution and the reaction mixture stirred at ambient temperature over 16 h. The 
solution was washed with 1 M HCl(aq), sat NaHCO3(aq), brine, dried (MgSO4), filtered and 
concentrated in vacuo. 
General procedure C (Ester deprotection) 
To a solution of crude N-(p-anisoyl)amino acid methyl ester (1 equiv) in MeOH was added 2 M 
NaOH(aq) (1.16 equiv). The solution was stirred for 1 h then the mixture was concentrated 
in vacuo and 1 M HCl(aq) added until pH <2. Upon acidification, a colourless precipitate of the 
product was formed. Filtration of the mixture followed by azeotropic removal of H2O by 
addition of toluene and concentration in vacuo gave the desired N-(p-anisoyl)amino acid 
product. 
General procedure D (Azlactone cyclisation) 
A mixture of N-(p-anisoyl)amino acid (1 equiv) in Ac2O was heated at 65 ºC for 1 h then 
concentrated in vacuo to afford the title compound. 
General procedure E (Formation of oxazolyl carbonates with triethylamine) 
Based upon a procedure by Fu and co-workers, Et3N (1.1–1.5 equiv) was added to a stirred 
solution of the desired azlactone (1 equiv) in THF at 0 ºC, followed by addition of the desired 
chloroformate (1.06 equiv). The mixture was stirred at 0 °C for 30 min before warming to 
ambient temperature and stirring over 16 h. The resulting solution was poured into H2O and the 
aqueous phase extracted with Et2O (× 3). The organic extracts were combined, washed with 
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0.1 M HCl(aq), sat NaHCO3(aq) solution, brine, dried (MgSO4), filtered and concentrated 
in vacuo. Purification by recrystallisation or silica chromatography gave the desired product. 
Procedures for Steglich rearrangement and related furanyl carbonate rearrangement: 
General procedure F (Standard protocol)  
To a mixture of azolium salt (x mol%) in solvent (typically THF, ~1 mL per 100 mg of 
carbonate) was added a solution of base in solvent (0.9x mol%). The mixture was stirred for 
20 min then a solution of carbonate (1 equiv) in solvent (typically THF, ~1 mL per 100 mg of 
carbonate) was added via cannula. The mixture was stirred for y min then concentrated in vacuo 
and, if necessary, the residue was purified by silica chromatography. 
General procedure G (Low temperature) 
To a mixture of azolium salt (x mol%) in THF or toluene (~1 mL per 100 mg of carbonate) was 
added a solution of base in solvent (0.9x mol%). The mixture was stirred for 20 min then cooled 
to -78 ºC and a cooled (-78 ºC) solution of carbonate (1 equiv) in THF or toluene (~1 mL per 
100 mg of carbonate) was added via cannula. The mixture was stirred for 16 h at -78 ºC then 
concentrated in vacuo, and, if necessary, the residue was purified by silica chromatography. 
General procedure H (One-pot) 
To a mixture of azolium salt (x mol%) and carbonate (1 equiv) in THF or toluene (~1 mL per 
100 mg of carbonate) was added a solution of base in solvent (0.9x mol%). The mixture was 
stirred for y min then concentrated in vacuo and, if necessary, the residue was purified by silica 
chromatography. 
For crossover experiments, 0.5 equiv of both carbonate substrates were combined in the relevant 
solvent, and following the aforementioned general procedure H, a sample of the product mixture 
was concentrated in vacuo then examined spectroscopically to determine the product 
distributions. 
General procedure I (Purification by extraction) 
To a mixture of triazolium salt (x mol%) in THF (~1 mL per 100 mg of carbonate) was added a 
solution of base in solvent (0.9x mol%). The mixture was stirred for 20 min then a solution of 
carbonate (1 equiv) in THF (~1 mL per 100 mg of carbonate) was added via cannula. The 
mixture was stirred for y min then quenched with 1 M HCl(aq), extracted with Et2O (× 3) and, if 
necessary, the residue was purified by silica chromatography. 
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General procedure J (Two-step domino cascade) 
To a mixture of azlactone (1 equiv) and triazolium salt (5 mol%) in THF (~1 mL per 100 mg of 
azlactone) was added Et3N (1.5 equiv) followed by the requisite aryl chloroformate (1.3 equiv). 
The mixture was stirred at ambient temperature, then Et3N·HCl was removed by filtration and 
the filtrate concentrated in vacuo. Purification by silica chromatography (EtOAc/petrol, 
Et2O/petrol or CH2Cl2/petrol) gave the desired product.  
General procedure K (Multi-step domino cascade with DCC) 
A mixture of N-(p-anisoyl) amino acid (1 equiv) and DCC (1.01 equiv) were stirred in THF for 
2 h then filtered (to remove dicyclohexylurea), followed by addition of triazolium salt 128 
(5 mol%), Et3N (1.5 equiv) and then phenyl chloroformate (1.3 equiv). The mixture was stirred 
at ambient temperature, then Et3N·HCl was removed by filtration and the filtrate concentrated 
in vacuo. Purification by silica chromatography (Et2O/petrol) gave the desired product.  
General procedure L (Alternative multi-step domino cascade protocol using aryl 
chloroformates) 
To a mixture of N-(p-anisoyl) amino acid (1 equiv) and triazolium salt 128 (5–10 mol%) in THF 
was added Et3N (3.5 equiv) followed by phenyl chloroformate (3 equiv), with significant 
exotherm and effervescence observed. The mixture was stirred at ambient temperature, then 
Et3N·HCl was removed by filtration and the filtrate concentrated in vacuo. Purification by silica 
chromatography (Et2O/petrol or CH2Cl2/petrol) gave the desired product. 
General procedure M (General Lewis base-promoted rearrangement) 
To a solution of carbonate (1 equiv) in solvent (~1 mL per 100 mg of carbonate) was added the 
requisite Lewis base (aminopyridine, amidine or isothiourea) (x mol%). The mixture was stirred 
for 5 min to 16 h, then concentrated in vacuo, and the residue purified by silica chromatography 
if necessary. 
For crossover experiments, 0.5 equiv of both carbonate substrates were combined in the relevant 
solvent, and following the aforementioned general procedure M, a sample of the product mixture 
was concentrated in vacuo then examined spectroscopically to determine the product 
distributions. 
General procedure N (Amide coupling via mixed anhydride) 
To a cooled (0 ºC) mixture of carboxylic acid (1 equiv) in CH2Cl2 was added 
N-methylmorpholine (1.15 equiv) over 5 min, followed by dropwise addition of ethyl 
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chloroformate (1 equiv) over 15 min. Finally, amine (1 equiv) was added over 15–20 min then 
the mixture was allowed to warm to ambient temperature slowly over 16 h. The reaction was 
quenched with H2O and extracted with CH2Cl2 (× 3). The organic fractions were combined and 
washed sequencially with 4% NaHCO3(aq) and 1 M HCl(aq), then dried (MgSO4), filtered and 
concentrated in vacuo. The crude product was then triturated with ice-cold pentane to obtain the 
purified product. 
General procedure O (Reduction of amino amides) 
To a mixture of amino amide (1 equiv) in THF was carefully added LiAlH4 (3 equiv of a 2.0 M 
solution in THF) at ambient temperature, with notable effervescence. The mixture was then 
heated at reflux (80–85 ºC) for 18–34 h, then the mixture was cooled in an ice bath, and H2O 
(x mL for x g of LiAlH4 used) was added carefully, followed by 15% KOH(aq) (x mL for x g of 
LiAlH4 used) and more H2O (3x mL for x g of LiAlH4 used). The mixture was stirred rapidly for 
5 min, then excess MgSO4 added to the mixture and the mixture stirred rapidly for 4–6 h. The 
mixture was then filtered through celite, eluting with Et2O, then the filtrate concentrated in vacuo 
to afford the crude product. 
General procedure P (Reduction of N-Boc-amino amides) 
To a mixture of N-Boc-amino amide (1 equiv) in THF was carefully added LiAlH4 (6 equiv of a 
2.0 M solution in THF) at ambient temperature, with notable effervescence. The mixture was 
then heated at reflux (80–85 ºC) for 18–34 h, then the mixture was cooled in an ice bath, 
and H2O (x mL for x g of LiAlH4 used) was added carefully, followed by 15% KOH(aq) (x mL 
for x g of LiAlH4 used) and more H2O (3x mL for x g of LiAlH4 used). The mixture was stirred 
rapidly for 5 min, then excess MgSO4 was added to the mixture and the mixture stirred rapidly 
for 4–6 h. The mixture was then filtered through celite, eluting with Et2O, then the filtrate 
concentrated in vacuo to afford the crude product. 
General procedure Q (Boc deprotection) 
To a mixture of carbamate (1 equiv) in CH2Cl2 was added TFA (~2 mL per g of carbamate) and 
the mixture stirred at ambient temperature for 16 h. The mixture was then concentrated in vacuo, 
followed by extraction from 1 M NaOH(aq) with CH2Cl2 (× 3). The organic fractions were 
combined, dried (MgSO4), filtered and concentrated to afford the desired amino amide. 
Preparation of furanyl carbonates via butenolides from (phenylthio)acetic acid 
General procedure R (Preparation of the butyrolactone) 
To a solution of diisopropylamine (2.21 equiv) in THF at 0 °C was added n-BuLi (2.5 M in 
hexanes, 2.21 equiv). After 15 min, the solution of LDA was cooled to -78 ºC and the 
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(phenylthio)acetic acid (1 equiv) was added as a solution in THF. After 1 h, the requisite epoxide 
(1.20 equiv) was added in one portion and the mixture allowed to warm to ambient temperature 
over 16 h. The reaction mixture was quenched with 2 M NaOH(aq) and extracted with Et2O 
(× 3). The aqueous layer was acidified with 10 M HCl(aq) and extracted with Et2O (× 3) and the 
combined organic extracts were washed with brine, dried (Na2SO4), filtered and concentrated 
in vacuo. Chromatographic purification (100% CH2Cl2) gave the desired product as a mixture of 
diastereomers, ~1–2:1 dr. The product was used without further purification. 
General procedure S (Alkylation of the butyrolactone) 
To a solution of diisopropylamine (1.3 equiv) in THF at 0 °C was added n-BuLi (2.5 M in 
hexanes, 1.3 equiv). After 15 min, the solution of LDA was cooled to -78 ºC and a solution of 
the requisite lactone (1 equiv) in THF was added over 15 min. After 30 min, a solution of the 
requisite halide* (1 equiv) in DMPU was added in one portion and the mixture allowed to warm 
to ambient temperature over 16 h. The reaction was quenched with sat NH4Cl(aq) and extracted 
with Et2O. The combined organic extracts were washed with H2O, brine, dried (Na2SO4), filtered 
and concentrated in vacuo. Chromatographic purification (20% Et2O:petrol) gave the desired 
product as a mixture of diastereomers, generally >9:1 dr in favour of the syn-diastereomer. 
* If using a reactive alkyl halide, such as benzyl bromide, only DMPU is required to promote the 
alkylation. If not activated, Finklestein catalysis should be employed using NaI (0.2–1 equiv). 
General procedure T (Oxidation/thermolysis to the butenolide) 
To a solution of lactone (1 equiv) in either CH2Cl2 or CHCl3 at 0 °C was added mCPBA (70% 
purity, 1 equiv) [NB. For large scale reactions the mCPBA was added portionwise to prevent 
overoxidation to the sulfone]. After 1 h, sat NaHCO3(aq) (excess) was added and the solution 
was extracted with EtOAc. The combined organic extracts were washed with brine and dried 
(Na2SO4), filtered and concentrated in vacuo to afford the crude sulfoxide. The crude sulfoxide 
was dissolved in toluene and heated at reflux for 16 h, then the mixture was concentrated 
in vacuo. Chromatographic purification (10% → 20% Et2O:petrol) gave the butenolide, 
generally as a mixture of tautomers.  
General procedure U (Preparation of the carbonate) 
To a cooled (0 ºC) solution of butenolide (mixture of tautomers) in THF was added Et3N 
(2 equiv) followed by dropwise addition of phenyl chloroformate (2 equiv) The mixture was 
warmed to ambient temperature over 16 h, then quenched with sat NH4Cl(aq) and extracted with 
Et2O. The organic fraction was dried (MgSO4), filtered and concentrated in vacuo to afford the 
crude carbonate product. Chromatographic purification (10% Et2O:petrol) gave the desired 
carbonate product. 
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General Procedure V (Resubjection of rearrangement products) 
With NHC: 
To a mixture of C-carboxybutenolide (either the α- or γ-regioisomer) (1 equiv) and triazolium 
salt 128 (10 mol%) in THF (~1 mL mmol-1) was added KHMDS (0.5 M solution in toluene, 
9 mol%) and the mixture stirred for 5 h. After this time, the mixture was concentrated in vacuo 
then analysed spectroscopically to determine the product distribution. 
With DMAP: 
To a solution of C-carboxybutenolide (either the α- or γ-regioisomer) (1 equiv) in THF (~1 mL 
mmol-1) was added DMAP (9 mol%) and the mixture stirred for 5 h. After this time, the mixture 
was concentrated in vacuo then analysed spectroscopically to determine the product distribution. 
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DL-Phenylalanine methyl ester hydrochloride 251 
 
 
To a stirred suspension of DL-phenylalanine 250 (12.5 g, 75.7 mmol) in MeOH (125 mL) at 0 ºC 
was added thionyl chloride (8.30 mL, 114mmol) dropwise. The mixture was allowed to warm to 
ambient temperature and stirred for 16 h. The mixture was concentrated in vacuo to afford the 
crude product as a pale yellow solid which was triturated with Et2O (250 mL) to afford the 
product as a colourless solid (16.3 g, quantitative). mp 158–161 °C, lit.158 161–162 ºC; δH 
(300 MHz, D2O) 7.45–7.37 (3H, m, ArH), 7.31–7.27 (2H, m, ArH), 4.42 (1H, ABX, JXB 7.4, JXA 
5.2, CH), 3.82 (3H, s, CH3), 3.34 (1H, ABX, JAB 14.6, JAX 5.2, PhCHAHB) and 3.21 (1H, ABX, 
JBA 14.6, JBX 7.4, PhCHAHB). Spectroscopic data are in accordance with the literature.159 
L-Phenylalanine methyl ester hydrochloride (S)-251 
 
 
Following the above procedure using L-phenylalanine (S)-250, the enantiomerically pure product 
was obtained in quantitative yield; mp 159–160 °C, lit.160 158–162 °C; [α] 20D  +19.5 (c 1.0, 
MeOH), lit.161 +18.1 (c 2.0, MeOH). Data are in accordance with the literature.  
4-Benzyl-2-(4-methoxyphenyl)-5-oxo-4,5-dihydrooxazole 254 
 
 
Following general procedure B, DL-phenylalanine methyl ester hydrochloride 251 (13.7 g, 
63.6 mmol), CH2Cl2 (140 mL), Et3N (20.8 mL, 149.4 mmol) and p-anisoyl chloride (10.6 g, 
62.4 mmol) in CH2Cl2 (17 mL) gave the amido ester product 252 as a pale cream solid (19.5 g, 
98%). δH (300 MHz, CDCl3) 7.72–7.66 (2H, m, MeOArH–3,5), 7.33–7.20 (3H, m, PhH), 7.16–
7.11 (2H, m, PhH), 6.95–6.89 (2H, m, MeOArH-2,6), 6.50 (1H, br d, J 7.5, NH), 5.11 (1H, dt, 
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J 7.5, 5.7, CHNH), 3.85 (3H, s, OCH3), 3.77 (3H, s, OCH3), 3.28 (1H, ABX, JAB 13.8, JAX 5.7, 
CHAHBPh) and 3.21 (1H, ABX, JBA 13.8, JBX 5.5, CHAHBPh).  
Following general procedure C, N-p-anisoyl-DL-phenylalanine methyl ester 252 (19.51 g, 
62.3 mmol), MeOH (125 mL) and 2 M NaOH(aq) (38 mL) gave the acid product 253 as a 
colourless solid (15.9 g, 85%). mp§ 109–112 ºC (glassy); δH (300 MHz, CDCl3) 7.51 (1H, d, 
J 8.6, MeOArH-3,5), 7.08–6.92 (5H, m, PhH), 6.72 (2H, d, J 8.6, MeOArH-2,6), 4.59 (1H, 
ABX, JXB 4.9, JXA 4.1, NHCH(Bn)COOH), 3.60 (3H, s, OCH3), 3.10 (1H, ABX, JAB 13.4, JAX 
4.1, CHAHBPh) and 2.91 (1H, ABX, JBA 13.4, JBX 4.9, PhCHAHB). Spectroscopic data are in 
accordance with the literature.106  
Following general procedure D, N-p-anisoyl-DL-phenylalanine 253 (5.00 g, 16.7 mmol) and 
Ac2O (8.5 mL) gave the title compound as a pale yellow solid (4.70 g, quantitative). mp§ 114–
115 ºC; δH (300 MHz, CDCl3) 7.81–7.67 (2H, m, MeOArH-3,5), 7.22–7.10 (5H, m, PhH), 6.89–
6.84 (2H, m, MeOArH-2,6), 4.59 (1H, ABX, JXB 6.7, JXA 5.0, CHNHR), 3.79 (3H, s, ArOCH3), 
3.28 (1H, ABX, JAB 13.9, JAX 5.0, CHAHBPh) and 3.10 (1H, ABX, JBA 13.9, JBX 6.7, CHAHBPh). 
Spectroscopic data are in accordance with the literature.106  
4-Benzyl-2-(4-methoxyphenyl)oxazolyl methyl carbonate 255 
 
 
Following general procedure E, Et3N (4.46 mL, 32.1 mmol), azlactone 254 (5.64 g, 20.0 mmol), 
THF (100 mL) and methyl chloroformate (2.33 mL, 30.1 mmol) gave, after crystallisation 
(Et2O/petrol), the title compound as a colourless solid (6.31 g, 93%). mp 58–60 ºC, lit.162 58–
60 ºC; δH (300 MHz, CDCl3) 7.83–7.78 (2H, m, MeOArH-3,5), 7.24–7.12 (5H, m, PhH), 6.88–
6.83 (2H, m, MeOArH-2,6), 3.80 (3H, s, COOCH3), 3.79 (2H, s, CH2Ph) and 3.77 (3H, s, 
ArOCH3). Spectroscopic data are in accordance with the literature.162  
4-Benzyl-2-(4-methoxyphenyl)oxazol-5-yl phenyl carbonate 256 
 
 
Following general procedure E, Et3N (3.72 mL, 26.7 mmol), azlactone 254 (4.70 g, 16.7 mmol), 
THF (70 mL) and phenyl chloroformate (3.14 mL, 25.1 mmol) gave, after recrystallisation 
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(Et2O/petrol), the product as a colourless solid (5.03 g, 75%). mp§ 93–94 ºC; δH (300 MHz, 
CDCl3) 7.96–7.91 (2H, m, MeOArH-3,5), 7.47–7.18 (10H, m, PhH), 6.99–6.94 (2H, m, 
MeOArH-2,6), 3.96 (2H, s, CH2Ph) and 3.87 (3H, s, ArOCH3). Spectroscopic data are in 
accordance with the literature.106  
Benzyl 4-benzyl-2-(4-methoxyphenyl)-oxazol-5-yl carbonate 257 
 Ph
N
O O
O
OBn
MeO
257
 
Following the general procedure E, Et3N (0.540 mL, 3.91 mmol), azlactone 254 (1.00 g, 
3.55 mmol), THF (25 mL) and benzyl chloroformate (0.890 mL, 3.76 mmol) gave, after 
chromatographic purification (25% Et2O:petrol), the product as a yellow oil (1.10 g, 74%). δH 
(300 MHz, CDCl3) 7.87 (2H, d, J 9.0, MeOArH-3,5), 7.41–7.39 (5H, m, PhH), 7.27–7.25 (5H, 
m, OCH2PhH), 6.92 (2H, d, J 9.0, MeOArH-2,6), 5.21 (2H, s, OCH2Ph), 3.85 (3H, s, OCH3) and 
3.85 (2H, s, CH2Ph). Spectroscopic data are in accordance with the literature.107  
4-Benzyl-2-(4-methoxyphenyl)-oxazol-5-yl 1,1,1-trichloro-2-methylpropan-2-yl carbonate 
258 
 
 
Following general procedure B, Et3N (3.91 mmol, 0.540 mL), azlactone 254 (1.00 g, 
3.55 mmol), THF (30 mL) and 1,1,1-trichloro-2-methylpropan-2-yl chloroformate (900 mg, 
3.76 mmol) gave, after chromatographic purification (25% Et2O:petrol), the product as a 
colourless solid (1.34 g, 78%). mp 62–64 °C, lit.124 62–64 ºC; δH (300 MHz, CDCl3) 7.89 (2H, 
d, J 9.0, MeOArH-3,5), 7.31–7.29 (5H, m, ArH), 6.93 (2H, d, J 9.0, MeOArH-2,6), 3.88 (2H, s, 
CH2), 3.85 (3H, s, OCH3) and 1.92 (6H, s, 2 × CH3). Data are in accordance with the 
literature.124  
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4-Benzyl-2-(4-methoxyphenyl)oxazol-5-yl naphthalen-1-yl carbonate 259 
 
 
Following general procedure E, Et3N (0.594 mL, 4.27 mmol), azlactone 254 (1.00 g, 
3.56 mmol), CH2Cl2 (10 mL) and 1-naphthyl chloroformate (0.660 mL, 4.09 mmol), gave the 
crude product as a yellow oil. Crystallisation (Et2O:hexane) gave the product as a colourless 
solid (828 mg, 51%). mp 86–88 ºC; δH (400 MHz, CDCl3) 7.95–7.89 (4H, m, MeOArH-3,5 and 
NapH), 7.80 (1H, d, J 8.3, NapH), 7.57 (2H, dt, 6.7, 3.0, ArH), 7.49 (1H, t, J 8.0, ArH), 7.39–
7.31 (5H, m, ArH), 7.27–7.24 (1H, m, ArH), 6.95 (2H, d, J 8.8, MeOArH-2,6), 3.97 (2H, s, 
PhCH2) and 3.85 (3H, s, OCH3); δC (100 MHz, CDCl3) 161.7 (MeOArC-1), 155.7 (ArC), 150.2 
(ArC), 146.6 (ArC), 145.9 (ArC), 137.6 (ArC), 134.8 (ArC), 129.1 (ArCH), 128.8 (ArCH), 128.3 
(ArCH), 128.0 (ArCH), 127.2 (ArCH), 127.2 (ArCH), 127.1 (ArCH), 126.9 (ArCH), 126.1 
(ArC), 125.4 (ArCH), 123.5 (ArC), 120.9 (ArCH), 119.9 (ArC), 117.3 (ArCH), 114.4 (ArCH), 
55.6 (OCH3) and 31.9 (CH2); m/z MS (ESI+) 469 (100, [M+NH4]+), HRMS (ESI+) C28H25N2O5+ 
([M+NH4]+) requires 469.1758, found 469.1758 (+0.0 ppm); IR νmax (KBr) /cm-1 3052 (Ar C-H), 
3027, 2970, 2913, 2835, 1792 (C=O), 1667 (Ar C=C), 1617 (C=N), 1603 (Ar C=C), 1459, 1502, 
1455, 1434, 1393, 1307, 1258 (C-O), 1213 (C-O) and 1180 (C-O). 
2-Phenyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazolium tetrafluoroborate 128 
 
 
Trimethyloxonium tetrafluoroborate (2.96 g, 20.0 mmol) was added to a solution of 
pyrrolidin-2-one (1.40 mL, 18.1 mmol) in CH2Cl2 (120 mL) and the mixture was stirred at 
ambient temperature for 16 h. Phenylhydrazine (1.80 mL, 18.1 mmol) was added and stirred for 
2 d before concentration in vacuo. The residue was dissolved in MeOH (10 mL) and triethyl 
orthoformate (40 mL) and heated at reflux (100 ºC) for 16 h. The resultant solid was filtered and 
recrystallised from MeOH to afford the title compound as a golden-orange solid (4.22 g, 85%). 
mp 154–156 ºC, lit.110 154–156 ºC; δH (300 MHz, d6-DMSO) 10.71 (1H, s, CH), 7.91–7.85 (2H, 
m, PhH-2,6), 7.73–7.60 (3H, m, PhH-3,4), 4.41 (2H, t, J 7.4, NCH2), 3.21 (2H, t, J 7.4, CCH2) 
and 2.75 (2H, tt, J 7.4, CH2CH2CH2). Data are in accordance with the literature.110 
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3-13C-2-Phenyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazolium tetrafluoroborate 3-13C-128 
 
Trimethyloxonium tetrafluoroborate (814 mg, 5.50 mmol) was added to a solution of 
pyrrolidin-2-one (0.415 mL, 5.36 mmol) in CH2Cl2 (120 mL) and the mixture was stirred at 
ambient temperature for 16 h. Phenylhydrazine (0.547 mL, 5.50 mmol) was added and stirred for 
2 d before concentration in vacuo. The residue was dissolved in MeOH (10 mL) and triethyl 
13C1-orthoformate (2.00 g, 13.4 mmol) and heated at reflux (100 ºC) for 16 h. Precipitation was 
induced by addition of Et2O (3 drops) and cooling to 0 ºC in an ice-bath. The resultant solid was 
filtered and triturated with cold (-78 ºC) EtOAc (5 mL) to afford the title compound as a 
pink-orange solid (1.24 g, 82%). mp 154–156 ºC; δH (300 MHz, d6-DMSO) 10.71 (1H, d, J 160, 
13CH), 7.91–7.85 (2H, m, PhH-2,6), 7.73–7.60 (3H, m, PhH-3,4), 4.41 (2H, t, J 7.4, NCH2), 3.21 
(2H, t, J 7.4, CCH2) and 2.75 (2H, tt, J 7.4, CH2CH2CH2). Data are in accordance with the 
unlabelled product 128. 
3-Benzyl-4,5-dimethylthiazolium chloride 203 
 
 
To a solution of 4,5-dimethylthiazole (2.30 g, 20.3 mmol) in acetonitrile (10 mL) was added 
benzyl chloride (2.57 g, 20.3 mmol) dropwise over 10 min. The solution was heated at reflux 
(85 ºC) for 24 h. The mixture was allowed to cool to ambient temperature then precipitation of 
the product was induced with gentle scraping with a spatula. The precipitate was collected by 
filtration and washed with cold CH3CN (10 mL). The product was dried in vacuo for 24 h, to 
afford the product as a colourless solid (2.97 g, 61%). mp 55–56 ºC, lit.163 56–58 ºC; δH 
(400 MHz, CDCl3) 11.88 (1H, s, SCHN), 7.37–7.32 (5H, m, PhH), 6.13 (2H, s, CH2Ph), 2.48 
(3H, s, CH3-4) and 2.36 (3H, s, CH3-5). Data are in accordance with the literature.163 
Bis(2,4,6-trimethylphenyl)imidazolium tetrafluoroborate 265 
 
N NMes Mes
BF4
265
 
To a solution of mesitidine (1.40 mL, 10.0 mmol) in toluene (20 mL) was added 
paraformaldehyde (300 mg, 10.0 mmol) with vigorous stirring and cooling to 10 ºC. After 
Chapter 8: Experimental details 
 
149 
30 min, further mesitidine (1.40 mL, 10.0 mmol) was added at 0 ºC, then HBF4(aq) (1.25 mL of 
a 40% w/v solution, 10.0 mmol) was added dropwise, stirred at ambient temperature for 30 min 
then heated to 40 ºC for 12 h. Addition of Et2O (10 mL) resulted in precipitation of an oily 
substance from which the liquor was decanted. The oily substance was triturated exhaustively 
with Et2O and hexane to afford the product as a brown/grey solid (2.57 g, 65%). mp§ 240–
243 ºC; δH (400 MHz, CDCl3) 8.80 (1H, t, J 1.5, NCHN), 7.53 (2H, d, J 1.5, NCHCHN), 6.97 
(4H, s, ArH-3,5), 2.30 (6H, s, 4-CH3Ar) and 2.05 (12H, s, 2,6-(CH3)2Ar); δC§ (100 MHz, CDCl3) 
141.2 (NArC-1), 137.0 (NCHN), 134.0 (ArC(CH3)-2), 130.5 (ArC(CH3)-4), 129.7 (ArCH-3,5), 
125.2 (NCHCHN), 21.1 (4-CH3Ar) and 17.1 (2,6-(CH3)2Ar); IR§ νmax (KBr) /cm-1 3118 (C-H), 
2944 (C-H), 2863 (C-H), 1625 (C=C/C=N), 1530 (C=C/C=N stretch), 1455 (C-H), 1377 (C-H) 
and 1221 (C-N). Data are in accordance with the literature.164  
(R)- and (RS)-Phenyl 4-benzyl-5-oxo-2-(4-methoxyphenyl)-4,5-dihydrooxazole- 
4-carboxylate 266 
 
 
All procedures F-M were employed to afford the title compound.  
Following general procedure F, KHMDS (13.5 µL, 6.75 µmol), triazolium salt 128 (2.05 mg, 
7.50 µmol), THF (3 mL) and oxazolyl carbonate 256 (300 mg, 0.750 mmol) gave, after 
chromatographic purification (20% Et2O:petrol), the title compound as a colourless oil (241 mg, 
80%). δH (300 MHz, CDCl3) 7.92–7.87 (2H, m, MeOArH-2,6), 7.43–7.37 (2H, m, PhH), 7.30–
7.19 (6H, m, PhH), 7.15–7.10 (2H, m, PhH), 6.98–6.94 (2H, m, MeOArH-2,6), 3.88 (3H, s, 
ArOCH3), 3.75 (1H, ABd, J 13.7, CHAHBPh) and 3.61 (1H, ABd, J 13.7, CHAHBPh). 
Spectroscopic data are in accordance with the literature.107  
Enantiomeric excesses were determined by HPLC with Chiralcel OD-H column (5% 
i-PrOH:hexane, flow rate = 1.0 mL min-1), tR(R) 13.8 min and tR(S) 18.9 min. 
Catalyst screening studies 
To evaluate the efficacy of all NHCs in the Steglich rearrangement protocol, the following 
procedure was employed. 
Following general procedure F or H, KHMDS (0.45-9 mol%), azolium salt precatalyst 
(0.5-10 mol%), THF (1 mL) and oxazolyl carbonate 256 (100 mg, 0.249 mmol) were used, and 
samples taken after specified times, concentrated in vacuo and inspected spectroscopically 
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(1H NMR); in cases where isolated yields are stated, chromatographic purification (20% 
Et2O:petrol) gave the title compound as a colourless oil. 
Results of screen with achiral azolium salts via preformation of NHC in situ: 
All reactions were carried out according to general procedure F above, at 10 mol% precatalyst 
loading in THF (1 mL, 0.249 mM concentration of carbonate substrate 256) after 1 h. 
Precatalyst Conversion (%) a 
Isolated 
 yield (%) 
128 >98 80 
203 11 - 
267 <5 - 
79 >90 68 
265 ~40 - 
245 >90 - 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
 
Results of screen with achiral azolium salts via one-pot protocol: 
All reactions were carried out according to general procedure H, at x mol% precatalyst loading in 
THF (1 mL, 0.249 mM concentration of carbonate substrate 256). 
Precatalyst 
(mol%) 
KHMDS 
(mol%) Time (min) 
Conversion 
(%) a 
no precatalyst 9 60 <5 
128 (10) 9 60 >98 (80) b 
128 (10) 9 5 >98 (80) b 
128 (1) 0.9 5 >98 
268 (1) 0.9 5 >98 
270 (1) 0.9 5 >98 
79 (9) 9 60 >95 
245 (9) 9 60 >95 
203 (9) 9 60 ~30 
267 (9) 9 60 72 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
b
 Isolation of homogenous purified product by chromatography 
 
Results of screen with achiral azolium salts using triethylamine as the base 
All reactions were carried out according to general procedure F above, at x mol% precatalyst 
loading and Et3N as the base at the stated molar equivalence, in the relevant solvent (1 mL, 
0.249 mM concentration of carbonate substrate 256). 
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Precatalyst 
(mol%) Base (mol%) Solvent Time 
Conversion 
(%) a 
128 (1) Et3N (0.9) THF >24 h <10 
128 (10) Et3N (9) +  
Et3N·HCl (1 equiv) 
THF 
2 h 
3 h 
75 
>98 
128 (10) Et3N (9) THF 2 h >98 
128 (10) Et3N (100) THF <5 min >98 
128 (10) Et3N (9) CH2Cl2 2 h ~75 
268 (10) Et3N (9) THF 2 h >98 
270 (10) Et3N (9) THF 4 h >98 
79 (10) Et3N (9) THF >24 h <10 
245 (10) Et3N (9) THF >24 h <5 
265 (10) Et3N (9) THF >24 h <5 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
 
Results of screen with chiral diazolium salts via preformation of NHC in situ: 
All reactions were carried out according to general procedure F above, at 10 mol% precatalyst 
loading in THF (1 mL, 0.249 mM concentration of carbonate substrate) after 1 h. Conversions 
were determined spectroscopically, and enantiomeric excesses were determined following 
chromatographic purification (20% Et2O:petrol). 
Chiral diazolium 
precatalyst 
Conversion 
(%) a 
ee of (R)-266 
(%) 
344 70 <5 
348 >98 <5 
354 <5 - 
138 65 11 
362 75 <5 
377 ~20 - 
380 ~65 <5 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
 
Results of screen with chiral triazolium salts via preformation of NHC in situ: 
All reactions were carried out according to general procedure F above, at 10 mol% precatalyst 
loading in either THF of toluene (1 mL, 0.249 mM concentration of carbonate substrate 256). 
Conversions were determined spectroscopically, and enantiomeric excesses were determined 
following chromatographic purification (20% Et2O:petrol). 
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Chiral triazolium 
salt Solvent 
Conversion 
(R)-266:254 (%) a 
ee of (R)-266 
(%) 
56 THF ~70:30 <5 
56 toluene ~55:45 <5 
134 THF >98:<2 20 (ent) 
134 toluene 95:5 20 (ent) 
399 THF >98:<2 <5 
399 toluene >98:<2 34 
164 THF >98:<2 16 
164 toluene 88:12 31 
137 THF >98:<2 <5 
137 toluene >98<:2 <5 
ent-170 THF >98:<2 <5 (ent) 
ent-170 toluene >95:<5 <5 (ent) 
416 THF >98:<2 <5 (ent) 
416 toluene 95:5 20 (ent) 
403 THF >98:<2 <5 
403 toluene 88:12 <5 
407 THF >98:<2 <5 
407 toluene 90:10 6 
 
   
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
 
Optimisation of asymmetric Steglich rearrangement using chiral oxazolidinone-derived 
triazolium salts 
 
All reactions were carried out according to general procedure F above, at 10 mol% precatalyst 
loading, with the relevant base and solvent stated (1 mL solvent, 0.249 mM concentration of 
carbonate substrate 256), and at the temperature stated. Conversions were determined 
spectroscopically, and enantiomeric excesses were determined following chromatographic 
purification (20% Et2O:petrol). 
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Precatalyst Base Solvent Temp (ºC) Time (h) 
Conversion 
(R)-266:254 
(%) a 
ee (%) 
399
N N
N
O
Ph
BF4
Ph
 
KHMDS PhCl rt 1 >98:2 13 
KHMDS Et2O rt 1 >98:2 27 
KHMDS toluene rt 1 >98:2 34 
KHMDS toluene -20 16 74:17 b 46 
KHMDS toluene -30 16 0:0 b - 
Et3N CH2Cl2 rt 4 90:10 22 
 
KHMDS PhCl rt 1 >98:2 8 
KHMDS toluene rt 1 88:12 31 
KHMDS toluene -30 16 63:37 50 
Cs2CO3 THF rt 1 80:20 25 
Cs2CO3 toluene rt 1 75:25 5 
NaHMDS toluene rt 1 70:30 33 
LiHMDS toluene rt 1 >98:2 39 
n-BuLi toluene rt 1 0:0 b - 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
b Remainder present as unreacted carbonate 256 
 
 
 (R)- and (RS)-Methyl 4-benzyl-5-oxo-2-(4-methoxyphenyl)-4,5-dihydrooxazole- 
4-carboxylate 249 
 
 
Procedures F-I were employed to afford the title compound.  
Following general procedure F, KHMDS (90.0 µL of a 0.5 M solution in toluene, 0.0450 mmol), 
triazolium salt 128 (13.7 mg, 50.0 µmol), THF (2 mL) and carbonate 255 (170 mg, 0.500 mmol) 
gave, after chromatographic purification (15% Et2O:petrol), the title compound as a colourless 
oil (129 mg, 76%). δH (300 MHz, CDCl3) 7.85–7.80 (2H, m, MeOArH-3,5), 7.20–7.14 (5H, m, 
PhH), 6.94–6.89 (2H, m, MeOArH-2,6), 3.85 (3H, s, OCH3), 3.83 (3H, s, OCH3), 3.63 (1H, 
ABd, J 13.7, CHAHBPh) and 3.48 (1H, ABd, J 13.7, CHAHBPh). Spectroscopic data are in 
accordance with the literature.110  
Enantiomeric excesses were determined by HPLC with Chiralcel OD-H column (2% 
i-PrOH:hexane, flow rate = 1.0 mL min-1), tR(R) 15.7 min and tR(S) 19.9 min. 
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Results of screen with achiral azolium salts via preformation of NHC in situ: 
All reactions were carried out according to general procedure F above, at x mol% precatalyst 
loading in THF (0.249 mM concentration of carbonate substrate). 
Precatalyst 
(mol%) 
KHMDS  
(mol%) Time (min) 
Conversion 
(%) a 
128 (10) 9 90 >98 (76) b 
128 (5) 4.5 90 >98 
128 (1) 0.9 90 >98 
128 (1) 0.9 5 >98 
79 (10) 9 90 ~75 (68) b 
245 (10) 9 90 <5 
a
 Determined by 1H NMR spectroscopic analysis of the crude reaction product 
b
 Isolated yield of homogeneous product following chromatographic purification 
 
Benzyl 4-benzyl-2-(4-methoxyphenyl)-5-oxo-4,5-dihydrooxazole-4-carboxylate 271 
 
 
Procedures F and H were employed to afford the title compound.  
Following general procedure F, KHMDS (36.0 µL of a 0.5 M solution in toluene, 18.0 µmol), 
triazolium salt 128 (5.46 mg, 20.0 µmol), THF (2 mL) and carbonate 257 (82.0 mg, 0.200 mmol) 
gave, after chromatographic purification (15% Et2O:petrol), the title compound as a colourless 
oil (150 mg, 75%). δH (300 MHz, CDCl3) 7.82 (2H, d, J 9.0, MeOArH-3,5), 7.35–7.31 (5H, m, 
PhH), 7.20–7.14 (5H, m, PhH), 6.91 (2H, d, J 9.0, MeOArH-2,6), 5.30 (1H, ABd, J 12.4, 
PhCHAHBO), 5.24 (1H, ABd, J 12.4, PhCHAHBO) 3.85 (3H, s, OCH3), 3.64 (1H, ABd, J 13.8, 
PhCHAHB) and 3.50 (1H, ABd, J 13.8, PhCHAHB). Spectroscopic data are in accordance with 
the literature.107 
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(R)- and (RS)-1,1,1-Trichloro-2-methylpropan-2-yl 4-benzyl-(4-methoxyphenyl)-5-oxo-4,5- 
dihydrooxazole-4-carboxylate 272 
 
 
Procedures F and H were employed to afford the title compound.  
Following the general procedure F, oxazolyl carbonate 258 (200 mg, 0.413 mmol), THF (2 mL), 
triazolium salt 128 (11.3 mg, 41.3 µmol) and KHMDS (74.4 µL of a 0.5 M in toluene, 
37.2 µmol) gave, after 1 h and chromatographic purification (20% Et2O:petrol), the product as a 
colourless oil (168 mg, 84%). δH (300 MHz, CDCl3) 7.82 (2H, d, J 8.8, MeOArH-3,5), 7.23–
7.18 (5H, m, PhH), 6.89 (2H, d, J 8.8, MeOArH-2,6), 3.86 (3H, s, OCH3), 3.59 (1H, ABd, 
J 13.6, CHAHB), 3.48 (1H, ABd, J 13.6, CHAHB), 1.95 (3H, s, CH3) and 1.91 (3H, s, CH3). 
Spectroscopic data are in accordance with the literature.125  
Enantiomeric excess for reaction was determined by derivatisation (see below). Absolute 
configuration assigned by analogy with the absolute configuration of related products.  
Naphthalen-1-yl 4-benzyl-2-(4-methoxyphenyl)-5-oxo-4,5-dihydrooxazole-4-carboxylate 
273 
 
 
Procedures F, H, J and M were employed to afford the title compound.  
Following general procedure M, N-p-anisoyl-DL-phenylalanine 253 (200 mg, 0.668 mmol), 
1-naphthyl chloroformate (0.325 mL, 2.00 mmol), Et3N (0.325 mL, 2.34 mmol), triazolium salt 
128 (9.12 mg, 33.4 µmol) and THF (2 mL), gave, after chromatographic purification (20% 
EtOAc:petrol), the product as a colourless oil (232 mg, 70%). δH (400 MHz, CDCl3) 7.96–7.90 
(1H, m, MeOArH-3,5), 7.88–7.83 (2H, m, NapH), 7.76 (1H, br d, J 8.1, ArH), 7.54–7.48 (2H, m, 
ArH), 7.45 (1H, t, J 8.2, ArH), 7.33–7.17 (6H, m, ArH), 6.97–6.63 (2H, m, MeOArH-2,6), 3.86 
(3H, s, OCH3), 3.81 (1H, ABd, J 13.7, PhCHAHB) and 3.68 (1H, ABd, J 13.7, PhCHAHB); δC 
(100 MHz, CDCl3) 174.0 (C-2), 164.6 (MeOArC-1), 163.7 (COOAr), 163.5 (ArC), 151.9 (ArC), 
146.0 (ArC), 134.6 (ArC), 132.8 (ArC), 130.5 (ArCH), 130.3 (ArCH), 128.4 (ArCH), 128.0 
(ArCH), 127.7 (ArCH), 126.9 (ArCH), 126.8 (ArCH), 126.7 (ArCH), 126.3 (ArCH), 125.2 
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(ArCH), 121.0 (ArCH), 117.1 (ArC), 114.3 (MeOArC-2,6), 77.9 (C-4), 55.6 (OCH3) and 40.1 
(CH2); m/z MS (ESI+) 451 (42, [M+H]+), 407 (100, [M+MeOH-Ph]+); HRMS (ESI+) 
C23H22O2N ([M+H]+) requires 344.1645, found 344.1647 (+0.4 ppm); IR νmax (KBr) /cm-1 3063, 
3033, 2965, 2937, 2841, 1822 (C=O), 1770 (C=O), 1645 (C=N), 1606 (Ar C=C), 1575, 1512, 
1495 (Ar C=C), 1442, 1426, 1390, 1307, 1263 (C-O), 1212 (C-O) and 1173 (C-O). 
2-(4-Methoxyphenyl)-4-methyloxazalone 511  
 
 
Following general procedure A, thionyl chloride (30.7 mL, 0.421 mol), DL-alanine 507 (25.0 g, 
0.281 mol) and MeOH (500 mL) gave, after trituration with Et2O, DL-alanine methyl ester 
hydrochloride 508 as a colourless solid (39.2 g, quantitative). mp 159–161 ºC, lit.165 155–
158 ºC; δH (300 MHz, CD3OD) 4.13 (1H, q, J 7.2, CHCH3), 3.84 (3H, s, OCH3) and 1.55 (3H, d, 
J 7.2, CH3). Data data are in accordance with the literature.108,165 
Following general procedure B, Et3N (91.0 mL, 0.653 mol), DL-alanine methyl ester 
hydrochloride 508 (38.8 g, 0.278 mol), CH2Cl2 (550 mL), p-anisoyl chloride (36.9 mL, 
0.273 mol) and CH2Cl2 (100 mL) gave, after recrystallisation (CH2Cl2/Et2O), amide 509 as a 
colourless solid (60.1 g, 91%). mp§ 107–108 ºC; δH (300 MHz, CDCl3) 7.79–7.74 (2H, m, 
MeOArH-3,5), 6.94–6.89 (2H, m, MeOArH-2,6), 6.65 (1H, br s, NH), 4.78 (1H, quin, J 7.2, 
CHCH3), 3.84 (3H, s, OCH3), 3.78 (3H, s, OCH3) and 1.51 (3H, d, J 7.2, CHCH3). Spectroscopic 
data are in accordance with the literature.107  
Following general procedure C, 2 M NaOH(aq) (120 mL), N-p-anisoyl-DL-alanine methyl ester 
509 (40.0 g, 0.169 mol) and MeOH (360 mL) gave, after purification, N-p-anisoyl-DL-alanine 
510 as a colourless solid (35.0 g, 93%). mp 176–178 ºC, lit.106 169–170 ºC; δH (300 MHz, 
d6-DMSO) 8.55 (1H, br d, J 7.2, NH), 7.89–7.84 (2H, m, MeOArH-3,5), 7.02–6.97 (2H, m, 
MeOArH-2,6), 4.45–4.34 (1H, m, CHCH3), 3.80 (3H, s, ArOCH3) and 1.37 (3H, d, J 7.3, 
CHCH3). Data are in accordance with the literature.106  
Ac2O (90 mL) was added to N-p-anisoyl-DL-alanine 510 (10.0 g, 0.447 mol) and the resultant 
solution heated to 65 ºC for 1 h before concentration in vacuo to give azlactone 511 as a 
colourless solid (9.09 g, 99%) which was used without further purification. mp 91–94 ºC, lit.106 
95–97 ºC; δH (300 MHz, CDCl3) 7.97–7.91 (2H, m, MeOArH-3,5), 7.02–6.97 (2H, m, 
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MeOArH-2,6), 4.45 (1H, q, J 7.6, NCHCH3), 3.91 (3H, s, ArOCH3) and 1.60 (3H, d, J 7.6, 
CHCH3). Data are in accordance with the literature.106 
2-(4-Methoxyphenyl)-4-methyloxazol-5-yl methyl carbonate 244 
 
 
Following general procedure E, Et3N (1.32 mL, 9.50 mmol), azlactone 511 (1.50 g, 7.31 mmol), 
THF (15 mL) and methyl chloroformate (2.10 mL, 27.2 mmol) gave, after recrystallisation 
(Et2O/petrol), the product as a colourless solid (1.64 g, 84%). mp 57–58 ºC, lit.106 60–61 ºC; δH 
(300 MHz, CDCl3) 7.90–7.86 (2H, m, MeOArH-3,5), 6.97–6.92 (2H, m, MeOArH-2,6), 3.98 
(3H, s, OCH3), 3.85 (3H, s, OCH3) and 2.13 (3H, s, CH3). Data are in accordance with the 
literature.106   
2-(4-Methoxyphenyl)-4-methyloxazol-5-yl phenyl carbonate 337 
 
 
Following general procedure E, Et3N (1.32 mL, 9.50 mmol), azlactone 511 (1.50 g, 7.31 mmol), 
THF (15 mL) and phenyl chloroformate (1.05 mL, 8.41 mmol) gave, after recrystallisation 
(Et2O/hexane), the product as a colourless solid (1.80 g, 5.53 mmol, 76%). mp§ 98–100 ºC; δH 
(300 MHz, CDCl3) 7.94–7.89 (2H, m, MeOArH-3,5), 7.48–7.42 (2H, m, OPhH-3,5), 7.36–7.29 
(3H, m, OPhH-2,4), 6.98–6.94 (2H, m, MeOArH-2,6), 3.86 (3H, s, OCH3) and 2.20 (3H, s, 
CH3). Spectroscopic data are in accordance with the literature.107 
(1,1,1-Trichloro-2-methylpropan-2-yl) 2-(4-methoxyphenyl)-4-methyloxazol-5-yl carbonate 
335 
 
 
Following general procedure E, Et3N (1.46 mL, 9.52 mmol), azlactone 511 (1.50 g, 7.32 mmol), 
THF (15 mL) and 2,2,2-trichloro-1,1-dimethylethyl chloroformate (1.86 g, 7.76 mmol) gave, 
after recrystallisation (Et2O/petrol), the product as a colourless solid (2.16 g, 72%). mp 97–
98 ºC, lit.108 97–101 ºC; δH (400 MHz, CDCl3) 7.90–7.86 (2H, m, MeOArH-3,5), 6.96–6.90 (2H, 
m, MeOArH-2,6), 3.86 (3H, s, OCH3), 2.14 (3H, s, CH3) and 2.02 (6H, s, C(CH3)2CCl3). Data 
are in accordance with the literature.108 
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2-(4-Methoxybenzamido)hexanoic acid 515 
 
 
Following general procedure A, DL-norleucine 512 (15.0 g, 115 mmol), MeOH (150 mL) and 
thionyl chloride (12.5 mL, 172 mmol) gave the crude methyl ester hydrochloride 513 as a pale 
yellow oil (20.8 g, quantitative). Without further purification, following general procedure B, 
ester hydrochloride 513 (20.5 g, 113 mmol), CH2Cl2 (150 mL), Et3N (36.3 mL, 261 mmol) and 
p-anisoyl chloride (14.8 mL, 109 mmol) in CH2Cl2 (30 mL) gave, after purification, the desired 
crude amide 514 as a colourless solid (26.7 g, 87%), which was used immediately without 
further purification. Following general procedure C, amide 514 (25.7 g, 91.8 mmol), MeOH 
(300 mL) and 2 M NaOH(aq) (68.9 mL) gave, after acidification, a suspension. Precipitation was 
induced upon scratching and the product was collected by filtration then dried azeotropically 
with toluene (100 mL × 5), giving acid 515 as a colourless solid (23.1 g, 87%). mp 135–138 ºC; 
δH (400 MHz, d6-DMSO) 12.51 (1H, br s, COOH), 8.41 (1H, d, J 7.7, CONH), 7.91–7.86 (2H, 
m, MeOArH-3,5), 7.04–6.96 (2H, m, MeOArH-2,6), 4.38–4.29 (1H, m, CHCOOH), 3.79 (3H, s, 
OCH3), 1.87–1.66 (2H, m, CHCH2), 1.44–1.20 (4H, m, CH2CH2) and 0.85 (3H, t, J 7.0, CH3); 
δC (100 MHz, d6-DMSO) 174.1 (COOH), 166.0 (CONH), 161.7 (MeOArC-1), 129.4 
(MeOArCH-3,5), 126.3 (MeOArC-4), 113.4 (MeOArCH-2,6), 55.4 (OCH3), 52.6 (CHN), 30.4 
(CH2), 28.1 (CH2), 21.8 (CH2CH3) and 13.9 (CH3); m/z MS (ESI+) 294 (35, [M+MeOH+H]+), 
266 (100, [M+H]+), 248 (40, [M–OH]+) and 135 (40, ArC≡O+); HRMS (ESI+) C14H20NO4 
([M+H]+), requires 266.1388, found 266.1392 (-1.6 ppm); IR νmax (KBr)/cm-1 3373 (br, OH), 
2923 (CH), 2963 (CH), 2348, 1721 (C=O), 1704 (C=O), 1615 (Ar C=C), 1575, 1539, 1506, 
1456, 1417, 1309 and 1256 (C-O). 
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4-Isopropyl-2-(4-methoxyphenyl)oxazol-5-yl phenyl carbonate 520 
 
 
Following general procedure A, DL-valine 349 (10.0 g, 0.855 mol), thionyl chloride (9.35 mL, 
0.128 mol) and MeOH (150 mL) gave ester hydrochloride 516 as a colourless solid (14.2 g, 
99%) which was used without further purification. mp 108–110 ºC, lit.168 112–114 ºC; 
δH (300 MHz, CDCl3) 8.85 (3H, br s, NH3+), 4.04–3.92 (1H, m, CHNH2), 3.83 (3H, s, OCH3), 
2.52–2.38 (1H, m, CH(CH3)2) and 1.12 (6H, dd, J 7.0, 2.9, CH(CH3)2). Data are in accordance 
with the literature.168  
Following general procedure B, Et3N (24.4 mL, 176 mmol), DL-valine methyl ester 
hydrochloride 516 (14.2 g, 84.9 mmol), CH2Cl2 (320 mL), p-anisoyl chloride (11.3 mL, 
83.3 mmol) and CH2Cl2 (25 mL) gave amide 517 as a pale yellow solid (19.8 g, 86%). mp§ 81–
83 ºC; δH (300 MHz, CDCl3) 7.80–7.75 (2H, m, MeOArH-3,5), 6.96–6.91 (2H, m, 
MeOArH-2,6), 6.55 (1H, br d, J 8.6, NH), 4.77 (1H, ABX, JXA 8.6, JXB 4.9, CHNH), 3.85 (3H, s, 
OCH3), 3.77 (3H, s, OCH3), 2.32–2.20 (1H, m, CH(CH3)2) and 1.02–0.96 (6H, m, CH(CH3)2). 
Spectroscopic data are in accordance with the literature.107  
Following general procedure C, 2 M NaOH(aq) (50 mL), N-p-anisoyl-DL-valine methyl ester 
517 (17.0 g, 63.9 mmol) and MeOH (150 mL) gave N-p-anisoyl-DL-valine 518 as a colourless 
solid (11.7 g, 72%). mp 150–152 ºC, lit.166 165–169 ºC; δH (300 MHz, CDCl3) 7.81–7.75 (2H, 
m, MeOArH-3,5), 6.97–6.91 (2H, m, MeOArH-3,5), 6.56 (1H, br d, J 8.4, NH), 4.77 (1H, ABX, 
JXA 8.4, JXB 4.9, CHNH), 3.85 (3H, s, ArOCH3), 2.42–2.29 (1H, m, CH(CH3)2), 1.05 (3H, d, 
J 7.1, CH(CH3)2) and 1.03 (3H, d, J 7.1, CH(CH3)2). Data are in accordance with the 
literature.166 
Following general procedure D, Ac2O (10 mL) and N-p-anisoyl-DL-valine 518 (4.36 g, 
17.4 mmol) gave the product 519 as a pale yellow solid (4.06 g, 99%). mp 45–47 ºC, lit.107 45–
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47 ºC; δH (300 MHz, CDCl3) 7.96–7.91 (2H, m, MeOArH-3,5), 6.98–6.93 (2H, m, MeOArH-
2,6), 4.24 (1H, d, J 4.5, NCH), 3.86 (3H, s, OCH3), 2.42–2.28 (1H, m, CH(CH3)2), 1.12 (3H, d, 
J 6.9, CH(CH3)2) and 0.99 (3H, d, J 6.9, CH(CH3)2). Data are in accordance with the 
literature.107  
Following general procedure E, Et3N (1.67 mL, 12.0 mmol), azlactone 519 (2.00 g, 8.57 mmol), 
THF (25 mL) and phenyl chloroformate (1.40 mL, 11.1 mmol) gave, after chromatographic 
purification (10% Et2O:petrol), carbonate 520 as a colourless oil (2.73 g, 90%). δH (300 MHz, 
CDCl3) 7.85–7.81 (2H, m, MeOArH-3,5), 7.39–7.32 (2H, m, PhH), 7.26–7.18 (3H, m, PhH), 
6.88–6.83 (2H, m, MeOArH-2,6), 3.76 (3H, s, OCH3), 2.86 (1H, sept, J 6.7, CH(CH3)2) and 1.24 
(6H, d, J 6.7, CH(CH3)2). Spectroscopic data are in accordance with the literature.110  
2-(4-Methoxyphenyl)-4-isobutyloxazalone 525 
 
 
Following general procedure A, thionyl chloride (16.7 mL, 22.9 mmol), DL-leucine 521 (20.0 g, 
15.2 mmol) and MeOH (270 mL) gave ester hydrochloride 522 as a colourless solid (27.4 g, 
99%). mp 146–147 ºC, lit.167 148–150 ºC; δH (300 MHz, CDCl3) 8.82 (3H, br s, NH3+), 4.15–
4.03 (1H, m, CHNH2), 3.80 (3H, s, OCH3), 2.02–1.74 (3H, m, CH2 and CH(CH3)2) and 0.97 
(6H, d, J 6.1, CH(CH3)2). Data are in accordance with the literature.167 
Following general procedure B, Et3N (24.4 mL, 176 mmol), DL-leucine methyl ester 
hydrochloride 522 (13.6 g, 74.7 mmol), CH2Cl2 (280 mL), p-anisoyl chloride (9.92 mL, 
73.3 mmol) and CH2Cl2 (20 mL) gave the crude amide 523 as a colourless solid (20.8 g, 99%) 
which was used immediately without further purification. δH (300 MHz, CDCl3) 7.78–7.73 (2H, 
m, MeOArH-3,5), 6.93–6.88 (2H, m, MeOArH-2,6), 6.58 (1H, br d, J 8.2, NH), 4.89–4.80 (1H, 
m, CHNH), 3.84 (3H, s, OCH3), 3.77 (3H, s, OCH3), 1.80–1.58 (3H, m, CH2 and CH(CH3)2) and 
0.97 (6H, d, J 6.0, CH(CH3)2). Spectroscopic data are in accordance with the literature.106 
Following general procedure C, 2 M NaOH(aq) (35 mL), N-p-anisoyl-DL-leucine methyl ester 
523 (15.0 g, 53.7 mmol) and MeOH (100 mL) gave N-p-anisoyl-DL-leucine 524 as a colourless 
solid (14.3 g, 85%). mp 133–135 ºC, lit.168 133–136 ºC; δH (300 MHz, CDCl3) 9.77 (1H, br s, 
COOH), 7.77–7.71 (2H, m, MeOArH-3,5), 6.91–6.84 (2H, m, MeOArH-2,6), 6.78 (1H, br d, 
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J 8.0, NH), 4.84–4.75 (1H, m, CHNH), 3.81 (3H, s, OCH3), 1.85–1.62 (3H, m, CH2 and 
CH(CH3)2) and 0.95 (6H, d, J 5.9, CH(CH3)2). Data are in accordance with the literature.106,168 
Following general procedure D, Ac2O (8 mL) was added to N-p-anisoyl-DL-leucine 524 (5.00 g, 
18.8 mmol) and the resultant solution stirred and heated to 65 ºC for 1 h before concentration 
in vacuo to give the title product 525 as a yellow oil that solidified on standing (4.67 g, quant). 
mp 66–67 ºC, lit.106 66–67 ºC; δH (300 MHz, CDCl3) 7.95–7.90 (2H, m, MeOArH-3,5), 6.99–
6.94 (2H, m, MeOArH-2,6), 4.38 (2H, ABX, JXA 8.9, JXB 5.7, CHCH2R), 3.88 (3H, s, OCH3), 
2.11–1.97 (1H, m, CHAHBCH(CH3)2), 1.86–1.76 (1H, m, CHAHBCH(CH3)2), 1.71–1.61 (1H, m, 
CH(CH3)2) and 1.03–0.98 (6H, m, CH(CH3)2). Data are in accordance with the literature.106 
4-Isobutyl-2-(4-methoxyphenyl)oxazol-5-yl phenyl carbonate 526 
 
 
Following general procedure E, Et3N (0.930 mL, 6.67 mmol), azlactone 525 (1.50 g, 
6.07 mmol), phenyl chloroformate (0.800 mL, 6.43 mmol) and THF (20 mL) gave, after 
chromatographic purification (20% Et2O:petrol), the product as a colourless oil (1.94 g, 87%).  
δH (300 MHz, CDCl3) 7.94–7.89 (2H, m, MeOArH-3,5), 7.48–7.41 (2H, m, PhH), 7.34–7.27 
(3H, m, PhH), 6.97–6.92 (2H, m, MeOArH-2,6), 3.86 (3H, s, OCH3), 2.40 (2H, d, J 6.9, CH2), 
2.09 (1H, sept, J 6.9, CH(CH3)2) and 0.99 (6H, d, J 6.9, CH(CH3)2). Spectroscopic data are in 
accordance with the literature.110 
4-Isobutyl-2-(4-methoxyphenyl)-oxazol-5-yl 1,1,1-trichloro-2-methylpropan-2-yl carbonate 
527 
 
 
Following general procedure E, Et3N (0.610 mL, 4.40 mmol), azlactone 525 (1.00 g, 
4.04 mmol), THF (30 mL) and 1,1,1-trichloro-2-methylpropan-2-yl chloroformate (1.02 g, 
4.24 mmol), gave, after chromatographic purification (25% Et2O:petrol), the product as a 
colourless solid (1.27 g, 70%). mp 68–70 °C, lit.124 68-70 ºC; δH (300 MHz, CDCl3) 7.89 (2H, d, 
J 9.0, MeOArH-3,5), 6.93 (2H, d, J 9.0, MeOArH-2,6), 3.85 (3H, s, OCH3), 2.34 (2H, d, J 6.9, 
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CH2), 2.05 (1H, sept, J 6.9, CH), 2.01 (6H, s, C(CH3)2CCl3) and 0.96 (6H, d, J 6.6, CH(CH3)2). 
Data are in accordance with the literature.124 
4-tert-Butyl-2-(4-methoxyphenyl)oxazol-5-yl phenyl carbonate 528 
 
 
Following general procedure E, Et3N (0.619 mL, 4.45 mmol), 2-(4-methoxyphenyl)-4-tert- 
butyloxazalonei (1.00 g, 4.05 mmol), THF (10 mL) and phenyl chloroformate (0.538 mL, 
4.29 mmol) gave, after chromatographic purification (10% Et2O:petrol), the product as a pale 
yellow oil (1.34 g, 90%). δH (300 MHz, CDCl3) 7.86–7.81 (2H, m, MeOArH-3,5), 7.40–7.33 
(2H, m, PhH), 7.27–7.18 (3H, m, PhH), 6.89–6.84 (2H, m, MeOArH-2,6), 3.78 (3H, s, OCH3) 
and 1.29 (9H, s, C(CH3)3). Spectroscopic data are in accordance with the literature.110  
2-(4-Methoxyphenyl)-4-(2′-(methylthio)ethyl)oxazol-5-yl phenyl carbonate 534 
 
 
A solution of DL-methionine 529 (20.0 g, 134 mmol) in MeOH (440 mL) was cooled to 0 ºC and 
thionyl chloride (20.0 mL, 275 mmol) was added dropwise over 45 min. The mixture was 
allowed to warm to ambient temperature over 16 h then concentrated in vacuo to afford the crude 
methyl ester hydrochloride 530 as a pale yellow oil which solidified on standing (20.8 g, 
quantitative) which was used without further purification. Following general procedure B, ester 
hydrochloride 530 (10.0 g, 50.1 mmol), CH2Cl2 (100 mL), Et3N (16.4 mL, 118 mmol) and 
p-anisoyl chloride (6.66 mL, 49.0 mmol) in CH2Cl2 (10 mL) gave the desired crude amide 531 
as a colourless solid (12.7 g, 87%), which was used without immdediately without further 
                                                 
i
 Kindly donated by Jennifer Thomson. 
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purification. Following general procedure C, amide 531 (10.0 g, 33.6 mmol), MeOH (67 mL) 
and 2 M NaOH(aq) (20 mL) gave the purified acid 532 as a colourless solid (8.38 g, 88%). mp 
131–133 ºC, lit.106 122–123 ºC; δH (400 MHz, d6-DMSO) 12.51 (1H, br s, COOH), 8.41 (1H, d, 
J 7.7, CONH), 7.91–7.86 (2H, m, MeOArH-3,5), 7.04–6.96 (2H, m, MeOArH-2,6), 4.38–4.29 
(1H, m, CHCOOH), 3.79 (3H, s, OCH3), 1.87–1.66 (2H, m, CHCH2), 1.44–1.20 (4H, m, 
CH2CH2) and 0.85 (3H, t, J 7.0, CH3). Spectroscopic data are in accordance with the literature.106 
According to general procedure D, N-p-anisoyl-DL-methionine 532 (4.00 g, 14.1 mmol) and 
Ac2O (8 mL) gave the azlactone product 533 as a yellow semi-solid (3.75 g, 99%) which was 
used without further purification. δH (400 MHz, CDCl3) 7.95–7.92 (2H, m, MeOArH-3,5), 6.99–
6.96 (2H, m, MeOArH-2,6), 4.56 (1H, dd, J 7.2, 5.8, NCH), 3.87 (3H, s, OCH3), 2.72 (2H, t, 
J 7.1, MeSCH2), 2.33–2.25 (1H, m, CHCHAHB), 2.17–2.08 (1H, m, CHCHAHB) and 2.11 (3H, s, 
SCH3). Spectroscopic data are in accordance with the literature.106 
According to general procedure E, Et3N (1.31 mL, 9.43 mmol), azlactone 533 (2.00 g, 
7.54 mmol), phenyl chloroformate (0.979 mL, 8.67 mmol) and THF (20 mL) gave, after 
purification by recrystallisation (Et2O/hexane), carbonate 534 as a colourless solid (2.81 g, 97%). 
mp 64–65 ºC; δH (400 MHz, CDCl3) 7.91–7.88 (2H, m, MeOArH-3,5), 7.45–7.40 (2H, m, PhH), 
7.31–7.27 (3H, m, PhH), 6.96–6.92 (2H, m, MeOArH-2,6), 3.83 (3H, s, OCH3), 2.89–2.81 (4H, 
m, CH2CH2SMe) and 2.15 (3H, s, SCH3); δC (100 MHz, CDCl3) 161.4 (MeOArC-1), 155.4 
(C=N), 150.7 (OPhC-1), 150.1 (OC(O)O), 145.6 (C-5), 129.7 (MeOArCH-3,5), 127.6 
(OPhCH-3,5), 126.8 (OPhCH-4), 122.7 (C-4), 120.5 (OPhCH-2,6), 119.7 (MeOArC-4), 114.1 
(MeOArCH-2,6), 55.3 (OCH3), 32.3 (SCH2), 25.3 (CH2) and 15.5 (SCH3); m/z MS (ESI+) 385 
(50, [M]+), 265 (100, [M–COOPh+H]+) and 264 (85, [M–COOPh]+); HRMS (ESI+) 
C20H19NO5S ([M]+) requires 385.0978, found 385.0973 (-1.4 ppm); IR νmax (KBr)/cm-1 3337, 
2948 (C-H), 1723 (C=O), 1634 (C=C), 1605 (Ar C=C), 1505 (C=N), 1261 (C-S) and 1164 
(C-O). 
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N-(4-Methoxybenzoyl)-O-benzyl-DL-tyrosine 283 
 
 
Following general procedure A, DL-tyrosine 279 (30.0 g, 166 mmol), MeOH (350 mL) and 
thionyl chloride (48.0 mL, 662 mmol) gave the crude methyl ester hydrochloride 280 as a pale 
cream solid (39.1 g, quantitative). Without further purification, following general procedure B, 
ester hydrochloride 280 (38.0 g, 164 mmol), CH2Cl2 (400 mL), Et3N (53.6 mL, 385 mmol) and 
p-anisoyl chloride (21.8 mL, 161 mmol) in CH2Cl2 (40 mL) gave the crude amide product 281 as 
a colourless solid (38.0 g, 70%). Without further purification, a suspension of crude amide 281 
(5.00 g, 15.2 mmol) and K2CO3 (2.31 g, 16.7 mmol) in DMF (40 mL) were stirred for 30 min 
then benzyl bromide (1.91 mL, 16.0 mmol) was added. The suspension was stirred for 16 h 
then H2O (50 mL) was added to induce precipitation. The colourless precipitate was collected by 
filtration and washed exhaustively with H2O then dried azeotropically with toluene (50 mL × 5) 
to afford the product 282 as a colourless solid (6.00 g, 78%), which was used without further 
purification. To a solution of benzyl ether 282 (4.00 g, 9.54 mmol) in THF (40 mL) was added 
2 M NaOH(aq) (5.70 mL) and the mixture stirred for 1 h then concentrated to ~6 mL in vacuo, 
then 2 M HCl(aq) was added to pH <3, inducing precipitation of the product on scratching. The 
product was collected by filtration then dried azeotropically with toluene (50 mL × 5), giving the 
title product 283 as a colourless solid (3.62 g, 94%). mp 140–142 ºC; δH (300 MHz, CD3OD) 
7.62–7.58 (2H, m, MeOArH-3,5), 7.28–7.13 (5H, m, PhH), 7.07–7.04 (2H, m, BnOArH-3,5), 
6.83–6.80 (2H, m, MeOArH-2,6), 6.77–6.74 (2H, m, BnOArH-2,6), 4.86 (2H, s, PhCH2), 4.83 
(3H, s, OCH3), 4.68 (1H, ABX, JXA 9.0, JXB 5.0, CHCOOH), 3.14 (1H, ABX, JAB 14.0, JAX 5.0, 
ArCHAHB) and 2.94 (1H, ABX, JBA 14.0, JBX 9.0, ArCHAHB); δC (75 MHz, CDCl3) 175.2 
(COOH), 169.5 (CONH), 163.9 (MeOArC-1), 159.0 (BnOArC-1), 138.7 (CH2PhC-1), 131.2 
(ArCH), 130.9 (MeOArC-4), 130.2 (ArCH), 129.4 (ArCH), 128.7 (ArCH), 128.5 (ArCH), 127.3 
(BnOArC-4), 115.8 (MeOArCH-2,6), 114.6 (BnOArCH-2,6), 70.9 (Ph–CH2O), 55.8 (OCH3) and 
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37.4 (BnOAr–CH2); m/z MS (ESI-) 404 (100, [M–H]-); HRMS (ESI-) C24H22NO5- ([M–H]) 
requires 404.1496, found 404.1498 (-0.5 ppm); IR νmax (KBr)/cm-1 3332 (OH), 3062 (CH), 3035 
(CH), 2927 (CH), 1734 (C=O), 1632 (C=O), 1608, 1527, 1505 and 1255 (C-O). 
4-(4-Benzyloxyphenyl)-2-(4-methoxyphenyl)-5-oxo-4,5-dihydrooxazole 284 
 
 
A mixture of N-p-anisoyl-O-benzyl-DL-tyrosine 283 (2.50 g, 6.17 mmol) and Ac2O (5.00 mL, 
52.9 mmol) were heated at 80 ºC for 1 h before concentration in vacuo. The remaining 
AcOH/Ac2O was removed azeotropically with toluene (20 mL × 5) to afford the azlactone 284 
(2.39 g, quantitative) as a colourless solid and was used without further purification. mp 118–
119 ºC; δH (400 MHz, CDCl3) 7.87 (2H, d, J 8.8, MeOArH-3,5), 7.41–7.28 (5H, m, PhH), 7.18 
(2H, d, J 8.5, BnOArH-3,5), 6.94 (2H, d, J 8.8, MeOArH-2,6), 6.86 (2H, d, J 8.5, BnOArH-2,6), 
5.00 (2H, s, PhCH2O), 4.62 (1H, ABX, JXA 6.3, JXB 4.9, H-4), 3.86 (3H, s, OCH3), 3.30 (1H, 
ABX, JBA 14.0, JBX 4.9, ArCHAHB) and 3.13 (1H, ABX, JAB 14.0, JAX 6.3, ArCHAHB); δC 
(100 MHz, CDCl3) 178.0 (C=O), 163.2 (ArC-O), 161.4 (ArC-O), 158.0 (N=C), 137.1 (PhC), 
130.8 (MeOArCH-3,5), 129.9 (ArCH), 128.7 (ArCH), 128.0 (ArCH), 127.8 (MeOArC-4), 127.6 
(ArCH), 118.2 (BnOArC-4), 114.8 (MeOArCH-2,6), 114.3 (BnOArCH-2,6), 70.0 (OCH2), 66.8 
(CH-N), 55.6 (OCH3) and 36.7 (CH2); m/z MS (CI+) 388 (28, [M+H]+) and 255 (100); HRMS 
(CI+) C24H22NO4 ([M+H]+) requires 388.1543, found 388.1549 (-1.5 ppm); IR νmax (KBr)/cm-1 
3059 (CH), 3014 (CH), 2917 (CH), 2860 (CH), 2841 (CH), 1814 (C=O), 1654 (C=N), 1609, 
1512, 1332, and 1247 (C-O). 
N-(4-Methoxybenzoyl)-DL-tyrosine 328  
 
 
Following general procedure C, methyl ester 281 (5.00 g, 15.2 mmol), MeOH (30 mL) and 2 M 
NaOH(aq) (17.1 mL, 34.2 mmol) gave the product as a colourless solid (4.20 g, 88%). mp 152–
154 ºC; δH (300 MHz, CD3OD) 7.74–7.68 (2H, m, MeOArH-3,5), 7.08–7.02 (2H, m, 
HOArH-3,5), 6.97–6.92 (2H, m, MeOArH-2,6), 6.71–6.63 (2H, m, HOArH-2,6), 4.72 (1H, 
ABX, JXB 8.1, JXA 5.1, CHCOOH), 3.83 (3H, s, OCH3), 3.21 (1H, ABX, JAB 13.9, JAX 5.1, 
ArCHAHB), 3.02 (1H, ABX, JBA 13.9, JBX 8.1, ArCHAHB); δC (75 MHz, d6-DMSO) 173.7 
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(COOH), 166.0 (CONH), 161.8 (MeOArC-1), 155.9 (HOArC-1), 130.1 (MeOArCH-3,5), 129.3 
(HOArCH-3,5), 128.4 (MeOArC-4), 126.3 (HOArC-4), 115.1 (MeOArCH-2,6), 113.6 
(HOArCH-2,6), 55.4 (OCH3), 54.8 (CHN) and 35.7 (CH2); m/z MS (ESI+) 316 (72, [M+H]+), 
298 ([M–H2O]+) and 135 (100, ArC≡O+); HRMS (CI+) C17H18NO5 ([M+H]+) requires 316.1193, 
found 316.1185 (+2.5 ppm); IR νmax (KBr)/cm-1 3335 (OH), 3019 (CH), 2936 (CH), 1717 
(C=O), 1636 (C=O), 1610, 1538, 1507, and 1262 (C-O). 
4-((4-Benzyloxy)benzyl)-2-(4-methoxyphenyl)-oxazolyl-5-yl phenyl carbonate 285 
 
 
Following general procedure E, Et3N (0.395 mL 2.84 mmol,), azlactone 284 (1.00 g, 
2.58 mmol), phenyl chloroformate (2.71 mmol, 0.310 mL) and THF (30 mL) gave, after 
recrystallisation (Et2O), the product 285 as a colourless solid (1.10 g, 84%). mp 116–117 °C; δH 
(400 MHz, CDCl3) 7.96 (2H, d, J 9.0, MeOArH-2,6), 7.48–7.30 (10H, m, PhH), 7.27–7.25 (2H, 
m, BnOArH-2,6), 6.95 (4H, app d, MeOArH-3,5 and BnOArH-3,5), 5.07 (2H, s, CH2), 3.93 (2H, 
s, CH2) and 3.90 (3H, s, OCH3); δC (75 MHz, CDCl3) 161.5 (MeOArC-1), 157.7 (C=N), 155.5 
(BnOArC-1), 150.8 (OPhC-1), 150.1 (OC(O)O), 145.6 (C-5), 137.2 (C), 130.1 (ArCH), 129.8 
(ArCH), 128.7 (ArCH), 128.0 (ArCH), 127.9 (ArCH), 127.5 (ArCH), 126.9 (ArCH), 123.8 
(C-4), 120.6 (ArCH), 119.9 (ArCH), 115.0 (MeOArCH-2,6), 114.2 (BnOArCH-2,6), 70.1 
(OCH2), 55.5 (OCH3) and 31.1 (CH2); m/z MS (ESI+) 530 (100, [M+Na]), HRMS (ESI+) 
C31H25NO6Na ([M+Na]), requires 530.1580, found 530.1584 (+0.9 ppm); IR νmax (KBr)/cm-1 
3033 (Ar-H), 2911 (Alk-H), 1800 (C=O), 1613 (Ar C=C) and 1214 (C-O). 
2-(4-Methoxyphenyl)-4-((4-phenoxycarbonyloxy)benzyl)oxazolyl-5-yl phenyl carbonate 535 
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Et3N (1.94 mL, 14.0 mmol) was added to a solution of N-p-anisoyl-DL-tyrosine 281 (1.00 g, 
3.17 mmol) in THF (20 mL) followed by the addition of phenyl chloroformate (1.50 mL, 
13.8 mmol) and stirred for 16 h. The resulting suspension was poured into 1 M HCl(aq) (10 mL) 
and extracted with Et2O (3 × 20 mL). The organic extracts were combined, washed with sat 
NaHCO3(aq) (20 mL), dried (MgSO4), filtered and concentrated in vacuo. Chromatographic 
purification (20% Et2O:petrol) afforded the product (1.46 g, 86%) as a colourless solid. mp 71–
74 °C; δH (300 MHz, CDCl3) 7.92 (2H, d, J 9.0, MeOArH-3,5), 7.45–7.21 (14H, m, ArH), 6.95 
(2H, d, J 9.0, MeOArH-2,6), 3.93 (2H, s, CH2) and 3.85 (3H, s, OCH3); δC (75 MHz, CDCl3) 
161.6 (MeOArC-1), 155.7 (C=N), 152.1 (C), 151.1 (C), 150.8 (C), 150.1 (C), 149.8 (C), 145.8 
(C-5), 135.7 (C), 130.1 (ArCH), 129.9 (ArCH), 129.7 (ArCH), 128.0 (ArCH), 126.4 (ArCH), 
126.4 (ArCH), 126.4 (ArCH), 123.0 (C-4), 121.0 (ArCH), 120.6 (ArCH), 119.8 (ArC), 114.3 
(MeOArCH-2,6), 55.5 (OCH3) and 31.0 (CH2); m/z MS (CI+) 538 (62, [M+H]), 418 (17, [M–
COOPh+H]); HRMS (ESI+) C31H23NO8Na ([M+Na]) requires 560.1321, found 560.1323 (+0.2 
ppm); IR νmax (KBr)/cm-1 3065 (Ar-H), 2934, 1798 (C=O), 1779 (C=O), 1614 (Ar C=C) and 
1235 (C-O). 
(R)- and (RS)-4-Methyl-5-oxo-2-(4-methoxyphenyl)-4,5-dihydro-oxazole-4-carboxylate 246 
 
 
Procedures F and H were employed to afford the title compound.  
Following general procedure F, carbonate 244 (585 mg, 2.22 mmol), triazolium salt 128 
(6.06 mg, 22.2 µmol), KHMDS (40.0 µL, 0.0200 mmol), THF (5 mL) gave, after 5 min and 
chromatographic purification (30% Et2O:petrol), the product 246 as a colourless solid (497 mg, 
84%). mp§ 58–60 ºC; δH (300 MHz, CDCl3) 8.00–7.95 (2H, m, MeOArH-3,5), 7.01–6.96 (2H, 
m, MeOArH-2,6), 3.89 (3H, s, OCH3), 3.79 (3H, s, COOCH3) and 1.77 (3H, s, CH3). 
Spectroscopic data are in accordance with the literature.110 
Enantiomeric excesses were determined by HPLC with Chiralcel OD-H column (2% 
i-PrOH:hexane, flow rate = 1.0 mL min-1), tR(R) 11.5 min and tR(S) 15.3 min. 
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(R)- and (RS)- Phenyl methyl-5-oxo-2-(4-methoxyphenyl)-4,5-dihydro-oxazole-4- 
carboxylate 248 
 
 
Procedures F, G, H, J, K and L were employed to afford the title compound.  
Following general procedure H, carbonate 337 (500 mg, 1.54 mmol), KHMDS (27.6 µL, 
13.8 µmol), triazolium salt 128 (4.20 mg, 15.4 µmol) and THF (5 mL) gave, after 5 min and 
chromatographic purification (20% Et2O:petrol), the product 248 as a colourless oil (410 mg, 
82%). δH (300 MHz, CDCl3) 7.97–7.92 (2H, m, MeOArH-3,5), 7.34–7.25 (2H, m, PhH-2,6), 
7.19–7.13 (1H, m, PhH-4), 7.05–6.99 (2H, m, PhH-3,5), 6.95–6.90 (2H, m, MeOArH-2,6), 3.81 
(3H, s, OCH3) and 1.80 (3H, s, CH3). Spectroscopic data are in accordance with the literature.110 
Enantiomeric excesses were determined by HPLC with Chiralcel OD-H column (2% 
i-PrOH:hexane, flow rate = 1.0 mL min-1), tR(R) 14.8 min and tR(S) 18.1 min. 
1,1,1-Trichloro-2-methylpropan-2-yl 2-(4-methoxyphenyl)-4-methyl-5-oxo-4,5- 
dihydrooxazole-4-carboxylate 336  
 
 
Procedure H was employed to afford the title compound.  
Following general procedure H, carbonate 335 (200 mg, 0.489 mmol), triazolium salt 128 
(6.68 mg, 24.5 µmol), KHMDS (39.2 µL, 19.6 µmol) and THF (2 mL) gave, after 5 min and 
chromatographic purification (10% Et2O:petrol), the product 336 as a colourless oil (144 mg, 
72%) which partially solidified on standing. δH (400 MHz, CDCl3) 7.97–7.92 (2H, m, 
MeOArH-3,5), 7.00–6.94 (2H, m, MeOArH-2,6), 3.89 (3H, s, OCH3), 1.93 (3H, s, 
C(CH3)2CCl3), 1.90 (3H, s, C(CH3)2CCl3) and 1.75 (3H, s, CH3). Spectroscopic data are in 
accordance with the literature.108 
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Naphthalen-1-yl 2-(4-methoxyphenyl)-4-methyl-5-oxo-4,5-dihydrooxazole-4-carboxylate 
339 
 
 
Procedures F, J and L were employed to afford the title compound.  
Following general procedure L, N-p-anisoyl-DL-alanine 510 (200 mg, 0.896 mmol), Et3N 
(0.436 mL, 3.14 mmol), 1-naphthyl chloroformate (0.436 mL, 2.69 mmol), triazolium salt 128 
(12.2 mg, 44.8 µmol) and THF (2 mL) gave, after chromatographic purification (20% 
Et2O:petrol) the product 339 as a colourless oil (235 mg, 70%). δH (400 MHz, CDCl3) 8.10–8.06 
(2H, m, MeOArH-3,5), 7.88–7.83 (2H, m, NapH-5,8), 7.75 (1H, br d, J 8.3, NapH-4), 7.52–7.48 
(2H, m, NapH-6,7), 7.44 (1H, t, J 7.9, NapH-3), 7.28 (1H, dd, J 7.6, 1.0, NapH-2), 7.04–7.01 
(2H, m, MeOArH-2,6), 3.90 (3H, s, OCH3) and 1.95 (3H, s, CH3); δC (100 MHz, CDCl3) 175.5 
(COOCR2), 165.0 (COOAr), 164.0 and 163.8 (MeOArC-1 and C=N), 146.1 (NapC-1), 134.7 
(NapC-4a), 130.5 (MeOArCH-3,5), 128.1 (NapCH-5), 127.0 (NapCH), 126.9 (NapCH), 126.8 
(NapCH), 126.4 (NapC-8a), 125.3 (NapCH-3), 121.0 (NapCH-8), 117.9 (NapCH-2), 117.5 
(MeOArC-4), 114.6 (MeOArCH-2,6), 73.2 (MeC(COOAr)), 55.7 (OCH3) and 20.6 (CH3); m/z 
MS (ESI+) 408 (100, [M+MeOH-H]+); HRMS (ESI+) C23H22NO6+ ([M+MeOH+H]+) requires 
408.1442, found 408.1440 (-0.5 ppm); IR νmax (thin film) /cm-1 3057, 3009, 2937, 2842, 1826 
(C=O), 1772 (C=O), 1645 (C=N), 1608, 1308, 1262 (C-O) and 1221 (C-O). 
(R)-Phenyl 4-ethyl-2-(4-methoxyphenyl)-5-oxo-4,5-dihydrooxazole-4-carboxylate (R)-536 
 
 
Procedure H was employed to afford the title compound.  
Following general procedure H, 4-ethyl-2-(4-methoxyphenyl)oxazol-5-yl phenyl carbonatei 
(68.0 mg, 0.200 mmol), THF (0.7 mL), triazolium salt 128 (7.88 mg, 20.0 µmol) and KHMDS 
(36.0 µL, 18.0 µmol) gave, after 60 min and chromatographic purification (20% Et2O:petrol), 
product as a colourless oil (47.6 mg, 70%, <5% ee). δH (400 MHz, CDCl3) 8.04 (2H, d, J 9.2, 
                                                 
i
 Kindly donated by Caroline Joannesse. 
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MeOArH-3,5), 7.40–7.09 (5H, m, PhH), 7.01 (2H, d, J 9.2, MeOArH-2,6), 3.90 (3H, s, OCH3), 
2.44 (1H, dq, J 14.2, 7.2, CHAHB), 2.36 (1H, dq, J 14.0, 7.2, CHAHB) and 1.01 (3H, t, J 7.2, 
CH3). Spectroscopic data are in accordance with the literature.125 
Enantiomeric excess was determined by HPLC with Chiralcel OD-H column (5% 
i-PrOH:hexane, flow rate = 1.0 mL min-1), tR(R) 9.2 min and tR(S) 11.6 min. 
Phenyl 2-(4-methoxyphenyl)-5-oxo-4-isopropyl-4,5-dihydrooxazole-4-carboxylate 537 
 
 
Procedure H was employed to afford the title compound.  
Following general procedure H, 2-(4-methoxyphenyl)-4-isopropyloxazol-5-yl phenyl carbonate 
carbonate 520 (100 mg, 0.283 mmol), triazolium salt 128 (7.73 mg, 28.3 µmol), KHMDS 
(50.9 µL, 25.5 µmol) and THF (1 mL) gave, after 1 h and chromatographic purification (20% 
Et2O:petrol), product 532 as a colourless oil (79.0 mg, 79%). δH (300 MHz, CDCl3) 8.05 (2H, d, 
J 9.0, MeOArH-3,5), 7.41–7.11 (5H, m, PhH), 7.01 (2H, d, J 9.0, MeOArH-2,6), 3.89 (3H, s, 
OCH3), 2.93 (1H, sept, J 6.6, CHMe2), 1.19 (3H, d, J 6.6, CH3) and 1.08 (3H, d, J 6.6, CH3). 
Spectroscopic data are in accordance with the literature.110  
Phenyl 4-butyl-2-(4-methoxyphenyl)-5-oxo-4,5-dihydrooxazole-4-carboxylate 538 
 
 
Procedure F was employed to afford the title compound. 
Following general procedure F, N-p-anisoyl-DL-norleucine 515 (900 mg, 3.39 mmol), Et3N 
(1.65 mL, 11.9 mmol), triazolium salt 128 (46.3 mg, 0.170 mmol), THF (9 mL) and phenyl 
chloroformate (1.14 mL, 10.2 mmol) gave, after chromatographic purification (3% → 20% 
Et2O:petrol), the title product as a colourless oil (934 mg, 75%). δH (400 MHz, CDCl3) 8.06–
8.02 (2H, m, MeOArH-3,5), 7.69–7.34 (2H, m, PhH-3,5), 7.26–7.22 (1H, m, PhH-4), 7.13–7.10 
(2H, m, PhH-2,6), 7.03–6.99 (2H, m, MeOArH-2,6), 3.88 (3H, s, OCH3), 2.45–2.38 (1H, m, 
C(4)HAHB), 2.34–2.28 (1H, m, C(4)HAHB), 1.44–1.35 (3H, m, CH3CH2CHAHB), 1.31–1.21 (1H, 
m, CH3CH2CHAHB) and 0.91 (3H, t, J 7.1, CH3); δC (100 MHz, CDCl3) 174.5 (COOCR2), 164.8 
(COOPh), 163.9 and 163.3 (MeOArC-1 and C=N), 150.4 (OPhC-1), 130.5 (MeOArCH-3,5), 
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129.6 (OPhCH-3,5), 126.6 (OPhCH-4), 121.2 (OPhCH-2,6), 117.4 (MeOArC-4), 114.5 
(MeOArCH-2,6), 76.8 (C-4), 55.7 (OCH3), 34.3 (CH2), 25.5 (CH2), 22.6 (CH2CH3) and 13.9 
(CH3); m/z MS (ESI+) 386 (100, [M+H]), 248 (72, [M–COOPh+H]) and 135 (38, 
ArC≡O); HRMS (ESI+) C21H22NO5 ([M+H]) requires 368.1489, found 368.1498 (-2.4 ppm); IR 
νmax (thin film)/cm-1 2961, 2934, 2874, 1823 (C=O), 1771 (C=O), 1653 (C=N), 1609, 1513, 
1308, 1262 (C-O) and 1173 (C-O). 
Phenyl isobutyl-2-(4-methoxyphenyl)-5-oxo-4,5-dihydrooxazole-4-carboxylate 539  
 
 
Procedure H was employed to afford the title compound.  
Following general procedure H, carbonate 526 (200 mg, 0.544 mmol), triazolium salt 128 
(1.49 mg, 5.44 µmol), KHMDS (9.60 µL, 4.90 µmol) and THF (2 mL) gave, after 5 min and 
chromatographic purification (10% Et2O:petrol), the product as a colourless oil (160 mg, 80%). 
δH (400 MHz, CDCl3) 8.07–8.04 (2H, m, MeOArH-3,5), 7.45–7.09 (5H, m, PhH), 7.05–6.99 
(2H, m, MeOArH-2,6), 3.90 (3H, s, OCH3), 2.48 (1H, ABX, JAB 14.1, JAX 6.0, 
CHAHBCH(CH3)2), 2.17 (1H, ABX, JBA 14.1, JBX 7.2, CHAHBCH(CH3)2), 1.83 (1H, app sept, 
J 6.6, CH(CH3)2), 1.01 (3H, d, J 6.6, CH(CH3)2) and 0.97 (3H, d, J 6.6, CH(CH3)2). 
Spectroscopic data are in accordance with the literature.107 
(R)- and (RS)- 1,1,1-Trichloro-2-methylpropan-2-yl 4-isobutyl-2-(4-methoxyphenyl)-5-oxo- 
4,5-dihydrooxazole-4-carboxylate 540 
 
 
Procedure H was employed to afford the title compound.  
Following general procedure H, carbonate 527 (200 mg, 0.444 mmol), chiral triazolium salt 399 
(1.75 mg, 4.44 µmol), KHMDS (8.00 µL, 4.00 µmol) and THF (2 mL) gave, after 6 h and 
chromatographic purification (10% Et2O:petrol), the enantioenriched product (R)-540 as a 
colourless solid (160 mg, 80%). mp 64–66 °C, lit.124 68–70 ºC (for racemate); [α] 20D  +40.4 
(c 0.2, CHCl3), lit.125 +60.6 (c 0.6, CHCl3, 91.2% ee); δH (300 MHz, CDCl3) 7.96 (2H, d, J 9.0, 
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MeOArH-3,5), 6.97 (2H, d, J 9.0, MeOArH-2,6), 3.87 (3H, s, OCH3), 2.36 (1H, ABX, JAB 14.4, 
JAX 5.7, CHH), 2.03 (1H, ABX, JBA 14.4, JBX 7.5, CHAHB), 1.90 (3H, s, CH3), 1.87 (3H, s, CH3), 
1.71 (1H, sept, J 6.6, CH), 0.94 (3H, d, J 6.6, CH3) and 0.89 (3H, d, J 6.6, CH3). Data are in 
accordance with the literature.124,125 
Enantiomeric excesses were determined by HPLC with Chiralcel OD-H column (1% 
i-PrOH:hexane, flow rate = 1.0 mL min-1), tR(R) 5.8 min and tR(S) 6.9 min.  
Phenyl 4-tert-Butyl-5-oxo-2-(4-methoxyphenyl)-4,5-dihydro-oxazole-4-carboxylate 541 
 
 
Procedure H was employed to afford the title compound.  
Following general procedure H, carbonate 528 (200 mg, 0.544 mmol), triazolium salt 128 
(14.9 mg, 54.4 µmol), KHMDS (96.0 µL, 49.0 µmol) and THF (2 mL) gave, after 1 h and 
chromatographic purification (20% Et2O:petrol), the title product as a colourless oil (140 mg, 
70%) which partially solidified on standing. δH (300 MHz, CDCl3) 8.08–8.03 (2H, m, 
MeOArH-3,5), 7.40–7.33 (2H, m, PhH), 7.26–7.22 (1H, m, PhH-4), 7.13–7.08 (2H, m, PhH), 
7.03–6.98 (2H, m, MeOArH-2,6), 3.89 (3H, s, OCH3) and 1.29 (9H, s, C(CH3)3). Spectroscopic 
data are in accordance with the literature.110  
Phenyl 2-(4-methoxyphenyl)-5-oxo-4-phenyl-4,5-dihydrooxazole-4-carboxylate 542 
 
 
Procedures H and J were employed to afford the title compound.  
Following general procedure J, 2-(4-methoxyphenyl)-4-phenyloxazol-5(4H)-onei (200 mg, 
0.748 mmol), triazolium salt 128 (10.0 mg, 37.4 µmol), THF (2 mL), Et3N (0.135 mL, 
0.972 mmol) and phenyl chloroformate (93.0 µL, 0.823 mmol) gave, after chromatographic 
purification (20% Et2O:petrol), the product as a colourless oil (217 mg, 75%). δH (400 MHz, 
CDCl3) 8.15–8.12 (2H, m, MeOArH-3,5), 7.86–7.84 (2H, m, PhH), 7.49–7.42 (3H, m, PhH), 
7.38–7.33 (2H, m, PhH), 7.23 (1H, tt, J 7.4, 1.4, PhH-4), 7.11–7.09 (2H, m, PhH-2,6), 7.05–7.02 
(2H, m, MeOArH-2,6) and 3.90 (3H, s, OCH3). Spectroscopic data are in accordance with the 
                                                 
i
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literature.110  
Phenyl 4-(4-benzyloxyphenyl)-2-(4-methoxyphenyl)-5-oxo-4,5-dihydrooxazole- 
4-carboxylate 543 
 
 
Procedure F, H, J, K and L have been employed to afford the title compound.  
Following general procedure K, amido-acid 283 (200 mg, 0.493 mmol), DCC (103 mg, 
0.498 mmol), triazolium salt 128 (7.04 mg, 25.8 µmol), THF (2 mL), Et3N (104 µL, 
0.747 mmol) and phenyl chloroformate (72.0 µL, 0.641 mmol) gave, after chromatographic 
purification (20% Et2O:petrol), the product as a colourless oil (210 mg, 84%); δH (300 MHz, 
CDCl3) 7.84–7.78 (2H, m, MeOArH-3,5), 7.33–7.21 (7H, m, ArH), 7.20–7.14 (1H, m, ArH), 
7.14–7.07 (2H, m, ArH), 7.04–7.00 (2H, m, ArH), 6.89–6.84 (2H, m, MeOArH-2,6), 6.77–6.71 
(2H, m, BnOArH-2,6), 4.89 (2H, s, PhCH2), 3.78 (3H, s, OCH3), 3.59 (1H, ABd, J 13.8, 
BnOArCHAHB) and 3.47 (1H, ABd, J 13.8, BnOArCHAHB); δC (100 MHz, CDCl3) 173.8 
(COOCR2), 164.7 (COOPh), 163.8 and 163.3 (MeOArC-1 and C=N), 158.4 (BnOArC-1), 150.4 
(OPhC-1), 137.0 (CH2PhC-1), 131.8 (ArCH), 130.4 (ArCH), 129.7 (ArCH), 128.7 (ArCH), 
128.1 (ArCH), 127.6 (ArCH), 126.7 (ArCH), 125.2 (MeOArC-4), 121.3 (ArCH), 117.4 
(BnOArC-4), 114.8 (OArCH-2,6), 114.5 (OArCH-2,6), 77.8 (C-3), 70.0 (OCH2), 55.7 (OCH3) 
and 39.7 (BnOAr–CH2); m/z MS (ESI+) 508 (10, [M+H]+), 135 (38, ArC≡O+) and 95 
(100); HRMS (ESI+) C31H26NO6 ([M+H]+) requires 508.1763, found 508.1760 (+0.6 ppm); IR 
νmax (thin film)/cm-1 3064 (CH), 3035 (CH), 2935 (CH), 2841 (CH), 1823 (C=O), 1766 (C=O), 
1647, 1609, 1512, 1493, 1325, 1307 and 1262 (C-O). 
Phenyl 2-(4-methoxyphenyl)-4-(2-(methylthio)ethyl)-5-oxo-4,5-dihydrooxazole-4-phenyl 
carboxylate 544 
 
 
Procedures F and H were employed to afford the title compound.  
Following general procedure H, KHMDS (9.34 µL, 4.67 µmol), triazolium salt 128 (1.42 mg, 
5.19 µmol), carbonate 534 (200 mg, 0.519 mmol) and THF (2 mL) gave, after chromatographic 
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purification (20% Et2O:petrol), the product (166 mg, 83%) as a pearlescent oil. δH (300 MHz, 
CD2Cl2) 8.05–8.00 (2H, m, MeOArH-3,5), 7.43–7.36 (2H, m, PhH), 7.30–7.26 (1H, m, PhH), 
7.11–7.07 (2H, m, PhH), 7.05–7.00 (2H, m, MeOArH-2,6), 3.88 (3H, s, OCH3), 2.75–2.50 (4H, 
m, CH2CH2SMe) and 2.08 (3H, s, SCH3); δC (75 MHz, CD2Cl2) 175.0 (COOR2), 165.4 
(COOPh), 164.7 (ArC), 164.5 (ArC), 151.1 (OPhC-1), 131.1 (ArCH), 130.4 (ArCH), 127.4 
(ArCH), 121.8 (OPhCH-2,6), 118.1 (MeOArC-4), 115.1 (MeOArCH-2,6), 76.3 (N-C), 56.4 
(OCH3), 34.3 (MeSCH2), 29.1 (SCH3) and 15.7 (CH2); m/z MS (ESI+) 386 (100, [M+H]); 
HRMS (ESI+) C20H20NO5S ([M+H]) requires 386.1062, found 386.1055 (-1.8 ppm); IR νmax 
(KBr)/cm-1 2921 (C-H), 2849 (C-H), 1820 (C=O), 1767 (C=O), 1641 (C=C), 1607 (Ar C=C), 
1509 (Ar C=C), 1457 (C-H), 1262 (C-N), 1187 (C-O) and 1173 (C-O). 
Phenyl 2-(4-methoxyphenyl)-5-oxo-4-(4-phenoxycarbonyloxy)benzyl-4,5-dihydrooxazole- 
4-carboxylate 329  
 
 
Procedures F and L were employed to afford the title compound. 
Following a stoichiometric modification to general procedure L, N-p-anisoyl-DL-tyrosine 328 
(250 mg, 0.793 mmol), Et3N (661 µL, 4.76 mmol), triazolium salt 128 (10.8 mg, 0.0397 mmol), 
THF (2.5 mL) and phenyl chloroformate (493 µL, 4.36 mmol) gave, after chromatographic 
purification (20% Et2O:petrol), the product as a colourless oil (281 mg, 66%). δH (300 MHz, 
CDCl3) 7.91–7.86 (2H, m, MeOArH-3,5), 7.43–7.32 (5H, m, ArH), 7.32–7.27 (2H, m, ArH), 
7.26–7.22 (3H, m, ArH), 7.21–7.08 (4H, m, ArH), 6.97–6.92 (2H, m, MeOArH-2,6), 3.86 (3H, s, 
OCH3), 3.74 (1H, ABd, J 13.8, ArCHAHB) and 3.59 (1H, ABd, J 13.8, ArCHaHB); δC (75 MHz, 
CDCl3) 173.8 (COOCR2), 164.6 (COOPh), 164.0 and 163.6 (MeOArC-1 and C=N), 152.0 
(ArC), 151.2 (ArC), 150.7 (ArC), 150.5 (ArC), 132.0 (ArCH), 131.3 (ArCH), 130.5 (ArCH), 
129.8 (ArCH), 126.8 (ArCH), 126.6 (MeOArC-4), 121.4 (ArCH), 121.2 (ArCH), 121.1 (ArCH), 
121.0 (ArCH), 117.2 (PhOC(O)OArC-4), 114.6 (OArCH-2,6), 77.6 (C-3), 55.8 (OCH3) and 39.7 
(CH2); m/z MS (ESI+) 538 (100, [M+H]+); HRMS (ESI+) C31H24NO8 ([M+H]) requires 
538.1501, found 538.1502 (-0.2 ppm); IR νmax (thin film)/cm-1 2934 (CH), 2824 (CH), 2360 
(CH), 1823 (C=O), 1773 (C=O), 1771 (C=O), 1646 (C=N), 1608, 1513, 1493, 1259, 1236 (C-O), 
1185, 1161, 980, 841, 742 and 687. 
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Phenyl diethylcarbamate 318 
 
To a solution of Et3N (0.750 mL, 5.34 mmol) in THF (20 mL) at 0 ºC was added phenyl 
chloroformate (0.650 mL, 5.14 mmol) and the resultant solution was warmed to ambient 
temperature over 16 h. H2O (10 mL) was added and the aqueous layer extracted with Et2O 
(10 mL × 3). The organic extracts were combined and washed successively with 0.1 M HCl(aq), 
sat NaHCO3(aq) (10 mL) and brine (10 mL), dried (MgSO4), filtered and concentrated in vacuo. 
Chromatographic purification (10% Et2O:petrol) afforded carbamate 318 as a pale yellow oil 
(672 mg, 68%). δH (400 MHz, CDCl3) 7.36–7.19 (2H, m, PhH-3,5), 7.12–7.08 (1H, m, PhH-4), 
7.06–7.02 (2H, m, PhH-2,6), 3.43–3.24 (4H, m, CH2CH3) and 1.23–1.06 (6H, m, CH2CH3). 
Spectroscopic data are in accordance with the literature.169 
Naphthalen-1-yl 2-(4-methoxyphenyl)-4-(4-((naphthalen-1-yloxy)carbonyloxy)benzyl)- 
5-oxo-4,5-dihydrooxazole-4-carboxylate 330 
 
  
Procedure L was employed to afford the title compound. 
Following a stoichiometric modification to general procedure L, N-p-anisoyl-DL-tyrosine 328 
(284 mg, 0.900 mmol), 1-naphthyl chloroformate (0.801 mL, 4.95 mmol), Et3N (0.750 mL, 
5.40 mmol), triazolium salt 128 (12.3 mg, 0.045 mmol) and THF (3 mL), gave, after 
chromatographic purification (20% EtOAc:petrol), the product as a colourless oil (402 mg, 
70%). δH (300 MHz, CDCl3) 8.09–8.06 (1H, m, ArH), 7.94–7.88 (2H, m, MeOArH-3,5), 7.83–
7.78 (2H, m, ArH), 7.63–7.41 (10H, m, ArH) 7.34–7.26 (3H, m, ArH), 7.00–6.95 (2H, m, 
MeOArH-2,6), 3.88 (1H, ABd, J 13.8, ArCHAHB), 3.87 (3H, s, OCH3) and 3.74 (1H, ABd, 
J 13.7, ArCHAHB); δC (75 MHz, CDCl3) 174.0 (COOCR2), 164.6 (MeOArC-1), 163.9 (COOAr), 
163.8 (ArC), 151.9 (ArC), 150.7 (ArC), 146.8, (ArC), 134.7 (ArC), 131.9 (ArCH), 131.2 (ArC), 
130.4 (ArCH), 128.14 (ArCH), 128.07 (ArCH), 127.1 (ArCH), 126.9 (ArCH), 126.8 (ArCH), 
126.6 (ArCH), 126.5 (ArCH), 126.5 (ArC), 126.4 (ArC), 125.4 (ArCH), 125.3 (ArCH), 112.0 
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(ArCH), 120.9 (ArCH), 117.9 (ArCH), 117.5 (ArC), 117.1 (ArC), 114.5 (MeOArC-2,6), 77.7 
(C-N), 55.6 (OCH3) and 39.4 (Ar–CH2); m/z MS (CI+) 638.2 (100, [M+H]+); HRMS (ESI+) 
C39H28O8N+ ([M+H]+) requires 638.1809, found 638.1807 (-0.4 ppm); IR νmax (KBr) /cm-1 3058, 
3011, 2937, 2841, 1822 (C=O), 1776 (C=O), 1742 (C=O), 1654 (C=N), 1605 (Ar C=C), 1574, 
1508, 1495 (Ar C=C), 1442, 1391, 1302, 1263 (C-O), 1229 (C-O), 1202 (C-O) and 1154 (C-O). 
N1,N2-Bis((S)-1-phenylethyl)imidazolium tetrafluoroborate 344 
 
 
To a solution of (S)-α-methylbenzylamine (1.21 g, 10.0 mmol) in toluene (20 mL) was added 
paraformaldehyde (300 mg, 10.0 mmol) with vigorous stirring and cooling to 10 ºC. After 
30 min, further (S)-α-methylbenzylamine (1.21 g, 10.0 mmol) was added at 0 ºC, to which was 
then added HBF4(aq) (1.25 mL of an ~8 M solution, 10.0 mmol) dropwise. After stirring for 
15 min, the ice-bath was removed and aqueous glyoxal (1.45 mL of a 40% w/v solution, 
10.0 mmol) was added dropwise. The mixture was stirred for 30 min at ambient temperature 
then heated to 40 ºC for 12 h. Et2O (10 mL) and H2O (10 mL) were added and the mixture 
extracted with Et2O (10 mL × 2). The organic fractions were combined, dried (MgSO4), filtered 
and concentrated in vacuo to afford a viscous brown oil. Exhaustive trituration with Et2O 
followed by heating to 50 ºC in vacuo for 12 h gave the title compound as a viscous orange oil 
(2.73 g, 75%). [α] 20D § +7.8 (c 0.5, CHCl3); δH (300 MHz, CDCl3) 11.04 (1H, s, NCHN), 7.32–
7.28 (2H, m, PhH), 7.26 (2H, s, NCHC), 7.24–7.20 (3H, m, PhH), 5.92 (2H, q, J 7.2, CHCH3) 
and 1.91 (6H, d, J 7.2, CH3). Spectroscopic data are in accordance with the literature.170 
N1,N2-Bis((S)-1-phenylethyl)imidazolinium tetrafluoroborate 348 
 
 
A mixture of aqueous glyoxal (1.13 mL of a 40% w/v solution, 7.80 mmol), 
(S)-α-methylbenzylamine (2.06 mL, 16.0 mmol), MgSO4 (4.00 g, 33.2 mmol) and formic acid 
(1 drop) was stirred for 15 min at ambient temperature. The suspension was filtered over celite 
and the filtrate concentrated in vacuo, redissolved in hexane (15 mL), dried (Na2SO4), filtered 
and concentrated in vacuo to afford the imine product 346 as an orange oil (2.04 g, 99%). [α] 20D  
-114.1 (c 0.2, CHCl3), lit.171 -113.9 (c 0.72, CHCl3); δH (300 MHz, CDCl3) 7.97 (2H, N=CH), 
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7.35–7.10 (10H, m, ArH), 4.32 (2H, q, J 6.7, CH(CH3)Ph) and 1.41 (6H, d, J 6.7, CH3). Data are 
in accordance with the literature.171 
To a stirred solution of diimine 346 (1.10 g, 4.16 mmol) in THF (6 mL) was added a solution of 
lithium aluminium hydride (3.12 mL of a 2.0 M solution, 6.24 mmol) in THF at 0 ºC. The 
mixture was warmed to ambient temperature over 16 h, then recooled to 0 ºC and ice-cold H2O 
added carefully until gas evolution ceased. An aqueous solution of KOH (3 mL of a 3 M 
solution) was added then the mixture was extracted with EtOAc (10 mL × 3). The organics were 
combined, washed with brine, dried (MgSO4), filtered and concentrated in vacuo to afford the 
diamine product 347 as an orange oil (890 mg, 80%). [α] 20D  -70.0 (c 0.5, CHCl3), lit.172 -69.4 (c 
1.1, CHCl3); δH (300 MHz, CDCl3) 7.39–7.09 (10H, m, PhH), 3.67 (2H, q, J 6.7, CH(CH3)Ph), 
2.50 (2H, br s, NH) and 1.36 (6H, d, J 6.7, CH3). Data are in accordance with the literature.172 
To a solution of diamine 347 (500 mg, 1.87 mmol) in MeOH (5 mL) was added triethyl 
orthoformate (0.78 mL, 4.69 mmol) and NH4BF4 (218 mg, 2.08 mmol). The mixture was heated 
at reflux (100 ºC) for 90 min, the mixture cooled to ambient temperature then Et2O added 
(5 mL), forming an oily precipitate. Exhaustive trituration (Et2O) gave the title compound 348 as 
an orange/yellow oil (500 mg, 73%). [α] 20D  +23.0 (c 0.5, CHCl3), lit.173 +23, (c 0.51, CHCl3); δH 
(400 MHz, CDCl3) 8.42 (1H, s, NCHN), 7.28–7.42 (10H, m, PhH), 4.94 (2H, q, J 6.9, 
PhCHCH3), 3.62–3.76 (4H, m, NCH2) and 1.73 (6H, d, J 6.9, CH3); δC§ (100 MHz, CDCl3) 
154.6 (NCHN), 137.5 (PhC-1), 129.3 (PhCH-2,6), 129.2 (PhCH-4), 127.0 (PhCH-3,5), 58.2 
(NCHMePh), 46.3 (CH2) and 18.9 (CH3). Data are in accordance with the literature.173 
(3S,7S)-3,7-Diisopropyl-2,3,7,8-tetrahydroimidazo[4,3-b:5,1-b']bis(oxazole)-4-ium 
trifluoromethanesulfonate 354 
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To a suspension of sodium borohydride (6.92 g, 183 mmol) in THF (200 mL) was added 
L-valine (8.90 g, 76.0 mmol) in one portion. The mixture was cooled to 0 ºC before addition of a 
solution of iodine (19.3 g, 76.0 mmol) in THF (50 mL) dropwise over 30 min. Once hydrogen 
gas evolution ceased, the mixture was heated at reflux (80 ºC) for 18 h then cooled to ambient 
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temperature. MeOH was added cautiously until the mixture became clear and was stirred for a 
further 30 min, upon which time the mixture was concentrated in vacuo to afford a colourless 
paste, which was redissolved in 20% KOH(aq) with stirring over 4 h. The mixture was extracted 
with CH2Cl2 (150 mL × 3), the organics combined, dried (Na2SO4), filtered and concentrated 
in vacuo to afford the crude product as a colourless semi-solid. Purification by distillation (117–
120 ºC /57 mm) afforded (S)-valinol 350 as a colourless oil (6.66 g, 85%). [α] 20D  +17.1 (c 0.5, 
EtOH), lit.174 +17.0 (c 10.0, EtOH); δH (300 MHz, CDCl3) 3.60 (1H, ABX, JAB 12.0, JAX 
1.9, OCHAHB), 3.26 (1H, ABX, JBA 12.0, JBX 11.0, OCHAHB), 2.56–2.47 (1H, m, CHNH2), 2.21 
(2H, br s, NH2), 1.52 (1H, J 6.9, CH(CH3)2) and 0.85 (6H, d, J 6.9, CH(CH3)2). Data are in 
accordance with the literature.174,175 
To a solution of (S)-valinol 350 (1.00 g, 9.69 mmol) in toluene (35 mL) was added diethyl 
oxalate (0.64 mL, 4.73 mmol) and the mixture heated at reflux (110 ºC) for 5 h. The mixture was 
then cooled to ambient temperature and hexane (35 mL) was added, forming a colourless 
precipitate of the product. Trituration with hexane (20 mL) gave the purified diamide 351 as a 
colourless solid (1.00 g, 81%). mp 171–174 ºC, lit.176 172–174 ºC; [α] 20D  -28.4 (c 0.5, MeOH), 
lit.176 -27.7 (c 1.5, MeOH); δH (300 MHz, d6-DMSO) 8.13 (2H, d, J 9.5, NH), 4.64 (2H, br s, 
OH), 3.41–3.57 (6H, m, CH2 and NCH), 1.82 (2H, sept d, J 6.9, 6.7, CHMe2), 0.85 (6H, d, J 6.5, 
CH3) and 0.82 (6H, d, J 6.4, CH3). Data are in accordance with the literature.176 
To a suspension of bis(hydroxymethyl)oxalamide 351 (900 mg, 3.46 mmol) in toluene (15 mL) 
was added thionyl chloride (0.560 mL, 7.64 mmol) and the mixture was heated to 90 ºC for 4 h. 
The mixture was cooled to ambient temperature then poured onto ice-cold 20% KOH(aq) 
(7.4 mL) and extracted with CH2Cl2 (20 mL × 3). The organics were combined, washed with sat 
NaHCO3(aq) (10 mL), dried (MgSO4) and concentrated in vacuo to afford the dichloride 352 as 
a colourless solid (960 mg, 93%). mp 130–132 ºC, lit.177 131–132 ºC; [α] 20D  -71.0 (c 0.5, 
CHCl3), lit.177 -68.8 (c 2, CHCl3); δH (300 MHz, CDCl3) 5.56 (2H, d, J 9.0, NH), 4.33–4.21 (2H, 
m, CHN), 3.72 (2H, ABX, JAB 11.1, JAX 4.2, CHAHBCl), 3.63 (2H, ABX, JBA 11.1, JBX 4.2, 
CHAHBCl), 1.62–1.54 (6H, m, CHMe2), 0.99 (6H, d, J 6.3, CH3) and 0.96 (6H, d, J 6.4, CH3). 
Data are in accordance with the literature.177 
A mixture of dichloride 352 (957 mg, 3.22 mmol) and KOH (452 mg, 8.05 mmol) in MeOH 
(30 mL) was heated at reflux (70 ºC) for 3 h, with KCl precipitation occurring throughout. The 
mixture was cooled to ambient temperature, poured into H2O (40 mL) and extracted with CH2Cl2 
(20 mL × 3). The organics were combined, washed with brine (30 mL), dried (MgSO4), filtered 
and concentrated in vacuo to afford the bisoxazoline 353 as a pale yellow oil which solidified on 
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standing to a pale cream solid (601 mg, 83%). mp 58–60 ºC, lit.178 50 ºC; [α] 20D  -157.9 (c 0.53, 
CHCl3), lit.178 -158.8 (c 0.97, CHCl3); δH (400 MHz, CDCl3) 4.44–4.30 (2H, m, HA-5), 4.11–
3.97 (4H, m, H-4 and HB-5), 1.79 (2H, sept d, J 6.7, 1.6, CH(CH3)2), 0.92 (6H, d, J 6.7, CH3) 
and 0.84 (6H, d, J 6.7, CH3). Data are in accordance with the literature.178  
To a suspension of silver(I) triflate (415 mg, 1.62 mmol) in CH2Cl2 (5 mL) was added 
chloromethyl pivalate (243 mg, 1.62 mmol) and the resulting suspension stirred for 45 min. The 
supernatant was transferred to the bisoxazoline 353 (250 mg, 1.12 mmol) and the mixture stirred 
at 40 ºC in the dark in a sealed Schlenk tube for 24 h. After cooling to ambient temperature, the 
reaction was quenched with MeOH (5 mL) and the mixture was concentrated in vacuo to afford 
a brown oil. Chromatographic purification (5% MeOH:CH2Cl2) and subsequent recrystallisation 
from CH2Cl2/Et2O gave the title compound 354 as a colourless solid (264 mg, 61%). [α] 20D  +54.6 
(c 0.5, CH2Cl2), lit.179 +55.0 (c 1.0, CH2Cl2); mp§ 155–157 ºC; δH (400 MHz, CDCl3) 8.73 (1H, 
s, NCHN), 5.07 (2H, dd, J 9.0, 7.9, CH2O), 4.98–4.93 (2H, m, CHCH2O), 4.83 (2H, dd, J 9.0 
and 4.1, CH2O), 2.35–2.31 (2H, m, CHCH3), 1.03 (6H, d, J 6.9, CH3), 0.99 (6H, d, J 6.9, CH3); 
δC (100 MHz, CDCl3) 125.6 (NCO), 120.6 (q, J 321, CF3), 116.3 (NCHN), 79.1 (CH2), 63.9 
(CHCH2), 31.1 (CHCH3), 17.6 (CH3) and 16.7 (CH3); 19F NMR (273 MHz, CDCl3) -78.6 (CF3). 
Data are in accordance with the literature.179 
(3aR,7aR)-1,3-Dibenzyl-3a,4,5,6,7,7a-hexahydro-1H-benzo[d]imidazolium 
tetrafluoroborate 138 
 
 
Following the procedure described by Jacobsen,139 a solution of L-tartaric acid (50.0 g, 
0.333 mol) in H2O (133 mL) was prepared, to which was added a mixture of (RS)-, (SR)- and 
meso-1,2-diaminocyclohexane 355 (80.0 mL, 0.650 mol). The addition was made at a rate such 
that the reaction temperature was maintained at 70 ± 2 ºC, then glacial acetic acid (33.0 mL, 
0.583 mol) was added at such a rate that the reaction temperature was maintained at 90 ± 2 ºC. A 
colourless precipitate formed upon addition of the acid, then the slurry was stirred vigorously as 
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the mixture was cooled to ambient temperature. The mixture was cooled further in an ice bath 
for 2 h and the precipitate collected by filtration. The wet filter cake was washed with 
ice-cold H2O (33 mL) then MeOH (5 × 33 mL) and dried in vacuo to afford the resolved product 
356 compound as a colourless solid (52.7 g, 31%). [α] 20D  +12.1 (c 0.5, H2O), lit.180 +12.5 
(c 4, H2O); mp 270 ºC decomp, lit.180 273 ºC decomp; δH (400 MHz, CD3OD) 4.20 (s, 2H, 
CH(OH), 3.30–3.17 (2H, m, +H3NCH), 2.08–1.97 (2H, m, +H3NCHCHAHB), 1.78–1.60 (2H, m, 
+H3NCHCHAHB), 1.47–1.31 (2H, m, CH2CHAHB) and 1.33–1.13 (2H, m, CH2CHAHB). Data are 
in accordance with the literature.180,181 
A mixture of (1R, 2R)-trans-cyclohexane-1,2-diammonium (S)-tartrate 356 (1.00 g, 3.77 mmol), 
K2CO3 (1.05 g, 7.58 mmol) and H2O (5 mL) were stirred until complete dissolution occurred, to 
which was then added EtOH (20 mL). The mixture was heated at reflux (80 ºC) and a solution of 
benzaldehyde (0.77 mL, 7.58 mmol) in EtOH (8 mL) was added over 30 min. The mixture was 
heated at reflux for a further 2 h, then, when the solution had cooled to ambient 
temperature, H2O (5 mL) was added and the mixture cooled to 0 ºC for 3 h. The mixture was 
concentrated in vacuo to afford the crude diimine. The residue was redissolved in CH2Cl2 
(15 mL), washed with H2O (10 mL × 2) and brine (10 mL × 2), dried (Na2SO4), filtered and 
concentrated in vacuo to afford the diimine 357 as a pale cream solid (1.05 g, 96%). mp 133–
135 ºC, lit.182 134–135 ºC; [α] 20D  -261.4, lit.183 -263 (c 0.19, CH3OH); δH (400 MHz, CDCl3) 8.20 
(2H, s, PhCH=N), 7.61 (4H, dd, J 7.6 and 2.1, PhH-2,6), 7.36–7.28 (6H, m, PhH-3,4), 3.42–3.35 
(2H, m, CH=NCH), 3.36–3.41 (2H, m, H-1), 1.89–1.63 (6H, m, H-3, 3’ and 4) and 1.45–1.57 
(2H, m, H-4’). Data are in accordance with the literature.182,183 
To a solution of (1R,2R)-bis(benzylidene)cyclohexyl-1,2-diimine 357 (1.05 g, 3.62 mmol) in 
MeOH (8 mL) was added NaBH4 (287 mg, 7.59 mmol) portionwise over 30 min. The solution 
was heated at reflux for 15 min then cooled to ambient temperature. H2O (8 mL) was added and 
the mixture extracted with CH2Cl2 (10 mL × 2). The organics were combined, washed with brine 
(10 mL), dried (MgSO4), filtered and concentrated in vacuo to afford the diamine 358 as a 
colourless oil (1.00 g, 94%). [α] 20D  -69.2 (c 0.5, CHCl3), lit.184 -68 (c 1.3, CHCl3); δH (400 MHz, 
CDCl3) 7.31–7.10 (10H, m, PhH), 3.82 (2H, ABd, J 13.2, CHAHBPh), 3.58 (2H, ABd, J 13.2, 
CHAHBPh), 3.41–3.36 (2H, m, H-1,2), 1.78 (2H, br s, NH), 1.89–1.63 (6H, m, HA,B-3,6, HA-4, 
and HA-5) and 1.57–1.45 (2H, m, HB-4,5). Data are in accordance with the literature.184,185  
A mixture of (1R, 2R)-dibenzylcyclohexyl-1,2-diamine 358 (500 mg, 1.70 mmol), triethyl 
orthoformate (0.70 mL, 4.25 mmol), MeOH (5 mL) and NH4BF4 (180 mg, 1.72 mmol) were 
heated at 110 ºC for 5 h. Hexane (15 mL) was added to the mixture to precipitate the product as a 
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colourless solid. Recrystallisation from CH2Cl2 afforded the title compound 138 as a colourless 
solid (550 mg, 82%). [α] 20D  = -66.8 (c 0.2, MeOH); mp 150–152 ºC; δH (400 MHz, CDCl3) 8.58 
(1H, s, NCHC), 7.32–7.26 (10H, m, PhH), 4.64 (2H, ABd, J 15.1, PhCHAHB), 4.51 (2H, ABd, 
J 15.1, PhCHAHB), 3.41–3.30 (2H, m, H-3a,7a), 2.02–1.92 (2H, m, HA-4,7), 1.72–1.58 (2H, 
m, HB-4,7) and 1.33–1.02 (4H, m, H-5,6); δC (100 MHz, CD3OD) 161.9 (CH-2), 134.8 (PhC-1), 
130.1 (PhCH-3,5), 129.7 (PhCH-4), 129.4 (PhCH-2,6), 69.0 (CH-3a,7a), 51.5 (Ph–CH2), 28.5 
(CH2-4) and 24.5 (CH2-5); IR νmax (KBr) νmax /cm-1 3108 (Ar C-H), 3072 (Ar C-H), 1611 
(C=N), 1586 (C=N), 1062 (C-N stretch) and 1059 (C-N stretch); m/z MS (ESI+) 305 (100, [M–
BF4]); HRMS (ESI+) C21H25N2 ([M–BF4]) requires 305.2018, found 305.2019 (+0.4 ppm). 
Boc-L-valine (S)-359 
 
 
To a solution of L-valine (35.1 g, 300 mmol) in NaOH(aq) (12.0 g in 300 mL) was added 
tert-butanol (200 mL) followed by slow addition of Boc2O (75.2 g, 360 mmol), with vigorous 
stirring. The mixture was stirred for 48 h at ambient temperature then the reaction was quenched 
with 1 M KHSO4(aq) to pH ~1. The mixture was saturated with NaCl, then extracted with Et2O 
(300 mL × 3). The combined organic fraction was dried (MgSO4), filtered and concentrated 
in vacuo to afford the crude product as a colourless oil which partially solidified on standing 
(52.6 g, 81%) which was used without further purification. [α] 20D  -5.5 (c 1.0, AcOH), lit.186 -6.3 
(c 1, AcOH); δH (400 MHz, CDCl3) 7.94 (1H, br s, COOH), 5.06 (1H, d, J 8.9, NHCH), 4.28 
(1H, dd, J 8.9, 4.5, NHCH), 2.27–2.19 (1H, m, CHMe2), 1.02 (3H, d, J 6.8, CH3) and 0.96 (3H, 
d, J 6.8, CH3). Data are in accordance with the literature.186 
Boc-DL-valine (RS)-359 
 
 
To a solution of DL-valine (7.02 g, 60.0 mmol) in NaOH(aq) (2.40 g in 30 mL) was added 
tert-butanol (40 mL) followed by slow addition of Boc2O (15.0 g, 68.9 mmol), with vigorous 
stirring. The mixture was stirred for 48 h at ambient temperature then the reaction was quenched 
with 1 M KHSO4(aq) to pH ~1. The mixture was saturated with NaCl, then extracted with Et2O 
(150 mL × 2). The combined organic fraction was dried (MgSO4), filtered and concentrated 
in vacuo to afford the crude product as a colourless oil which partially solidified on standing 
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(10.9 g, 84%). The product was used without further purification. Spectroscopic data as for 
N-Boc-L-valine. 
 (S)-tert-Butyl 1-(2,5-dimethylphenylamino)-3-methyl-1-oxobutan-2-ylcarbamate 360 
 
 
A solution of Boc-L-valine (S)-359 (6.74 g, 31.0 mmol) in CH2Cl2 (80 mL) was cooled to 0 °C, 
followed by addition of N-methylmorpholine (3.41 mL, 31.0 mmol), then dropwise addition of 
ethyl chloroformate (2.97 mL, 31.0 mmol) and the mixture was stirred for 20 min. 
2,5-Dimethylaniline (3.82 mL, 31.0 mmol) was added slowly, then warmed to ambient 
temperature over 16 h, then the reaction was quenched with H2O (100 mL) and extracted with 
CH2Cl2 (100 mL × 3). The organic fractions were combined and washed sequentially with 4% 
NaHCO3(aq) (100 mL) and 1 M HCl(aq) (100 mL), then dried (MgSO4), filtered and 
concentrated in vacuo. The crude product was then triturated with ice-cold pentane to obtain the 
product as a pale green solid (9.01 g, 91%). mp 155–156 ºC; [α] 20D  -54.4 (c 1.0, MeOH); δH 
(400 MHz, d6-DMSO) 9.22 (1H, s, amide NH), 7.14 (1H, s, ArH-3), 7.07 (1H, d, J 8.0, 
carbamate NH), 6.90–6.88 (1H, m, ArH-6), 6.85 (1H, d, J 8.5, ArH-4), 3.93 (1H, t, J 8.0, 
BocNHCH), 2.23 (3H, s, ArCH3-5), 2.12 (3H, s, ArCH3-2), 2.06–1.95 (1H, m, CHMe2), 1.39 
(9H, s, C(CH3)3), 0.93 (3H, d, J 6.8, CH3) and 0.90 (3H, d, J 6.8, CH3); δC (100 MHz, 
d6-DMSO) 170.5 (CONHAr), 156.1 (NHCOt-Bu), 135.9 (ArC-1), 135.5 (ArC-5), 130.5 (ArC-2), 
130.3 (ArCH-3), 126.1 (ArCH-6), 125.8 (ArC-4), 78.4 (OC(CH3)3), 60.4 (CHCONHAr), 30.5 
(CHMe2), 28.4 (OC(CH3)3), 20.7 (Ar–CH3-5), 19.6 (CH3), 18.5 (CH3) and 17.5 (Ar–CH3-2); m/z 
MS (ESI+) 321 (100, [M+H]+), 265 (69, [M–t-Bu]+), 221 (17, [M–Boc]+); HRMS (ESI+) 
C18H29O3N2+ ([M+H]+) requires 321.2173, found 321.2174 (+0.4 ppm); IR νmax (KBr) /cm-1 
3316 (NH), 2973, 2963, 1691 (C=O), 1660 (C=O), 1579, 1524, 1491, 1457, 1379, 1368, 1298, 
1283, 1247, 1171, 1048, 1024, 887, 814 and 684. 
(S)-N1-(2,5-Dimethylphenyl)-N2,3-dimethylbutane-1,2-diamine 361 
 
NH HNMe
361
  
Follwing general procedure P, Boc-protected amide 360 (958 mg, 3.00 mmol), LiAlH4 (9.00 mL 
of a 2 M solution in THF, 18.0 mmol) and THF (10 mL), gave, after workup (0.68 mL H2O, 
0.68 mL KOH(aq) and 2.04 mL H2O), the diamine 361 as a pink/purple oil (630 mg, 95%). [α] 20D  
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+5.0 (c 1.73, CHCl3); δH (400 MHz, CDCl3) 6.94 (1H, d, J 7.4, ArH-3), 6.48 (1H, br d, J 7.4, 
ArH-4), 6.44 (1H, s, ArH-6), 4.15 (1H, br s, ArNH), 3.22 (1H, dt, J 11.8, 4.2, ArNHCHAHB), 
2.96 (1H, ddd, J 11.8, 7.5, 4.2, ArNHCHAHB), 2.51 (1H, ddd, J 7.5, 6.4, 4.2, MeNHCH), 2.41 
(3H, s, NCH3), 2.31 (3H, s, ArCH3-5), 2.12 (3H, s, ArCH3-2), 1.96 (1H, dt, J 13.2, 6.8, CHMe2), 
1.02 (3H, d, J 6.8, CHCH3) and 0.96 (3H, d, J 6.8, CHCH3); δC (100 MHz, CDCl3) 146.9 
(NArC-1), 136.8 (NArC-5), 130.0 (NArC-3), 119.5 (NArC-2), 117.3 (NArC-6), 110.9 (NArC-4), 
64.2 (MeNHCH), 43.3 (ArNHCH2), 33.9 (NHCH3), 29.0 (CHMe2), 21.4 (Ar–CH3-5), 19.6 
(CHCH3), 18.5 (CHCH3) and 17.2 (Ar–CH3-2); m/z MS (ESI+) 221 (100, [M+H]+); HRMS 
(ESI+) C14H25N2+ ([M+H]+) requires 221.2012, found 221.2017 (+2.1 ppm); IR νmax (thin film) 
/cm-1 3370 (N-H), 3015, 2958, 2927, 2871, 2796, 1615, 1582, 1520, 1455, 1387, 1368, 1313, 
1298, 1155, 1137, 1100, 1035, 1001, 840, 792 and 716. 
(S)-1-(2,5-Dimethylphenyl)-4-isopropyl-3-methyl-4,5-dihydro-1H-imidazol-3-ium 
tetrafluoroborate 362 
 
  
A mixture of diamine 361 (200 mg, 0.908 mmol), triethyl orthoformate (0.370 mL, 2.27 mmol), 
MeOH (2.5 mL) and NH4BF4 (96.0 mg, 0.916 mmol) were heated at 100 ºC for 6 h, then 
concentrated in vacuo. The mixture was triturated with Et2O (5 mL × 3) and EtOAc (5 mL). The 
mixture was redissolved in CH2Cl2 then loaded onto a short silica plug (~2 cm depth). The 
product was eluted with CH2Cl2 then increased to 2.5% MeOH:CH2Cl2 to afford the product as a 
green/brown oil (140 mg, 48%). [α] 20D  +38.7 (c 0.5, CHCl3); δH (400 MHz, CDCl3) 8.12 (1H, s, 
NCHN), 7.13 (1H, s, ArH-6), 7.10 (2H, d, J 3.3, ArH), 4.50–4.44 (1H, m, (i-Pr)CH), 4.33 (1H, 
app t, J 11.7, NCHAHB), 3.80 (1H, ABX, JBA 11.1, JBX 7.8, NCHAHB), 3.26 (3H, s, NCH3), 
2.33–2.26 (4H, m, NCH and ArCH3), 2.26 (3H, s, ArCH3) and 0.97 (6H, app t, J 6.5, CH(CH3)2); 
δC (100 MHz, CDCl3) 157.8 (NCHN), 137.9 (NArC-1), 134.6 (ArC), 131.7 (ArCH), 130.6 
(ArCH), 130.5 (ArC), 126.5 (ArC), 67.0 (NCH), 52.0 (NCH2), 33.1 (NCH3), 27.0 (Ar–CH3), 
20.7 (Ar–CH3), 17.8 (CHCH3), 17.4 (CHMe2) and 14.2 (CHCH3); m/z MS (ESI+) 231 (100, [M–
BF4]+); C15H23N2+ ([M–BF4]+) requires 231.1856, found 231.1856 (+0.1 ppm); IR νmax (thin 
film) /cm-1 3636, 3089, 2969, 2880, 1715 (C=N), 1652, 1619, 1576, 1515, 1509, 1464, 1428, 
1397, 1377, 1315, 1270, 1215, 1161, 1134, 1058 (br, C-N) 910, 823, 765, 719 and 675. 
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tert-Butyl (S)-3-methyl-1-oxo-1-((S)-1-phenylethylamino)butan-2-ylcarbamate 363 
 
  
Following general procedure N, Boc-L-valine (673 mg, 3.10 mmol), N-methylmorpholine 
(0.341 mL, 3.10 mmol), ethyl chloroformate (0.295 mL, 3.10 mmol), (S)-α-methylbenzylamine 
(0.400 mL, 3.10 mmol) and CH2Cl2 (10 mL) gave, after purification, the product as a colourless 
solid (648 mg, 65%). mp 146 ºC; [α] 20D  -80.7 (c 1.1, MeOH); δH (400 MHz, CDCl3) 7.35–7.29 
(4H, m, PhH), 7.20–7.15 (1H, m, PhH-4), 6.20 (1H, br s, amide NH), 5.15–5.06 (2H, m, 
carbamate NH and PhCHMe), 3.84 (1H, dd, J 8.6, 6.3, BocNHCH), 2.14–2.06 (1H, m, 
CH(Ph)Me), 1.49 (3H, d, J 6.9, PhCHCH3), 1.43 (9H, s, C(CH3)3) and 0.91–0.87 (4H, m, 
CH3CHCH3). m/z MS (ESI+) 321 (100, [M+H]+), 265 (46, [M–t-Bu]+), 221 (14, [M–Boc]+). 
HRMS (ESI+) C18H29O3N2+ ([M+H]+) requires 321.2173, found 321.2174 (+0.4 ppm); IR νmax 
(KBr) /cm-1 3326 (br, N-H), 3313 (N-H), 3255 (N-H), 3071, 2977 (C-H), 1685 and 1646 (C=O), 
1527, 1392, 1367, 1299, 1250 (C-O), 1177, 1016, 881, 757 and 698. 
(S)-tert-Butyl (RS)-3-methyl-1-oxo-1-(1-phenylethylamino)butan-2-ylcarbamate 364 
 
  
Following general procedure N, Boc-DL-valine (2.69 g, 12.4 mmol), N-methylmorpholine 
(1.36 mL, 12.4 mmol), ethyl chloroformate (1.20 mL, 12.4 mmol), (S)-α-methylbenzylamine 
(1.60 mL, 12.4 mmol) and CH2Cl2 (40 mL) gave, after purification, the product as a colourless 
solid (2.94 mg, 74%). mp 137–139 ºC; δH (400 MHz, CDCl3) 7.35–7.23 (4H, m, PhH), 7.28–
7.23 (1H, m, PhH-4), 6.31 (1H, br d, J 7.8, amide NH), 5.11 (2H, app t, J 5.5, carbamate NH and 
PhCHMe), 3.85 (1H, dd, J 8.5, 6.4, BocNHCH), 2.16–2.07 (1H, m, CH(Ph)Me), 1.49 (3H, d, 
J 6.9, PhCHCH3), 1.42 (9H, s, C(CH3)3), 0.97 (3H, d, J 6.8, (R)-diastereomer CH3), 0.93–0.88 
(4H, m, both diastereomers CHCH3) and 0.87 (3H, d, J 6.8, (S)-diastereomer CH3); m/z MS 
(ESI+) 321 (100, [M+H]+), 265 (48, [M–t-Bu]+), 221 (15, [M–Boc]+); HRMS (ESI+) 
C18H29O3N2+ ([M+H]+) requires 321.2173, found 321.2177 (+0.9 ppm); IR νmax (KBr) /cm-1 
3326 (br, N-H), 3284 (br, N-H), 3079, 2977 (C-H), 2934, 1703, 1686 and 1648 (C=O, mixture of 
diastereomers), 1553, 1527, 1494, 1451, 1392, 1366, 1302, 1290, 1250 (C-O), 1174, 1016, 878, 
761 and 699. 
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(S)-2-Amino-N-(2,5-dimethylphenyl)-3-methylbutanamide 365 
 
 
Following general procedure Q, Boc-protected amide 360 (5.00 g, 15.7 mmol), TFA (10 mL) 
and CH2Cl2 (50 mL) gave, after purification, the desired product as a pale green solid (3.45 g, 
quantitative). The product was used without further purification. mp 120 ºC; [α] 20D  +3.7 (c 1.0, 
MeOH); δH (400 MHz, CDCl3) 9.53 (1H, br s, amide NH), 7.96 (1H, s, ArH-6), 7.05 (1H, dd, 
J 7.7, 0.9, ArH-3), 6.85 (1H, dd, J 7.6, 3.7, ArH-4), 3.42 (1H, d, J 3.5, NH2CH), 2.48 (1H, sept 
d, J 7.0, 3.5, CH(CH3)2), 2.33 (3H, s, ArCH3-5), 2.24 (3H, s, ArCH3-2), 1.49 (2H, br s, NH2), 
1.06 (3H, d, J 7.0, CH3) and 0.89 (3H, d, J 7.0, CH3); δC (100 MHz, CDCl3) 172.3 (CONHAr), 
136.5 (ArC-5), 135.8 (ArC-1), 130.0 (ArCH-3), 124.9 (ArCH-4) 124.4 (ArC-2), 121.6 
(ArCH-6), 60.6 (CHCONHAr), 30.7 (CHMe2), 21.2 (Ar–CH3-5), 19.8 (CH3), 17.3 (CH3) and 
15.9 (Ar–CH3-2). m/z MS (ESI+) 221 (100, [M+H]+), 243 (13, [M+Na]+); HRMS (ESI+) 
C13H21ON2+ ([M+H]+) requires 221.1648, found 221.1649 (+0.3 ppm); IR νmax (KBr) /cm-1 
3375, 3279 (amide N-H), 3047 (Ar C-H), 3022 (Ar C-H), 2987 (N-H), 2986 (N-H), 2955 (N-H), 
2924, 2885, 2869, 1644 (C=O) and 1582.  
(S)-N1-(2,5-Dimethylphenyl)-3-methylbutane-1,2-diamine 366 
 
  
Following general procedure O, amido amide 365 (918 mg, 2.78 mmol), LiAlH4 (3.47 mL of a 
2 M solution in THF, 6.95 mmol) and THF (6 mL), gave, after workup (0.26 mL H2O, 0.26 mL 
KOH(aq) and 0.79 mL H2O), the product as a pale orange oil (550 mg, 95%). Product was used 
without further purification. [α] 20D
 
+19.7 (c 0.97, CHCl3); δH (400 MHz, CDCl3) 6.94 (1H, d, 
J 7.4, ArH-3), 6.48 (1H, d, J 7.4, ArH-4), 6.44 (1H, s, ArH-6), 4.06 (1H, br s, ArNH), 3.28–3.26 
(1H, m, ArNHCHAHB), 2.87 (1H, ABd, J 10.3, ArNHCHAHB), 2.84–2.78 (1H, m, NH2CH), 2.30 
(3H, s, ArCH3–5), 2.13 (3H, s, ArCH3–2), 1.77–1.65 (1H, m, CH(CH3)2), 1.23 (2H, br s, NH2), 
1.01 (3H, d, J 6.8, CHCH3) and 0.97 (3H, d, J 6.8, CHCH3); δC (100 MHz, CDCl3) 146.5 
(NArC-1), 136.6 (NArC-5), 129.9 (NArCH-3), 119.3 (NArC-2), 117.4 (NArCH-6), 110.8 
(NArCH-4), 56.1 (NH2CH), 48.0 (ArNHCH2), 32.7 (CH(CH3)2), 21.6 (ArCH3–5), 19.4 
(CHCH3), 17.9 (CHCH3) and 17.1 (ArCH3–2); m/z MS (ESI+) 207 (100, [M+H]+); HRMS 
(ESI+) C13H23N2+ ([M+H]+) requires 207.1856, found 207.1856 (+0.1 ppm); IR (thin film) νmax 
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/cm-1 3387 (N-H, broad), 2959, 2932, 1614 (Ar C=C), 1582, 1522 (Ar C=C), 1459, 1377, 1298, 
1264, 1169, 1002, 842 and 793. 
(S)-1-(2,5-Dimethylphenyl)-4-isopropyl-4,5-dihydro-1H-imidazole 367 
 
 
A mixture of diamine 366 (200 mg, 0.969 mmol), toluene (3 mL), NH4BF4 (102 mg, 
0.969 mmol) and triethyl orthoformate (0.80 mL) were heated at 90 ºC for 16 h, then cooled to 
ambient temperature and diluted with Et2O (10 mL) and washed with 0.1 M NaOH(aq) (3 mL). 
The organic fraction was dried (MgSO4), filtered and concentrated to obtain the product as a 
dark orange oil (165 mg, 79%). [α] 20D  -6.0 (c 0.4, CHCl3); δH (400 MHz, CDCl3) 7.11–7.09 (2H, 
m, ArH-3 and NCHN), 6.99 (1H, d, J 7.7, ArH-4), 6.81 (1H, s, ArH-6), 4.02 (1H, dddd, J 10.3, 
9.0, 6.5, 1.9, NCHi-Pr), 3.70 (1H, ABX, JAB 10.3, JAX 9.0, NCHAHB), 3.30 (1H, app t, J 9.0, 
NCHAHB), 2.30 (3H, s, ArCH3-5), 2.26 (3H, s, ArCH3-2), 1.90–1.79 (1H, m, CHMe2), 1.04 (3H, 
d, J 6.8, CH3) and 0.95 (3H, d, J 6.8, CH3); δC (100 MHz, CDCl3) 153.7 (NCHN), 140.2 
(ArC-1), 136.7 (ArC-5), 131.4 (ArCH-3), 129.1 (ArC-2), 126.2 (ArCH-4), 123.2 (ArCH-6), 72.7 
(i-PrCHN), 52.5 (NCH2), 33.1 (CHMe2), 20.9 (Ar–CH3-5), 18.9 (CH3), 18.5 (Ar–CH3-2) and 
18.3 (CH3); m/z MS (ESI+) 217 (100, [M+H]+); HRMS (ESI+) C14H21N2+ ([M+H]+) requires 
217.1699, found 217.1699 (+0.0 ppm); IR νmax (thin film) /cm-1 3377, 3070 (Ar CH), 2960, 
2926, 2872, 1665 (C=N), 1615, 1584, 1526, 1509, 1463, 1382, 1300, 1275, 1224, 1173, 1139, 
1061, 1003, and 794. 
(S)-1-Benzyl-3-(2-tert-butylphenyl)-5-isopropyl-4,5-dihydro-1H-imidazolium 
tetrafluoroborate 377 
 
 
L-Valine (6.57 g, 56.1 mmol) and NaOH (2.34 g) were dissolved in H2O (17 mL). Et2O (90 mL) 
was added, the mixture was cooled to 0 °C and stirred rapidly. Benzoyl chloride (6.58 mL, 
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56.6 mmol) and a solution of NaOH (2.34 g) in H2O (6 mL) were added alternatively 
portionwise over 90 min, then the mixture was warmed to ambient temperature over 16 h. The 
mixture was then concentrated to half volume in vacuo before conc. HCl (5 mL) was added to 
induce precipitation of the product. The product was collected by filtration and washed with 
Et2O (100 mL) and dried, to obtain N-benzoylvaline 374 as a colourless solid (10.3 g, 83%), 
which was used immediately without further purification. A suspension of N-benzoylvaline 374 
(1.50 g, 6.78 mmol) in CH2Cl2 (20 mL) was cooled to 0 °C and N-methylmorpholine (0.751 mL, 
6.78 mmol) was added before dropwise addition of ethyl chloroformate (0.671 mL, 6.78 mmol). 
After 20 min, 2-tert-butylaniline (1.06 mL, 6.78 mmol) was added to the suspension. The 
mixture was warmed to ambient temperature over 16 h then quenched with H2O (30 mL). The 
mixture was diluted with CH2Cl2 (20 mL) and extracted with CH2Cl2 (30 mL × 3). The 
combined organics were washed successively with 4% NaHCO3(aq) (30 mL) and 1 M HCl(aq) 
(30 mL), then dried (MgSO4), filtered and concentrated in vacuo. The product was triturated 
with pentane (20 mL) to obtain the diamide product 375 as a colourless solid (1.36 g, 53%) 
which was used without further purification. To a suspension of diamide 375 (1.00 g, 
4.06 mmol) in THF (10 mL) was added a solution of LiAlH4 (9.13 mL, 18.3 mmol) and the 
mixture heated at reflux for 72 h, then quenched at 0 °C with H2O (0.69 mL), 40% KOH(aq) 
(0.69 mL) and further H2O (2.07 mL), before drying with excess MgSO4 and filtration through 
celite. Following concentration in vacuo, chromatographic purification (10% EtOAc:petrol) gave 
the diamine 376 as a clear colourless oil (790 mg, 60%). [α] 20D  +0.3 (c 1.6, CHCl3); δH 
(400 MHz, CDCl3) 7.27–7.22 (4H, m, ArH), 7.20–7.16 (2H, m, ArH), 7.07 (1H, td, J 7.6, 1.4, 
NArH-4), 6.63–6.58 (2H, m, ArH), 4.76 (1H, t, J 4.4, ArNH), 3.74 (1H, ABd, J 12.8, 
PhCHAHB), 3.71 (1H, ABd, J 12.8, PhCHAHB), 3.20 (1H, dt, J 11.5, 4.4, ArNHCHAHB), 2.95 
(1H, ddd, J 11.4, 6.6, 4.4, ArNHCHAHB), 2.65 (1H, td, J 6.6, 4.0, BnNHCH), 2.03–1.91 (1H, m, 
CH(CH3)2), 1.37 (9H, s, C(CH3)3), 0.97 (3H, d, J 6.8, CH3) and 0.90 (3H, d, J 6.8, CH3); δC 
(100 MHz, CDCl3) 147.1 (NHArC-1), 140.5 (PhC-1), 133.5 (NHArC-2), 128.5 (PhCH), 128.4 
(PhCH), 127.2 (ArCH), 127.1 (ArCH), 126.2 (ArCH), 116.5 (NHArC-4), 111.5 (NHArC-6), 
61.9 (BnNCH), 51.1 (Ph–CH2), 43.3 (ArNHCH2), 34.4 (C(CH3)3), 29.9 (C(CH3)3), 29.3 
(CH(CH3)2), 20.0 (CH3) and 18.4 (CH3); m/z MS (ESI+) 325 (100, [M+H]+); HRMS (ESI+) 
C22H33N2+ ([M+H]+) requires 325.2644, found 325.2639 (-1.3 ppm); IR νmax (thin film) /cm-1 
3425 (br, N-H), 2958, 2930, 1644, 1504, 1443, 1055, 834, 741 and 697. 
A mixture of diamine 376 (186 mg, 0.573 mmol), NH4BF4 (60.1 mg, 0.573 mmol), triethyl 
orthoformate (0.23 mL) and MeOH (1.6 mL) were heated at 80 °C for 16 h then concentrated 
in vacuo before dissolution in CH2Cl2 and filtration to remove excess NH4BF4. The mixture was 
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concentrated in vacuo then chromatographic purification (10% MeOH:CH2Cl2) gave the title 
product as a clear colourless oil (225 mg, 93%). [α] 20D  -0.7 (c 1.4, CHCl3); δH (400 MHz, CDCl3) 
8.01 (1H, s, NCHN), 7.36 (1H, dd, J 8.1, 1.3, ArCH-6), 7.27–7.21 (6H, m, ArCH), 7.17–7.13 
(2H, m, ArCH), 4.87 (1H, ABd, J 14.6, PhCHAHB), 4.44 (1H, ABd, J 14.6, PhCHAHB), 4.32–
4.26 (1H, m, Me2CHCH), 4.11 (1H, app t, J 11.6, ArNCHAHB), 3.81 (1H, ABX, JBA 11.6, JBX 
9.9, ArNCHAHB), 2.34–2.23 (1H, m, CHMe2), 1.21 (9H, s, C(CH3)3), 0.93 (3H, d, J 6.8, CH3), 
and 0.80 (3H, d, J 7.0, CH3); δC (100 MHz, CDCl3) 158.8 (NCHN), 147.0 (NArC-1), 134.0 
(NArC-2), 132.2 (PhC), 130.6 (ArCH), 130.0 (ArCH), 129.5 (PhCH), 129.3 (PhCH), 129.0 
(ArCH), 128.8 (ArCH), 128.3 (ArCH), 65.0 (NCH(i-Pr)), 54.9 (ArNCH2), 50.2 (Ph–CH2), 35.7 
(C(CH3)3), 32.0 (C(CH3)3), 26.6 (CHMe2), 18.0 (CH3) and 14.4 (CH3); m/z MS (ESI+) 335 (100, 
[M–BF4]+); HRMS (ESI+) C23H31N2+ ([M–BF4]+) requires 335.2487, found 335.2479 
(-2.4 ppm); IR νmax (thin film) /cm-1 3389, 3069, 2957, 2924, 2850, 1635 (C=N), 1457, 1366, 
1259, 1086, 1057, 1036, 753 and 703. 
(R)-5-Benzyl-2-phenyl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium tetrafluoroborate 
56 
 
 
Boc2O (52.6 g, 0.241 mol) was added dropwise to a stirred solution of L-phenylalanine (34.7 g, 
0.210 mol) in 1 M NaOH(aq) (210 mL) and t-BuOH (140 mL). The reaction mixture was stirred 
at ambient temperature for 24 h then acidified to ~pH 1 with 1 M KHSO4(aq) and extracted with 
Et2O (250 mL × 3). The organic extracts was combined, washed with brine (100 mL), dried 
(MgSO4), filtered and concentrated in vacuo to afford Boc-L-phenylalanine 545 as a colourless 
oil (57.9 g, 85%). [α] 20D  +24.0 (c 1.03, EtOH), lit.187 +24.7 (c 1.50, EtOH); δH (400 MHz, CDCl3) 
8.35 (1H, br s, COOH), 7.32–7.18 (5H, m, PhH), 4.94 (1H, d, J 7.9, NH), 4.61 (1H, app q, J 6.5, 
CHCOOH), 3.21 (1H, ABX, JAB 13.8, JAX 5.4, PhCHAHB), 3.09 (1H, ABX, JBA 13.8, JBX 6.5, 
PhCHAHB ), 1.42 (6H, s, C(CH3)3) and 1.28 (3H, s, C(CH3)3). Data are in accordance with the 
literature.187 
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To a solution of Boc-L-phenylalanine 545 (15.7 g, 53.2 mmol) in CH2Cl2 (200 mL) was added 
2,2-dimethyl-1,3-dioxane-4,6-dione (7.61 g, 52.7 mmol) and DMAP (8.78 g, 71.9 mmol). The 
mixture was cooled to -5 ºC, then a solution of DCC (10.9 g, 52.7 mmol) in CH2Cl2 (100 mL) 
was added dropwise over 1 h, after which the mixture was stirred for 20 h at -5 °C. The mixture 
was warmed to ambient temperature, whereby the precipitate was removed by filtration. The 
filtrate was then washed with KHSO4(aq) (5% w/v, 100 mL × 4) and brine (100 mL) and dried 
(MgSO4) at +5 °C (refrigerator) over 18 h. The solution was concentrated in vacuo to ~200 mL 
and the crude product was used immediately without further purification. To the solution of 
crude ketomalonate 387 (assumed ~53.2 mmol) in CH2Cl2 (200 mL) was added glacial AcOH 
(30 mL) and the mixture cooled to -5 ºC. NaBH4 (4.63 g, 115 mmol) was added portionwise over 
3 h at -5 °C, then the reaction mixture was stirred at -5 °C for a further 20 h. The reaction 
mixture was washed with H2O (100 mL × 2), brine (100 mL × 2), dried (MgSO4), filtered and 
concentrated in vacuo to afford a pale yellow oil, and the malonate product 388 was crystallised 
from Et2O as a colourless solid (10.2 g, 56% from L-phenylalanine). mp 120–121 ºC, lit.188 111–
113 ºC; [α] 20D § +4.5 (c 1.0, MeOH); δH (300 MHz, CDCl3) 7.38–7.23 (5H, m, PhH), 4.52–4.49 
(1H, m, NH), 4.32–4.24 (1H, m, CHNH), 3.96 (1H, td, J 2.0, 0.5, CHC(O)), 2.90 (2H, d, J 6.4, 
PhCH2), 2.36–2.14 (2H, m, CH2CHC(O)), 1.82 (3H, s, CH3), 1.78 (3H, s, CH3) and 1.40 (9H, s, 
C(CH3)3). Data are in agreement with the literature.188,189 
A solution of malonate derivative 388 (8.76 g, 23.2 mmol) in toluene (100 mL) was heated at 
110 ºC for 5 h, then the mixture was concentrated in vacuo to afford the crude protected 
pyrrolidinone product 389 as a brown oil (7.09 g, quantitative yield) which was used 
immediately without further purification. To a cooled (0 ºC) solution of pyrrolidinone 389 
(3.00 g, 10.9 mmol) in CH2Cl2 (100 mL) was added TFA (1.86 mL, 24.1 mmol) dropwise. The 
reaction was allowed to warm to ambient temperature and stirred for 4 h. The reaction was 
quenched slowly with sat NaHCO3(aq) (100 mL) and extracted with CH2Cl2 (50 mL). The 
combined organic fraction was washed with H2O (100 mL), brine (50 mL), dried (MgSO4), 
filtered and concentrated in vacuo to afford the crude pyrrolidinone 390 as a yellow solid 
(1.91 g, quantitative) which was used immediately without further purification. To a solution of 
pyrrolidinone 390 (1.00 g, 5.71 mmol) in CH2Cl2 (40 mL) was added trimethyloxonium 
tetrafluoroborate (0.930 g, 6.29 mmol) and the reaction stirred for 16 h at ambient temperature. 
To the solution was added phenylhydrazine (0.620 mL, 6.29 mmol) and stirred for a further 16 h. 
The mixture was concentrated in vacuo then redissolved in MeOH (2 mL) and triethyl 
orthoformate (20 mL) and heated to 80 ºC for 16 h. The mixture was concentrated in vacuo and 
the product precipitated from EtOAc to give a yellow solid. Recrystallisation from MeOH gave 
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the title product 56 as a golden crystalline solid (1.03 g, 50%). mp 191–192 °C, lit.146 
195.1 - 196.5 °C; [α] 20D  +8.7 (c 1.04, MeCN), lit.146 +9.1 (c unspecified, MeCN); δH (300 MHz, 
CDCl3) 10.02 (1H, s, NCHN), 7.86–7.80 (2H, m, PhH), 7.60–7.53 (3H, m, PhH), 7.38–7.22 (5H, 
m, PhH), 5.41–5.32 (1H, m, BnCHN), 3.54 (1H, ABX, JAB 13.5, JAX 5.0, PhCHAHB), 3.23–3.17 
(1H, m, CHAHB-7), 3.15 (1H, ABX, JBA 13.5, JBX 8.8, PhCHAHB), 3.04–2.88 (2H, m, CHAHB-6 
and CHAHB-7) and 2.70–2.59 (1H, m, CHAHB-6); Data are in accordance with the literature.146  
(S)-5-((tert-Butyldimethylsilyloxy)diphenylmethyl)-2-phenyl-2,5,6,7-tetrahydropyrrolo 
[2,1-c][1,2,4]triazolium tetrafluoroborate 134 
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To a solution of (S)-pyroglutamic acid (10.0 g, 77.5 mmol) in MeOH (252 mL) at -15 ºC was 
added thionyl chloride (6.23 mL, 85.7 mmol) dropwise. The mixture was stirred at -15 ºC for 
30 min then warmed to ambient temperature before concentration in vacuo to afford the crude 
ester product 392 as a viscous yellow oil (11.1 g, quantitative). The product was used without 
further purification. To a cooled (-78 ºC) solution of the pyroglutamate 392 (5.00 g, 34.9 mmol) 
in THF (40 mL) was added phenylmagnesium bromide (40.0 mL of a 3 M solution in Et2O, 
120 mmol) over 30 min. The mixture was warmed to -40 ºC for 15 min then warmed to 0 ºC for 
30 min, then the reaction was quenched with 5% HCl(aq) (~30 mL). The product was extracted 
with CH2Cl2 (50 mL × 5). The organic extracts were combined, dried (MgSO4), filtered through 
celite, concentrated in vacuo and the residue was recrystallised from Et2O to afford the desired 
tertiary alcohol product 393 as a colourless solid (5.02 g, 54%). mp 189–190 ºC, lit.190 191–
192 ºC; [α] 20D  -81.2 (c 1.0, CHCl3), lit.190 -80.8 (c 1.3, CHCl3); δH (400 MHz, CDCl3) 7.46–7.17 
(10H, m, PhH), 4.58 (1H, br s, NH), 4.70–4.64 (1H, dd, J 8.2, 4.8, NHCH), 3.87 (1H, br s, OH), 
2.36–2.28 (1H, m, C(O)CHAHB), 2.26–2.17 (1H, m, C(O)CHAHB), 2.12–2.04 (1H, m, 
C(O)CH2CHAHB) and 1.95–1.87 (1H, m, C(O)CH2CHAHB). Data are in agreement with the 
literature.190 
To a cooled (0 ºC) solution of alcohol 393 (1.50 g, 5.59 mmol) and Et3N (1.01 mL, 7.29 mmol) 
in CH2Cl2 (30 mL) was added TBSOTf (1.70 mL, 7.29 mmol). The reaction mixture was 
warmed to ambient temperature over 5 h. Another portion of TBSOTf (0.850 mL, 3.65 mmol) 
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and Et3N (0.495 mL, 3.65 mmol) were added and the mixture stirred for 2 h at ambient 
temperature. The reaction mixture was quenched with H2O (12 mL) and extracted with CH2Cl2 
(30 mL). The organic layer was dried (Na2SO4) and concentrated in vacuo. Chromatographic 
purification (30% EtOAc:petrol) gave the product 394 as a the product as a colourless solid 
(2.04 g, 96%). mp§ 138–140 ºC; [α] 20D  -63.0 (c 0.5, CHCl3), lit. –65.0 (c 1.01, CHCl3); δH 
(300 MHz, CDCl3) 7.38–7.28 (10H, m, PhH), 5.83 (1H, br s, NH), 4.66 (1H, dd, J 8.2, 3.3, 
NHCH), 2.19–2.09 (2H, m, COCH2), 1.91–1.80 (1H, m, COCH2CHAHB), 1.10–0.89 (1H m, 
COCH2CHAHB), 0.92 (9H, s, SiC(CH3)3), -0.34 (3H, s, SiCH3) and -0.39 (3H, s, SiCH3). Data 
are in accordance with the literature.191  
To a solution of lactam 394 (1.00 g, 2.62 mmol) in CH2Cl2 (16 mL) was added 
trimethyloxonium tetrafluoroborate (426 mg, 2.88 mmol) and the mixture stirred for 16 h. To the 
solution was added phenylhydrazine (0.258 mL, 2.62 mmol) and stirred for 24 h. The mixture 
was then concentrated in vacuo and the residue redissolved in MeOH (1.18 mL) and triethyl 
orthoformate (6.35 mL) and heated at reflux (100 ºC) for 16 h. The mixture was cooled to 
ambient temperature and concentrated in vacuo then triturated with Et2O (~20 mL) to afford the 
title product 134 as a brown solid (606 mg, 41%). mp 208–210 ºC, lit.192 210–211 ºC; [α] 20D  
-108.4 (c 0.5, MeCN), lit.192 -112.4 (c 0.5, MeCN); δH (300 MHz, CDCl3) 9.07 (1H, s, NCHN), 
7.73–7.69 (2H, m, PhH), 7.55–7.45 (5H, m, PhH), 7.45–7.35 (4H, m, PhH), 7.00 (2H, t, J 7.3, 
NPhH-3,5), 6.95 (2H, app br s, NPhH-2,6), 6.11 (1H, d, J 8.3, CH-5), 3.25–3.14 (1H, m, 
CHAHB-7), 3.00–2.88 (1H, m, CHAHB-7), 2.87–2.62 (1H, m, CHAHB-6), 1.77–1.65 (1H, m, 
CHAHB-6), 0.96 (9H, s, Si(CH3)3), -0.32 (3H, s, SiCH3) and -0.35 (3H, s, SiCH3). Data are in 
accordance with the literature.192 
(S)-5-Benzyl-6,6-dimethyl-2-phenyl-5,6-dihydrooxazolo[2,3-c][1,2,4]triazol-2-ium 
tetrafluoroborate 399 
 
 
To a suspension of L-phenylalanine methyl ester hydrochloride (S)-250 (20.0 g, 97.2 mmol) in 
EtOH (60 mL) was added Na2CO3 (30.1 g, 284 mmol) and Boc2O (24.5 g, 112 mmol). The 
suspension was stirred for 48 h at ambient temperature. The colourless suspension was filtered 
through celite and the filtrate concentrated in vacuo to afford Boc-L-phenylalanine methyl ester 
546 as a clear yellow oil (27.2 g, 91%). [α] 20D  +49.2 (c 1.0, CH2Cl2), lit.193 +46.9 (c 3.4, CH2Cl2); 
δH (400 MHz, CDCl3) 7.06–7.03 (5H, m, ArH), 5.37 (1H, br d, J 8.3, NH), 4.47 (1H, app q, 
J 7.2, CHNH), 3.52 (3H, s, OCH3), 3.01 (1H, ABX, JAB 13.7, JAX 5.6, PhCHAHB), 2.90 (1H, 
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ABX, JBA 13.7, JBX 7.0, PhCHAHB) and 1.42–1.30 (9H, m, C(CH3)3). Data are in accordance 
with the literature.193 
To a cooled (0 °C) solution of Boc-L-phenylalanine methyl ester 546 (10.0 g, 35.8 mmol) in 
Et2O (100 mL) was added methylmagnesium bromide (37.0 mL of a 3.0 M solution in THF, 
111 mmol) slowly via cannula. The mixture was stirred for 16 h at ambient temperature, 
quenched with ice-cold H2O (~30 mL), then filtered through celite. The (partially aqueous) 
filtrate was extracted with CH2Cl2 (50 mL × 2) and the combined organics were washed with 
brine (100 mL), dried (MgSO4), filtered and concentrated in vacuo to afford the crude alcohol 
product 547 as a pale yellow solid (7.32 g, 73%) which was used immediately without further 
purification. To a cooled (0 °C) solution of the crude alcohol 547 (5.00 g, 17.9 mmol) in THF 
(50 mL) was added potassium tert-butoxide (2.21 g, 19.7 mmol). The mixture was stirred for 
16 h at ambient temperature and then concentrated in vacuo to afford a viscous yellow oil. The 
oil was dissolved in EtOAc (100 mL) and washed with brine (100 mL) and the aqueous phase 
extracted with EtOAc (20 mL × 2). The combined organics were dried (MgSO4), filtered and 
concentrated in vacuo to give a clear yellow oil. Chromatographic purification (25% 
EtOAc:petrol) gave the oxazolidinone 548 as a yellow oil (3.51 g, 79%); [α] 20D  -108.2 (c 1.0, 
CHCl3), lit.194 -103.5 (c 0.6, CHCl3); δH (300 MHz, CDCl3) 7.37–7.15 (5H, m, ArH), 4.79 (1H, 
br s, NH), 3.74–3.65 (1H, m, CHNH2), 2.84 (1H, ABX, JAB 13.3, JAX 3.7, PhCHAHB), 2.67 (1H, 
ABX, JBA 13.3, JBX 10.8, PhCHAHB), 1.49 (3H, s, CH3) and 1.46 (3H, s, CH3). Data are in 
accordance with the literature.194 
To a solution of oxazolidinone 548 (1.86 g, 9.06 mmol) in CH2Cl2 (30 mL) was added 
trimethyloxonium tetrafluoroborate (1.48 g, 10.0 mmol) then the mixture was stirred for 16 h. 
Phenylhydrazine (0.902 mL, 9.06 mmol) was added and the solution was stirred for a further 
24 h. The mixture was concentrated in vacuo and the residue dissolved in triethyl orthoformate 
(20 mL) and MeOH (4 mL) and heated at reflux (100 °C) for 18 h. The resultant precipitate was 
collected by filtration and washed with cold EtOAc to obtain the purified title product 399 as a 
light brown solid (2.02 g, 57%). mp 178–180 °C, lit.73 177–179 °C; [α] 20D  -73.0 (c 0.5, MeCN), 
lit.73 -76.4 (c 1.0, MeCN); δH (300 MHz, CDCl3) 9.03 (1H, s, NCHN), 7.64–7.25 (10H, m, ArH), 
5.28 (1H, t, J 8.1, CH2CHN), 3.40 (1H, ABd, J 14.0, PhCHAHB), 3.19 (1H, ABd, J 14.0, 
PhCHAHB), 1.71 (3H, s, CH3) and 1.58 (3H, s, CH3). Data are in accordance with the literature.73 
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(S)-6,6-Dimethyl-2-phenyl-5-isopropyl-5,6-dihydrooxazolo[2,3-c][1,2,4]triazol-2-ium 
tetrafluoroborate 164 
 
 
To a cooled (0 °C) suspension of L-valine (20.0 g, 171 mmol) in MeOH (200 mL) was added 
thionyl chloride (36.5 mL, 502 mmol) dropwise, after which the reaction was stirred at ambient 
temperature for 16 h. The reaction mixture was then concentrated in vacuo to give a pale yellow 
solid, which was washed with Et2O (100 mL) to afford the ester hydrochloride (S)-516 as a 
colourless solid (28.6 g, quantitative); mp 164–165 °C, lit.195 169–170 °C; [α] 20D  +24.2 (c 1.0, 
MeOH), lit.196 +22.3 (c 2.0, MeOH); δH (300 MHz, D2O) 4.01 (1H, d, J 4.7, CHNH), 3.83 (3H, 
s, OCH3), 2.42–2.25 (1H, m, CHMe2), 0.92 (3H, d, J 4.4, CH(CH3)A) and 0.90 (3H, d, 
CH(CH3)B). Data are in accordance with the literature.195,196 
To a suspension of (S)-valine methyl ester hydrochloride (S)-516 (20.0 g, 119 mmol) in EtOH 
(60 mL) was added NaHCO3 (26.1 g, 310 mmol) and Boc2O (29.6 g, 136 mmol). The mixture 
was stirred for 48 h at ambient temperature then the colourless suspension was filtered through 
celite and the filtrate concentrated in vacuo to afford the carbamate product 549 as a pale yellow 
oil (27.5 g, quantitative) which was used without further purification. [α] 20D  -4.0 (c 0.5, AcOH), 
lit.197 -6.3 (c 1, AcOH); δH (400 MHz, CDCl3) 5.05 (1H, d, J 8.7, CHNH), 4.17 (1H, ABX, 
JXA 8.7, JXB 4.8, CHNH), 3.68 (3H, s, OCH3), 2.16–1.98 (1H, m, CHMe2), 1.51–1.34 (9H, m 
OC(CH3)3), 0.90 (3H, d, J 6.9, CH(CH3)A) and 0.85 (3H, d, J 6.9, CH(CH3)B). Data are in 
accordance with the literature.197 
To a cooled (0 °C) solution of Boc-L-valine methyl ester 549 (10.0 g, 43.2 mmol) in Et2O 
(100 mL) was added methylmagnesium bromide (46.0 mL of a 3.0 M solution in THF, 
138 mmol) dropwise at ambient temperature. The reaction was stirred for 48 h, quenched with 
ice-cold H2O (~30 mL) and filtered through celite. The filtrate was extracted with CH2Cl2 
(50 mL × 2) and the combined organic phase was washed with brine (100 mL), dried (MgSO4), 
filtered and concentrated in vacuo to afford the crude alcohol 550 as a colourless oil (8.34 g, 
83%) which was used without further purification. [α] 20D  +11.5 (c 1.0, CH2Cl2), lit.198 +9.1 
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(c 0.01, CH2Cl2); δH (400 MHz, CDCl3) 4.85 (1H, d, J 10.2, CHNH), 3.36 (1H, dd, J 10.2, 2.7, 
CHNH), 2.12–2.03 (1H, m, CHMe2), 1.43–1.40 (9H, m, OC(CH3)3), 1.24 (3H, s, C(CH3)A), 1.20 
(3H, s, C(CH3)B), 0.95 (3H, d, J 6.8, CH(CH3)A) and 0.91 (3H, d, J 6.8, CH(CH3)B). Data are in 
accordance with the literature.198 
To a cooled (0 °C) solution of 550 (3.00 g, 13.0 mmol) in THF (60 mL) was added potassium 
tert-butoxide (1.60 g, 14.3 mmol). The solution was warmed to ambient temperature over 16 h 
and concentrated in vacuo then redissolved in EtOAc (50 mL) and washed with 0.5 M HCl (aq) 
(40 mL) and brine (50 mL). The combined organics were dried (MgSO4), filtered and 
concentrated in vacuo to give a clear yellow oil. Chromatographic purification (25% 
EtOAc:petrol) gave the oxazolidinone 551 as a colourless solid (1.94 g, 95%); mp 85–87 °C, 
lit.194 87–89 °C; [α] 20D  +24.1 (c 1.0, CHCl3), lit194 +21.3 (c 0.8, CHCl3); δH (400 MHz, CDCl3) 
6.06 (1H, s, NH), 3.18 (1H, dd, J 8.6, 6.7, NHCH), 1.88–1.79 (1H, m, CHMe2), 1.49 (3H, s, 
OC(CH3)A), 1.38 (3H, s, OC(CH3)B), 0.99 (3H, d, J 6.6, CH(CH3)A) and 0.92 (3H, d, J 6.6, 
CH(CH3)B). 
To a solution of 551 (1.86 g, 11.8 mmol) in CH2Cl2 (50 mL) was added trimethyloxonium 
tetrafluoroborate (1.93 g, 13.0 mmol) and the mixture was stirred for 16 h. Phenylhydrazine 
(1.16 mL, 11.8 mmol) was added and the solution was stirred for a further 24 h. The mixture was 
then concentrated in vacuo and the residue dissolved in triethyl orthoformate (28 mL) and 
MeOH (6 mL) and heated at reflux (100 °C) for 18 h. The solution was concentrated to 
approximately half volume in vacuo and the product precipitated upon addition of Et2O (~1 mL). 
The precipitate was collected by filtration and washed with ice-cold EtOAc to afford the title 
product 164 as a pale brown solid (2.04 g, 50%). mp 112–118 °C, lit.73 179–180 °C; [α] 20D  -5.0 
(c 1.0, MeCN), lit.73 -7.0 (c 0.5, MeCN); δH (300 MHz, d6-DMSO) 9.54 (1H, s, NCHN), 7.99–
7.54 (5H, m, PhH), 4.63 (1H, d, J 7.5, i-PrCHN), 2.50–2.35 (1H, m, i-PrCH), 2.02 (3H, s, 
C(CH3)A), 1.82 (3H, s, C(CH3)B), 1.22 (3H, d, J 6.6, CH(CH3)A) and 1.12 (3H, d, J 6.6, 
CH(CH3)B). Data are in accordance with the literature.73 
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(S)-5-Benzyl-2-phenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-ium 
tetrafluoroborate 403 
 
 
To a mixture of of sodium borohydride (2.60 g, 68.8 mmol) in THF (80 mL) was added 
L-phenylalanine (5.00 g, 30.2 mmol). The mixture was cooled to 0 °C and a solution of iodine 
(7.67 g, 30.2 mmol) in THF (20 mL) was added dropwise over 40 min. After gas evolution had 
ceased, the reaction was heated at reflux (80 °C) for 18 h. When the reaction had cooled to 
ambient temperature, MeOH was added slowly until the solution became clear and the mixture 
was stirred for a further 30 min. The mixture was concentrated in vacuo to afford a colourless 
paste, which was redissolved in KOH(aq) (20% w/v, 100 mL) with stirring over 4 h. The mixture 
was extracted with CH2Cl2 (150 mL × 2), the organics layers were combined, dried (Na2SO4), 
filtered and concentrated in vacuo to afford the crude product as a colourless solid. 
Recrystallisation from Et2O gave the product (S)-phenylalaninol 400 as a colourless solid 
(2.49 g, 55%). mp 88–90 °C, lit.199 86–88 °C; [α] 20D  -22.3 (c 1.01, CHCl3), lit.199 -21.7 (c 1.0, 
CHCl3); δH (400 MHz, CDCl3) 7.36–7.18 (5H, m, PhH), 3.66 (1H, ABX, JAB 10.6, JAX 3.9, 
CHAHBOH), 3.41 (1H, ABX, JBA 10.6, JBX 7.2, CHAHBOH), 3.18–3.11 (1H, m, CHNH2), 2.82 
(1H, ABX, JAB 13.5, JAX 5.2, PhCHAHB), 2.55 (1H, ABX, JBA 13.5, JBX 8.6, PhCHAHB) and 1.79 
(2H, br s, NH2). Data are in accordance with the literature.199 
To a cooled (0 ºC) solution of (S)-phenylalaninol 400 (500 mg, 3.31 mmol) and Et3N (1.38 mL, 
9.92 mmol) in CH2Cl2 (10 mL) was added chloroacetyl chloride (0.28 mL, 3.47 mmol) 
dropwise. The mixture was warmed to ambient temperature over 16 h then sat NaHCO3(aq) 
(10 mL) added and the mixture extracted with CH2Cl2 (20 mL × 3). The organics were combined 
and washed with 1 M H2SO4(aq) (10 mL), H2O (10 mL) and brine (10 mL), then dried (Na2SO4), 
filtered and concentrated in vacuo to afford the crude amide intermediate 401 as a brown oil 
which was used immediately in the subsequent step. The product was redissolved in THF 
(10 mL) and cooled to 0 ºC before addition of potassium tert-butoxide (405 mg, 3.61 mmol). The 
mixture was warmed to ambient temperature over 90 min then concentrated in vacuo then 
partitioned between EtOAc (10 mL) and brine (10 mL). The aqueous fraction was extracted with 
EtOAc (10 mL × 2), then the combined organic fractions was dried (MgSO4), filtered and 
concentrated in vacuo to afford the crude morpholinone product. Chromatographic purification 
(40% EtOAc:petrol) gave the morpholinone 402 as a colourless solid (420 mg, 66%). mp 85–
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87 ºC, lit.200 86–87 ºC; [α] 20D  +4.2 (c 1.0, MeOH), lit.200 +4.0 (c 0.66 MeOH); δH (400 MHz, 
CDCl3) 7.33–7.16 (5H, m, PhH), 5.89 (1H, br s, NH), 4.22 (1H, ABd, J 17.8, OCHAHBCO), 4.19 
(1H, ABd, J 17.8, OCHAHBCO), 3.88 (1H, ABX, JAB 11.5, JAX 3.8, OCHAHBCH), 3.77 (1H, 
ddd, J 9.2, 5.8, 3.8, NHCH), 3.46 (1H, ABX, JBA 11.5, JBX 5.8, OCHAHBCH), 2.85 (1H, ABX, 
JAB 13.5, JAX 5.8, CHAHBPh) and 2.70 (1H, ABX, JBA 13.5, JBX 9.2, CHAHBPh). Data are in 
accordance with the literature.200  
To a solution of lactam 402 (400 mg, 2.09 mmol) in CH2Cl2 (12 mL) was added 
trimethyloxonium tetrafluoroborate (337 mg, 2.28 mmol) and the mixture was stirred for 16 h. 
To the mixture was then added phenylhydrazine (0.206 mL, 2.09 mmol) and the mixture was 
stirred for 20 h. The mixture was then concentrated in vacuo and redissolved in MeOH (1.5 mL) 
and triethyl orthoformate (4.5 mL). The mixture was heated at reflux (110 ºC) for 16 h then 
cooled to ambient temperature, whereby the product had precipitated.i The product was collected 
by filtration and washed with cold (-78 ºC) EtOAc (~5 mL) to afford the title product 403 as a 
pale peach solid (230 mg, 29%). mp 190–195 ºC; [α] 20D  -18.1 (c 0.8, MeOH); δH (400 MHz, 
d6-DMSO) 10.91 (1H, s, NCHN), 7.90–7.88 (2H, m, PhH), 7.76–7.71 (2H, m, PhH), 7.71–7.65 
(1H, m, PhH-4), 7.43–7.40 (2H, m, NPhH-2), 7.36–7.32 (3H, m, NPhH), 5.23 (1H, ABd, J 16.2, 
OCHAHB), 5.15 (1H, ABd, J 16.2, OCHAHB), 4.85 (1H, app dq, J 9.7, 5.9, BnCH), 4.01–3.93 
(2H, m, OCH2CHBn), 3.50 (1H, ABX, JAB 13.6, JAX 5.9, PhCHAHB) and 3.18 (1H, ABX, 
JBA 13.6, JBX 9.7, PhCHAHB); δC (100 MHz, d6-DMSO) 149.9 (NCHN), 135.1 (N=C), 134.9 
(NArC-1), 134.9 (CH2PhC-1), 130.8 (ArCH-4), 130.4 (ArCH), 129.5 (ArCH), 129.0 (ArCH), 
127.5 (ArCH), 120.7 (ArCH), 65.1 (OCH2), 61.5 (OCH2), 56.3 (NCH) and 37.5 (Ph–CH2); m/z 
MS (ESI+) 292 (100, [M–BF4]+); HRMS (ESI+) C18H18ON3+ ([M–BF4]+) requires 292.1444, 
found 292.1443 (-0.4 ppm); IR νmax (KBr) /cm-1 3337, 3141, 3060 (Ar C-H), 3026, 2987, 2969, 
1585 (C=N), 1536, 1497 (Ar C=C), 1469, 1118 (C-O) and 1054 (br). 
 
 
 
 
 
 
 
                                                 
i
 In the event of no precipitation, the mixture was concentrated in vacuo, redissolved in EtOAc (5 mL), then Et2O 
(1 drop) was added to induce precipitation). 
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(S)-5-Benzyl-2,6,6-triphenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c][1,4]oxazin-2-ium 
tetrafluoroborate 407 
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Free basification of methyl ester: 
A solution of L-phenylalanine methyl ester hydrochloride (S)-251 (5.00 g, 23.2 mmol) was 
dissolved in Et2O (25 mL) and NaOH(aq) (25.0 mL of 1 M solution, 25.0 mmol) was added. The 
product was extracted with Et2O (25 mL × 2), dried (MgSO4), filtered and concentrated in vacuo 
to afford the free base as a colourless oil (2.50 g, 60%).  
Conversion to the diphenyl alcohol: 
The free base (2.50 g, 13.9 mmol) was dissolved in Et2O (25 mL). Phenylmagnesium bromide 
(16.3 mL of a 3.0 M in Et2O, 48.9 mmol) was added dropwise then the mixture was heated at 
reflux (60 °C) for 18 h. The reaction was quenched with ice-cold H2O (60 mL), then extracted 
with CH2Cl2 (50 mL × 2). The organic phases were combined, washed with brine (50 mL), dried 
(MgSO4), filtered and the solvent removed in vacuo to give a pale yellow solid. Recrystallisation 
from EtOAc gave the alcohol product 404 as a colourless solid (2.58 g, 61%). mp 138–139 °C, 
lit.201 134–136 ºC; [α] 20D  -90.0 (c 1.0, CHCl3), lit.201 -86.0 (c 1.53, CH2Cl2); δH (400 MHz, 
CDCl3) 7.69–7.66 (2H, m, ArH), 7.65–7.62 (2H, m, ArH), 7.37–7.30 (6H, m, ArH), 7.27–7.20 
(5H, m, ArH), 4.21 (1H, ABX, JXB 10.8, JXA 2.5, CHNH2), 2.68 (1H, ABX, JAB 13.9, JAX 2.5, 
PhCHAHB) and 2.49 (1H, ABX, JBA 13.9, JBX 10.8, PhCHAHB). Data are in accordance with the 
literature.201  
To a cooled (0 ºC) solution of tertiary alcohol 404 (1.00 g, 3.30 mmol) and Hünig’s base 
(0.575 mL, 3.30 mmol) in CH2Cl2 (10 mL) was added chloroacetyl chloride (0.262 mL, 
3.30 mmol) dropwise. The mixture was warmed to ambient temperature over 16 h then sat 
NaHCO3(aq) (10 mL) added and the mixture extracted with EtOAc (30 mL × 3). The organics 
were combined and washed with 1 M H2SO4(aq) (10 mL), H2O (10 mL) and brine (10 mL), then 
dried (MgSO4), filtered and concentrated in vacuo to afford the crude amide intermediate 405 as 
a cream solid which was used immediately without further purification. The product was 
redissolved in THF (10 mL) and cooled to 0 ºC before addition of potassium tert-butoxide 
(404 mg, 3.60 mmol), and allowed to warm to ambient temperature over 90 min before 
concentration in vacuo and partitioning between EtOAc (10 mL) and brine (10 mL). The 
aqueous fraction was extracted with EtOAc (15 mL × 2), then the organic fractions were 
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combined, dried (MgSO4), filtered and concentrated in vacuo to afford the desired morpholinone 
product 406 (970 mg, 86%). mp 187–188 ºC; [α] 20D  +15.0 (c 0.5, CHCl3); δH (400 MHz, CDCl3) 
7.42–7.21 (13H, m, PhH), 7.11–7.09 (2H, m, PhH), 5.96 (1H, br d, J 3.7, NH), 4.42–4.36 (2H, 
m, NHCH and OCHAHB), 3.94 (1H, ABd, J 17.2, OCHAHB), 2.73 (1H, ABX, JAB 13.4, JAX 11.2, 
PhCHAHB) and 2.42 (1H, ABX, JBA 13.4, JBX 2.7, PhCHAHB); δC (75 MHz, CDCl3) 168.3 
(NCO), 143.3 (OCPhC-1), 140.3 (OCPhC-1), 137.8 (PhC-1CH2), 129.5, 128.9, 128.5, 127.9, 
127.6, 127.2, 126.8, 125.4, 80.1 (Ph2C), 63.9 (COCH2), 57.0 (BnCH) and 39.2 (Ph–CH2); m/z 
MS (ESI+) 344 (100, [M+H]+); HRMS (ESI+) C23H22O2N+ ([M+H]+) requires 344.1645, found 
344.1647 (+0.4 ppm); IR νmax (KBr) /cm-1 3175 (NH), 3120, 3060, 6027, 2953, 2917, 2896, 
1682 (C=O), 1603 (Ar C=C), 1493, 1448, 1413, 1323 and 1098 (C-O). 
To a solution of lactam 406 (0.500 g, 1.46 mmol) in CH2Cl2 (5 mL) was added 
trimethyloxonium tetrafluoroborate (235 mg, 1.57 mmol) and the mixture stirred for 16 h. To the 
mixture was then added phenylhydrazine (0.143 mL, 1.46 mmol) and the mixture stirred for 
20 h. The mixture was then concentrated in vacuo and redissolved in MeOH (1 mL) and triethyl 
orthoformate (4 mL). The mixture was heated at reflux (110 ºC) for 18 h then cooled to ambient 
temperature and concentrated in vacuo. The dark brown oil was redissolved in MeOH:Et2O 
(1:20) and was cooled to -78 ºC to induce precipitation. The mixture was filtered rapidly and 
washed with cold (-78 ºC) Et2O (5 mL) to afford the title product 407 as a brown solid (250 mg, 
32%). mp 120 ºC; [α] 20D  +3.0 (c 0.5, MeOH); δH (300 MHz, CHCl3) 9.04 (1H, s, NCHN), 7.53–
7.30 (6H, m, PhH), 7.36–7.16 (12H, m, PhH), 6.98 (2H, d, J 6.7, PhH), 6.19 (1H, ABX, JXA 9.7, 
JXB 6.0, PhCH2CH), 5.34 (1H, ABX, JAB 17.1, JAX 9.7, PhCHAHB), 4.77 (1H, ABX, JBA 17.1, 
JBX 6.0, PhCHAHB) and 2.85–2.74 (2H, d, J 8.4, OCH2); δC (75 MHz, CHCl3) 148.7 (NCHN), 
140.5 (N-C), 137.0 (N-C), 134.6 (PhC), 134.4 (PhC), 131.3 (PhCH), 130.6 (PhCH), 130.5 
(PhCH), 130.2 (PhCH), 130.1 (PhCH), 130.0 (PhCH), 129.8 (PhCH), 129.21 (PhCH), 129.16 
(PhCH-4), 128.4 (PhCH-4), 127.3 (p-PhCH), 120.3 (PhCH), 81.8 (CPh2), 60.9 (BnCH), 57.5 
(OCH2) and 38.1 (Ph–CH2); m/z MS (ESI+) 444 (100, [M–BF4]+); HRMS (ESI+) C30H26N3O+ 
([M–BF4]+) requires 444.2070, found 444.2067 (-0.6 ppm); IR νmax (KBr) /cm-1 3116, 3059 
(Ar CH), 3028, 2920, 1597, 1576 (C=N), 1530, 1496 (Ar C=C), 1450, 1406, 1279, 1259, 1233, 
1204, 1158, 1083 (br), 1052, 1031, 972, 758, 719, 703 and 680. 
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(5aR,10bS)-2-Phenyl-4,5a,6,10b-tetrahydroindeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]-
oxazinium tetrafluoroborate 137 
 
 
Sodium hydride (60% wt in mineral oil, 273 mg, 6.84 mmol) was suspended in hexane (10 mL) 
then left to stand for 5 min before removal of the supernatant via cannula. This procedure was 
repeated (× 2), then THF (100 mL) was added. The mixture was cooled to 0 ºC then (1S,2R)-
1-amino-2,3-dihydro-1H-inden-2-ol 408 (500 mg, 3.35 mmol) was added. The mixture was 
stirred for 15 min then further aminoindanol 408 (500 mg, 3.35 mmol) was added. The mixture 
was heated to 70 ºC for 40 min then cooled to 0 ºC before ethyl chloroacetate (0.732 mL, 
6.84 mmol) was added slowly. The mixture was stirred for 30 min then heated at reflux for 2 h. 
After cooling to ambient temperature, the solution was washed with brine (20 mL × 2) and the 
aqueous layers combined and back-extracted with EtOAc (10 mL × 2). The combined organics 
were dried (MgSO4) with vigorous stirring over 16 h then filtered and concentrated in vacuo to 
afford a pale orange/brown solid. Hexane (30 mL) was added to the crude solid and the 
heterogeneous mixture heated at reflux for 2 h, cooled to ambient temperature then the hexanes 
removed by filtration. Final trituration with cold (-78 ºC) EtOAc (10 mL) gave the morpholinone 
409 as a colourless solid (799 mg, 63%). mp§ 198–200 ºC decomp; [α] 20D § +55.2 (c 0.2, CHCl3); 
δH (400 MHz, CDCl3) 7.86 (1H, br d, J 4.4, NH), 7.39–7.24 (4H, m, ArH), 4.78 (1H, t, 
J 4.4, H-4a), 4.54 (1H, t, J 4.4, H-9a), 4.17 (2H, s, CH2-2), 3.23 (1H, dd, J 17.0 and 4.4, HA-9) 
and 3.10 (1H, d, J 17.0, HB-9); δC§ (100 MHz, CDCl3) 169.8 (C=O), 140.7 (C-8a), 139.2 (C-4b), 
128.3 (CH-8), 127.4 (CH-6), 125.1 (CH-7), 123.9 (CH-5), 76.1 (CH-9a), 66.4 (CH2-2), 58.6 
(CH-4a) and 37.6 (CH2-9). IR§ νmax (KBr) /cm-1 3425 (br, H-bonded NH), 3183 (free NH), 2934 
(C-H), 2928, 2843, 1641 (C=O), 1462 (C-H), 1372 (C-H) and 1103 (C-O). Spectroscopic data 
(1H NMR) are in accordance with the literature.202  
Trimethyloxonium tetrafluoroborate (213 mg, 1.44 mmol) was added to a solution of 
morpholinone 409 (250 mg, 1.32 mmol) in CH2Cl2 (8 mL) and the mixture was stirred at 
ambient temperature for 16 h. Phenylhydrazine (0.130 mL, 1.32 mmol) was added and stirred for 
48 h before concentration in vacuo. The residue was dissolved in MeOH (1 mL) and triethyl 
orthoformate (3 mL) and heated at reflux for 16 h at 100 ºC. The precipitate was filtered and 
recrystallised from MeOH to afford the title compound 137 as a colourless solid (250 mg, 50%). 
mp§ 205–207 ºC; [α] 20D  +300.4 (c 0.5, MeCN), lit.147 +294.4 (c unspecified, MeCN); δH 
Chapter 8: Experimental details 
 
200 
(400 MHz, CD3OD) 11.10 (1H, s, NCHN), 7.93–7.86 (2H, m, NPhH-2,6), 7.65–7.55 (3H, m, 
NPhH-3,4), 7.52 (1H, dd, J 7.1 and 1.4, H-7), 7.33–7.22 (3H, m, H-8,9,10), 5.91 (1H, d, 
J 4.0, H-10b), 5.13 (1H, ABd, J 16.4, HA-4), 4.97 (1H, ABd, J 16.4, HB-4), 4.89 (1H, app t, 
J 4.3, H-5a), 3.36 (1H, ABX, JAB 17.2, JAX 4.9, HA-6) and 3.17 (1H, obscured AB d, 
J ~17, HB-6). Data are in accordance with the literature.147  
(5aS,6R,9S,9aR)-6,11,11-Trimethyl-2-phenyl-5a,6,7,8,9,9a-hexahydro-4H-6,9-methano-
benzo[b][1,2,4]triazolo[4,3-d][1,4]oxazin-2-ium tetrafluoroborate 416 
 
 
 
To a cooled (-40 °C) solution of potassium tert-butoxide (18.4 g, 103 mmol) in Et2O (125 mL) 
was added D-camphor 410 (12.5 g, 82.0 mmol) in Et2O (40 mL) dropwise over 25 min. Once 
addition was complete the mixture was stirred at ambient temperature for 1 h, recooled to -40 °C 
and isoamyl nitrite (22.0 mL, 164 mmol) was added dropwise over 30 min. The bright orange 
solution was warmed to ambient temperature over 16 h and then extracted with H2O 
(50 mL × 3). The combined aqueous phases were acidified to pH 2 with conc. HCl (~8 mL) and 
extracted with CH2Cl2 (50 mL × 3). The combined organic layers were washed successively with 
sat NaHCO3(aq) (20 mL), H2O (20 mL) and brine (20 mL) then dried (MgSO4), filtered and 
concentrated in vacuo to give the crude oxime 411 as a yellow solid (19.9 g, 84%) as a ~2:1 
mixture of E/Z-diastereomers which was used immediately without further purification. To a 
cooled (0 °C) solution of oxime 411 (12.1 g, 66.8 mmol) in THF (30 mL) was added LiAlH4 
(50.0 mL of a 1 M solution in THF, 100 mmol) dropwise over 30 min. After H2 evolution had 
ceased, the solution was heated at reflux (80 °C) for 30 min. The solution was allowed to cool to 
ambient temperature, diluted with Et2O (65 mL) and quenched with H2O (4 mL), NaOH (10% 
w/v, 4 mL) and H2O (12 mL). The mixture was filtered through celite and the filtrate was 
concentrated in vacuo to give the crude syn-amino alcohol product 412 (~8:1 dr) as a colourless 
solid (10.6 g, 94%) which was used immediately without further purification. To a cooled (0 °C) 
solution of the amino alcohol 412 (2.30 g, 13.6 mmol) and Et3N (3.02 mL, 21.7 mmol) in 
CH2Cl2 (60 mL) was added chloroacetyl chloride (1.19 mL, 14.9 mmol) dropwise over 30 min. 
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The solution was warmed to ambient temperature over 16 h then recooled to 0 °C and a solution 
of potassium tert-butoxide (6.40 g, 57.0 mmol) in isopropanol (50 mL) was added over 30 min. 
The mixture was allowed to warm to ambient temperature and stirred for 18 h before 
concentration in vacuo. The brown residue was taken up in EtOAc (20 mL) and H2O (30 mL) 
added. The product was extracted with EtOAc (20 mL × 3) and the combined organic fraction 
was dried (Na2SO4), filtered and concentrated in vacuo to give a brown solid. Chromatographic 
purification (50% EtOAc:petrol) gave the morpholinone 414 as a pale yellow solid (640 mg, 
44%). [α] 20D  +96.1 (c 1.0, CHCl3), lit.203 +95.0 (c 1.0, CHCl3); mp§ 94–97 °C; δH (400 MHz, 
CDCl3) 5.93 (1H, br s, NH), 4.12 (1H, d, J 15.4, CHAHB-2), 3.78 (1H, d, J 15.4, CHAHB-2), 3.65 
(1H, d, J 6.8 CH-8a), 3.37 (1H, d, J 6.8, CH-4a), 1.62–1.54 (4H, m, CH-5, CH2-7 and 
CHAHB-6), 1.13 (3H, s, (CH3)C-8), 1.08–1.02 (1H, m, CHAHB-6), 0.99 (3H, s, CH3) and 0.85 
(3H, s, CH3). Data are in accordance with the literature.203 
To a solution of morpholinone 414 (200 mg, 0.956 mmol) in CH2Cl2 (20 mL) was added 
trimethyloxonium tetrafluoroborate (169 mg, 1.14 mmol) and the mixture was stirred for 16 h at 
ambient temperature. Phenylhydrazine (94.1 µL, 0.956 mmol) was added and the solution was 
stirred for 24 h. The mixture was then concentrated in vacuo and the residue triturated with Et2O 
(10 mL) to give a light brown solid that was dissolved in chlorobenzene (1 mL) and triethyl 
orthoformate (5 mL) and then heated at reflux (125 °C) for 12 h. The mixture was concentrated 
in vacuo then triturated with Et2O (10 mL) to afford the title product 416 as a colourless solid 
(75.9 mg, 20%). [α] 20D  +28.8 (c 0.5, CHCl3), lit.203 +29.4 (c 1.0, CHCl3); mp§ 191–192 °C; δH 
(300 MHz, CDCl3) 10.28 (1H, s, NCHN), 7.91–7.89 (2H, m, ArH), 7.55–7.52 (3H, m, ArH), 
5.07 (1H, d, J 15.1, CHO), 4.67 (1H, d, J 15.1, CHN), 4.48 (1H, d, J 7.0 CH), 4.08 (1H, d, J 7.0, 
CH2), 2.66 (1H, d, J 4.5 CH2), 1.96–1.84 (1H, m, CH2), 1.68–1.58 (1H, m, CH2), 1.39–1.24 (1H, 
m, CH2), 1.03 (3H, s, CH3), 0.88 (3H, s, CH3) and 0.66 (3H, s, CH3). Data are in accordance with 
the literature.203  
(3aS,4S,7R,7aR)-7,8,8-Trimethylhexahydro-4,7-methanobenzo[d]oxazol-2(3H)-one 413 
 
 
To a cooled (0 °C) solution of the crude amino alcohol 412 (see above, p 196) (1.50 g, 
8.87 mmol) and Et3N (2.47 mL, 17.7 mmol) in CH2Cl2 (40 mL) was added triphosgene (1.04 g, 
3.53 mmol). The mixture was stirred at ambient temperature for 16 h and then washed with 
NH4Cl(aq) (30 mL) and brine (30 mL). The combined aqueous phases were combined and 
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extracted with EtOAc (30 mL × 2). The combined organic fractions were dried (MgSO4), filtered 
and concentrated in vacuo to give the crude product as a brown solid. Chromatographic 
purification (40% EtOAc:petrol) gave the product 413 as a colourless solid (919 mg, 53%); mp 
137–138 °C, lit.204 138–140 °C; [α] 20D  -37.1 (c 1.0, CH2Cl2), lit.204 -33 (c 1.0, CH2Cl2); δH 
(400 MHz, CDCl3) 6.06 (1H, br s, NH), 4.38 (1H, d, J 8.1, CH-7a), 3.76 (1H, dd, J 8.1, 1.1, 
CH-3a), 1.85 (1H, app d, J 4.6, CH-4), 1.75–1.65 (1H, m, CHAHB-6), 1.58–1.53 (1H, m, 
CHAHB-6), 1.08 (3H, s, (CH3)C-7), 1.03 (3H, s, CH3), 0.99–0.95 (2H, m, CH2-5) and 0.89 (3H, 
s, CH3). Data are in accordance with the literature.204 
1,1,1-Trichloro-2-methylpropan-2-yl 2-benzyl-2-(4-methoxybenzamido)-3-oxo-3- 
(((S)-1-phenylethyl)amino)propanoate 553 
 
 
To a solution of (racemic) rearrangement product 272 (100 mg, 0.206 mmol) in CH2Cl2 (2 mL) 
was added DMAP (2.52 mg, 20.6 µmol) followed by (S)-α-methylbenzylamine (26.6 µL, 
0.206 mmol). The mixture was stirred for 16 h then diluted with CH2Cl2 (5 mL) and quenched 
with NH4Cl(aq) (8 mL). The product was extracted with EtOAc (5 mL × 3) and the organic 
fractions combined, dried (MgSO4), filtered and concentrated in vacuo to afford the crude 
product. In the case of the reaction with the racemic C-carboxyazlactone, chromatographic 
purification (30% EtOAc:petrol) gave the product 553 as a pale yellow oil (88.7 mg, 71%) as a 
50:50 mixture of diastereomers. δH (300 MHz, CDCl3) 7.73 (2H, d, J 2.5, MeOArCH-3,5), 7.70 
(2H, d, J 2.5, MeOArCH-3,5), 7.58 (1H, s, CONH), 7.49 (1H, s, CONH), 7.46–7.38 (5H, m, 
PhH), 7.36–7.25 (9H, m, PhH), 7.17–7.13 (3H, m, PhH), 7.08–7.03 (2H, m, PhH), 6.90–6.95 
(4H, m, MeOArCH-2,6), 6.79–6.76 (2H, m, PhH), 6.54 (1H, d, J 8.0, CONH), 6.47 (1H, d, J 7.8, 
CONH), 5.22–5.10 (2H, m, PhCH(Me)), 4.03 (1H, ABd, J 14.1, PhCHAHB), 3.95 (1H, ABd, 
J 14.1, PhCHAHB), 3.88 (6H, s, OCH3), 3.54 (1H, ABd, J 14.1, PhCHAHB), 3.39 (1H, ABd, 
J 14.1, PhCHAHB), 2.04 (3H, s, C(CH3)2CCl3), 2.02 (3H, s, C(CH3)2CCl3), 1.90 (3H, s, 
C(CH3)2CCl3), 1.79 (3H, s, C(CH3)2CCl3), 1.65 (3H, d, J 7.0, CH(CH3)) and 1.57 (3H, d, J 6.9, 
CH(CH3)); δC (75 MHz, CDCl3) 168.0 (C=O), 166.04 (MeOArC-1), 166.00 (MeOArC-1), 164.8 
(C=O), 164.6 (C=O), 162.5 (C=O), 142.0 (CH(Me)PhC-1), 141.8 (CH(Me)PhC-1), 134.9 
(PhC-1), 134.5 (PhC-1), 130.2 (ArCH), 130.1 (ArCH), 129.1 (ArCH), 128.9 (ArCH), 128.4 
(ArCH), 128.2 (ArCH), 128.0 (ArCH), 127.5 (ArCH), 127.2 (ArCH), 126.8 (ArCH), 126.3 
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(ArCH), 126.2 (MeOArC-4), 113.9 (MeOArCH-2,6), 105.9 (CCl3), 90.8 (OCMe2), 90.6 
(OCMe2), 67.6 (CR2(CO)2), 67.5 (CR2(CO)2), 55.5 (OCH3), 50.1 (PhCH(Me)), 49.8 
(PhCH(Me)), 39.2 (Ph–CH2), 39.0 (Ph–CH2), 21.2 (CH3), 21.1 (CH3), 21.0 (CH3) and 20.8 
(CH3); m/z MS (ESI+) 605 (100, ([{35Cl3}M+H]+), 607 (97, [{35Cl237Cl}M+H]+), 609 (30, 
[{35Cl37Cl2}M+H]+) and 611 (4, ([{37Cl3}M+H]+); HRMS (ESI+) C30H32Cl3N2O5+ 
([{35Cl3}M+H]+) expected 605.1371, found 605.1369 (-0.3 ppm); IR νmax (thin film) /cm-1 3375, 
3087, 3064, 3031, 2975, 2930, 1741 (br d, C=O),1685 (br d, C=O), 1654 (d, C=O), 1607 (Ar 
C=C), 1522, 1477,1257 (C-O) and 705 (C-Cl).  
1H NMR Spectroscopic analysis (400 MHz) of the crude reaction product was used to determine 
the ee of the rearrangement using chiral NHCs. 
3-Methyl-5-phenylfuran-2-yl phenyl carbonate 435 
 
 
A mixture of 2-methyl-4-oxo-4-phenylbutyric acid 433 (3.00 g, 15.6 mmol), Ac2O (3.95 mL, 
41.8 mmol) and AcOH (5.14 mL, 89.8 mmol) were heated at 100 ºC for 3 h then concentrated 
in vacuo to afford the crude product as a pale yellow oil. Addition of toluene and concentration 
in vacuo (× 3) to remove the remainder of the Ac2O and AcOH gave the desired 3H- and 5H- 
butenolide products 434 (2.72 g, quantitative, 65:35 ratio of tautomers) as a yellow oil which 
partially solidified on standing. The crude products were sufficiently pure to be used without 
further purification. Major (3H-) tautomer: δH (400 MHz, CDCl3) 7.58–7.32 (4H, m, PhH-3,5), 
7.31 (1H, m, PhH-4), 5.60 (1H, d, J 2.7, C=CH), 3.52 (1H, qd, J 7.6, 2.7, CH3CH) and 1.48 (3H, 
d, J 7.6, CH3); Minor (5H-) tautomer: δH (400 MHz, CDCl3) 7.65–7.57 (2H, m, PhH-2,6), 7.58–
7.32 (3H, m, PhH-3,5 and C=CH), 7.17–7.13 (1H, m, PhH-4), 5.91 (1H, quint, J 1.9, CHPh) and 
2.03 (3H, t, J 1.9, CH3). Data are in accordance with the literature.27 
To a solution of diisopropylamine (2.87 mL, 20.5 mmol) in THF (25 mL), cooled to 0 ºC, was 
added n-BuLi (7.87 mL of a 2.5 M solution in hexanes, 19.7 mmol). The mixture was stirred for 
15 min then cooled to -78 ºC before addition of a solution of the butenolide mixture 434 (2.72 g, 
15.6 mmol) in THF (20 mL). The dienolate solution immediately became an intense red colour 
and was stirred for 30 min at -78 ºC. The dienolate solution was then added dropwise to a 
solution of phenyl chloroformate (2.55 mL, 20.3 mmol) in THF (15 mL) at -78 ºC then allowed 
to warm to ambient temperature. The mixture was poured into 0.5 M HCl(aq) (100 mL) and 
extracted with Et2O (40 mL × 3). The organics were combined, washed with brine (30 mL), 
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dried (MgSO4), filtered and concentrated in vacuo to afford a viscous orange oil. 
Chromatographic purification (5% Et2O:petrol) afforded the title product as a colourless solid 
(2.07 g, 64%). mp§ 96–98 ºC; δH (400 MHz, CDCl3) 7.59 (2H, dt, J 8.3, 1.5, CPhH-2,3), 7.46–
7.41 (2H, m, PhH), 7.38–7.34 (2H, m, PhH), 7.32–7.28 (3H, m, PhH), 7.28–7.22 (1H, m, PhH), 
6.52 (1H, s, furanH-4) and 2.02 (3H, s, CH3). Spectroscopic data are in accordance with the 
literature.107  
(RS) and (S)-Phenyl 3-methyl-2-oxo-5-phenyl-2,3-dihydrofuran-3-carboxylate 436 
 
 
Procedures F, H, M and V have been employed to obtain the product. 
To a solution of furanyl carbonate 435 (100 mg, 0.340 mmol) in THF (1 mL) was added chiral 
isothiourea 312 (10.5 mg, 34.0 µmol, 10 mol%). After 60 min, the mixture was concentrated 
in vacuo. Chromatographic purification (20% Et2O:petrol) gave the product as a colourless oil 
that solidified on standing (70.1 mg, 70%). mp§ 61 ºC; [α] 20D  +65.0 (c 0.20, CH2Cl2, 95% ee). 
Spectroscopic data are in agreement with the literature.205 
Chiral HPLC Chiralpak AS-H (5% IPA:hexane, flow rate 1 mL min-1) tR(S) 13.7 min, tR(R) 
16.0 min, 95% ee. Absolute configuration confirmed by comparitive reaction with 
(R)-TADMAP according to Vedejs.205 Furanyl carbonate 435 (29.4 mg, 0.100 mmol) and 
(R)-TADMAP 238 (4.37 mg, 10.0 µmol) were dissolved in CH2Cl2 (1.0 mL) and allowed to stir 
for 24 h, then quenched with methyl iodide (0.1 mL) and concentrated in vacuo. 1H NMR 
Spectroscopic analysis of the crude mixture indicated a ~60:40 mixture of α- and 
γ−carboxybutenolide products 436 and 437. Chromatographic purification (20% Et2O:petrol) 
gave the (major) product 436 as a colourless solid (15.1 mg, 49%, 85% ee, (S)-absolute 
configuration for the major enantiomer). 
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Phenyl 4-methyl-5-oxo-2-phenyl-2,5-dihydrofuran-2-carboxylate 437  
 
 
Procedures F, H, M and V have been employed to obtain the product. 
According to procedure F, to a solution of triazolium salt 128 (1.41 mg, 6.80 µmol) in THF 
(1 mL) was added KHMDS (12.2 µL of a 0.5 M solution in toluene, 6.12 µmol) and the mixture 
stirred for 10 min. A solution of furanyl carbonate 435 (200 mg, 0.680 mmol) in THF (1 mL) 
was added. After 5 min, the mixture was concentrated in vacuo. Chromatographic purification 
(20% Et2O:petrol) gave the product as a colourless oil (170 mg, 85%). δH (400 MHz, CDCl3) 
7.58–7.55 (3H, m, OPhH-3,5), 7.44–7.39 (3H, m, PhH), 7.34–7.30 (2H, m, PhH), 7.20–7.18 (1H, 
m, OPhH-4), 7.00–6.98 (2H, m, OPhH-2,6) and 1.99 (3H, s, CH3). Data are in accordance with 
the literature.205  
4-Oxo-2,4-diphenylbutyronitrile 456 
 
 
To a slurry of chalcone (2.08 g, 10.00 mmol) in acetone (5 mL) was added acetone cyanohydrin 
(0.530 g, 6.25 mmol), followed by tetrabutylammonium hydroxide(aq) (0.140 mL of a 40% w/v 
solution, 6.25 mmol). The mixture was heated at 100 ºC for 2 h then cooled to ambient 
temperature. H2O (3 mL) was added to the mixture to induce precipitation of the product. The 
precipitate was collected by filtration and then washed with H2O (25 mL), then recrystallised 
from EtOH (25 mL) as a colourless solid (1.21 g, 82%). mp 124–126 ºC, lit.206 122–125 ºC; δH 
(400 MHz, CDCl3) 7.88–7.84 (1H, m, C(O)PhH-2,6), 7.65–7.54 (1H, m, C(O)PhH-4), 7.51–7.27 
(8H, m, PhH), 4.51 (1H, ABX, JXA 7.9, JXB 6.0, (NC)CHPh), 3.64 (1H, ABX, JAB 18.0, JAX 7.9, 
PhC(O)CHAHB) and 3.46 (1H, ABX, JBA 18.0, JBX 6.0, PhC(O)CHAHB). Data are in accordance 
with the literature.206 
Methyl 4-oxo-2,4-diphenylbutyrate 457 
 
 
To a mixture of 4-oxo-2,4-diphenylbutyronitrile 456 (1.00 g, 4.25 mmol) in methanol (10 mL) 
was added conc. HCl(aq) (10 mL). The mixture was heated at reflux for 64 h then cooled to 
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ambient temperature. The mixture was extracted with Et2O (15 mL × 3) then concentrated in 
vacuo to afford the product as a colourless solid (1.06 g, 93%). Product was used without further 
purification. mp 104–106 ºC, lit.207 103–104 ºC; δH (400 MHz, CDCl3) 7.92–7.88 (2H, m, 
C(O)PhH-2,6), 7.53–7.47 (1H, m, C(O)PhH-4), 7.44–7.09 (7H, m, PhH), 4.12 (1H, ABX, JXA 
7.9, JXB 6.0, (NC)CHPh), 3.83 (1H, ABX, JAB 18.0, JAX 7.9, PhC(O)CHAHB), 3.56 (3H, s, 
COOCH3) and 3.27 (1H, ABd, ABX, JBA 18.0, JBX 6.0, PhC(O)CHAHB). Data are in accordance 
with the literature.207 
4-Oxo-2,4-diphenylbutyric acid 458 
 
 
A mixture of methyl oxo-butyrate 457 (970 mg, 3.61 mmol), CHCl3 (20 mL) and conc. HCl(aq) 
(20 mL) was heated at 100 ºC for 72 h. The mixture was concentrated in vacuo to remove the 
CHCl3, and the acid precipitate was collected by filtration. The product was washed with Et2O 
(10 mL) and H2O (10 mL) to afford the product as a colourless solid (681 mg, 70%). mp 150–
152 ºC, lit.207 152–153 ºC; δH (400 MHz, CDCl3) 10.45 (1H, br s, COOH), 7.91–7.89 (2H, m, 
C(O)PhH-2,6), 7.48–7.14 (8H, m, PhH), 4.25 (1H, ABX, JXA 8.0, JXB 6.0, (NC)CHPh), 3.87 
(1H, ABX, JAB 18.0, JAX 8.0, PhC(O)CHAHB) and 3.21 (3H, ABd, ABX, JBA 18.0, JBX 6.0, 
PhC(O)CHAHB). Data are in accordance with the literature.207 
(3RS,5RS)-5-Phenyl-3-(phenylthio)dihydrofuran-2(3H)-one 468 
 
 
Following general procedure R, n-BuLi (105 mL, 263 mmol), diisopropylamine (36.6 mL, 
261 mmol), THF (380 mL), (phenylthio)acetic acid (20.0 g, 119 mmol) in THF (100 mL) and 
styrene oxide (16.3 mL, 143 mmol), followed by pTSA•H2O (200 mg, 1.16 mmol) and toluene 
(200 mL) gave the desired crude lactone 468 as a colourless solid (22.3 g, 69%) as a mixture of 
diastereomers (~1–2:1 dr). Product was treated as an intermediate and was used immediately in 
subsequent steps. 
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3-Benzyl-5-phenylfuran-2-yl phenyl carbonate 473 
 
 
Following general procedure S, n-BuLi (11.6 mL, 28.9 mmol), diisopropylamine (3.41 mL, 
24.4 mmol), THF (50 mL), lactone 468 (6.00 g, 22.2 mmol) in THF (25 mL) and benzyl bromide 
(16.3 mL, 143 mmol) in DMPU (13 mL) gave the crude alkylated product 469. Chromatographic 
purification (20% → 30% Et2O:petrol) gave the alkylated lactone 469 as a colourless solid 
(6.40 g, 80%) as a mixture of diastereomers (15:1 dr). mp 110–112 ºC; Data for the major 
diastereomer: δH (400 MHz, CDCl3) 7.63 (2H, dt, J 8.2, 1.7, PhH), 7.49–7.44 (1H, m, PhH), 
7.41–7.31 (7H, m, PhH), 7.22–7.17 (1H, m, PhH), 7.15–7.11 (2H, m, PhH), 6.61–6.58 (2H, m, 
SPhH-2,6), 4.02 (1H, ABX, JXB 8.9, JXA 7.5, OCH), 3.47 (2H, ABd, J 13.2, PhCHAHB), 3.01 
(1H, ABd, J 13.2, PhCHAHB), 2.80 (1H, ABX, JAB 14.1, JAX 7.5, CHCHAHB) and 2.33 (1H, dd, 
JBA 14.1, JBX 8.9, CHCHAHB); δC (75 MHz, CDCl3) 177.6 (C=O), 139.4 (PhC-1), 137.8 
(SPhCH-3), 135.6 (CH2PhC-1), 130.6 (SPhC-1), 130.5 (CH2PhC-2), 130.4 (ArCH), 129.8 
(ArCH), 129.4 (ArCH), 128.9 (ArCH), 128.8 (ArCH), 128.3 (PhCH-4), 126.0 (SPhCH-2), 78.2 
(CH-5), 58.4 (C-3), 43.7 (Ph–CH2) and 40.9 (CH2-4); IR νmax (KBr) /cm-1 2978, 1770 (C=O), 
1488, 1439, 1172 (C-O), 1070, 980, 752 and 697; Structure confirmed by X-ray crystallographic 
analysis (see Appendix). 
Following general procedure T, benzylated lactone 469 (1.50 g, 4.16 mmol), mCPBA (970 mg, 
5.30 mmol) and CHCl3 (6 mL), followed by heating in toluene (10 mL) gave the crude 
butenolide product as a yellow oily solid. Chromatographic purification (10% Et2O:petrol) gave 
the desired butenolides 471 as a colourless solid (544 mg, 52%) as a mixture of butenolide 
tautomers (~3:1). mp 68–70 ºC; Data for the major (5H-) tautomer: δH (400 MHz, CDCl3) 7.48–
7.24 (10H, m, PhH), 6.94 (1H, q, J 1.9, CH=C), 5.90 (1H, q, J 1.9, OCH), 3.70 (1H, ABd, J 1.9, 
PhCHAHB) and 3.69 (1H, ABd, J 1.9, PhCHAHB); Data for the minor (3H-) tautomer: δH 
(400 MHz, CDCl3) 7.68 (1H, t, J 2.9, PhCH-4), 7.55–7.51 (2H, m, PhH), 7.48–7.43 (2H, m, 
PhH), 7.42–7.24 (5H, m, PhH), 5.65 (1H, dd, J 8.3, 6.0, C=CH), 3.77–3.72 (1H, m, PhCHAHB) 
and 3.20 (1H, ddd, J 17.5, 6.0, 3.0, PhCHAHB).  
Following general procedure U, butenolides 471 (200 mg, 0.800 mmol), Et3N (0.112 mL, 
0.800 mmol), MeCN (2 mL) and phenyl chloroformate (0.100 mL, 0.800 mmol) gave, after 
chromatographic purification (5% Et2O:petrol), the carbonate product 473 as a colourless solid 
(178 mg, 60%). mp 95–96 ºC; δH (400 MHz, CDCl3) 7.58 (2H, dt, J 8.3, 1.5, PhH), 7.45–7.40 
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(3H, m, PhH), 7.37–7.22 (10H, m, PhH), 6.46 (1H, s, furanH-4) and 3.78 (2H, s, PhCH2); δC 
(100 MHz, CDCl3) 151.0 (OPhC-1), 150.7 (C=O), 147.6 (furanC-5), 146.4 (furanC-1), 139.2 
(CH2PhC-1), 130.2 (4-PhC-1), 129.8 (PhCH), 129.7 (PhCH), 128.83 (PhCH), 128.76 (PhCH), 
128.75 (PhCH), 128.72, (PhCH) 127.6 (PhCH), 126.8 (PhCH), 126.6 (PhCH), 126.5 (PhCH), 
123.5 (PhCH), 121.1 (PhCH), 120.8 (PhCH), 108.8 (furanC-3), 107.8 (furanCH-4) and 30.0 (Ph–
CH2); m/z MS (ESI+) 371 (100, [M+H]+); HRMS (ESI+) C24H19O4+ ([M+H]+) requires 
371.1278, found 371.1279 (+0.3 ppm); IR νmax (KBr) /cm-1 3063 (Ar-H), 2924, 2858, 1796 
(C=O), 1656 (Ar-H), 1648 (Ar C=C), 1218 (C-O), 1194 (C-O), 1115, 1052 and 760 (furan CH).  
3-(4-Bromobenzyl)-5-phenylfuran-2-yl phenyl carbonate 474 
 
 
Following general procedure S, n-BuLi (5.56 mL, 13.9 mmol), diisopropylamine (1.71 mL, 
12.2 mmol), THF (25 mL), lactone 468 (3.00 g, 11.1 mmol) in THF (5 mL) and 4-bromobenzyl 
bromide (2.78 g, 11.1 mmol) in DMPU (6.7 mL) gave the crude alkylated product. 
Chromatographic purification (25% Et2O:petrol) gave the desired alkylated lactone 470 as a 
colourless solid (3.00 g, 62%) as a mixture of diastereomers (15:1 dr). mp 126–127 ºC; Data for 
the major diastereomer: δH (400 MHz, CDCl3) 7.62–7.59 (2H, m, ArH), 7.51–7.45 (3H, m, 
ArH), 7.41–7.37 (2H, m, ArH), 7.22–7.15 (5H, m, ArH), 6.69–6.66 (2H, m, ArH), 4.26 (1H, app 
t, J 8.0, OCH), 3.39 (1H, ABd, J 13.4, ArCHAHB), 2.99 (1H, ABd, J 13.4, ArCHAHB), 2.77 (1H, 
ABX, JAB 14.2, JAX 7.6, CHAHB-4) and 2.35 (1H, ABX, JBA 14.2, JBX 8.6, CHAHB-4); δC 
(100 MHz, CDCl3) 176.9 (C=O), 139.0 (PhC-1), 137.5 (ArCH), 134.3 (BrArC-1), 132.2 (ArCH), 
131.9 (ArCH), 130.2 (ArCH), 130.0 (SPhC-1), 129.5 (ArCH), 128.62 (ArCH), 128.58 (ArCH), 
125.6 (BrArC-4), 77.8 (CH-5), 57.5 (C-3), 42.7 (Ar–CH2) and 40.4 (CH2-4); m/z MS (ESI+) 456 
(97, [{79Br}M+NH4]+) and 458 (100, [{81Br}M+NH4]+); HRMS (ESI+) C23H1979BrSO2+ 
([{79Br}M+NH4]+) requires 456.0627, found 456.0627 (-0.7 ppm); IR νmax (KBr) /cm-1 2977, 
1769 (C=O), 1488, 1439, 1405, 1326, 1237, 1218, 1164 (C-O), 1072, 1043, 1027, 1012, 984, 
752 and 696. 
Following general procedure T, lactone 470 (2.70 g, 6.15 mmol), mCPBA (1.44 g, 8.36 mmol) 
and CH2Cl2 (8 mL), followed by heating in toluene (10 mL) gave the crude butenolide as a 
yellow solid. Chromatographic purification (15% Et2O:petrol) gave the desired butenolides 472 
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as a yellow solid (1.46 g, 72%) as a mixture of tautomers (4:1 ratio). mp 80–81 ºC; Data for 
major (5H-) tautomer: δH (400 MHz, CDCl3) 7.49–7.46 (2H, m, ArH), 7.42–7.36 (3H, m, ArH), 
7.25–7.23 (2H, m, ArH), 7.15–7.18 (3H, m, PhH), 6.97 (1H, q, J 1.7, =CH), 5.91 (1H, q, J 1.7, 
OCH) and 3.65 (2H, br app d, J 1.7, ArCH2). Product used without further purification. 
Following general procedure U, butenolides 472 (448 mg, 1.36 mmol), Et3N (0.378 mL, 
2.72 mmol), THF (3 mL) and phenyl chloroformate (0.341 mL, 2.72 mmol) gave, after 
chromatographic purification (5% Et2O:petrol), the carbonate product 474 as a colourless solid 
(354 mg, 58%). mp 92 ºC; δH (400 MHz, CDCl3) 7.58–7.56 (2H, m, BrArH-3,5), 7.44–7.40 (4H, 
m, ArH), 7.37–7.33 (2H, m, ArH), 7.31–7.22 (4H, m, ArH), 7.16–7.13 (2H, m, BrArH-2,6), 6.42 
(1H, s, furanH-4) and 3.71 (2H, s, CH2); δC (100 MHz, CDCl3) 150.8 (OPhC-1), 150.6 (C=O), 
147.7 (furanC-5), 146.4 (furanC-2), 138.1 (BrArC-4), 131.7 (ArCH), 130.6 (ArCH), 130.0 
(CPhC-1), 129.8 (ArCH), 128.8 (ArCH), 127.7 (ArCH), 126.8 (ArCH), 123.5 (ArCH), 120.7 
(OPhCH-2,6), 120.4 (BrArC-1), 108.2 (furanC-3), 107.5 (furanCH-4) and 29.5 (CH2); m/z MS 
(ESI+) 346 (97, [{79Br}M+NH4–PhOCO]+), 348 (100, [{81Br}M+NH4–PhOCO]+); HRMS 
(ESI+) C17H1781BrNO2+ ([{81Br}M+NH4–PhOCO]+) requires 348.0417, found 348.0416, 
(-0.2 ppm); IR νmax (KBr) /cm-1 3062 (ArH), 2924, 2858, 1797 (C=O), 1655 (ArH), 1648 (ArH), 
1606 (ArH), 1594 (ArH), 1556 (ArH), 1488, 1405, 1216 (C-O), 1194 (C-O), 1114, 1072 
(ArC-Br), 1053, 1011, 930 and 760 (furan CH). 
(3RS,5RS)-5-(4-Fluorophenyl)-3-(phenylthio)dihydrofuran-2(3H)-one 476 
 
O O
SPh
F
476
 
Following general procedure R, n-BuLi (15.3 mmol), diisopropylamine (2.17 mL, 15.4 mmol), 
THF (20mL), (phenylthio)acetic acid (1.18 g, 7.03 mmol) in THF (6 mL) and 4-fluorostyrene 
oxide (1.00 mL, 8.43 mmol), followed by pTSA•H2O (50.0 mg, 0.290 mmol), toluene (30 mL) 
and MgSO4 (~5 g) gave the desired product as a colourless solid (1.46 g, 72%) as a mixture of 
diastereomers (~1–2:1 dr). Product was treated as an intermediate and was used immediately in 
subsequent steps. 
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5-(4-Fluorophenyl)-3-methylfuran-2-yl phenyl carbonate 479 
 
 
Following general procedure S, n-BuLi (4.28 mmol), diisopropylamine (0.510 mL, 3.62 mmol), 
THF (8 mL), lactone 476 (950 mg, 3.30 mmol) in THF (3 mL) methyl iodide (0.205 mL, 
11.1 mmol) in DMPU (2.0 mL), the crude alkylated product was obtained. Chromatographic 
purification (30% Et2O:petrol) gave the desired lactone 477 as a colourless solid (545 mg, 55%) 
as a mixture of diastereomers (10:1 dr). mp 42–42 ºC. Data for the major diastereomer: δH 
(300 MHz, CDCl3) 7.61–7.57 (2H, m, SPhH), 7.47–7.34 (3H, m, ArH), 6.98–6.88 (4H, m, ArH), 
5.31 (1H, ABX, JXB 9.0, JXA 7.0, OCH), 2.61 (1H, ABX, JAB 13.7, JAX 7.0, CHAHB), 2.37 (1H, 
ABX, JBA 13.7, JBX 9.0, CHAHB) and 1.67 (3H, s, CH3); δC (75 MHz, CDCl3) 177.3 (C=O), 
162.8 (d, J 248, C-F), 137.2(SPhCH-3,5), 134.7 (d, J 2.8, FArC-4), 130.5 (SPhCH-4), 130.0 
(SPhC-1), 129.4 (SPhCH-2,6), 127.6 (d, J 8.3, FArCH-3,5), 115.8 (d, J 21.7, FArCH-2,6), 76.7 
(CH-O), 52.9 (PhSCMe), 44.1 (CH2), and 23.8 (CH3); δF (282 MHz, CDCl3) -113.5 (Ar-F); m/z 
MS (ESI+) 320 (100, [M+NH4]+); HRMS (ESI+) C17H15FO2S+ ([M+NH4]+) requires 320.1115, 
found 320.1118 (+0.9 ppm); IR νmax (KBr) /cm-1 2977, 1769 (C=O), 1488, 1439, 1405, 1326, 
1237, 1218, 1164 (C-O), 1072, 1043, 1027, 1012, 984, 752 and 696.  
Following general procedure T, the methylated lactone 477 (543 mg, 1.80 mmol), mCPBA 
(488 mg, 1.98 mmol) and CHCl3 (10 mL), gave the crude sulfoxide, which was heated in toluene 
(10 mL). Chromatographic purification (30% Et2O:petrol) gave the desired butenolides 478 as a 
colourless oil (205 mg, 59%) as a mixture of tautomers (4:1); Data for major (5H-) tautomer: δH 
(400 MHz, CDCl3) 7.26–7.21 (2H, m, FArH-3,5), 7.11–7.03 (3H, m, FArH-2, CH=C), 5.85 (1H, 
app t, J 1.8, OCH) and 2.00 (1H, t, J 1.8, CH3); δC (75 MHz, CDCl3) 174.6 (C=O), 163.6 (d, 
J 238, FArC-1), 148.3 (CH=CMe), 131.4 (FArC-4), 130.5 (CH=CMe), 128.8 (d, J 9, 
FArCH-3,5), 116.3 (FArCH-2,6), 81.8 (OCH) and 11.0 (CH3); δF (282 MHz, CDCl3) -112.6 
(Ar-F); m/z MS (ESI+) 193 (100, [M+H]+); HRMS (ESI+) C11H10O2F+ ([M+H]+) requires 
193.0659, found 193.0657 (-0.7 ppm); IR νmax (thin film) /cm-1 2924, 2852, 1760 (C=O), 1606 
(Ar C=C), 1509 (C=C), 1226 and 1087 (C-F and C-O), 959, 881, 838 and 786. 
To a solution of diisopropylamine (0.710 mL, 5.08 mmol) in THF (15 mL), cooled to 0 ºC, was 
added n-BuLi (2.03 mL of a 2.5 M solution in hexanes, 5.08 mmol). The mixture was stirred for 
15 min then cooled to -78 ºC before addition of a solution of the butenolides 478 (750 mg, 
3.91 mmol) in THF (15 mL). The dienolate solution immediately became an intense red colour 
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and was stirred for 30 min at -78 ºC. The dienolate solution was then added dropwise to a 
solution of phenyl chloroformate (0.637 mL, 5.08 mmol) in THF (15 mL) at -78 ºC then allowed 
to warm to ambient temperature. The mixture was poured into 0.5 M HCl(aq) (100 mL) and 
extracted with Et2O (30 mL × 3). The organics were combined, washed with brine (20 mL), 
dried (MgSO4), filtered and concentrated in vacuo to afford an orange oil. Chromatographic 
purification (2.5% EtOAc:petrol) afforded the product 479 as a colourless solid (944 mg, 84%). 
mp 63-65 °C; δH (400 MHz, CDCl3) 7.60–7.57 (2H, m, ArH), 7.49–7.44 (2H, m, ArH), 7.35–
7.31 (3H, m, ArH), 7.11–7.06 (2H, m, FArH-2), 6.48 (1H, s, furanCH-4) and 2.04 (3H, s, CH3); 
δC (100 MHz, CDCl3) 162.1 (d, J 245, FArC-1), 150.9 (furanC-5), 150.6 (OPhC-1), 146.2 
(C=O), 146.2 (furanC-2), 129.7 (PhCH), 126.7 (PhCH), 126.6 (d, J 3.2, FArC-4), 125.1 (d, J 8.4, 
FArC-3,5), 120.7 (PhCH), 115.7 (d, J 20.1, FArCH-2,6), 108.3 (furanC-4), 104.8 (furanC-3) and 
8.6 (CH3); m/z MS (ESI+) 335 (100, [M+Na]+); HRMS (ESI+) C18H13O4NaF+ ([M+Na]+) 
requires 335.0696; found 335.0699 (+1.0 ppm); IR νmax (KBr) 3059, 2935 (C-H), 1794 (C=O), 
1659 (Ar C=C), 1597, 1561 and 758 (furan CH). 
(RS)- and (S)-Phenyl 3-benzyl-2-oxo-5-phenyl-2,3-dihydrofuran-3-carboxylate 554 
 
 
Procedures H and M have been applied to afford the product. 
Following general procedure M, carbonate 473 (30.0 mg, 81.0 µmol), isothiourea 312 (2.51 mg, 
8.10 µmol) and THF (0.5 mL) gave, after purification (10% Et2O:petrol) the product as a 
colourless solid (20.0 mg, 67%). mp 110–112 ºC; [α] 20D  +43.5 (c 0.23, CH2Cl2, 95% ee); δH 
(400 MHz, CDCl3) 7.57–7.51 (2H, m, OPhH-3,5), 7.41–7.35 (5H, m, ArH), 7.28–7.23 (6H, m, 
ArH), 7.08–7.04 (2H, m, OPhH-2,6), 5.96 (1H, s, CH-4), 3.64 (1H, ABd, J 13.6, CHAHB) and 
3.49 (1H, ABd, J 13.6, CHAHB); δC (100 MHz, CDCl3) 173.1 (C-2), 166.4 (COOPh), 154.6 
(C-5), 150.4 (OPhC-1), 134.2 (CH2PhC-1), 130.4 (ArCH), 130.2 (ArCH), 129.6 (ArCH), 128.9 
(ArCH), 128.6 (ArCH), 127.7 (ArCH), 127.6 (ArC), 126.6 (ArCH), 125.3 (OPhCH-3,5), 121.3 
(OPhCH-2,6), 101.8 (CH-4), 61.9 (C-3) and 40.8 (CH2); m/z (ESI+) 388 (100, [M+NH4]+); 
HRMS (ESI+) C24H22NO4+ ([M+NH4]+) requires 388.1543, found 388.1543 (-0.1 ppm); IR νmax 
(thin film) /cm-1 1803 (C=O), 1760 (C=O), 1653 (Ar C=C), 1493, 1449, 1280, 1209, 1187 (C-O), 
1159, 1127, 1073, 696, 749 and 688. 
Enantiomeric excess was determined by HPLC with Chiralcel AS-H column (5% 
i-PrOH:hexane, flow rate = 1.0 mL min-1), tR(S) 15.8 min and tR(R) 21.6 min, 95% ee. 
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Phenyl 4-benzyl-5-oxo-2-phenyl-2,5-dihydrofuran-2-carboxylate 555 
 
 
Procedures H and M have been applied to afford the product. 
According to procedure H, to a solution of triazolium salt 128 (1.47 mg, 5.40 µmol) in THF 
(2 mL) was added KHMDS (9.72 µL of a 0.5 M solution in toluene, 4.86 µmol) and the mixture 
stirred for 10 min. Furanyl carbonate 473 (200 mg, 0.540 mmol) was added and, after 5 min, the 
mixture was concentrated in vacuo. Chromatographic purification (20% Et2O:petrol) gave the 
product as a colourless oil (134 mg, 67%). δH (400 MHz, CDCl3) 7.56–7.53 (2H, m, PhH), 7.46–
7.41 (3H, m, PhH), 7.38–7.21 (9H, m, PhH and CH-4), 7.01–6.97 (2H, m, OPhH-2,6), 3.72 (1H, 
ABX, JAB 16.9, JAX 1.6, PhCHAHB) and 3.67 (1H, ABX, JBA 16.9, JBX 1.6, PhCHAHB); δC 
(100 MHz, CDCl3) 171.3 (butenolide C=O), 166.0 (COOPh), 150.2 (OPhC-1), 147.1 (=CH), 
136.5 (quat C), 135.3 (quat C), 135.1 (quat C), 129.64 (PhCH), 129.64 (PhCH), 129.2 (PhCH), 
129.04 (PhCH), 129.04 (PhCH), 127.2 (PhCH), 126.6 (PhCH), 125.9 (PhCH), 121.0 
(OPhCH-2,6), 87.9 (O-C) and 31.9 (CH2); m/z (ESI+) 388 (100, [M+NH4]+); HRMS (ESI+) 
C24H22NO4+ ([M+NH4]+) requires 388.1543, found 388.1543 (-0.1 ppm); IR νmax (thin film) 
/cm-1 1773 (C=O), 1761 (C=O), 1647 (Ar C=C), 1493, 1451, 1189 (C-O), 1053, 1025, 734 and 
676. 
(RS)- and (S)-Phenyl 3-(4-bromobenzyl)-2-oxo-5-phenyl-2,3-dihydrofuran-3-carboxylate 
556 
 
 
Procedures H and M have been applied to afford the product. 
According to general procedure M, carbonate 474 (30.0 mg, 48.2 µmol), isothiourea 312 
(1.49 mg, 4.82 µmol) and THF (0.5 mL) gave, after purification (10% Et2O:petrol), the product 
as a colourless solid (21.6 mg, 72%). mp 151 ºC; [α] 20D  +66.0 (c 0.2, CH2Cl2, 87% ee); δH 
(400 MHz, CDCl3) 7.59–7.56 (2H, m, PhH), 7.43–7.37 (7H, m, ArH), 7.29–7.26 (1H, m, 
OPhH-4), 7.16–7.12 (2H, m, BrAr(2,6)H), 7.09–7.06 (2H, m, OPhH-2,6), 5.94 (1H, s, butenolide 
CH), 3.58 (1H, ABd, J 13.7, CHAHB) and 3.46 (ABd, J 13.7, CHAHB); δC (100 MHz, CDCl3) 
172.9 (butenolide C=O), 166.3 (COOPh), 155.1 (butenolide C-5), 150.5 (OPhC-1), 133.3 
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(BrArC-4), 132.0 (ArCH), 131.8 (ArCH), 130.7 (ArCH-4), 129.8 (ArCH), 129.0 (ArCH), 127.4 
(CPhC-1), 126.7 (CPhCH-4), 125.5 (CPhCH-2,6), 122.0 (BrArC-1), 121.3 (BrArCH-2,6), 101.3 
(butenolide CH-4), 61.7 (butenolide C-3) and 39.9 (CH2); m/z MS (ESI+) 466 (100, 
[{79Br}M+NH4]+) and 468 (98, [{81Br}M+H]+); HRMS (ESI+) C24H2179BrNO4+ 
([{79Br}M+NH4]+) requires 466.0648, found 466.0641, (-1.6 ppm); IR νmax (KBr) /cm-1 3090, 
1778 (C=O), 1757 (C=O), 1591 (C=C), 1489, 1421, 1405, 1209, 1188 (C-O), 1056, 1024, 1013, 
963, 913, 798, 738 and 689 (C-Br). 
Enantiomeric excesses were determined by HPLC with Chiralcel AS-H column (5% 
i-PrOH:hexane, flow rate = 1.0 mL min-1), tR(S) 20.3 min and tR(R) 28.0 min, 87% ee. 
Phenyl 3-(4-bromobenzyl)-2-oxo-5-phenyl-2,5-dihydrofuran-5-carboxylate 557 
 
 
Procedures H and M have been applied to afford the product. 
Following general procedure H, carbonate 474 (60.2 mg, 0.134 mmol), triazolium salt 128 
(3.65 mg, 13.4 µmol), KHMDS (24.2 µL, 12.1 µmol) and THF (1 mL), gave, after 
chromatographic purification (10% → 20% Et2O:petrol), the product as a colourless oil 
(48.0 mg, 80%, contaminated with ~5% butenolide 472); δH (400 MHz, CDCl3) 7.56–7.54 (5H, 
m, PhH), 7.49–7.43 (2H, m, ArH), 7.38–7.35 (3H, m, ArH and CH=C), 7.24–7.20 (1H, m, 
OPhCH-4), 7.14 (2H, app d, J 8.4, BrArH-2,6), 7.00–6.98 (2H, m, OPhH-2,6), 3.67 (1H, ABX, 
JAB 16.9, JAX 1.5, CHAHB) and 3.62 (1H, ABX, JBA 16.9, JBX 1.5, CHAHB); δC (100 MHz, 
CDCl3) 171.1 (butenolide C=O), 165.9 (COOPh), 150.3 (OPhC-1), 147.4 (butenolide CH-4), 
135.5 (quat C), 135.0 (quat C), 134.7 (quat C), 132.2 (BrArCH-3,5), 130.8 (BrArCH-2,6), 129.8 
(ArCH), 129.7 (ArCH), 129.3 (ArCH), 126.7 (OPhCH-4), 125.9 (PhCH), 121.3 (BrArC-1), 
121.0 (OPhCH-2,6), 88.0 (butenolide C-5) and 31.4 (CH2); IR νmax (thin film) /cm-1 3107, 3057, 
1804 (C=O), 1760 (C=O), 1652, 1591 (C=C), 1490, 1406, 1281, 1188 (C-O), 1126, 1072, 1013, 
94, 833, 755 and 688 (C-Br); m/z MS (ESI+) 449 (100, [{79Br}M+H]+) and 451 (98, 
[{81Br}M+H]+); HRMS (ESI+) C24H1879BrO4+ ([{79Br}M+H]+) requires 449.0383, found 
449.0378, (-1.1 ppm). 
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(RS)- and (S)-Phenyl 5-(4-fluorophenyl)-3-methyl-2-oxo-2,3-dihydrofuran-3-carboxylate 
558 
 
 
Procedures H and M have been applied to afford the product. 
Following general procedure M, carbonate 479 (100 mg, 0.320 mmol) and chiral isothiourea 312 
(9.89 mg, 32.0 µmol) in THF (1 mL) gave, after 1 h and chromatographic purification (50% 
CH2Cl2:petrol), the product as a colourless solid (72.0 mg, 72%); [α] 20D
 
+141.5 (c 0.2, CH2Cl2, 
77% ee); mp 42–44 °C; δH (400 MHz, CDCl3) 7.61–7.57 (2H, m, ArH), 7.31–7.27 (2H, m, 
ArH), 7.19–7.14 (1H, m, ArH-4), 7.09–7.00 (4H, m, ArH), 5.86 (1H, s, furanH-4) and 1.71 (3H, 
s, CH3); δC (100 MHz, CDCl3) 174.2 (butenolide C=O), 165.9 (COOPh), 163.9 (d, J 250, 
FArC-1), 153.8 (OPhC-1), 150.3 (furanC-5), 129.5 (PhCH), 127.4 (d, J 9, FArCH-3,5), 126.5 
(PhCH), 123.8 (d, J 3, FArC-4), 121.1 (PhCH), 116.1 (d, J 22, FArCH-2,6), 103.4 (d, J 2, 
C=CH), 56.0 (C-3) and 20.4 (CH3); m/z MS (ESI+) 330 (100, [M+NH4]+); HRMS (ESI+) 
C18H13FO4+ ([M+NH4]+) requires 330.1136, found 330.1139 (+0.9 ppm); IR νmax (KBr) 3119, 
3073, 2925 (C-H), 2854, 1805 (C=O), 1769, 1741 (C=O), 1653, 1601, 1510.  
Enantiomeric excesses determined by chiral HPLC: Chiralpak AS-H (5% IPA:hexane, flow rate 
1 mL min-1) tR(R): 12.7 min, tR(S): 17.0 min, 77% ee. 
Phenyl 2-(4-fluorophenyl)-4-methyl-5-oxo-2,5-dihydrofuran-2-carboxylate 559 
 
 
Following general procedure H, carbonate 479 (100 mg, 0.320 mmol), triazolium salt 128 
(8.75 mg, 32.0 µmol), KHMDS (57.6 µL, 28.8 µmol) and THF (1 mL) gave, after 5 min and 
chromatographic purification (100% CH2Cl2), the product as a colourless oil (67.0 mg, 67%); δH 
(400 MHz, CDCl3) 7.54–7.48 (3H, m, C=CH and ArH); 7.30–7.25 (2H, m, ArH), 7.18–7.14 (1H, 
m, ArH-4), 7.08–7.03 (2H, m, ArH), 6.95–6.92 (2H, m, ArH) and 1.95 (3H, s, CH3); δC 
(100 MHz, CDCl3) 171.8 (C=O); 166.0 (C=O), 163.2 (d, J 248.2, FArC-1), 150.2 (OPhC-1), 
146.2 (C=CH), 131.2 (ArC), 131.2 (CH=C), 129.6 (ArCH), 128.0 (d, J 8.3, FArCH-3), 126.6 
(ArCH), 120.9 (ArCH), 116.1 (d, J 22.2, FArCH-2), 86.9 (OC(COOPh)) and 10.8 (CH3); m/z 
MS (ESI+) 318 (100, [M+NH4]+); HRMS (ESI+) C17H20O3NS+ ([M+NH4]+) requires 318.1158, 
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found 318.1161 (+0.8 ppm); IR νmax (thin film) 3532, 3084, 2960 (C-H), 1770 (br, 2 × C=O), 
1660 (C=C), 1603 and 1509. 
5-Methyl-3-phenylfuran-2-yl phenyl carbonate 487 
 
 
To a cooled (0 ºC) solution of diisopropylamine (0.890 mL, 6.30 mmol) in THF (10 mL) was 
added n-BuLi (2.64 mL of a 2.5 M solution in hexanes, 6.60 mmol). After 20 min at 0 °C, the 
LDA solution was cooled to -78 °C, and a solution of the butyrolactone 484i (1.06 g, 6.00 mmol) 
in THF (2 mL) was added. The reaction temperature was maintained at -78 °C for 30 min, and a 
solution of phenylselenenyl chloride (1.72 g, 9.00 mmol) in THF (5 mL) was added. The 
resultant mixture was slowly allowed to warm to ambient temperature (over 2 h), diluted with 
EtOAc (50 mL), washed with NH4Cl(aq) (20 mL), dried (Na2SO4), filtered and concentrated 
in vacuo. Chromatographic purification (7.5% → 10% Et2O:petrol) gave the selanyl intermediate 
485 as a colourless solid, which was used immediately without characterisation. To a cooled 
(0 °C) solution of the phenylselanyl intermediate 485 in CHCl3 (10 mL) was added mCPBA 
(70% purity, 2.22 g, 9.00 mmol) portionwise at 0 °C and the mixture was allowed to warm to 
ambient temperature over 3 h or until TLC indicated the reaction was complete. A further 
portion of CHCl3 (10mL) was added along with 5% Na2CO3(aq) (20 mL). The layers were 
separated, the organic phase was washed with 5% Na2CO3(aq) (20mL), dried (Na2SO4), filtered 
and concentrated in vacuo. Chromatographic purification (25% Et2O:petrol) gave the butenolide 
486 as a colourless solid (418 mg, 40%). mp 45–46 °C, lit.208 45–46 °C; δH (400 MHz, CDCl3) 
7.85 (2H, dd, J 8.0, 1.6, PhH), 7.54 (1H, d, J 1.8, =CH), 7.44–7.38 (3H, m, PhH), 5.15 (1H, qd, 
J 6.8, 1.8, OCH) and 1.51 (3H, d, J 6.8, CH3). Data are in accordance with the literature.208 
To a cooled (-78 ºC) solution of butenolide 486 (50.0 mg, 0.287 mmol) in THF (2 mL) was 
added KHMDS (0.636 mL of a 0.5 M solution in toluene, 0.318 mmol) dropwise and the mixture 
was stirred for 30 min, turning an intense red/orange colour. Phenyl chloroformate (37.8 µL, 
0.301 mmol) was added in one portion and the mixture allowed to warm to ambient temperature 
over 2 h. The mixture was quenched with sat NH4Cl(aq) (10 mL) and extracted with Et2O 
(10 mL × 3), then dried (MgSO4), filtered and concentrated in vacuo to afford a suspension. To 
the suspension was added petrol (10 mL) and Et2O (2 mL), and the filtrate was cooled (+5 ºC, 
refrigerator) for 16 h to afford the recrystallised product 487 as a colourless solid (49.8 mg, 
                                                 
i
 Kindly donated by Louis Morrill. 
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53%). mp 72–73 ºC; δH (300 MHz, CDCl3) 7.57–7.54 (2H, m, PhH), 7.47–7.41 (4H, m, PhH), 
7.34–7.27 (4H, m, PhH), 6.33 (br q, J 1.0, furanH-4) and 2.36 (3H, d, J 1.0 Hz, CH3); δC 
(75 MHz, CDCl3) 151.0 (OPhC-1), 150.7 (C=O), 146.4 (furanC-5), 144.3(furanC-2), 131.2 
(CPhC-1), 129.8 (PhCH), 128.9 (OPhC-1), 127.0 (PhCH-4), 126.8 (PhCH-4), 126.5 (PhCH), 
120.8 (PhCH), 109.0 (furanC-3), 106.8 (furanCH-4) and 13.7 (CH3); IR νmax (KBr) 3050, 2936 
(C-H), 1790 (C=O), 1658 (Ar C=C), 1586, 1555 and 1201 (C-O); Structure confirmed by X-ray 
crystallographic analysis (see Appendix).  
NB. MS analysis could not be obtained due to the instability of the carbonate 487. 
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Chapter 9: Appendix 
X-ray crystallographic data 
Crystal data and structure refinement for 469 
 
 
Identification code  469 (Reference code: ccas11) 
Empirical formula  C23 H20 O2 S 
Formula weight  360.45 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  Pbca 
Unit cell dimensions a = 11.2854(18) Å α= 90°. 
 b = 16.089(3) Å β= 90°. 
 c = 20.401(3) Å γ = 90°. 
Volume 3704.2(10) Å3 
Z 8 
Density (calculated) 1.293 Mg/m3 
Absorption coefficient 0.189 mm-1 
F(000) 1520 
Crystal size 0.20 × 0.20 × 0.20 mm3 
Theta range for data collection 2.42 to 25.34°. 
Index ranges -13<=h<=13, -19<=k<=19, -24<=l<=24 
Reflections collected 33533 
Independent reflections 3329 [R(int) = 0.0825] 
Completeness to theta = 25.00° 97.9 %  
Absorption correction Multiscan 
Max. and min. transmission 1.000 and 0.9632 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3329 / 0 / 235 
Goodness-of-fit on F2 1.175 
Final R indices [I>2sigma(I)] R1 = 0.0525, wR2 = 0.1846 
R indices (all data) R1 = 0.0607, wR2 = 0.2161 
Largest diff. peak and hole 0.520 and -0.513 e.Å-3 
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Table 33: Atomic coordinates (×104) and equivalent isotropic displacement parameters (Å2 × 103) for 469. U(eq) is 
defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O(1) 6434(1) 3493(1) 985(1) 18(1) 
C(2) 5740(2) 2953(1) 657(1) 17(1) 
O(2) 4678(1) 2970(1) 709(1) 21(1) 
C(3) 6497(2) 2366(1) 239(1) 17(1) 
C(4) 7745(2) 2515(1) 502(1) 17(1) 
C(5) 7694(2) 3368(2) 838(1) 18(1) 
S(3) 5969(1) 1296(1) 309(1) 20(1) 
C(6) 6354(2) 1043(2) 1129(1) 24(1) 
C(7) 7387(2) 577(2) 1240(2) 35(1) 
C(8) 7712(3) 379(2) 1872(2) 51(1) 
C(9) 7027(4) 636(2) 2390(2) 62(1) 
C(10) 5989(3) 1100(2) 2289(2) 49(1) 
C(11) 5651(3) 1299(2) 1651(1) 32(1) 
C(12) 6331(2) 2582(2) -499(1) 18(1) 
C(13) 6544(2) 3493(2) -654(1) 19(1) 
C(14) 5600(2) 4048(2) -664(1) 24(1) 
C(15) 5792(2) 4890(2) -776(1) 27(1) 
C(16) 6930(2) 5187(2) -879(1) 27(1) 
C(17) 7871(2) 4634(2) -875(1) 26(1) 
C(18) 7682(2) 3793(2) -773(1) 22(1) 
C(19) 8396(2) 3429(1) 1461(1) 19(1) 
C(20) 8016(2) 3048(2) 2036(1) 26(1) 
C(21) 8683(2) 3113(2) 2606(1) 31(1) 
C(22) 9744(2) 3544(2) 2603(1) 31(1) 
C(23) 10139(2) 3907(2) 2031(1) 30(1) 
C(24) 9462(2) 3857(2) 1463(1) 22(1) 
________________________________________________________________________________ 
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Table 34: Bond lengths [Å] and angles [°] for 469 
_____________________________________________________  
O(1)-C(2)  1.347(3) 
O(1)-C(5)  1.468(3) 
C(2)-O(2)  1.203(3) 
C(2)-C(3)  1.533(3) 
C(3)-C(4)  1.526(3) 
C(3)-C(12)  1.556(3) 
C(3)-S(3)  1.829(2) 
C(4)-C(5)  1.535(3) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-C(19)  1.501(3) 
C(5)-H(5A)  1.0000 
S(3)-C(6)  1.775(3) 
C(6)-C(11)  1.392(4) 
C(6)-C(7)  1.404(4) 
C(7)-C(8)  1.378(5) 
C(7)-H(7A)  0.9500 
C(8)-C(9)  1.373(6) 
C(8)-H(8A)  0.9500 
C(9)-C(10)  1.404(6) 
C(9)-H(9A)  0.9500 
C(10)-C(11)  1.392(4) 
C(10)-H(10A)  0.9500 
C(11)-H(11A)  0.9500 
C(12)-C(13)  1.518(3) 
C(12)-H(12A)  0.9900 
C(12)-H(12B)  0.9900 
C(13)-C(14)  1.391(4) 
C(13)-C(18)  1.393(3) 
C(14)-C(15)  1.390(4) 
C(14)-H(14A)  0.9500 
C(15)-C(16)  1.386(4) 
C(15)-H(15A)  0.9500 
C(16)-C(17)  1.385(4) 
C(16)-H(16A)  0.9500 
C(17)-C(18)  1.386(4) 
C(17)-H(17A)  0.9500 
C(18)-H(18A)  0.9500 
C(19)-C(24)  1.387(3) 
C(19)-C(20)  1.392(3) 
C(20)-C(21)  1.389(4) 
C(20)-H(20A)  0.9500 
C(21)-C(22)  1.383(4) 
C(21)-H(21A)  0.9500 
C(22)-C(23)  1.379(4) 
C(22)-H(22A)  0.9500 
C(23)-C(24)  1.389(4) 
C(23)-H(23A)  0.9500 
C(24)-H(24A)  0.9500 
 
C(2)-O(1)-C(5) 111.95(17) 
O(2)-C(2)-O(1) 121.4(2) 
O(2)-C(2)-C(3) 128.1(2) 
O(1)-C(2)-C(3) 110.46(18) 
C(4)-C(3)-C(2) 102.81(18) 
C(4)-C(3)-C(12) 114.66(19) 
C(2)-C(3)-C(12) 109.50(18) 
C(4)-C(3)-S(3) 114.91(16) 
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C(2)-C(3)-S(3) 110.79(15) 
C(12)-C(3)-S(3) 104.25(15) 
C(3)-C(4)-C(5) 105.26(17) 
C(3)-C(4)-H(4A) 110.7 
C(5)-C(4)-H(4A) 110.7 
C(3)-C(4)-H(4B) 110.7 
C(5)-C(4)-H(4B) 110.7 
H(4A)-C(4)-H(4B) 108.8 
O(1)-C(5)-C(19) 109.30(18) 
O(1)-C(5)-C(4) 104.46(17) 
C(19)-C(5)-C(4) 114.65(19) 
O(1)-C(5)-H(5A) 109.4 
C(19)-C(5)-H(5A) 109.4 
C(4)-C(5)-H(5A) 109.4 
C(6)-S(3)-C(3) 102.09(11) 
C(11)-C(6)-C(7) 120.5(3) 
C(11)-C(6)-S(3) 121.0(2) 
C(7)-C(6)-S(3) 118.5(2) 
C(8)-C(7)-C(6) 119.7(3) 
C(8)-C(7)-H(7A) 120.1 
C(6)-C(7)-H(7A) 120.1 
C(9)-C(8)-C(7) 120.0(3) 
C(9)-C(8)-H(8A) 120.0 
C(7)-C(8)-H(8A) 120.0 
C(8)-C(9)-C(10) 121.1(3) 
C(8)-C(9)-H(9A) 119.4 
C(10)-C(9)-H(9A) 119.4 
C(11)-C(10)-C(9) 119.2(3) 
C(11)-C(10)-H(10A) 120.4 
C(9)-C(10)-H(10A) 120.4 
C(10)-C(11)-C(6) 119.4(3) 
C(10)-C(11)-H(11A) 120.3 
C(6)-C(11)-H(11A) 120.3 
C(13)-C(12)-C(3) 113.42(19) 
C(13)-C(12)-H(12A) 108.9 
C(3)-C(12)-H(12A) 108.9 
C(13)-C(12)-H(12B) 108.9 
C(3)-C(12)-H(12B) 108.9 
H(12A)-C(12)-H(12B) 107.7 
C(14)-C(13)-C(18) 118.8(2) 
C(14)-C(13)-C(12) 120.1(2) 
C(18)-C(13)-C(12) 121.1(2) 
C(15)-C(14)-C(13) 120.6(2) 
C(15)-C(14)-H(14A) 119.7 
C(13)-C(14)-H(14A) 119.7 
C(16)-C(15)-C(14) 120.4(2) 
C(16)-C(15)-H(15A) 119.8 
C(14)-C(15)-H(15A) 119.8 
C(17)-C(16)-C(15) 119.2(2) 
C(17)-C(16)-H(16A) 120.4 
C(15)-C(16)-H(16A) 120.4 
C(16)-C(17)-C(18) 120.7(2) 
C(16)-C(17)-H(17A) 119.7 
C(18)-C(17)-H(17A) 119.7 
C(17)-C(18)-C(13) 120.4(2) 
C(17)-C(18)-H(18A) 119.8 
C(13)-C(18)-H(18A) 119.8 
C(24)-C(19)-C(20) 119.0(2) 
C(24)-C(19)-C(5) 119.5(2) 
C(20)-C(19)-C(5) 121.5(2) 
C(21)-C(20)-C(19) 120.3(2) 
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C(21)-C(20)-H(20A) 119.8 
C(19)-C(20)-H(20A) 119.8 
C(22)-C(21)-C(20) 120.2(2) 
C(22)-C(21)-H(21A) 119.9 
C(20)-C(21)-H(21A) 119.9 
C(21)-C(22)-C(23) 119.7(2) 
C(21)-C(22)-H(22A) 120.1 
C(23)-C(22)-H(22A) 120.1 
C(22)-C(23)-C(24) 120.3(2) 
C(22)-C(23)-H(23A) 119.9 
C(24)-C(23)-H(23A) 119.9 
C(23)-C(24)-C(19) 120.5(2) 
C(23)-C(24)-H(24A) 119.8 
C(19)-C(24)-H(24A) 119.8 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table 35: Anisotropic displacement parameters (Å2 × 103) for 469. The anisotropic displacement factor exponent 
takes the form: -2pi2[ h2 a*2U11 + ...  + 2 h k a* b* U12] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 13(1)  24(1) 18(1)  -4(1) -1(1)  1(1) 
C(2) 16(1)  22(1) 12(1)  3(1) -2(1)  1(1) 
O(2) 14(1)  28(1) 22(1)  -2(1) -1(1)  2(1) 
C(3) 14(1)  19(1) 19(1)  -1(1) 1(1)  0(1) 
C(4) 13(1)  22(1) 17(1)  -1(1) -1(1)  2(1) 
C(5) 12(1)  23(1) 18(1)  0(1) 0(1)  0(1) 
S(3) 20(1)  21(1) 19(1)  -1(1) -1(1)  -2(1) 
C(6) 25(1)  23(1) 24(1)  6(1) -4(1)  -6(1) 
C(7) 27(1)  28(1) 49(2)  12(1) -9(1)  -7(1) 
C(8) 48(2)  44(2) 61(2)  25(2) -29(2)  -13(2) 
C(9) 83(3)  57(2) 45(2)  26(2) -41(2)  -34(2) 
C(10) 72(2)  50(2) 24(2)  9(1) -4(1)  -29(2) 
C(11) 37(2)  37(2) 23(1)  4(1) -2(1)  -10(1) 
C(12) 16(1)  23(1) 15(1)  -1(1) 0(1)  0(1) 
C(13) 21(1)  25(1) 11(1)  0(1) -2(1)  -2(1) 
C(14) 18(1)  33(1) 21(1)  4(1) 2(1)  3(1) 
C(15) 31(1)  23(1) 28(1)  4(1) 2(1)  6(1) 
C(16) 39(2)  20(1) 24(1)  1(1) -1(1)  -4(1) 
C(17) 24(1)  31(1) 24(1)  3(1) -2(1)  -6(1) 
C(18) 19(1)  28(1) 18(1)  3(1) 0(1)  2(1) 
C(19) 17(1)  21(1) 18(1)  -3(1) -2(1)  2(1) 
C(20) 22(1)  34(2) 22(1)  4(1) -1(1)  -3(1) 
C(21) 34(1)  39(2) 20(1)  7(1) -3(1)  2(1) 
C(22) 30(1)  40(2) 22(1)  -7(1) -11(1)  4(1) 
C(23) 21(1)  38(2) 30(1)  -7(1) -6(1)  -4(1) 
C(24) 20(1)  26(1) 20(1)  -2(1) 0(1)  -1(1) 
______________________________________________________________________________ 
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Table 36: Hydrogen coordinates (× 104) and isotropic displacement parameters (Å2 × 103) for 469 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(4A) 8329 2518 140 21 
H(4B) 7968 2077 820 21 
H(5A) 7968 3806 525 21 
H(7A) 7860 400 881 42 
H(8A) 8410 64 1949 61 
H(9A) 7259 499 2824 74 
H(10A) 5522 1275 2651 59 
H(11A) 4946 1607 1574 39 
H(12A) 6884 2240 -762 22 
H(12B) 5514 2434 -632 22 
H(14A) 4817 3851 -594 29 
H(15A) 5140 5263 -782 33 
H(16A) 7063 5763 -951 33 
H(17A) 8654 4834 -942 32 
H(18A) 8333 3418 -784 26 
H(20A) 7296 2741 2039 31 
H(21A) 8410 2861 2999 37 
H(22A) 10199 3589 2993 37 
H(23A) 10876 4192 2025 35 
H(24A) 9732 4119 1073 26 
________________________________________________________________________________ 
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Table 37: Torsion angles [°] for 469 
________________________________________________________________  
C(5)-O(1)-C(2)-O(2) -178.9(2) 
C(5)-O(1)-C(2)-C(3) 0.7(2) 
O(2)-C(2)-C(3)-C(4) -167.2(2) 
O(1)-C(2)-C(3)-C(4) 13.2(2) 
O(2)-C(2)-C(3)-C(12) 70.5(3) 
O(1)-C(2)-C(3)-C(12) -109.1(2) 
O(2)-C(2)-C(3)-S(3) -43.9(3) 
O(1)-C(2)-C(3)-S(3) 136.46(16) 
C(2)-C(3)-C(4)-C(5) -21.0(2) 
C(12)-C(3)-C(4)-C(5) 97.8(2) 
S(3)-C(3)-C(4)-C(5) -141.46(16) 
C(2)-O(1)-C(5)-C(19) -137.47(19) 
C(2)-O(1)-C(5)-C(4) -14.3(2) 
C(3)-C(4)-C(5)-O(1) 21.8(2) 
C(3)-C(4)-C(5)-C(19) 141.44(19) 
C(4)-C(3)-S(3)-C(6) 46.54(19) 
C(2)-C(3)-S(3)-C(6) -69.42(18) 
C(12)-C(3)-S(3)-C(6) 172.88(15) 
C(3)-S(3)-C(6)-C(11) 80.3(2) 
C(3)-S(3)-C(6)-C(7) -99.7(2) 
C(11)-C(6)-C(7)-C(8) -0.6(4) 
S(3)-C(6)-C(7)-C(8) 179.4(2) 
C(6)-C(7)-C(8)-C(9) 0.0(5) 
C(7)-C(8)-C(9)-C(10) 0.2(5) 
C(8)-C(9)-C(10)-C(11) 0.1(5) 
C(9)-C(10)-C(11)-C(6) -0.7(4) 
C(7)-C(6)-C(11)-C(10) 0.9(4) 
S(3)-C(6)-C(11)-C(10) -179.1(2) 
C(4)-C(3)-C(12)-C(13) -62.1(3) 
C(2)-C(3)-C(12)-C(13) 52.8(3) 
S(3)-C(3)-C(12)-C(13) 171.42(16) 
C(3)-C(12)-C(13)-C(14) -93.7(3) 
C(3)-C(12)-C(13)-C(18) 84.8(3) 
C(18)-C(13)-C(14)-C(15) -1.5(4) 
C(12)-C(13)-C(14)-C(15) 177.1(2) 
C(13)-C(14)-C(15)-C(16) 0.0(4) 
C(14)-C(15)-C(16)-C(17) 0.6(4) 
C(15)-C(16)-C(17)-C(18) 0.3(4) 
C(16)-C(17)-C(18)-C(13) -1.9(4) 
C(14)-C(13)-C(18)-C(17) 2.4(4) 
C(12)-C(13)-C(18)-C(17) -176.1(2) 
O(1)-C(5)-C(19)-C(24) -137.9(2) 
C(4)-C(5)-C(19)-C(24) 105.2(3) 
O(1)-C(5)-C(19)-C(20) 43.7(3) 
C(4)-C(5)-C(19)-C(20) -73.2(3) 
C(24)-C(19)-C(20)-C(21) 1.5(4) 
C(5)-C(19)-C(20)-C(21) 179.9(2) 
C(19)-C(20)-C(21)-C(22) -1.3(4) 
C(20)-C(21)-C(22)-C(23) -0.2(4) 
C(21)-C(22)-C(23)-C(24) 1.5(4) 
C(22)-C(23)-C(24)-C(19) -1.3(4) 
C(20)-C(19)-C(24)-C(23) -0.1(4) 
C(5)-C(19)-C(24)-C(23) -178.6(2) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Crystal data and structure refinement for 487 
 
 
Identification code  487 (Reference code: ccas12) 
Empirical formula  C18 H14 O4 
Formula weight  294.29 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 5.5181(18) Å α= 90°. 
 b = 16.785(5) Å β= 92.690(9)°. 
 c = 15.844(4) Å γ = 90°. 
Volume 1466.0(8) Å3 
Z 4 
Density (calculated) 1.333 Mg/m3 
Absorption coefficient 0.094 mm-1 
F(000) 616 
Crystal size 0.20 × 0.20 × 0.20 mm3 
Theta range for data collection 2.43 to 25.34°. 
Index ranges -5<=h<=6, -20<=k<=15, -18<=l<=19 
Reflections collected 9188 
Independent reflections 2645 [R(int) = 0.0527] 
Completeness to theta = 25.00° 98.7 %  
Absorption correction Multiscan 
Max. and min. transmission 1.000 and 0.944 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2645 / 0 / 201 
Goodness-of-fit on F2 1.093 
Final R indices [I>2sigma(I)] R1 = 0.0552, wR2 = 0.1406 
R indices (all data) R1 = 0.0724, wR2 = 0.1555 
Extinction coefficient 0.018(3) 
Largest diff. peak and hole 0.241 and -0.224 e.Å-3 
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Table 38: Atomic coordinates (× 104) and equivalent isotropic displacement parameters (Å2 × 103) for 487. U(eq) is 
defined as one third of the trace of the orthogonalised Uij tensor 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O(1) 11637(3) 932(1) 10394(1) 47(1) 
O(7) 8568(3) 3072(1) 9309(1) 37(1) 
O(2) 9136(3) 1969(1) 9972(1) 40(1) 
O(6) 11944(3) 2953(1) 10181(1) 41(1) 
C(2) 10198(4) 1540(1) 10632(1) 39(1) 
C(3) 10050(4) 1605(1) 11477(1) 35(1) 
C(4) 11555(4) 967(1) 11801(1) 40(1) 
C(5) 12459(5) 573(1) 11149(1) 46(1) 
C(6) 10116(4) 2705(1) 9856(1) 34(1) 
C(8) 9111(4) 3869(1) 9089(1) 33(1) 
C(9) 7462(4) 4439(1) 9301(1) 36(1) 
C(10) 7848(4) 5217(1) 9050(1) 38(1) 
C(11) 9844(4) 5409(1) 8594(1) 36(1) 
C(12) 11446(4) 4820(1) 8385(1) 40(1) 
C(13) 11094(4) 4040(1) 8629(1) 40(1) 
C(14) 8754(4) 2209(1) 11951(1) 33(1) 
C(15) 9720(4) 2466(1) 12735(1) 34(1) 
C(16) 8511(4) 3023(1) 13200(1) 39(1) 
C(17) 6315(4) 3336(1) 12892(1) 45(1) 
C(18) 5346(4) 3087(1) 12112(1) 43(1) 
C(19) 6538(4) 2527(1) 11648(1) 39(1) 
C(20) 14054(6) -125(2) 11076(2) 63(1) 
________________________________________________________________________________ 
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Table 39: Bond lengths [Å] and angles [°] for 487 
_____________________________________________________  
O(1)-C(2)  1.357(2) 
O(1)-C(5)  1.395(2) 
O(7)-C(6)  1.339(2) 
O(7)-C(8)  1.417(2) 
O(2)-C(6)  1.364(2) 
O(2)-C(2)  1.378(2) 
O(6)-C(6)  1.186(2) 
C(2)-C(3)  1.349(3) 
C(3)-C(4)  1.435(3) 
C(3)-C(14)  1.468(3) 
C(4)-C(5)  1.342(3) 
C(4)-H(4)  0.9500 
C(5)-C(20)  1.473(3) 
C(8)-C(9)  1.373(3) 
C(8)-C(13)  1.374(3) 
C(9)-C(10)  1.385(3) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.383(3) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.377(3) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.381(3) 
C(12)-H(12)  0.9500 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.397(3) 
C(14)-C(19)  1.398(3) 
C(15)-C(16)  1.381(3) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.389(3) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.387(3) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.380(3) 
C(18)-H(18)  0.9500 
C(19)-H(19)  0.9500 
C(20)-H(20A)  0.9800 
C(20)-H(20B)  0.9800 
C(20)-H(20C)  0.9800 
 
C(2)-O(1)-C(5) 104.95(15) 
C(6)-O(7)-C(8) 117.27(15) 
C(6)-O(2)-C(2) 114.70(16) 
C(3)-C(2)-O(1) 113.51(17) 
C(3)-C(2)-O(2) 131.89(19) 
O(1)-C(2)-O(2) 114.59(16) 
C(2)-C(3)-C(4) 103.52(17) 
C(2)-C(3)-C(14) 128.08(18) 
C(4)-C(3)-C(14) 128.33(18) 
C(5)-C(4)-C(3) 108.79(18) 
C(5)-C(4)-H(4) 125.6 
C(3)-C(4)-H(4) 125.6 
C(4)-C(5)-O(1) 109.22(18) 
C(4)-C(5)-C(20) 134.22(19) 
O(1)-C(5)-C(20) 116.57(18) 
O(6)-C(6)-O(7) 128.54(18) 
O(6)-C(6)-O(2) 126.45(18) 
O(7)-C(6)-O(2) 105.01(17) 
C(9)-C(8)-C(13) 122.51(18) 
Chapter 9: Appendix 
 
227 
C(9)-C(8)-O(7) 116.59(17) 
C(13)-C(8)-O(7) 120.70(17) 
C(8)-C(9)-C(10) 118.35(19) 
C(8)-C(9)-H(9) 120.8 
C(10)-C(9)-H(9) 120.8 
C(11)-C(10)-C(9) 120.44(19) 
C(11)-C(10)-H(10) 119.8 
C(9)-C(10)-H(10) 119.8 
C(12)-C(11)-C(10) 119.59(19) 
C(12)-C(11)-H(11) 120.2 
C(10)-C(11)-H(11) 120.2 
C(11)-C(12)-C(13) 120.90(19) 
C(11)-C(12)-H(12) 119.5 
C(13)-C(12)-H(12) 119.5 
C(8)-C(13)-C(12) 118.19(19) 
C(8)-C(13)-H(13) 120.9 
C(12)-C(13)-H(13) 120.9 
C(15)-C(14)-C(19) 118.53(19) 
C(15)-C(14)-C(3) 119.59(18) 
C(19)-C(14)-C(3) 121.87(18) 
C(16)-C(15)-C(14) 120.7(2) 
C(16)-C(15)-H(15) 119.7 
C(14)-C(15)-H(15) 119.7 
C(15)-C(16)-C(17) 120.2(2) 
C(15)-C(16)-H(16) 119.9 
C(17)-C(16)-H(16) 119.9 
C(18)-C(17)-C(16) 119.6(2) 
C(18)-C(17)-H(17) 120.2 
C(16)-C(17)-H(17) 120.2 
C(19)-C(18)-C(17) 120.4(2) 
C(19)-C(18)-H(18) 119.8 
C(17)-C(18)-H(18) 119.8 
C(18)-C(19)-C(14) 120.6(2) 
C(18)-C(19)-H(19) 119.7 
C(14)-C(19)-H(19) 119.7 
C(5)-C(20)-H(20A) 109.5 
C(5)-C(20)-H(20B) 109.5 
H(20A)-C(20)-H(20B) 109.5 
C(5)-C(20)-H(20C) 109.5 
H(20A)-C(20)-H(20C) 109.5 
H(20B)-C(20)-H(20C) 109.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Table 40: Anisotropic displacement parameters (Å2 × 103) for 487. The anisotropic displacement factor exponent 
takes the form: -2pi2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 73(1)  33(1) 34(1)  2(1) -2(1)  13(1) 
O(7) 45(1)  30(1) 36(1)  5(1) -9(1)  1(1) 
O(2) 55(1)  30(1) 34(1)  5(1) -9(1)  0(1) 
O(6) 47(1)  36(1) 39(1)  3(1) -11(1)  1(1) 
C(2) 52(1)  29(1) 34(1)  3(1) -7(1)  3(1) 
C(3) 41(1)  30(1) 35(1)  4(1) -3(1)  -2(1) 
C(4) 52(1)  32(1) 34(1)  7(1) -5(1)  5(1) 
C(5) 68(2)  33(1) 36(1)  7(1) -2(1)  12(1) 
C(6) 46(1)  30(1) 28(1)  0(1) -2(1)  4(1) 
C(8) 40(1)  27(1) 30(1)  2(1) -6(1)  -1(1) 
C(9) 39(1)  38(1) 31(1)  4(1) 3(1)  5(1) 
C(10) 44(1)  35(1) 36(1)  1(1) 3(1)  8(1) 
C(11) 41(1)  32(1) 35(1)  2(1) -4(1)  2(1) 
C(12) 35(1)  42(1) 42(1)  7(1) 4(1)  4(1) 
C(13) 42(1)  37(1) 41(1)  -1(1) 2(1)  10(1) 
C(14) 36(1)  30(1) 33(1)  5(1) -1(1)  -2(1) 
C(15) 39(1)  29(1) 35(1)  5(1) 0(1)  -5(1) 
C(16) 49(1)  31(1) 36(1)  1(1) 5(1)  -7(1) 
C(17) 51(2)  33(1) 51(1)  6(1) 16(1)  1(1) 
C(18) 37(1)  42(1) 51(1)  16(1) 5(1)  7(1) 
C(19) 39(1)  38(1) 40(1)  9(1) -2(1)  -3(1) 
C(20) 99(2)  47(2) 44(1)  4(1) -2(1)  28(1) 
______________________________________________________________________________  
 
 
Table 41: Hydrogen coordinates ( × 104) and isotropic displacement parameters (Å2 × 10 3) for 487 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(4) 11860 843 12381 47 
H(9) 6091 4303 9612 43 
H(10) 6736 5622 9193 46 
H(11) 10107 5944 8425 43 
H(12) 12812 4952 8070 47 
H(13) 12193 3633 8481 48 
H(15) 11225 2257 12950 41 
H(16) 9184 3192 13733 46 
H(17) 5482 3718 13213 54 
H(18) 3852 3305 11896 52 
H(19) 5846 2355 11119 47 
H(20A) 15612 44 10863 95 
H(20B) 13287 -511 10683 95 
H(20C) 14324 -373 11632 95 
________________________________________________________________________________ 
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Table 42: Torsion angles [°] for 487 
________________________________________________________________  
C(5)-O(1)-C(2)-C(3) 0.6(2) 
C(5)-O(1)-C(2)-O(2) -178.57(18) 
C(6)-O(2)-C(2)-C(3) 74.9(3) 
C(6)-O(2)-C(2)-O(1) -106.11(19) 
O(1)-C(2)-C(3)-C(4) -0.2(2) 
O(2)-C(2)-C(3)-C(4) 178.8(2) 
O(1)-C(2)-C(3)-C(14) 177.14(19) 
O(2)-C(2)-C(3)-C(14) -3.8(4) 
C(2)-C(3)-C(4)-C(5) -0.4(3) 
C(14)-C(3)-C(4)-C(5) -177.7(2) 
C(3)-C(4)-C(5)-O(1) 0.8(3) 
C(3)-C(4)-C(5)-C(20) -179.1(3) 
C(2)-O(1)-C(5)-C(4) -0.9(3) 
C(2)-O(1)-C(5)-C(20) 179.0(2) 
C(8)-O(7)-C(6)-O(6) -1.4(3) 
C(8)-O(7)-C(6)-O(2) 178.34(14) 
C(2)-O(2)-C(6)-O(6) 11.2(3) 
C(2)-O(2)-C(6)-O(7) -168.49(15) 
C(6)-O(7)-C(8)-C(9) -117.54(19) 
C(6)-O(7)-C(8)-C(13) 67.4(2) 
C(13)-C(8)-C(9)-C(10) -1.1(3) 
O(7)-C(8)-C(9)-C(10) -176.02(17) 
C(8)-C(9)-C(10)-C(11) 0.3(3) 
C(9)-C(10)-C(11)-C(12) 0.3(3) 
C(10)-C(11)-C(12)-C(13) -0.2(3) 
C(9)-C(8)-C(13)-C(12) 1.1(3) 
O(7)-C(8)-C(13)-C(12) 175.88(18) 
C(11)-C(12)-C(13)-C(8) -0.5(3) 
C(2)-C(3)-C(14)-C(15) -145.5(2) 
C(4)-C(3)-C(14)-C(15) 31.2(3) 
C(2)-C(3)-C(14)-C(19) 35.8(3) 
C(4)-C(3)-C(14)-C(19) -147.5(2) 
C(19)-C(14)-C(15)-C(16) 0.0(3) 
C(3)-C(14)-C(15)-C(16) -178.71(17) 
C(14)-C(15)-C(16)-C(17) -0.2(3) 
C(15)-C(16)-C(17)-C(18) -0.1(3) 
C(16)-C(17)-C(18)-C(19) 0.7(3) 
C(17)-C(18)-C(19)-C(14) -0.9(3) 
C(15)-C(14)-C(19)-C(18) 0.6(3) 
C(3)-C(14)-C(19)-C(18) 179.24(18) 
________________________________________________________________  
 
 
 
 
 
 
 
 
 
 
Chapter 9: Appendix 
 
230 
Representative NMR experiment for crossover studies 
e.g. Crossover experiment with phenylalanine-derived phenyl carbonate 256 (0.125 mM 
concentration) and alanine-derived naphthyl carbonate 338 (0.125 mM concentration) following 
general procedure H, using THF, Et3N and triazolium salt 128. 
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Overlaid 1H NMR spectra (400 MHz, CDCl3) of the reaction mixture (black) and all possible 
products (for colour coding, see above figure): 
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